## Kuwait National Action Plan On Antimicrobial Resistance 2022

This document was prepared by: Dr. Rima Moghnieh, MD, FRCP (WHO consultant), Dr. Abeer Aly Omar (Head of Surveillance Department, Infection Control Directorate MOH-WHO NFP AMRKuwait), Dr. Ahmed Al-Motawaa (Director of Infection Control Directorate-MOH, Coordinator of the National Committee for the Proper Use of Antimicrobials) along with professionals and stakeholders from Kuwait whose names are listed below (alphabetical order):

- 1. Ph. Alaa Al-Furaih, Pharmaceutical Services Directorate-WHO GLASS-AMC NFP -MOH
- 2. Dr. Abeer Albaho, Director of Health Promotion Department. MOH
- 3. Ph. Adel Al Salem, Director of Central Medical Stores Directorate-MOH
- 4. Ph. Abdullah Awadh Alenezi, Head of Tablet Department -Central Medical Stores Directorate MOH
- 5. Dr. Ahlam Jeragh, Head of Medical Laboratories Department Al Adan Hospital, Head of Microbiology and Virology Committee- Medical Laboratories Council MOH-WHO GLASS-AMR NFP
- 6. Dr. Ali Lairy, Senior Specialist-General Surgery-Jaber Al-Ahmed Hospital-MOH
- 7. Mrs. Anwar Ali, Environment Health department, Public Health Directorate MOH
- 8. Dr. Ayed Al-Shemmari, Director of Pharmaceutical Services Directorate- MOH
- 9. Dr. Deena Al Dhubaib, Director of Primary Healthcare Directorate -MOH
- 10. Dr. Emad Elsayed Younis, The Expertise of the national project for control of TB and Brucellosis in bovine in Kuwait
- 11. Dr. Hanan Al-Sarawi, Director of Research and Studies Office- Kuwait Environment Public authority (KEPA)
- 12. Ph. Jaber AL-Khaledi, Director of Pharmaceutical and Herbal Medicines Registration and Control Administration-MOH
- 13. Dr. Jenan Fakhra, Family Medicine Senior Registrar - Primary Healthcare Directorate MOH
- 14. Dr. Kholoud Al Fadhalah, Head of Infection Control Department. Infection Control Directorate MOH- WHO NFP IPC.
- 15. Ph. Maryam Al-Yaseen, Director of Drug Inspection Control-MOH
- 16. Dr. Mohammad Al Seaidan, Director of Public Health Directorate- MOH
- 17. Dr. Noufa Alshammari, Director of the Technical Directorate- MOH
- 18. Dr. Sarah Al-Qabandi, Head of Public Health Laboratories-Public Health Directorate MOH
- 19. Dr. Sherine Gaber, Public Health Directorate-MOH
- 20. Dr.Suad Abul, Director of Medical Licensing Department MOH
- 21. Dr. Yousef Saud Al Shridah, Director of Epidemiology and zoonosis diseases- Animal Health Department -PAAF

## Contents

| Abbreviations and acronyms                                                                     | p.4   |
|------------------------------------------------------------------------------------------------|-------|
| Foreword                                                                                       | p.6   |
| Executive summary                                                                              | p.7   |
| Background                                                                                     | p.11  |
| Introduction                                                                                   | p.11  |
| Situation analyses and Assessment                                                              | p.15  |
| Country Response and Governance Plans                                                          | p.25  |
| AMR Awareness                                                                                  |       |
| Operational and budget plan                                                                    | p.32  |
| AMR Surveillance                                                                               |       |
| Operational and budget plan                                                                    | p.52  |
| Infection prevention and Control                                                               |       |
| Operational and budget plan                                                                    | p.79  |
| Antibiotic Use                                                                                 |       |
| Operational and budget plan                                                                    | p.113 |
| References                                                                                     | p.133 |
| Annexes                                                                                        | p.136 |
| Annex 1: Governance: Strategic plan, and Monitoring and Evaluation plan                        | p.137 |
| Annex 2: AMR Awareness: Strategic plan, and Monitoring and Evaluation plan                     | p.146 |
| Annex 3: AMR Surveillance: Strategic plan, and Monitoring and Evaluation plan                  | p.173 |
| Annex 4: Infection prevention and Control: Strategic plan, and Monitoring and Evaluation  plan | p.210 |
| Annex 5: Antibiotic Use: Strategic plan, and Monitoring and Evaluation plan                    | p.258 |

## Abbreviations and acronyms

| AMC   | Antimicrobial consumption                                   |
|-------|-------------------------------------------------------------|
| AMR   | Antimicrobial resistance                                    |
| AMS   | Antimicrobial Stewardship                                   |
| CAP   | College of American Pathologists                            |
| CDC   | Centre for Disease Control                                  |
| CE    | Continuous Education                                        |
| CLSI  | Clinical and Laboratory Standards Institute                 |
| CME   | Continuous medical education                                |
| CMS   | Central Medical Stores                                      |
| CRE   | Carbapenem resistant  Enterobacteriaceae                    |
| EPA   | Environment Public Authority                                |
| ESBL  | extended-spectrum beta-lactamases                           |
| FAO   | Food and Agriculture Organization                           |
| GLASS | Global Antimicrobial Resistance and Use Surveillance System |
| HAI   | Healthcare -associated infection                            |
| HCWs  | Healthcare workers                                          |
| HIS   | Hospital Information System                                 |
| ICD   | Infection Control Directorate                               |
| IPC   | Infection prevention and control                            |
| KEPA  | Kuwait Environment Public authority                         |
| KIMS  | Kuwait Institute of Medical Specializations                 |
| KISR  | Kuwait Institute of Scientific Research                     |
| LIS   | Laboratory Information System                               |
| MDR   | Multidrug resistant                                         |
| MDROs | Multidrug resistant organisms                               |
| MOE   | Ministry of Education                                       |

| MOH  Ministry of Health                                              |
|----------------------------------------------------------------------|
| MOHE  Ministry of Higher Education                                   |
| MRSA  Methicillin resistant  Staphylococcus aureus                   |
| NAP  National Action Plan                                            |
| NFP  National Focal point                                            |
| NGOs  Non-Governmental Organizations                                 |
| NMCG  National Multisectoral Coordinating Group                      |
| OIE  World Organization of Animal Health                             |
| ToR  Terms of reference                                              |
| TOT  Training of trainers                                            |
| PAAET  The Public Authority of Applied Education and Training        |
| PAAF  The Public Authority of Agriculture Affairs and Fish Resources |
| PAFN  The Public authority for Food and nutrition                    |
| PSD  Pharmaceutical Services Directorate                             |
| WHO   World Health Organization                                      |

## Forward

This national action plan for Kuwait to combat antimicrobial resistance has been formulated in the line of  the  WHO  strategic  objectives.  It  addresses  the  involvement  of  all  the  related  sectors  including human and veterinary medicine, food chain, finance, environment, and the general public consumers. Therefore, the National Committee for the Proper Use of Antimicrobials was involved and technical subcommittees were established to prepare this plan.

## Executive summary

This national action plan for Kuwait to combat antimicrobial resistance has been formulated in the line of the WHO strategic objectives. It addresses the involvement of all the related sectors including human and veterinary medicine, agriculture, finance, environment, and the general public consumers.

The AMR NAP was prepared over a period of three months covering the governance of the plan and the structure of the work to be done in AMR awareness, surveillance, infection prevention and control, rational antimicrobial use. Research and sustainability regarding AMR were included in the corresponding pillars.

The preparation of the plan was done through meetings held by the WHO consultant and the WHO national AMR focal person at MOH (Dr. Abeer Aly) with stakeholders from the different ministries and authorities including the MOH, PAAF, and KEPA. The approach to the plan development was based on mapping the current situation regarding each pillar and then building on what is available a new plan to be executed over the coming five years.

Regarding the situation analysis, Kuwait had already started its response regarding the AMR pandemic. Regarding country response and governance, an NMCG has already been formed and an AMR focal person and IPC focal person have already been appointed and are working.

Major work on AMR prior to the plan development was concentrated on the its control in humans.

## AMR Awareness

The MOH has already started few activities that improve general public awareness about AMR in human health. Short films, advertisements, SMS, posters, brochures and leaflets have already been prepared and distributed during the activities of National campaigns of proper use of antibiotics performed by the IPC Directorate. During the past 2 years, this material is broadcasted during the World Antimicrobial Awareness Week. Education about AMR is included in some human healthrelated specialties but not in all and not in veterinary or agriculture professionals' continuous education.

Besides the organization of the f ocal persons' functions and the inter -ministerial communications, the plan targets general public awareness campaigns and yearlong awareness messages, regarding human and non-human health. AMR-related education is another target of this plan in basic primary education, undergraduate university education, postgraduate studies, as well as continuous

education of professionals. Collaboration with FAO, OIE and other regional/international NGOs that already have AMR education-related programs is strongly encouraged. Drug companies play a major role in promoting the use of antimicrobials, where both MOH and PAAF would demand in the future that these companies provide impartial education about AMR, along with its causes and consequences. The country will actively participate in the World Antimicrobial Awareness Week, however the efforts targeting AMR awareness will be spread throughout the yearly calendar.

## AMR Surveillance

Public and private hospitals have well-equipped microbiology laboratories that provide reliable microbiology data. Individual facility-based AMR surveillance is being performed in some hospitals, that do issue their own antibiograms, yet this practice is not available throughout the country. A focus group has already been created at MOH and has started gathering data to be reported to WHO GLASS platform and the AMR data bank is increasing gradually. A central AMR laboratory is not available, yet a CDC laboratory is in the process of being built and its budget has already been assigned. In non-human health sectors, there is no real tangible data about AMR except for few research projects that cannot be counted as representative to these fields.

The NAP started with an organizational effort to link hospitals to the central AMR surveillance unit at MOH, and to empower and enlarge this unit (that is the 'GLASS Unit' now) to become the national AMR surveillance unit. This unit would enable hospitals to issue their own local antibiograms to be compiled at a later stage in a national AMR report, that will be periodically reviewed and updated. A central AMR reference laboratory is planned to be present within the new CDC, where confirmation of AMR as well as training and quality control of the laboratories in the country will be organized. Broader and more active participation in GLASS platform data feeding is also anticipated in the NAP, not to mention CAP accreditation for the laboratories in the country. AMR detection and surveillance represent in the non-human health sector is a major priority of the upcoming NAP. Mapping of available AMR data in these fields is planned, as well as improving the veterinary/agriculture laboratory capacity at PAAF to detect and ultimately report and surveil AMR. AMR-related research projects in agriculture, food safety and environment will be prioritized in universities or in grants and funds through KEPA research office.

## Infection Prevention and Control

The work in the IPC pillar has been quite advanced in the country with the presence of a central IPC directorate at MOH that coordinates IPC among the different hospitals. All hospitals (public and private) already have local functioning IPC offices with the supervision and coordination by the IPC directorate at MOH. IPC guidelines are available, but some need updating. IPC training is performed centrally and locally in the hospitals. Regarding the structural basis of the IPC in Kuwait, adequate hygiene and sanitation of drinking water is available in the country as well as proper waste management is under the authority of the Ministry of Public Works. Surveillance of healthcare associated infections is well established in hospitals, however, this work is still mostly manual and thus requires important resources in terms of time and workforce. IPC in the veterinary world is applied through biosecurity measures in farms under the authority of PAAF that makes sure that animals are vaccinated according to OIE guidelines. There is an infrastructure related to the safety and quality control of products in the food chain.

Regarding the Governance in this pillar, more organization is required, whereby IPC focal persons in PAAF, KEPA and food safety authorities will be appointed. These functions will be assigned to existing employees and will be added to their TOR. This strategy was proposed by the stakeholders, since it is feasible considering the actual workload and it minimizes extra costs. Although a lot has already been done at MOH, the plan targets further improvement in IPC. In order to improve compliance with IPC principles in healthcare facilities, the plan suggests implementation of IPC through decrees and mandates. On the other hand, an update of the national IPC guidelines was suggested based on the latest WHO guidelines on core components of IPC programmed at the national and acute health care facility level.  Since digitalization of hospital data and medical records is currently in process in Kuwaiti hospitals, it was suggested that HAI surveillance be linked directly from the hospitals to IPC directorate. Additionally, availability of a digital surveillance system has been suggested to minimize paper work, improve efficiency and save time. IPC education has already been touched upon in the plan at all levels in the human and non-human health sectors including basic undergraduate and continuous postgraduate education. National IPC guidelines in non-human health sectors including animal health, agriculture and environment will be developed.

## Rational Use of Antimicrobials

The regulatory authorities of proper procurement legislation and control of importation and sale of registered medicines are well established in the country and well controlled by MOH authorities. There is a legislation that prohibit selling antimicrobials without a prescription of a certified health

## Kuwait national action plan on antimicrobial resistance 2022

professional. On the inpatient level, post-prescription review for appropriateness of antimicrobial agents 48 to 72 hours after administration is being performed in public hospitals, yet only depending on the presence of qualified personnel and ID physicians. In general, national authorities work with close communication with OIE, FAO and WHO, in addition to being part of GCC.

The organization of the governance of this pillar is one of the priorities in the upcoming NAP through assigning its responsibilities to specific focal persons in MOH, PAAF and KEPA. Other priorities include establishing inter-ministerial communication and putting a high-priority list of antimicrobials that should not be used in veterinary medicine or as crop growth promoters. In human health, antimicrobial stewardship programs in hospitals will be implemented and they are planned to be controlled at a central unit in MOH with clear national antimicrobial usage guidelines that are regularly updated according to national antibiograms and AMR epidemiologic data. In order to achieve these aims, a national task force will be appointed to include professionals from the public and private sectors with the needed academic and scientific expertise. Likewise, antimicrobial use guidelines in the agriculture and veterinary fields are to be put and implemented, and their sale would be exclusively based upon veterinary prescriptions. Finally, training courses and workshops targeting rational antimicrobial use in human and non-human health sectors should be provided periodically.

## Background

## Introduction

Antimicrobial (including antibiotic, antiviral, antifungal and antiprotozoal) agents are critical tools for fighting infectious diseases in humans, terrestrial and aquatic animals and plants, but they are becoming ineffective. 1

Alarming levels of resistance have been reported in countries of all income levels, with the result that common diseases are becoming untreatable, and lifesaving medical procedures riskier to perform. Drug-resistant infections already cause at least 700,000 deaths globally a year, including 230,000 deaths from multidrug-resistant tuberculosis, a figure that could increase to 10 million deaths globally per year by 2050 under the most alarming scenario if no action is taken. Around 2.4 million people could die in high-income countries between 2015 and 2050 without a sustained effort to contain antimicrobial resistance (AMR). 1

The emergence of AMR is a complex problem driven by many interconnected factors, in particular the use and misuse of antimicrobials. Antimicrobial use, in turn, is influenced by an interplay of the knowledge, expectations and interactions of prescribers and patients, economic incentives, characteristics of the health system and the regulatory environment. 2

AMR will affect everybody, regardless of where they live, their health, economic circumstances, lifestyle or behavior. It will affect sectors beyond human health, such as animal health, agriculture, food security and economic development. 3

In the light of this complexity, coordinated interventions are needed that simultaneously target the behavior of healthcare providers and patients and change important features of the environments in which they interact. 2

Alert to this crisis, the May 2015 World Health Assembly endorsed a global action plan to tackle AMR. All Member States are urged to have in place, national action plans on antimicrobial resistance that are aligned with the global action plan with Whole-of-society engagement including a one health approach. 3

## Situation analyses and Assessment

AMR in Kuwait is a serious problem resulting in increases in morbidity, mortality and healthcare costs. Similar to other countries, Kuwait faces challenges to combat AMR. Resistant organisms are implicated in several outbreaks in hospitals for example Methicillin resistant Staphylococcus aureus (MRSA), Multi drug resistant (MDR) Acinetobacter spp, MDR. Pseudomonas. aeruginosa and Carbapenem resistant Enterobacteriaceae (CRE).

There is no nationwide surveillance of AMR, data are available from individual studies from some hospitals. The prevalence of extended spectrum beta lactamase (ESBL) &amp; CRE isolates in positive blood cultures of patients in a teaching hospital in Kuwait over a 2-year period were studied. 24.9% of Enterobacteriaceae were ESBL producers and 5.2% were CRE. 4

There is an alarming high prevalence (11.3%) of colistin-resistant Enterobacteriaceae among healthy food handlers in community while the fecal carriage rate of CRE was (5.3%) .  According to single 5 center study, there was a high burden of Acinetobacter. baumannii (A. baumannii) related infections among Intensive care units (ICU) patients and multiple outbreaks were detected during the study period. 6

Data from Kuwait National Healthcare-associated infections surveillance system (KNHSS) 7,8 reported alarming results. The most common organisms isolated from Healthcare associated infections (HAIs) in 2019 and 2020 were Klebsiella pneumoniae( K .pneumoniae) .  In 2019 CR K.pneumoniae represented 26.7 % from all K.pneumoniae isolated  from different types of HAIs. However, in 2020 it is doubled to reach 50.1 %. A. baumannii which is the 4 th common organisms causing HAIs in both 2019 and 2020 shows increasing MDR rates. In 2019, MDR A.baumannii represented 82.9 %  and increased to reach 88.5 % in 2020.

Kuwait is a low tuberculosis (TB) incidence (~ 24 cases/100 000 population) country with low (~ 1.1%) incidence of MDR-TB. Nearly 85% of all TB cases and &gt; 90% of MDR-TB cases occur in expatriate population. These cases mainly arise due to reactivation of latent TB infection acquired previously by TB patients in their respective countries. 9,10 Until recently, rifampicin-resistant TB/MDR-TB among Kuwaiti subjects were infrequently detected and transmission of DR-TB was rarely reported in Kuwait. 11-14 A fourfold increase in the detection of MDR-TB among Kuwaiti subjects was noted in recent years (2014 -2017); however, the factors responsible for this sudden increase remained unknown and transmission of MDR-TB within Kuwait was not apparent from routine surveillance studies. 15

Kuwait has a low-prevalence of HIV-1 infection. However, the detection of major mutations conferring resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors (NNRTIs) in 12.5% of ART-naive patients, and about 30% of treatment-experienced patients. 16 Misuse of the antibiotics in the healthcare setting is a big challenge. In 2008, a national study to assess the physicians, adherence to the local hospital antibiotic guidelines was conducted in 9 Ministry of Health (MOH) hospitals. The results revealed that 25% of the prescriptions were unnecessary (not indicated) while only 30.4% of the prescriptions were fully adherent to the guidelines. 17

Misuse of antibiotics by public plays an important role in driving the emergence and dissemination of resistance. Understanding patients' knowledge and practices concerning antibiotics can help to mitigate antibiotic resistance and sustain antibiotic effectiveness. 18 Communication to public on the association between unnecessary antimicrobial use and the emergence and spread of AMR seems an important component of strategies to control AMR. 19-20 A cross-sectional survey was performed using a pretested self-administered questionnaire on a sample of 770 randomly selected Kuwaiti individuals. Nearly three-quarters (72.8%) of respondents had been prescribed antibiotics within 12 months prior to the study period, and 36% of them had not finished the course of treatment. Over one-quarter (27.5%) were self-medicated with antibiotics to treat mainly common cold, sore throat and cough. Self-medication was more prevalent among those who were prescribed antibiotics and those who had attitudes towards using and accessing antibiotic inappropriately. Almost 47% of participants had low knowledge regarding action, use, safety and resistance of antibiotics. Forty one percent of respondents had attitudes towards using and accessing antibiotic inappropriately. 21 During the activities of Kuwait National Campaign for the Proper Use of Antimicrobials 2019, assessment of the level of knowledge, attitudes and practices towards antibiotic use among public attending Kuwait MOH Healthcare facilities was performed by using a questionnaire. The results revealed insufficient knowledge regarding the antibiotic utilization (median knowledge score was 60%, IQR=80-40) with poor attitude (median attitude score was 40%, IQR=60-20) however, the practice was better (median practice score was 77.8%, IQR= 88.9-55.6) 22

The environmental dimension of antimicrobial resistance has received comparatively less focus than AMR in human or animal health. However, the natural environment is an important reservoir of antimicrobial resistance. Drug-resistant microbes are in people, animals, food, and the environment (in water, soil and air) 23 . Due to demographic and environmental factors, the marine environment of the Gulf Cooperation Council (GCC) region may be particularly susceptible to the threat of antimicrobial resistance. However, there is currently little information on the presence of AMR in the GCC marine environment to inform the design of appropriate targeted surveillance activities. To date no studies have addressed the issue of AMR in marine systems, which represents a key data gap in Kuwait. A baseline survey that is the first to obtain information on the prevalence of AMR within bacterial isolates collected from Kuwait's marine environment. In GCC, the studies have identified the presence of AMR bacteria in fish and seawater collected from locations close to sewage discharges 24 and within the effluent itself 25 . The presence of AMR bacteria has also been used as an indicator to monitor the exposure of green turtles (Chelonia mydas) to different marine pollutants 26

Recently, a study objective was to develop 27 , implement and conduct a rapid regional baseline monitoring survey of the presence of AMR in the GCC marine environment, through the analysis of seawater collected from high-risk areas across four GCC states: (Bahrain, Oman, Kuwait, and the United Arab Emirates). 560 Escherichia coli strains were analyzed as part of this monitoring programme between December 2018 and May 2019. Multi-drug resistance (resistance to three or more structural classes of antimicrobials) was observed in 32.5% of tested isolates. High levels of reduced susceptibility to ampicillin (29.6%), nalidixic acid (27.9%), tetracycline (27.5%), sulfamethoxazole (22.5%) and trimethoprim (22.5%) were observed. Reduced susceptibility to the high priority critically important antimicrobials: azithromycin (9.3%), ceftazidime (12.7%), cefotaxime (12.7%), ciprofloxacin (44.6%), gentamicin (2.7%) and tigecycline (0.5%), was also noted. A subset of 173 isolates was whole genome sequenced, and high carriage rates of qnrS1 (60/173) and blaCTX-M15 (45/173) were observed, correlating with reduced susceptibility to the fluoroquinolones and third generation cephalosporins, respectively.

A base line survey study 28 had been conducted. In total, 598 isolates of Escherichia coli (351 seawater; 247 bivalves) were isolated from seawater and biota (Venus clam, Circenita callipyga) across Kuwait coastline, and screened for their potential for resistance against an array of commonly deployed frontline antibiotics frontline (23 antibiotics) by micro-dilution (48 h incubation) onto the custom dehydrated 96well Sensititre™ GN2F panels (GN2F, Thermo Scientif ic, UK). Results demonstrate the resistant was widespread across all sites (seawater: summer 89 - 64%; winter 9057% and biota: summer 77%; winter 88%). Ranking the resistance profiles for seawater and biota across both summer and winter periods suggests that the profile of resistance may be influenced by seasonal factors. For example, in strains of E. coli isolated from winter biota samples displayed a high-level of resistance to FOX (51.4%), which then dropped substantially in samples screened from the su mmer (7.7%). Likewise, the resistance profiles between seawater and biota samples didn't always mirror each other and could point different drivers, within each matrix, being responsible for the promotion and maintenance of AMR. The dataset available doesn 't allow for definitive statements to be made about either of these subjects, but does point to future research lines to follow. This spread of observed resistances to older as well as new antibiotics, encompassing almost all tested classes and including antimicrobials used for a variety of clinical and veterinary applications is of some concern.

## National SWOT analysis as per each pillar

## Governance and multisectoral 'One Health' coordination

| Strengths     | • A national multisectoral coordinating group (NMCG) is already  established that includes high-rank influential employees and  professionals of the Kuwaiti government from all sectors.   • It has strong political support, authority to act. It is accountable to the  government. It is formed of and supported by technical experts.  • This group is responsible to facilitate and coordinate development of the  national AMR action plan, to facilitate and oversee implementation,  monitoring and evaluation of the AMR action plan, and to ensure regular  data collection and information sharing among all relevant sectors and  stakeholders.  • There are a few tools and data to form a basis for preparation of a  national action plan on AMR such HAI surveillance in hospitals, reporting  AMR to GLASS platform, as well as other audit tools for hand hygiene and  other issues related to IPC in hospital settings.   |
|---------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Weaknesses    | • Technical working groups are not available in all sectors except for a few  in human health. Relevant groups will be formed at a later stage as per  this NAP on AMR.  • Focal persons for the coordination between different ministries and  authorities regarding the 'One Health' approach are not available except  in the MOH.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Opportunities | • A preliminary draft of situation analysis (SWOT), strategic objectives,  interventions and activities for the NAP on AMR was put by the NMCG,  yet, the operational and monitoring plans are to be developed.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Threats       | • None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

## AMR Awareness

| Strengths     | • Regarding activities that target national awareness of AMR, only the  Infection Control Directorate in MOH already prepared AMR-relevant  information focusing on human health and this material is diffused to the  general public only during the AMR/ABX awareness week.  • On the public level, there was a study done by the Infection Control  Directorate about the estimation of knowledge, attitudes and practice of  the general public regarding antibiotic use in humans and the sample was  randomly selected individuals from outpatient clinics.  • Among professional in human health, workshops and educational  activities targeting AMR in human health are sometimes offered by MOH,  scientific societies, drug companies, hospitals, and universities, but it is  not regular or structured.  • Regarding the inclusion of AMR and related topics in quality assurance  programs, only IPC is included in accreditation standards of healthcare  facilities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|---------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Weaknesses    | • Regarding activities that target national awareness of AMR, public  communication programs targeting the general audiences in human  health practice, animal health practice, plant production and crops, food  chain and in the environmental sector are not available.  • Material prepared by the Infection Control Directorate MOH targeting the  general public (mentioned above) is not diffused all yearlong and does  not include AMR information based in the One Health approach.  • Education and information on AMR is not available in school curricula.  • There is a weak communication between ministries and authorities  regarding the importance of AMR, where each one works alone.  • There are no undergraduate studies/specialties in animal health and  agriculture, in Kuwait. These professionals receive their degrees and  training outside the country.  • For those who should be licensed to work in Kuwait, they should undergo  an interview and licensing exam that do not include questions related to  AMR.  • AMR and related topics in special targeted modules are only included in  undergraduate curricula in Medical Schools and not in other related  fields.  • AMR and related topics are not mandatory in continuing education  programs in any field. CE is not mandatory for obtaining work licenses for  newcomers to Kuwait or for license renewal. However, CME is needed for  promotion of physicians and dentists.  • In the veterinary/agriculture fields, there is no central structured training  for professionals by PAAF regarding AMR.  Some activities related to  antibiotic use are offered by drug companies for promotional purposes. |
| Opportunities | • A general CE program is going to be built soon for pharmacists (needs  time to expand and encompass aspects of AMR)  • In  the  veterinary/agriculture  fields,  PAAF  closely  communicates  with  FAO/OIE  and  concerned  professionals  attend  few  educational  activities/workshops organized by FAO/OIE.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

|         | • Regarding the Country participation in international or regional AMR  awareness campaigns, the IPC directorate regularly participate with the  WHO regarding human health. Otherwise in non-human health sector,  the country participates in some meetings organized by FAO or OIE  however; this is not structured or systematic. Kuwait is part of the GCC  AMR group and participates in all its activities.  • Now AMR is recognized a national priority where there will be inter- ministerial collaboration and commitment through this national action  plan to combat AMR.  • Relation between PAAF, MOH, FAO, OIE, WHO and KEPA is an opportunity  to enhance AMR awareness in different fields based on the One Health  approach, in addition to being part of GCC.   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Threats | • None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

## AMR Surveillance

|               | • National authorities work with close communication with OIE, FAO and  WHO, in addition to being part of GCC.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|---------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Weaknesses    | • National AMR surveillance and antimicrobial use monitoring systems are  not available.    • As for the incidence and prevalence of AMR in humans, there are no  national reports on this issue.  • Regarding surveillance of AMR in isolates from animals, plants, food and  environment, it is unavailable, thus the incidence and prevalence of AMR  in these fields is unavailable too.  • Monitoring of use of antimicrobial agents in humans is almost not available  except for a national study that is starting and did not expand yet.   • Monitoring  of  use  of  antimicrobial  agents  in  animals,  plants  and  environment does not exist except for monitoring antibiotic residue in food  products like milk, meat, poultry, eggs and vegetables.  • In addition, data on the extent and impact of AMR such as human  morbidity, mortality and other health outcomes in relation to AMR, as  well as data on economic impact of AMR in humans, animals, plants,  food, and the environment are not available.   • A national mechanism coordinates the different national AMR  surveillance and antimicrobial use monitoring systems is not available.   • A  National  Reference  Lab  for  antimicrobial  resistance  for  human  and  animal sectors is not available.  • A national research agenda for AMR surveillance is not available. |
| Opportunities | • An  opportunity  is  the  enrolment  of  Kuwaiti  MOH  in  GLASS-  AMC  and  utilization of this platform.  • It  is  economically  feasible  to  increase  manpower  to  perform  AMR  surveillance activities and report data in all sectors.  • There is one laboratory that is assigned for reporting AMR data to GLASS  platform and this can be extended for national AMR surveillance.  • There is a proposal for the accreditation of 2 laboratories in the country  by The College of American Pathologists (CAP) and if this pilot project  succeeds, this will extend to other labs in the country.  • There is an opportunity to conduct AMR-related research in these fields: a  decree regarding environment protection in Kuwait exists to support the  recommendation from KEPA and PAAF for the need to conduct AMR  research in these fields. The presence of this decree facilitates submitting  research proposals and projects and getting funded.   • Another opportunity is the ppresence of research centres that are  interested in performing studies on AMR and expanding it throughout the  country (KEPA, KISR and Kuwait University)  • Relation between PAAF, MOH, FAO, OIE, WHO is an opportunity to  enhance AMR surveillance in different fields based on the One Health  approach                                             |
| Threats       | • None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

## IPC

Strengths

## Human Health

- · On the national level in Kuwait, there is a national central IPC directorate/national office in the MOH, established since 1980. This national office communicates with all IPC teams in public and private healthcare facilities across the country. This directorate has national IPC guidelines that are being regularly updated, plus checklists and audit tools.
- · On the hospital level, each hospital has an IPC office that consists of at least 1 Medical Doctor (MD) and around 5 to 10 nurses depending on the hospital size/number of hospital beds, and this office is in close communication with the central IPC directorate. IPC policies and procedures are included in hospital accreditation standards and are being regularly audited by accreditation bodies.
- · Regarding IPC professionals in healthcare facilities, they have usually an MD degree and an advanced degree in public health or microbiology. Their IPC/AMR training is mandatory for a period of 2 months before joining the job. It is condensed and well-structured prepared by the MOH central IPC directorate. Training for the HAI surveillance is done at the IPC directorate while the IPC training is done in MOH hospitals. Regular in-service training is done for the IPC professionals in the Central IPC directorate. Additionally, targeted training   is performed when there is any updates or new policies/ guidelines.
- · Upon hiring in hospitals, nurses who will work at IPC offices receive mandatory training for 3 months in the form of in-hospital training by IPC professionals as per specific material prepared and supplied by the central IPC directorate. Recently, they receive HAI surveillance training in the IPC directorate. IPC nurses receive regular refreshing training while targeted training is performed when there is any updates or new policies/ guidelines.
- · Regarding general HCWs training, there is a training program in each hospital for HCWs and the IPC team in the hospital is responsible for it. All newly employed HCWs receive an IPC training and nurses should receive an IPC training on a yearly basis, but this issue is not very well structured or followed, and this should be worked on and improved.
- · Healthcare-associated infections (HAI): National HAI surveillance is being implemented in all MOH hospitals. It is prospective patientbased facility wide includes all types of infections in all inpatient locations with calculation of risk adjusted rates. Dialysis surveillance for chronic outpatient hemodialysis patients is also done. Surveillance is based on CDC/NHSN methodology. For MDROs,

incidence density/1000 patient days and % of the total isolates of 8 groups of MRDOs are calculated. Reports and feedback are disseminated and discussed with the relevant stockholders. National data base and benchmarks of HAI are prepared in the IPC directorate.

- · Healthcare waste management: There is a structured management program of the hazardous waste generated from healthcare systems (solid and liquid waste). The MOH has guidelines for both types of wastes. There are incinerators with KEPA's authority to oversee the functioning of these incinerators. (Responsible entities: Hotel service Directorate, Health Licence Directorate, special committee in KEPA)
- · Waste water management system: There is a structured management program under the authority of the Ministry of public works and being monitored from KEPA &amp; Ministry of Public Works.
- · On the healthcare facility level, there is a presence of safe sufficient drinking water and adequate sanitation and hygiene, where there is regular testing of the quality of water used in healthcare.
- · Food handling in healthcare facilities and community:
- o regular testing of food handlers by MOH,
- o presence of health cards;
- o guidelines for food handling in healthcare facilities depending on department plus general guidelines for cooking, storage…. etc.

## · Vaccination programs:

- o availability of up-to-date guidelines and vaccines for the pediatric and adult population
- o robust vaccination coverage for the pediatric population
- o adult vaccination guidelines stratified by age, occupation, comorbidities especially respiratory diseases, seasonal events like Pilgrimage.

## Non-human health sectors (food production/animal husbandry/ veterinary/ agriculture/ environmental fields)

- · Animal Husbandry/Agriculture/Food Production:
- o Biosecurity measures are present in the farms under the responsibility of PAAF
- o There are guidelines for vaccinating, isolating and treating animals against infectious diseases (based on OIE guidelines) monitored and audited by PAAF.
- o All animals should be registered and there is a veterinary laboratory at PAAF.
- o Infrastructure related to the safely securing/auditing/quality control of products in the food chain is present, whether

## Weaknesses

## Opportunities

being the food produced in the country or imported. The responsible entities are the PAFN and PAAF.

- o Food is examined chemically and microbiologically according to GSO standards in public health labs in MOH.

## · Environment:

- o Disposal of diseases animals and waste is well organized and controlled and closely monitored by PAAF.

## Human Health

- · Regarding IPC education in the country in general, there are no opportunities of learning about IPC outside the formal teaching provided by the central IPC directorate. There no courses given at universities or masters degrees or structured continuous education programs.
- · Regarding HAI surveillance, HAI data is collected manually intrahospital and reported to MOH IPC directorate manually and this represents a gap. Responsible authorities believe that it is better that this work becomes computerized. This issue should be imposed on hospitals to shift from manual to electronic work. Yet, even in hospitals that already have electronic medical records, IPC data is not linked to these records and there is still a lot of manual work to link between the two.
- · Healthcare waste management : disposal is not optimized similar to the public sector; it needs monitoring and better implementation.
- · Long term care facilities (LTCF): There isn't a proper structure or specialized manpower and no specific IPC guidelines for LTCF.
- · Vaccination Programs: vaccination uptake in adults is weak and needs to be improved, thus raise adult awareness regarding the importance of vaccination for the prevention of many vaccinepreventable diseases.

## Non-human health sectors

- · Animal Husbandry/Agriculture/Food Production:
- o Absence of National guidelines for infection control biosecurity measures in animal husbandry.
- o There are no research projects directly related to IPC/AMR in animal husbandry or agriculture
- · Veterinary Education and Training:
- o There are no veterinary schools or education in Kuwait
- o Veterinarians receive their degrees and training outside the country.
- o Absence of centrally oriented courses or education for veterinary professionals regarding IPC/AMR.
- · Research: A gap is the absence of IPC/AMR research in these fields.

Human Health

- · In healthcare facilities, IPC bundles of care are already available and implemented but need updating by including new evidence-based recommendations from the medical literature.
- · Healthcare-associated infections: this data should become automatically retrievable from the computerized system to be implemented in healthcare facilities similar to other information in medical records, not to mention to link all relevant lab data to IPC data. And from another side, this IPC data should be digitally linked and available in real time on the network of central IPC directorate.
- · Long term care facilities (LTCF):
- o Under the responsibility of Public Authority of Disability Affairs which is a separate authority from MOH and which is recently supervised by the Minister of Health.
- o There are two large centers and several satellite centers linked together.
- o The team responsible for supervision of the IPC program in LTCF centers constitutes of a part time doctor and four full time nursing staff with basic knowledge of IPC.

## Non-human health sectors:

- · Animal Husbandry/Agriculture/Food Production:
- o Surveillance of infectious diseases such as brucellosis, TB, etc. is present.
- o There are veterinary testing laboratories at PAAF.
- Veterinary Education and Training:
- o In order to be licensed to work in Kuwait, professionals who are hired from outside the country should undergo an interview and licensing exam. This procedure should be repeated every 2 years to renew the license. The exam and interview do not include questions related to IPC/AMR.
- o The continuous education on IPC and AMR is only provided by drug companies.

## · Environment:

- o Presence of sewage effluent monitoring guidelines but not targeting the spread of AMR. This represents a potential or opportunity to perform studies aiming at monitoring the presence of resistant organisms in sewage effluent.

## · Research:

- o There is an opportunity to conduct AMR-related research in these fields: a decree regarding environment protection in Kuwait exists to support the recommendation from KEPA and PAAF for the need to conduct IPC/AMR research in these fields. The presence of this decree facilitates submitting research proposals and projects and getting funded.
- •

|         | o Relation between PAAF, MOH, FAO, OIE, WHO is an  opportunity to enhance IPC in different fields based on the  One Health approach, in addition to being part of GCC.   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Threats | • None                                                                                                                                                                   |

## Rational Use of Antimicrobials

- · There is a national human/animal/plant drug regulatory authority (Pharmaceutical and Herbal Medicines Registration and Control Administration in MOH) that works using international standards and guidelines, not to mention that they have their own protocols for drug marketing authorization to ensure that antimicrobial agents are quality assured, safe and effective.
- · Pharmaceutical and Herbal Medicines Registration and Control Administration in MOH is responsible for quality management system for the antimicrobial agents supply chain as well as the preservation of antimicrobial agents.
- · Pharmaceutical and Herbal Medicines Registration and Control Administration and The Dug Inspection Control in MOH are responsible for detecting and combating counterfeit antimicrobial agents.
- · Pharmaceutical and Herbal Medicines Registration and Control Administration in MOH is responsible for regulating and controlling drug promotional practices (humans/animals). This entity does not allow drug promotion outside what is written in the brochure. But in the veterinary field, this issue is not being audited.
- · As for the reimbursement lists for human health, this is under the authority of Pharmaceutical and Herbal Medicines Registration and Control Administration and no reimbursement occurs outside the protocols of this entity.
- · There is a legislation that prohibit selling of antimicrobials without a prescription of a certified health professional.
- · Veterinarians prescribe mass antimicrobial prophylactic therapy for herds or for treatment purposes, in addition to mass vaccination as prophylaxis when necessary according to guidelines of OIE
- · Antibiotic residue is detected in milk, meat, poultry, eggs and vegetables. There is a washout period during which the animal does not receive any antimicrobials (prior to the milking process or slaughtering).
- · Post-prescription review for appropriateness of antimicrobial agents 48 -72 h after administration is done in public hospitals only depending on the presence of qualified personnel and ID physicians.
- · National authorities work with close communication with OIE, FAO and WHO, in addition to being part of GCC.

## Strengths

## Weaknesses

## Opportunities

Threats

- · Pharmaceutical and Herbal Medicines Registration and Control Administration in MOH) does not systematically audit drug promotional practices in the animal field.
- · Identifying/addressing economic incentives that encourage inappropriate use of antimicrobial agents does not exist, as well as that optimize the use of antimicrobial agents in all sectors do not exist.
- · Regarding the purchasing and prescribing of antimicrobial agents, a national essential medicine list is not available. On the institutional level, some healthcare facilities have their own essential medicine lists and others don't.
- · There are standard treatment guidelines for use of antimicrobial agents in humans, but they need to be expanded and updated. These guidelines are present in public and private hospitals. These guidelines and their application are not properly audited.
- · Standard treatment guidelines for use of antimicrobial agents in animals do not exist. Veterinary practitioners follow OIE guidelines and practice from what they have learned during their basic education. Responsible governmental authorities don't teach these guidelines and audit its proper practice or not; guidelines workshops do not exist. There is no follow-up on updated versions of these guidelines in animal health.
- · There are no legislations to prevent the use of antibiotics used in humans and animals' therapy as growth promotors in animals and for crop protection
- · There is no list or policies for the use of critically important antimicrobials. These legislations need to be activated. Policies on reduction in nontherapeutic use of antimicrobial agents in animal health are not available.
- · Well-established Antimicrobial stewardship programs are not available in healthcare  facilities  (primary,  secondary  and  tertiary  care,  private  and public). However, Some activities are available in some healthcare settings.
- · Qualified human resources are very scarce; the available infectious diseases specialists and clinical microbiologists are not enough to run Antimicrobial Stewardship program in all facilities. Same issue with clinical pharmacists in addition to that these pharmacists need to be trained on AMS.
- · Direct communication of the results of audits and reviews to all sectors using antimicrobial agents needs to be activated.
- · A national research agenda for antimicrobial use and stewardship is not available.
- · Authorities are working on formulating an essential medicine list.
- · Relation between PAAF, MOH, FAO, OIE, WHO is an opportunity to enhance antimicrobial stewardship in different fields based on the One Health approach
- · None

## Country response

## Governance

A National Committee for the proper use of antimicrobials was formulated by a ministerial decree signed by His Excellency the Minister of Health. This committee has members representing different specialties and sectors all over the country and headed by the Assistant Undersecretary of technical affairs and coordinated by the Director of Infection Control Directorate with the following as members:

- 1. WHO National Focal point of AMR-MOH
- 2. Director of Public Health Directorate -MOH
- 3. Director of Pharmaceutical Services Directorate -MOH
- 4. Director of Central Medical Stores Directorate-MOH
- 5. Director of Technical Directorate-MOH
- 6. Director of Primary Healthcare Directorate-MOH
- 7. Director of Medical Licensing Department-MOH
- 8. Director of Health Promotion Department-MOH
- 9. Director of Drug Inspection Control-MOH
- 10. Director of Pharmaceutical and Herbal Medicines Registration and Control AdministrationMOH
- 11. Head of Public Health Laboratories-MOH
- 12. Head of Microbiology and Virology Committee- Council of Medical Laboratories-MOH
- 13. Director of Research and Studies Office- Kuwait Environment Public authority (KEPA)
- 14. Representative from The Public authority for Food and nutrition (PAFN)
- 15. Representative of Animal Health Department-The Public Authority of Agriculture Affairs and Fish Resources (PAAF)
- 16. Representative of Agriculture Sector -Public Authority of Agriculture Affairs and Fish Resources (PAAF)

The purpose of this committee is to oversee and, when necessary, to coordinate AMR-related activities in all sectors

## Governance Operational and Budget Plan

<!-- image -->

| Activity                                                                                                                                                                                                   | Sub- activity                                                                                                     | Sub-sub-  activity                                                                                                | Sub-sub- sub- activity                                                                                            | Unit                                                                                                              | Quantity                                                                                                          | Date                                                                                                              | Location                                                                                                          | Responsib le entity                                                                                               | Cost                                                                                                              | Source   Of  funding                                                                                              | Indicator                                                                                                         |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|
| Strategic Objective G1. National coordination between focal points in the different sectors and different pillars                                                                                          | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars |
| G1.1  Identify  the  needed  AMR focal  points in  human  health,  animal  health,  welfare,  and  productio n, food  safety and  security,  Plants and  agricultur e, and  environm ent.  The TOR  should | G1.1.1  Define the  TOR of  focal  points in  each of  these  sectors                                             |                                                                                                                   |                                                                                                                   | G1.1.1  TOR                                                                                                       | G1.1.1  5                                                                                                         | G1.1.1  Done                                                                                                      | -                                                                                                                 | G1.1.1  NMCG                                                                                                      | G1.1.1  None                                                                                                      | G1.1.1  None                                                                                                      | G1.1.1  TOR are  put                                                                                              |

| authoritie s along  with a  yearly  meeting  of the  different  focal  persons.   |                                                                                                            |                                                                        |                                                                                                             |                                    |             |                    |                |                |                                                          |                |                                                                                                                                        |
|-----------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------|------------------------------------|-------------|--------------------|----------------|----------------|----------------------------------------------------------|----------------|----------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                   | G1.1.2  Employ  and assign  the   functions  of a focal  person for  each pillar  and for  AMR in  general | G1.1.2.1  Assign  AMR focal  points for  each pillar  in human  health | G1.1.2.1.1  one focal  point for  each of  the  following  pillars:  IPC,  Surveillan ce,  ABX,  Awarenes s | G1.1.2.1  Focal  persons  assigned | G1.1.2.1  4 | G1.1.2.1  3 months | G1.1.2.1  MOH  | G1.1.2.1  NMCG | G1.1.2.1  Assigned  from  existing  ministry  employee s | G1.1.2.1  None | G1.1.2  Focal  persons  for each  pillar at  MOH are  assigned.  Focal  points in  PAAF, and  KEPA, and   food  safety   are  assigned |
|                                                                                   |                                                                                                            | G1.1.2.2  Assign the  general  focal   person  in MOH                  | G1.1.2.2.1  Dr. Abeer  Aly  pending  assignmen t/  New  employee                                            | G1.1.2.2  Focal  person  assigned  | G1.1.2.2  1 | G1.1.2.2  3 months | G1.1.2.2  MOH  | G1.1.2.2  NMCG | G1.1.2.2  Assigned  from  existing  ministry/e mployees  | G1.1.2.2  None |                                                                                                                                        |
|                                                                                   |                                                                                                            | G1.1.2.3  Assign 1  focal                                              | G1.1.2.3.1                                                                                                  | G1.1.2.3  Letter  from             | G1.1.2.3  1 | G1.1.2.3  3 months | G1.1.2.3  PAAF | G1.1.2.3  NMCG | G1.1.2.3  Assigned  from                                 | G1.1.2.3  None |                                                                                                                                        |

| person in  animal  health  and  agricultur e fields for  all pillars  including  IPC,  Surveillan ce,  ABX,  Awarenes s   | Represent ative in  NMCG   is the  focal  person   or  authoritie s appoint  a person             | NMCG  through   MOH  Undersecr etary  General   |             |                    |                        |                | existing  authority  employee s                                      |                |
|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|-------------------------------------------------|-------------|--------------------|------------------------|----------------|----------------------------------------------------------------------|----------------|
| G1.1.2.4  Assign 1  focal  person in  KEPA for  all pillars  including  IPC,  Surveillan ce,  ABX,  Awarenes s            | G1.1.2.4.1  Represent ative in  NMCG   is the  focal  person   or  authoritie s appoint  a person | G1.1.2.4  Focal  person  assigned               | G1.1.2.4  1 | G1.1.2.4  3 months | G1.1.2.4  KEPA         | G1.1.2.4  NMCG | G1.1.2.4  Assigned  from  existing  authority  employee s            | G1.1.2.4  None |
| G1.1.2.5  Assign 1  Focal  person in  food  safety  IPC:  Surveillan ce:                                                  | G1.1.2.5.1  leave the   decision  to  ministries /authoriti es                                    | G1.1.2.5  Focal  person  assigned               | G1.1.2.5  1 | G1.1.2.5  3 months | G1.1.2.5  Food  safety | G1.1.2.5  NMCG | G1.1.2.5  Assigned  from  existing  ministry  /authority  employee s | G1.1.2.5  None |

|                                                                                                                        |                                                                                                                                                  | ABX  Awarenes s                                                                                                        |                                                                                                                        |                                                                                                                        |                                                                                                                        |                                                                                                                        |                                                                                                                        |                                                                                                                        |                                                                                                                        |                                                                                                                        |
|------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                        | G1.1.2  Include  inter- ministerial  communic ation and  coordinati on with  the  general   AMR focal  person in  the TOR  of the  focal  points |                                                                                                                        | G1.1.2  TOR                                                                                                            | G1.1.2  5                                                                                                              | G1.1.2  3 months                                                                                                       | G1.1.2  MOH                                                                                                            | G1.1.2  NMCG                                                                                                           | G1.1.2  None                                                                                                           | G1.1.2  None                                                                                                           | G1.1.2  None                                                                                                           |
| Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan                           | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan |
| G2.1  Form  inter- ministerial  NMCG  committe e                                                                       | G2.1.1  Nominate  the  members  and have  a  ministerial  decree  about  their  appointm ent                                                     |                                                                                                                        | G2.1.1  One  Health  Committe e                                                                                        | G2.1.1  1                                                                                                              | G2.1.1  Already  available                                                                                             |                                                                                                                        |                                                                                                                        |                                                                                                                        |                                                                                                                        | G2.1.1  Already  available                                                                                             |
|                                                                                                                        | G2.1.2  Write the  TOR of  the NMCG                                                                                                              |                                                                                                                        | G2.1.2  TOR                                                                                                            | G2.1.2  1                                                                                                              | G2.1.2  Already  available                                                                                             |                                                                                                                        |                                                                                                                        |                                                                                                                        |                                                                                                                        | G2.1.2  Already  available                                                                                             |

|                                                                                                  | that  include:  to  facilitate  and  oversee  implemen tation,  monitorin g and  evaluation  of the  AMR  action  plan   |                                                                                               |                                                                                               |                                                                                               |                                                                                               |                                                                                               |                                                                                               |                                                                                               |                                                                                               |                                                                                               |
|--------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|
|                                                                                                  | G2.1.3  The  NMCG  has  dedicated  funds for   administr ative  costs.                                                   | G2.1.3.1  NMCG  puts a  budget for  administr ative costs                                     | G2.1.3.1  Budget                                                                              | G2.1.3.1  1                                                                                   | G2.1.3.1  3 months                                                                            | G2.1.3.1  MOH                                                                                 | G2.1.3.1  NMCG                                                                                | G2.1.3.1  To be  assigned  later                                                              | G2.1.3.1  MOH                                                                                 | G2.1.3.1  A budget  is put and  provided                                                      |
| Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals    | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                            | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals |
| G3.1  Technical  groups for  specific  activities  are  created  when  needed  from all  sectors | G3.1.1  Mapping  of  profession als  throughou t the  country  from  public and  private                                 |                                                                                               | G3.1.1  Mapping  of  profession als                                                           | G3.1.1  1                                                                                     | G3.1.1  3 months                                                                              | G3.1.1  MOH/PAA F/KEPA/P AFN                                                                  | G3.1.1  NMCG/  MOH  Undersecr etary  general  /Director  General in  PAAF/KEP A/PAFN          | G3.1.1  None                                                                                  | G3.1.1  None                                                                                  | G3.1.1  Technical  groups  are  formed  for each  pillar,  including  represent ative of  One |

<!-- image -->

|                                                                                                                     | sectors  that could  be part of  technical  groups  when  needed.                                                                                                                          |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                                         |                                                                                                                     | Health  approach                                                                                                    |
|---------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|
| Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR                                                                        | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR                     | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR |
| G4.1  Formulate  or  endorse  guidelines   for the  different  topics,  along with  tools                           | G4.1.1  Each  technical  group for  each pillar  will agree  on  existing  guidelines  or  producing  new  guidelines  or  endorsing  internatio nal  guidelines  and make  them  national | G4.1.1  Guidelines  as per  each pillar  need                                                                       | G4.1.1  4                                                                                                           | G4.1.1  1 year                                                                                                      | G4.1.1  MOH/PAA F/KEPA/P AFN                                                                                        | G4.1.1  Technical  groups/  Focal  persons of  each pillar                                                          | G4.1.1  None  (Professio nals are  from the  ministries /authoriti es and will  perform  these  consultan cies as  part of  their jobs) | G4.1.1  None                                                                                                        | G4.1.1  Guideline s are  available  when  needed                                                                    |

N.B. Refer to Annex 1 for Governance Axis Strategic and Monitory plans

## AMR Awareness Operational and Budget Plan

## Global action plan strategic objective 1: Improve awareness and understanding of antimicrobial resistance through effective communication, education and training.

| Activity                                                                                                                                                                     | Sub- activity                                                                                           | Sub-sub-  activity                                                                         | Sub-sub- sub- activity                                                                     | Unit                                                                                       | Quantity                                                                                   | Date                                                                                       | Location                                                                                   | Responsib le entity                                                                        | Cost                                                                                       | Source   Of  funding                                                                       | Indicator                                                                                  |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|
| Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up                                                                                   | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up              | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up |
| 1.1.1 To  designate  a specific  employee  or post  that is  responsibl e of  realizing  the plan,  do the  proper  communic ations and  follow up  on the  progress  of the | 1.1.1  Assign  one  employee /post to  overlook  these  activities  in MOH,  KEPA,  PAAF,  food  safety |                                                                                            |                                                                                            | 1.1.1  Employee  or  position                                                              | 1.1.1   1                                                                                  | 1.1.1   3 months                                                                           | 1.1.1   MOH                                                                                | 1.1.1   MOH ,  KEPA,   PAAF,   PAFN                                                        | 1.1.1  New  Employee  Or   assign the  function  to existing  employee                     | 1.1.1  MOH                                                                                 | 1.1.1  Awarenes s Focal  person  assigned                                                  |
|                                                                                                                                                                              | 1.1.2 Put  TOR of  employm ent                                                                          |                                                                                            |                                                                                            | 1.1.2  -TOR for   MOH  focal  person  -PAAF  focal  person                                 | 1.1.2   4                                                                                  | 1.1.2   2 months                                                                           | 1.1.2   MOH                                                                                | 1.1.2   NMCG                                                                               | 1.1.2  None                                                                                | 1.1.2  None                                                                                | 1.1.2 TOR  is put  for all 4  focal  persons.                                              |

<!-- image -->

|                                                                                                                             |                                                                                                                                         | -KEPA  Focal  person  -PAFN   Focal  person                                                                                 |                                                                                                                             |                                                                                                                             |                                                                                                                             |                                                                                                                             |                                                                                                                             |                                                                                                                             |                                                                                                                                    |
|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                             | 1.1.3  Letter of  employm ent or  assignmen t of   Responsib ilities of  focal  persons in  the 4  ministries /authoriti es             | 1.1.3  Letter                                                                                                               | 1.1.3  1 per  ministry/a uthority                                                                                           | 1.1.3   3 months                                                                                                            | 1.1.3   MOH  PAAF  KEPA  PAFN                                                                                               | 1.1.3   MOH,  KEPA,   PAAF,   PAFN                                                                                          | 1.1.3  None                                                                                                                 | 1.1.3  None                                                                                                                 | 1.1.3  Letter of  employm ent or  assignme nt of  duties to   specific  focal  persons in  the 4  ministries /authoriti es is done |
| Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs             | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs        |
| 1.2.1  Establish  an  evidence- based  public  communic ations  program  targeting  the  general  public in  the            | 1.2.1.1  Estimate  the  knowledg e, attitude  and  practice of  general  public  regarding  AMR in  humans,  animals,  agricultur e and | 1.2.1.1  Already  done   on a  random  sample.  in  outpatient  clinics on  the use of  antibiotics  in humans              |                                                                                                                             | 1.2.1.1  Done                                                                                                               |                                                                                                                             |                                                                                                                             |                                                                                                                             |                                                                                                                             | 1.2.1.1  Done                                                                                                                      |

<!-- image -->

| communit y   | environm ent                                                                                  |                                                                                                                |                                                                                                                |                                                     |                 |                        |                                       |                                                                                |                                                                    |                                       |                                                                                                    |
|--------------|-----------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|-----------------------------------------------------|-----------------|------------------------|---------------------------------------|--------------------------------------------------------------------------------|--------------------------------------------------------------------|---------------------------------------|----------------------------------------------------------------------------------------------------|
|              | 1.2.1.2  Conduct  national  public  awareness  campaigns  based on  the One  health  approach | 1.2.1.2.1  Preparatio n of  material  regarding  the  awareness  campaign  based on  the One  health  approach | 1.2.1.2.1.1  Assign a  team   to  formulate  and  design the  public  communic ation  material  regarding  AMR | 1.2.1.2.1.1  Already   done                         |                 | 1.2.1.2.1.1  Done      |                                       |                                                                                |                                                                    |                                       | 1.2.1.2.1. 1 Done                                                                                  |
|              |                                                                                               |                                                                                                                | 1.2.1.2.1.2  Produce  the   public  communic ation  material  regarding  AMR                                   | 1.2.1.2.1.1  Already  available  for AMR  in humans |                 | 1.2.1.2.1.1  Done      |                                       |                                                                                |                                                                    |                                       | 1.2.1.2.1. 1 Done                                                                                  |
|              |                                                                                               |                                                                                                                | 1.2.1.2.1.3  Update  the  communic ation  material  to cover  all aspects  of the  One                         | 1.2.1.2.1.3  Updated  communic ation  material      | 1.2.1.2.1.3   1 | 1.2.1.2.1.3   6 months | 1.2.1.2.1.3  MOH/  PAAF/  KEPA/  PAFN | 1.2.1.2.1.3  The  awarenes s technical  task force  from  MOH/PAA F/KEPA/P AFN | 1.2.1.2.1.3  To be  determine d by the  responsibl e  authoritie s | 1.2.1.2.1.3  MOH/  PAAF/  KEPA/  PAFN | 1.2.1.2.1. 3 The  communic ation  material  covers all  fields of  One  Health  approach  (Yes/No) |

|                                                                                                             | health  approach:  Animal  Health,  Agricultur e, food  safety and  environm ent                                       |                                                                                          |                         |                       |                                   |                                                     |                                                                     |                                       |                                                                 |
|-------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|-------------------------|-----------------------|-----------------------------------|-----------------------------------------------------|---------------------------------------------------------------------|---------------------------------------|-----------------------------------------------------------------|
| 1.2.1.2.2  Put a  yearly  plan on  broadcasti ng and  posting  the public  communic ation  material  on AMR | 1.2.1.2.2.1  Broadcasti ng is all  year long,  not only  during the  AMR  awareness  week  (specific   timing,  place) | 1.2.1.2.2.1  Broadcasti ng  schedule   (TV, Bill  boards,  advertise ment in  malls,  …) | 1.2.1.2.2.1  1          | 1.2.1.2.2.1  6 months | 1.2.1.2.2.1  MOH  Media  Office   | 1.2.1.2.2.1  MOH/  Media  Office                    | 1.2.1.2.2.1   To be  determine d by the  responsibl e  authoritie s | 1.2.1.2.2.1  MOH/  PAAF/  KEPA/  PAFN | 1.2.1.2.2. 1  Schedule  is put   (Yes/No)                       |
|                                                                                                             | 1.2.1.2.2.2  Prepare  costing of  the plan                                                                             | 1.2.1.2.2.2  Detailed  costing of  the plan                                              | 1.2.1.2.2.2  1          | 1.2.1.2.2.2  8 months | 1.2.1.2.2.2  MOH/MO  Informati on | 1.2.1.2.2.2  MOH/  Media  Office  /MO  Informati on | 1.2.1.2.2.2  None                                                   | 1.2.1.2.2.2  None                     | 1.2.1.2.2. 2  Costing  plan is  finalized                       |
| 1.2.1.2.3  Launch  the  broadcasti ng plan                                                                  |                                                                                                                        | 1.2.1.2.3  Advertise ments   launched  according  to a yearly  schedule                  | 1.2.1.2.3  1  plan/year | 1.2.1.2.3  1 year     | 1.2.1.2.3  MOH/MO  Informati on   | MOH/  Media  Office  /MO  Informati on              | 1.2.1.2.3  The  budget  that was  put while  costing all  the       | 1.2.1.2.3  MOH/PAA F/KEPA/P AFN       | 1.2.1.2.3  Proportio n of the  plan that  was put  on  schedule |

|                                                                                                                                                                                                                                                         |                                                   |              |                     |                                                |                                          | advertise ments                                                  |                 |                                                                           |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------|--------------|---------------------|------------------------------------------------|------------------------------------------|------------------------------------------------------------------|-----------------|---------------------------------------------------------------------------|
| 1.2.1.2.4  Engage  different  types of  media  including  social  media in  AMR  awareness  such as  putting  material/a ds  periodicall y on  ministry/g overnmen tal  websites,  social  media  accounts  like  Facebook,  Twitter,  Instagram , etc. | 1.2.1.2.4  Media  message                         | 1.2.1.2.4  1 | 1.2.1.2.4  1 year   | 1.2.1.2.4  MOH/MO  Informati on                | MOH/  Media  Office  /MO  Informati on   | 1.2.1.2.4  To be  determine d by the  responsibl e  authoritie s | 1.2.1.2.4  MOH  | 1.2.1.2.4  Types of  media or  social  media   that   mention  AMR/mon th |
| 1.2.1.2.5  Involve a  public  figure like   Dr.  Abdullah                                                                                                                                                                                               | 1.2.1.2.5  Involveme nt of a  public  figure (Dr. | 1.2.1.2.5  1 | 1.2.1.2.5  3 months | 1.2.1.2.5  MOH/  TV/  Social  Media  Networks/ | 1.2.1.2.5  MOH/Me dia  Office/Aw areness | 1.2.1.2.5  None                                                  | 1.2.1.2.5  None | 1.2.1.2.5  Public  figure (Dr.  Abdullah  Al-Sanad)  sending              |

| Al-Sanad  (spokespe rson  MOH) in  delivering  AMR  messages,  like  tweets on  twitter or  messages  in Talk  Shows or  through  TV  ads/News  bar   |                                                                                                                                                                            | Abdullah  Al-Sanad)   |                |                       | Platforms         | focal  person                                                         |                   |                   | message  regarding  AMR                                                |
|-------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------|----------------|-----------------------|-------------------|-----------------------------------------------------------------------|-------------------|-------------------|------------------------------------------------------------------------|
| 1.2.1.2.6  Discuss  AMR in TV  talk shows                                                                                                             | 1.2.1.2.6.1  MOH  sends a  letter to  Ministry  of  Informati on/ asking  to host  profession als in AMR  to discuss  this issue  on TV and  thus raise  public  awareness | 1.2.1.2.6.1  Letter   | 1.2.1.2.6.1  1 | 1.2.1.2.6.1  2 months | 1.2.1.2.6.1  MOH  | 1.2.1.2.6.1  Awarenes s focal  person/  MOH  undersecr etary  general | 1.2.1.2.6.1  None | 1.2.1.2.6.1  None | 1.2.1.2.6. 1  Proportio n of talk  shows  episodes  that  discuss  AMR |
| 1.2.1.2.7                                                                                                                                             | 1.2.1.2.7.1                                                                                                                                                                | 1.2.1.2.7.1           | 1.2.1.2.7.1  2 | 1.2.1.2.7.1  2 months | 1.2.1.2.7.1  PAAF | 1.2.1.2.7.1  PAAF                                                     | 1.2.1.2.7.1  None | 1.2.1.2.7.1  None | 1.2.1.2.7. 1                                                           |

|                                                                                                     |                                                                                                                                                             | Involve  Non-  Governme ntal  Organizati ons  (NGOs) in  AMR  awareness  campaign                   | Contact  FAO and  OIE and   ask about  their  communic ations  program  regarding  AMR and  communic ate with  them the  NAP on   | Letter to  FAO and  OIE/Kuwai t offices                                                             |                                                                                                     |                                                                                                     | KEPA  PAFN                                                                                          | KEPA  PAFN                                                                                          |                                                                                                     |                                                                                                     | None                                                                                                |
|-----------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|
| Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools                                                         | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools                               | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools |
| 1.3.1  Include  basic AMR  education  in school  curricula                                          | 1.3.1.1  MOH  sends a  letter with  key facts  about  AMR,  antibiotics , hygiene  and IPC  basics  through  the School  Health  Administr ation  asking to |                                                                                                     |                                                                                                                                   | 1.3.1.1  Letter                                                                                     | 1.3.1.1   1                                                                                         | 1.3.1.1   2 months                                                                                  | 1.3.1.1  MOH                                                                                        | 1.3.1.1  MOH/Sch ool Health  Administr ation                                                        | 1.3.1.1  None                                                                                       | 1.3.1.1  None                                                                                       | 1.3.1.1  Letter  sent Yes  or No                                                                    |

| related to  these  topics in  school  curricula                                                                                  |                                                                                                                                                                                                                                 |                              |               |                      |                                          |                                                                              |                                                   |                      |                                                             |
|----------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------|---------------|----------------------|------------------------------------------|------------------------------------------------------------------------------|---------------------------------------------------|----------------------|-------------------------------------------------------------|
| 1.3.1.2  Prepare a  module/A dd  material  related to  basic AMR  knowledg e,  antibiotics , hygiene  and IPC in  the  curricula | 1.3.1.2.1  Create a  committe e of  comprisin g of AMR  profession al and  education  profession als to  create a  module  about  basic AMR  knowledg e,  antibiotics , hygiene  and IPC to  be  included  in school  curricula | 1.3.1.2.1  Committe e        | 1.3.1.2.1   1 | 1.3.1.2.1   2 months | 1.3.1.2.1  MOH/Min istry of  Education   | 1.3.1.2.1  MOH/  Awarenes s Focal  person/  awarenes s technical  task force | 1.3.1.2.1  Rewardin g of the  committe e  members | 1.3.1.2.1  MOH/  MOE | 1.3.1.2.1  Module  prepared  Yes/No                         |
|                                                                                                                                  | 1.3.1.2.2  Include  this  module in  secondary                                                                                                                                                                                  | 1.3.1.2.2  Letter  from  MOH | 1.3.1.2.2   1 | 1.3.1.2.2   8 months | 1.3.1.2.2  MOH/  Ministry  of  Education | 1.3.1.2.2  MOH/  School  Health  Administr ation/                            | 1.3.1.2.2  None                                   | 1.3.1.2.2  None      | 1.3.1.2.2  Percent of  schools  that teach  the AMR  module |

|                                                                                                                                                        |                                                                                                          | school  education                                                                                               |                                                                                                          |                                                                                                          |                                                                                                          |                                                                                                          | Ministry  of  Education                                                                                       |                                                                                                          |                                                                                                          | in their  secondary  school  curricula                                                                   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|
|                                                                                                                                                        |                                                                                                          | 1.3.1.2.3  Yearly  AMR  module  workshop s involving  teachers                                                  | 1.3.1.2.3  Workshop                                                                                      | 1.3.1.2.3  1/year                                                                                        | 1.3.1.2.3 1  year                                                                                        | 1.3.1.2.3  MOH/  Ministry  of  Education                                                                 | 1.3.1.2.3  MOH/  School  Health  Administr ation  /Health  Promotio n  Directorat e/  Ministry  of  Education | 1.3.1.2.3  To be  determine d by MOE                                                                     | 1.3.1.2.3  MOE                                                                                           | 1.3.1.2.3  Proportio n of  teachers  who  attend  these  workshop s                                      |
| Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach                                               | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach        | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach      | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach |
| 1.4.1  Establish  an  evidence- based  communic ation  program  targeting  the  healthcare  providers  for human  health,  animal  health,  agricultur | 1.4.1.1  Estimate  knowledg e,  attitudes  and  practices  related to  AMR  among  healthcar e workers   | 1.4.1.1.1  Prepare a  survey to  estimate  this  knowledg e among  healthcar e workers  and  identify  the gaps | 1.4.1.1.1  Already  done  2011                                                                           |                                                                                                          | 1.4.1.1.1  Done                                                                                          |                                                                                                          |                                                                                                               |                                                                                                          |                                                                                                          | 1.4.1.1.1  Done                                                                                          |

| e and  environm ent sector   |                                                                                                                                                                                     |                                                                                                                                                                                                  |                                                                                     |               |                      |                |                                          |                 |                 |                                                                                                                                                               |
|------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|---------------|----------------------|----------------|------------------------------------------|-----------------|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                              | 1.4.1.2  Conduct  awareness  program  within  hospitals,  primary  Healthcar e, among  physicians , nurses,  pharmacis ts,  dentists,  physiothe rapists,  and other  HC  providers | 1.4.1.2.1  MOH  mandates  to all  hospitals  and  primary  Health  care  centers to  provide  mandator y sessions  about  AMR to all  employee s who are  subject to  contract/li cense  renewal | 1.4.1.2.1  Letter   from  MOH to  hospitals  and to  primary  Health  care  centers | 1.4.1.2.1   2 | 1.4.1.2.1   2 months | 1.4.1.2.1  MOH | 1.4.1.2.1  MOH/Awa reness  Focal  person | 1.4.1.2.1  None | 1.4.1.2.1  None | 1.4.1.2.1  Proportio n of  hospitals  and  primary  Health  care  centers  that   provide  and  request  yearly  attendanc e of   AMR  conferenc es/session s |
|                              | 1.4.1.3  AMR  mandator y courses  for  pharmacis ts in  private  practice  who are  subject to                                                                                      | 1.4.1.3.1  Letter  from  MOH to  Drug  Inspection  Control to  request   evidence  of AMR   course  attendanc                                                                                    | 1.4.1.3.1  Letter                                                                   | 1.4.1.3.1  1  | 1.4.1.3.1  6 months  | 1.4.1.3.1  MOH | 1.4.1.3.1  MOH                           | 1.4.1.3.1  None | 1.4.1.3.1  None | 1.4.1.3.1  Letter is   issued                                                                                                                                 |

| contract/  license  renewal                                                                                                                  | e about  AMR   upon  license  renewal                                                            |                                                              |              |                   |                                                   |                                                                |                                      |                 |                                |
|----------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|--------------------------------------------------------------|--------------|-------------------|---------------------------------------------------|----------------------------------------------------------------|--------------------------------------|-----------------|--------------------------------|
| 1.4.1.4   Link  of AMR  course  attendanc e to  hospital  pharmacis ts' and  primary  Healthcar e   pharmacis ts'  promotio n.               | 1.4.1.4.1  MOH  recomme nds yearly  attendanc e for  promotio n                                  | 1.4.1.4.1  Mandate                                           | 1.4.1.4.1  1 | 1.4.1.4.1  1 year | 1.4.1.4.1  MOH                                    | 1.4.1.4.1  MOH  Undersecr etary  general/  AMR  Focal  person/ | 1.4.1.4.1  None                      | 1.4.1.4.1  None | 1.4.1.4.1  Mandate  is  issued |
| 1.4.1.5  Preparatio n of a  bank of  presentati ons, films,  articles,  etc.  diffused  to these  syndicates  and  hospitals  to be used  as | 1.4.1.5.1  Toolkit for   AMR  communic ation  program   to be used  in hospital  and  syndicates | 1.4.1.5.1  Toolkit  (Slide  sets, films,  articles,  etc...) | 1.4.1.5.1  1 | 1.4.1.5.1  1 year | 1.4.1.5.1  NMCG/A wareness  Technical  task force | 1.4.1.5.1  NMCG/A wareness  Technical  task force              | 1.4.1.5.1  To be  determine d by MOH | 1.4.1.5.1  MOH  | 1.4.1.5.1  Toolkit  available  |

|                                                                                                                                                           | material  in their  AMR  communic ation  programs.                                                                                                        |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                           | 1.4.1.6  Syndicates  and  hospitals  send  yearly  report to  MOH  about this  activity                                                                   | 1.4.1.6  Report to  MOH  from  hospitals                                                                                                                  | 1.4.1.6  Once/  year/  hospital                                                                                                                           | 1.4.1.6  Yearly  starting 1  year from  starting  the plan                                                                                                | 1.4.1.6  Hospitals                                                                                                                                        | 1.4.1.6  AMR  Focal  person                                                                                                                               | 1.4.1.6  None                                                                                                                                             | 1.4.1.6  None                                                                                                                                             | 1.4.1.6  Proportio n of  hospitals  that send  report   about  AMR   Awarenes s activities  to MOH                                                        |
| Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach |
| 1.5.1  Conduct  an  awareness  program  among  veterinari ans,  agricultur e  profession als,  environm ental  workers,  in  addition                     | 1.5.1.1  Prepare  AMR  awareness  toolkit  including  slide sets,  short  films,  lectures,  posters  for these  profession als                           | 1.5.1.1   AMR  toolkit                                                                                                                                    | 1.5.1.1   1                                                                                                                                               | 1.5.1.1   6 months                                                                                                                                        | 1.5.1.1   PAAF  KEPA  PAFN                                                                                                                                | 1.5.1.1  Awarenes s  Technical  Task force                                                                                                                | 1.5.1.1  To be  determine d by the  responsibl e  authoritie s                                                                                            | 1.5.1.1   PAAF  KEPA   PAFN                                                                                                                               | 1.5.1.1   AMR  toolkit   is  available                                                                                                                    |

<!-- image -->

| to  profession als in  PAAF,  KEPA, and  food  safety.   |                                                                                                                                                                                                                             |                                                                                                                                                                                               |                                                            |                                            |                    |                              |                                                         |                  |                  |                                                                                           |
|----------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------|--------------------------------------------|--------------------|------------------------------|---------------------------------------------------------|------------------|------------------|-------------------------------------------------------------------------------------------|
|                                                          | 1.5.1.2  Integrate  AMR  awareness  in  continuou s  education  programs  of  veterinari ans,  agricultur e  profession als,  environm ental  workers,  in  addition  to  profession als in  PAAF,  KEPA, and  food  safety | 1.5.1.2.1   The focal  person in  each  ministry/a uthority  checks  education al  activities  in their  facilities  and   Includes   AMR   awareness  as a topic  of  continuou s  education | 1.5.1.2.1   AMR  education  sessions   in PAAF  KEPA  PAFN | 1.5.1.2.1   2 per year  in each  specialty | 1.5.1.2.1   1 year | 1.5.1.2.1   PAAF  KEPA  PAFN | 1.5.1.2.1   Focal  person in  each  ministry/a uthority | 1.5.1.2.1   None | 1.5.1.2.1   None | 1.5.1.2.1   Number  of AMR   Awarenes s sessions  per year  in each   Ministry/a uthority |
|                                                          |                                                                                                                                                                                                                             | 1.5.1.2.2                                                                                                                                                                                     | 1.5.1.2.2                                                  | 1.5.1.2.2                                  | 1.5.1.2.2          | 1.5.1.2.2                    | 1.5.1.2.2                                               | 1.5.1.2.2        | 1.5.1.2.2        | 1.5.1.2.2                                                                                 |

|                                                                                      |                                                                                                                   | Mandate  that   all drug  companie s' education al  activities  should  include  AMR  awareness                                                                                                           | Mandate                                                                                | 1   | 6 months           | PAAF                       | - Awarenes s  focal  person in  PAAF/Dire ctor  General of   PAAF                 | None            | None            | Proportio n of  promotio nal  activities  by drug  companie s in  these  fields that  include  messages  about  AMR   |
|--------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------|-----|--------------------|----------------------------|-----------------------------------------------------------------------------------|-----------------|-----------------|-----------------------------------------------------------------------------------------------------------------------|
| 1.5.2  Country  participat es the  regional/i nternation al AMR  awareness  campaign | 1.5.2.1  Participat e actively  in WHO  regional  AMR  campaign   and FAO  and  OIE   activities  related to  AMR | 1.5.2.1.1  Register  Kuwait  authoritie s (KEPA,  PAAF,  MOH) to  participat e in the  yearly  schedule  of AMR  activities  in WHO,  FAO, OIE   And  encourage  individual  healthcar e  profession als, | 1.5.2.1.1  Participati on in  Internatio nal  activities  organized  by WHO  FAO   OIE |     | 1.5.2.1.1   1 year | 1.5.2.1.1  MOH  PAAF  KEPA | 1.5.2.1.1  Focal  persons in  MOH  PAAF  KEPA/  Awarenes s  Technical  Task force | 1.5.2.1.1  None | 1.5.2.1.1  None | 1.5.2.1.1  Proportio n of  events  related to  AMR in  which the  country  participat es                              |

|                                                           | veterinari ans,  agricultur e  profession als,  environm ental  workers  to  participat e   |                 |                 |                 |
|-----------------------------------------------------------|---------------------------------------------------------------------------------------------|-----------------|-----------------|-----------------|
| 1.5.2.2  Participat e in GCC  activities  related to  AMR | 1.5.2.2.1  Kuwait is  part of  GCC AMR  Group                                               | 1.5.2.2.1  Done | 1.5.2.2.1  Done | 1.5.2.2.1  Done |
|                                                           | 1.5.2.2.2  Kuwait  participat es in all  the AMR  activities  GCC                           | 1.5.2.2.2  Done | 1.5.2.2.2  Done | 1.5.2.2.2  Done |

Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food safety, and environment related specialties.

| as a core  compone nt of  profession al   education,  training,  certificati on   | in  undergrad uate  curricula  for human  health  (medical,  nursing,  dental  and  pharmace utical),  food  safety,  and  environm ent  related  specialties   |                                                                                                                                            |                   |              |                     |                            | ss  technical  task force                                                                        |                 |                 |                                  |
|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|-------------------|--------------|---------------------|----------------------------|--------------------------------------------------------------------------------------------------|-----------------|-----------------|----------------------------------|
|                                                                                   | .                                                                                                                                                               | 1.6.1.1.2  Letter  from  MOH,  PAFN  KEPA to  Ministry  of Higher  Education  to impose  on  universitie s/authoriti es to  include  these | 1.6.1.1.2  Letter | 1.6.1.1.2  1 | 1.6.1.1.2  6 months | 1.6.1.1.2  MOH  KEPA  PAFN | 1.6.1.1.2  Awarenes s focal  persons in  all  ministries /authoriti es /  Awarenes s task  force | 1.6.1.1.2  None | 1.6.1.1.2  None | 1.6.1.1.2  Letter  sent   Yes/No |

|                                                                                                                                                                                                                                                       | modules  in the  correspon ding  education  programs.                                                                                                                                                                                            |                                                                                                                    |                                                    |                     |                                  |                                                                                     |                 |                 |                                  |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|----------------------------------------------------|---------------------|----------------------------------|-------------------------------------------------------------------------------------|-----------------|-----------------|----------------------------------|
| 1.6.1.2   AMR and  related  topics  based on  the One  Health  approach  included  in the  licensing  procedure  for  nurses,  dentists,  physicians ,  pharmacis ts,  veterinari ans and  other  profession als for  which  licensing  is  required. | 1.6.1.2.1  Letter  from  MOH,  PAAF,  PAFN and  KEPA  to  licensing   bodies of  these  profession als to  include  AMR and  its related  topics   in  licensing  exams  and  interviews  or in the  evaluation  procedure  for license  renewal | 1.6.1.2.1  Letter  from,  MOH,  PAAF,  PAFN and  KEPA, to  the  licensing  bodies of  each of  these  profession s | 1.6.1.2.1  1 per  profession /per  licensing  body | 1.6.1.2.1  3 months | 1.6.1.2.1  MOH  PAAF  KEPA  PAFN | 1.6.1.2.1   MOH,  PAAF,  PAFN and  KEPA  /AMR  focal  persons in  all  authoritie s | 1.6.1.2.1  None | 1.6.1.2.1  None | 1.6.1.2.1  Letters  sent  Yes/No |

Strategic Objective Include 1.7 AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food chain and environment

<!-- image -->

<!-- image -->

|                                                                                                                                                                          | part of  these  standards                                                                                                                                                    |                                                                                                      |                    |              |                     |                 |                                                                     |                 |                 |                                                                              |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------|--------------------|--------------|---------------------|-----------------|---------------------------------------------------------------------|-----------------|-----------------|------------------------------------------------------------------------------|
| 1.7.2 IPC  and  rational  use of  antimicro bials is  checked in  the  procedure  of  licensing  farms,  animal  husbandry ,  agricultur e, aquatic  and  marine  fields | 1.7.2.1  Review of   large  animal/po ultry  farms   licensing  policies  and  procedure s,   to include   IPC and  proper  ABX use  and  preventio n of ABX  use as  growth | 1.7.2.1.1  Mandate  that ABX  are not to  be used as  growth  promoters                              | 1.7.2.1.1  Mandate | 1.7.2.1.1  1 | 1.7.2.1.1  3 months | 1.7.2.1.1  PAAF | 1.7.2.1.1  PAAF  Director  General  /PAAF  awarenes s focal  person | 1.7.2.1.1  None | 1.7.2.1.1  None | 1.7.2.1.1  Mandate  issued                                                   |
|                                                                                                                                                                          |                                                                                                                                                                              | 1.7.2.1.2  Letter  from  PAAF  Director  General to  licensing  office to  include  these  points in | 1.7.2.1.2  Letter  | 1.7.2.1.2  1 | 1.7.2.1.2  3 months | 1.7.2.1.2  PAAF | 1.7.2.1.2  PAAF  Director  General                                  | 1.7.2.1.2  None | 1.7.2.1.2  None | 1.7.2.1.2  AMR- related  topics   are  included  in  licensing  conditions . |

## Kuwait national action plan on antimicrobial resistance 2022

the standards

N.B. Refer to Annex 2 for AMR Awareness Axis Strategic and Monitory plans

## AMR Surveillance Operational and Budget Plan

## Global action plan strategic objective 2: Strengthen the knowledge and evidence base through surveillance and research.

<!-- image -->

| Strategic  intervent ions                                                                                                                | Activity                                                                                                                                                                | Sub- activity                                                                                                             | Sub-sub-  activity                                                                                                        | Sub-sub- sub- activity                                                                                                    | Unit                                                                                                                      | Quantity                                                                                                                  | Date                                                                                                                      | Location                                                                                                                  | Responsi ble  entity                                                                                                      | Cost                                                                                                                      | Source   Of  funding                                                                                                      | Indicator                                                                                                                 |
|------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach                | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach                                               | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach |
| 2.1.1  Establish  a  national  coordina tion  structure  for AMR  surveilla nce in  humans,  veterinar y  agricultu re and  environ ment | and  approve  terms of  referenc e for a  national  coordina ting  committ ee for  AMR  surveilla nce with  the  mandate  to  oversee  the AMR  surveilla nce  program, |                                                                                                                           |                                                                                                                           |                                                                                                                           | 2.1.1  Committ ee that  includes  focal for  human,  vets,  agricultu re,  environ ment  and Food  safety                 | 2.1.1   1                                                                                                                 | 2.1.1   6 months                                                                                                          | 2.1.1  MOH                                                                                                                | 2.1.1  MOH                                                                                                                | 2.1.1  None                                                                                                               | 2.1.1  None                                                                                                               | 2.1.1  Committ ee is  formed  yes/No                                                                                      |

<!-- image -->

| Veterinar y,  agricultu re,  environm ent and  Food  safety.                                                                                                                                                           |                                                                    |                                              |              |                       |                |                |                 |                 |                         |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|----------------------------------------------|--------------|-----------------------|----------------|----------------|-----------------|-----------------|-------------------------|
| 2.1.1.2.  Write  and  approve  terms of  referenc e for a   central  office  that  executes  the  National  surveilla nce in  humans  and  receives  data  from  other  AMR  offices in  PAAF,  KEPA and  food  safety | 2.1.1.2.1  Write  terms of  referenc e of the  AMR  office at  MOH | 2.1.1.2.1  TOR of a  central  office at  MOH | 2.1.1.2.1  1 | 2.1.1.2.1   3  months | 2.1.1.2.1  MOH | 2.1.1.2.1  MOH | 2.1.1.2.1  None | 2.1.1.2.1  None | 2.1.1.2.1  TOR  written |

| 2.1.1.2.2  Create  the AMR  coordina ting  office at  MOH.   | 2.1.1.2.2. 1 Include  the  already  existing  Glass  team  into the  MOH  National  AMR  office for  Human  sector at  MOH.                 | 2.1.1.2.2. 1.1 Add 2  employe es with a  support  from IT  at MOH  to be  able to  handle  nationwi de data  (to do  the  functions  of the  central  office).   | 2.1.1.2.2. 1.1  Addition al  employe es   | 2.1.1.2.2. 1.1   2   | 2.1.1.2.2. 1.1   6 months   | 2.1.1.2.2. 1.1   MOH   | 2.1.1.2.2. 1.1   MOH/Inf ormation  system  administr ation   | 2.1.1.2.2. 1.1   2 extra  employe es   | 2.1.1.2.2. 1.1   MOH   | 2.1.1.2.2. 1.1   2 extra  employe es are  employe d.  Yes/No   |
|--------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------|----------------------|-----------------------------|------------------------|--------------------------------------------------------------|----------------------------------------|------------------------|----------------------------------------------------------------|
|                                                              | 2.1.1.2.2. 2  Mandate  that each  MOH  hospital  has an  AMR  surveilla nce focal  person  that  coordina tes with  Central  AMR  surveilla |                                                                                                                                                                  | 2.1.1.2.2. 2  Mandate                     | 2.1.1.2.2. 2   1     | 2.1.1.2.2. 2   3 months     | 2.1.1.2.2. 2   MOH     | 2.1.1.2.2. 2   MOH                                           | 2.1.1.2.2. 2   None                    | 2.1.1.2.2. 2  None     | 2.1.1.2.2. 2  Mandate  issued  Yes/No                          |

|                                                                                                                 | nce  office.   |                                           |              |                     |                                       |                               |                 |                 |                                                                                   |
|-----------------------------------------------------------------------------------------------------------------|----------------|-------------------------------------------|--------------|---------------------|---------------------------------------|-------------------------------|-----------------|-----------------|-----------------------------------------------------------------------------------|
| 2.1.1.2.3  Inform  PAAF,PA FN and  KEPA  about  the need  for AMR  surveilla nce in  their  respectiv e fields. |                | 2.1.1.2.3  Letter                         | 2.1.1.2.3  2 | 2.1.1.2.3  1 month  | 2.1.1.2.3  MOH                        | 2.1.1.2.3  MOH                | 2.1.1.2.3  None | 2.1.1.2.3  None | 2.1.1.2.3  Letter  sent                                                           |
| 2.1.1.2.4  Nominat e AMR  focal  persons  in PAAF,  KEPA,  and Food  safety                                     |                | 2.1.1.2.4  Nominati on of  focal  persons | 2.1.1.2.4  3 | 2.1.1.2.4  3 months | 2.1.1.2.4  PAAF and   KEPA  and  PAFN | 2.1.1.2.4  PAAF/  KEPA/  PAFN | 2.1.1.2.4  None | 2.1.1.2.4  None | 2.1.1.2.4  AMR  surveilla nce focal  persons  appointe d in all 3   authoriti es. |
| 2.1.1.2.5  Write the  job  descripti on of  these  focal  persons.  The job  descripti on would  be to          |                | 2.1.1.2.5  TOR                            | 2.1.1.2.5 3  | 2.1.1.2.5 3 months  | 2.1.1.2.5  PAAF and   KEPA  and  PAFN | 2.1.1.2.5  PAAF/  KEPA/  PAFN | 2.1.1.2.5 None  | 2.1.1.2.5  None | 2.1.1.2.5  TOR  are set                                                           |

<!-- image -->

|                                                                                                                                                            | collect  AMR  data and  supply it  to the  Central  AMR  office  and full  coordina tion with  the  Central  AMR  office at  MOH.   |                                                                                                                       |                  |                    |              |                                                       |               |               |                                                                  |
|------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|------------------|--------------------|--------------|-------------------------------------------------------|---------------|---------------|------------------------------------------------------------------|
| 2.1.1.3  Identify  priority  organism s for the  purpose  of  national  AMR  surveilla nce in  human  sector,  animal  sector,  plants  and  Environm ent. |                                                                                                                                     | 2.1.1.3  List of  priority  organism s for  AMR  surveilla nce in   humans,  animals,  agricultu re and  food  safety | 2.1.1.3   1 list | 2.1.1.3   3 months | 2.1.1.3  MOH | 2.1.1.3  Central   committ ee for  AMR  surveilla nce | 2.1.1.3  None | 2.1.1.3  None | 2.1.1.3  List is  available  and  includes  all listed  sectors. |

| Choose a  list of  labs  (dealing  with  specimen  from  humans)  that can  provide  reliable  AMR  data will  form a  sentinel  for  starting  AMR  data  collectio   |                                                                       | 2.1.1.4.1   List of  labs that  potential ly will  submit   AMR  data   Already  exist for  2021  GLASS  Data   | 2.1.1.4.1   1          | 2.1.1.4.1   3 months   | 2.1.1.4.1   MOH /  GLASS  team                          | 2.1.1.4.1   MOH                                         | 2.1.1.4.1   None   | 2.1.1.4.1   None   | List is  chosen  (8 Labs  submitte d GLASS  data for  2021  -Amiri  -Adan  - Mubarak  Alkhabee r  -Jaber  - Farwania  -Jahra  -Chest  -Ibn Sina)   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|------------------------|------------------------|---------------------------------------------------------|---------------------------------------------------------|--------------------|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.1.1.4.2  Increase  the  number  of labs  that are  included  in the list  on yearly                                                                                  | 2.1.1.4.2. 1  Establish  close  communi cation  between  central  AMR | 2.1.1.4.2. 1  New  Labs in  the list                                                                            | 2.1.1.4.2. 1  10 /year | 2.1.1.4.2. 1  1 year   | 2.1.1.4.2. 1  MOH/  Central  AMR  Surveilla nce  office | 2.1.1.4.2. 1  MOH/  Central  AMR  Surveilla nce  office | 2.1.1.4.2. 1  None | 2.1.1.4.2. 1  None | 2.1.1.4.2. 1  Proportio n of labs  in the  country  that are  included  in the list                                                                |

<!-- image -->

|                                                     | basis  until it  becomes  represen tative of  the  national  data.   | OFFICE  that also  collects  data for  glass  with the  lab  council  to have a  list of  labs that  are  accredite d by the  council,  and to  include  them in  the list of  labs  eligible  to submit  data to  GLASS  and  National  AMR  surveilla nce   |                               |                      |                      |                                             |                                             |                               |                   |                                             |
|-----------------------------------------------------|----------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------|----------------------|----------------------|---------------------------------------------|---------------------------------------------|-------------------------------|-------------------|---------------------------------------------|
| 2.1.1.5  Establish  an  antimicr obial  resistanc e | 2.1.1.5.1  integrate  all MOH  laborator ies in  network  with the   | 2.1.1.5.1. 1  Training  of  hospital  AMR  Surveilla                                                                                                                                                                                                          | 2.1.1.5.1. 1  TOT  Worksho ps | 2.1.1.5.1. 1  1/year | 2.1.1.5.1. 1  1 year | 2.1.1.5.1. 1  MOH/  Central  AMR  Surveilla | 2.1.1.5.1. 1  MOH/  Central  AMR  Surveilla | 2.1.1.5.1. 1  30,000  KD/year | 2.1.1.5.1. 1  MOH | 2.1.1.5.1. 1  Yearly  worksho p  performe d |

|                                                | surveilla nce  network  for  human  health     | national  referenc e Lab.                                                                                                                            | nce focal  persons  for data  cleaning  and data  entry  into the  MOH  surveilla nce  system   |                                        |                   |                        | nce  office                                            | nce  office                                            |                 |                 | Yes/No                                           |
|------------------------------------------------|------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|----------------------------------------|-------------------|------------------------|--------------------------------------------------------|--------------------------------------------------------|-----------------|-----------------|--------------------------------------------------|
|                                                |                                                | 2.1.1.5.2  Generate  yearly  report  about  AMR in  humans  in  general  and  mainly  priority  organism s in  humans  by the  MOH  central  office. |                                                                                                 | 2.1.1.5.2  Report                      | 2.1.1.5.2  1/year | 2.1.1.5.2  2 years     | 2.1.1.5.2  MOH/  Central   AMR   Surveilla nce  office | 2.1.1.5.2  MOH/  Central   AMR   Surveilla nce  office | 2.1.1.5.2  None | 2.1.1.5.2  None | 2.1.1.5.2  Yearly  human  AMR  report is  issued |
| 2.1.2  Participa te in  Global  Antimicr obial | 2.1.2.1  Nominat e a  hospital  ad a  team for |                                                                                                                                                      |                                                                                                 | 2.1.2.1  Team ad  hospital  nominat ed |                   | 2.1.2.1  Already  done |                                                        |                                                        |                 |                 | 2.1.2.1  Already  done                           |

| Resistanc e  Surveilla nce  System  (GLASS- AMR)   | GLASS  reporting  with TOR                                                                             |                                                                             |                                                                    |                                            |                                        |                                       |                          |                                                             |                                                             |                            |                     |                                                        |
|----------------------------------------------------|--------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|--------------------------------------------------------------------|--------------------------------------------|----------------------------------------|---------------------------------------|--------------------------|-------------------------------------------------------------|-------------------------------------------------------------|----------------------------|---------------------|--------------------------------------------------------|
|                                                    | 2.1.2.2  Give the  GLASS  team the  authority  to  request  and  collect  data  from labs  nationwi de |                                                                             |                                                                    |                                            | 2.1.2.2  Letter  from  MOH             | 2.1.2.2   1 to each  lab or  hospital | 2.1.2.2   Already  done  |                                                             |                                                             |                            |                     | 2.1.2.2   Already  done                                |
|                                                    |                                                                                                        | 2.1.2.2.1  The team  initiates  data  collectio n from a  sentinel  of labs |                                                                    |                                            | 2.1.2.2.1  Report  submitte d to glass | 2.1.2.2.1  1/year                     | 2.1.2.2.1  Started  2021 |                                                             |                                                             |                            |                     | 2.1.2.2.1  Started  2021                               |
|                                                    | 2.1.2.3  Send  yearly  report to  glass  with  increasin g                                             | 2.1.2.3.1  Central  GLASS  focal  group  (Part of  AMR  central             | 2.1.2.3.1  1  Yearly  training  of GLASS  focal  persons  on GLASS | 2.1.2.3.1. 1.1  Central  worksho ps yearly | 2.1.2.3.1. 1.1  Training  worksho p    | 2.1.2.3.1. 1.1  1/year                | 2.1.2.3.1. 1.1  2 years  | 2.1.2.3.1. 1.1  MOH/  Central   AMR   Surveilla nce  office | 2.1.2.3.1. 1.1  MOH/  Central   AMR   Surveilla nce  office | 2.1.2.3.1. 1.1  20,000  KD | 2.1.2.3.1. 1.1  MOH | 2.1.2.3.1. 1.1  Worksho p done,  yes/No  have 10- 20 % |

|                                                                                                                                                                        | number  of  contribut ing labs                                                                                                                                         | office),  chooses  from the  list of  eligible  accredite d labs  submitte d by  central  entity of  medical  labs to  AMR  office,                                    | data  collectio n,  manage ment  and  entry                                                                                                                            |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        | increase  in  number  of  participa ting labs  in GLASS  annually                                                                                                      |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                        |                                                                                                                                                                        | 2.1.2.3.2  Yearly  lab  report is  sent to  GLASS  with  increasin g  number  of  contribut ing labs  every  year.                                                     |                                                                                                                                                                        | 2.1.2.3.2  Report  sent to  GLASS                                                                                                                                      | 2.1.2.3.2  1/year                                                                                                                                                      | 2.1.2.3.2  Started  already                                                                                                                                            | 2.1.2.3.2  MOH/  Central  AMR  Surveilla nce  office                                                                                                                   | 2.1.2.3.2  MOH/  Central  AMR  Surveilla nce  office                                                                                                                   | 2.1.2.3.2  None                                                                                                                                                        | 2.1.2.3.2  None                                                                                                                                                        | 2.1.2.3.2  Data is  available  in the  yearly  GLASS  report                                                                                                           |
| Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, |
| 2.2.1  Lab in  Hospitals  become                                                                                                                                       | 2.2.1.1  Pilot with  2 labs                                                                                                                                            |                                                                                                                                                                        |                                                                                                                                                                        | 2.2.1.1  Lab CAP  affiliation                                                                                                                                          | 2.2.1.1  2                                                                                                                                                             | 2.2.1.1  1 year                                                                                                                                                        | 2.2.1.1  Labs                                                                                                                                                          | 2.2.1.1  Medical  Laborato                                                                                                                                             | 2.2.1.1  To be  determin ed                                                                                                                                            | 2.2.1.1  MOH                                                                                                                                                           | 2.2.1.1  Started  already                                                                                                                                              |

| CAP  certified  (College  of  American pathologi sts)                                     |                                                                                            |                                                                                             |                            |                         |                          |                         | ries  Council                                                   |                               |                 |                                                                                            |
|-------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|----------------------------|-------------------------|--------------------------|-------------------------|-----------------------------------------------------------------|-------------------------------|-----------------|--------------------------------------------------------------------------------------------|
|                                                                                           | 2.2.1.2  Increase  the  number  of labs  that are  CAP  members                            | 2.2.1.2.1  Lab  council  puts a  plan for  sequenti al  recruitm ent of  labs into  the CAP | 2.2.1.2.1  Plan            | 2.2.1.2.1  1            | 2.2.1.2.1  1 year        | 2.2.1.2.1  Lab  council | 2.2.1.2.1  MOH                                                  | 2.2.1.2.1  None               | 2.2.1.2.1  None | 2.2.1.2.1  List is put  already                                                            |
|                                                                                           |                                                                                            | 2.2.1.2.2  Sequenti al  recruitm ent of  labs into  CAP                                     | 2.2.1.2.2  Labs  recruited | 2.2.1.2.2  2  labs/year | 2.2.1.2.2  5 years       | 2.2.1.2.2  Labs         | 2.2.1.2.2  Medical  Laborato ries  Council                      | 2.2.1.2.2  To be  determin ed | 2.2.1.2.2  MOH  | 2.2.1.1  Proportio n of Labs  that are  CAP  affiliated                                    |
| 2.2.2  Improve  private  labs  capacity  to be  eligible  for  submitti ng data  to GLASS | 2.2.2.1  Reinforce  the  accredita tion  activity  of the lab  council  that  audits  labs | 2.2.2.1.1  Mandate  from  MOH  that each  private  lab  should  pass the  accredita tion by | 2.2.2.1.1  Mandate         | 2.2.2.1.1  1            | 2.2.2.1.1  12-24  months | 2.2.2.1.1  MOH          | 2.2.2.1.1  MOH/Me dical lab.  council/ Medical  Licensing  Dep. | 2.2.2.1.1  None               | 2.2.2.1.1  None | 2.2.2.1  Proportio n of labs  that are  functiona l and that  have  passed  the  accredita |

<!-- image -->

| and  National  AMR                                                          | accordin g to  availabilit y of  qualified  microbiol ogist,  results of  External  QC and  abidance  to  guideline   | the Lab  council                                                                                                                                                      |                                                                             |                                                                             |                                                                             |                                                                             |                                                                             |                                                                             |                                                                             |                                                                             |                                                                             | tion  testing                                                               |
|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|
|                                                                             | s                                                                                                                     | 2.2.2.1.2  Accredita tion of  the lab  council  includes  the  availabili ty of  qualified  microbiol ogist,  results of  External  QC and  abidance  to  guideline s |                                                                             | s                                                                           | 2.2.2.1.2  Update  of  accredita tion  standard s of labs                   | 2.2.2.1.2                                                                   | 2.2.2.1.2  6 months                                                         | 2.2.2.1.2  Labs                                                             | 2.2.2.1.2  Medical  Lab  council                                            | 2.2.2.1.2  None                                                             | 2.2.2.1.2  None                                                             | Updated  accredita tion  standard s of Labs  prepared                       |
| Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment                                           | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment                                                                                           | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment |
| 2.3.1                                                                       | 2.3.1.1                                                                                                               | 2.3.1.1.1                                                                                                                                                             | 2.3.1.1.1. 1                                                                |                                                                             | 2.3.1.1.1. 1                                                                | 2.3.1.1.1. 1                                                                | 2.3.1.1.1. 1                                                                | 2.3.1.1.1. 1                                                                | 2.3.1.1.1. 1                                                                | 2.3.1.1.1. 1                                                                | 2.3.1.1.1. 1                                                                | 2.3.1.1.1. 1                                                                |

| Collect  AMR  data  from  Vets   | Map  available  data On  AMR in  vet and  agricultu re in the  country.   | Agricultu re and  Environ ment  focal  persons  collect  available  info  about  AMR in  the  country  and issue   | Map  PAAF  labs and  the type  of AMR  data that  is  generate d.   | Report  about  PAAF  Labs                                          | 1               | 6 months               | PAAF   Vet labs          | PAAF                     | None                 | None               | Report is   Submitte d to  central  AMR  surveilla nce  office                                     |
|----------------------------------|---------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------|--------------------------------------------------------------------|-----------------|------------------------|--------------------------|--------------------------|----------------------|--------------------|----------------------------------------------------------------------------------------------------|
|                                  |                                                                           |                                                                                                                    | 2.3.1.1.1. 2  Collect  available  data  about  AMR in  PAAF/PA FN   | 2.3.1.1.1. 2  Report  from  PAAF and  food  safety  focal  persons | 2.3.1.1.1. 2  2 | 2.3.1.1.1. 2  6 months | 2.3.1.1.1. 2  PAAF/PA FN | 2.3.1.1.1. 2  PAAF/PA FN | 2.3.1.1.1. 2  None   | 2.3.1.1.1. 2  None | 2.3.1.1.1. 2  AMR  Vets  /food  reports  are    submitte d to  central  AMR  Surveilla nce  office |
|                                  | 2.3.1.2  Improve  vet lab  capacity  in a way  they  generate             | 2.3.1.2.1  Establish  quality  control  of Vet  Microbio logy labs                                                 | 2.3.1.2.1. 1  Assign  expert to   establish  a system  for          | 2.3.1.2.1. 1  1  professio nal  assigned                           | 2.3.1.2.1. 1  1 | 2.3.1.2.1. 1  1 year   | 2.3.1.2.1. 1  PAAF       | 2.3.1.2.1. 1  PAAF       | 2.3.1.2.1. 1  Salary | 2.3.1.2.1. 1  PAAF | 2.3.1.1.1. 1  Professio nal is  assigned                                                           |

| data  about  AMR vets  and  agricultu re   |                                                                              | quality  control  and put a  plan          | /employ ed                    |                                           |                        |                              |                     |                                            |                     |                                                                                                       |
|--------------------------------------------|------------------------------------------------------------------------------|--------------------------------------------|-------------------------------|-------------------------------------------|------------------------|------------------------------|---------------------|--------------------------------------------|---------------------|-------------------------------------------------------------------------------------------------------|
|                                            | 2.3.1.2.1. 2  Execute  the plan  of quality  control in  Vet labs            |                                            | 2.3.1.2.1. 2  qc of vet  labs | 2.3.1.2.1. 2  1                           | 2.3.1.2.1. 2  2 year   | 2.3.1.2.1. 2  vet labs       | 2.3.1.2.1. 2  PAAF  | 2.3.1.2.1. 2  to be  determin ed by  PAAF  | 2.3.1.2.1. 2  PAAF  | 2.3.1.2.1. 2  Proportio n of VET  Labs that   Participat e in  external  quality  control  activities |
|                                            | Extend  Vet  Micro  Labs to  identify  priority  organism s     antibiogr am | 2.3.1.2.2. 1  Increase  man  power         | 2.3.1.2.2. 1  Employe es      | 2.3.1.2.2. 1  To be  determin ed Per  lab | 2.3.1.2.2. 1  6 months | 2.3.1.2.2.  1  Vet Labs      | 2.3.1.2.2.  1  PAAF | 2.3.1.2.2.  1  to be  determin ed by  PAAF | 2.3.1.2.2.  1  PAAF | 2.3.1.2.2. 1  none                                                                                    |
|                                            |                                                                              | 2.3.1.2.2. 2  Road  map and  full  project | 2.3.1.2.2. 2  Project         | 2.3.1.2.2. 2  1                           | 2.3.1.2.2. 2  1 year   | 2.3.1.2.2. 2  PAAF/Ve t labs | 2.3.1.2.2. 2  PAAF  | 2.3.1.2.2. 2  none                         | 2.3.1.2.2. 2  none  | 2.3.1.2.2. 2  The  project is  put with  specified  budget                                            |

|                                                                                                                                                  |                                                                                                              |                                         |                            |                       |                                                      |                                                      |                              |                    | and  ready for  executio n                        |
|--------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|-----------------------------------------|----------------------------|-----------------------|------------------------------------------------------|------------------------------------------------------|------------------------------|--------------------|---------------------------------------------------|
|                                                                                                                                                  | 2.3.1.2.2. 3  Worksho ps for  training  about  antibiogr am                                                  | 2.3.1.2.2. 3  Worksho p                 | 2.3.1.2.2. 3  1/year       | 2.3.1.2.2. 3  1 year  | 2.3.1.2.2. 3  PAAF  Central   Lab, or  assigned  lab | 2.3.1.2.2. 3  PAAF                                   | 2.3.1.2.2. 3  Worksho p cost | 2.3.1.2.2. 3  PAAF | 2.3.1.2.2. 3  Worksho p is  performe d.           |
| 2.3.1.2.3  Impleme nt  national  surveilla nce for  antibiogr am  priority  animal  pathogen s,  zoonotic  and  commen sal  bacterial  isolates. | 2.3.1.2.3. 1  Choose a  number  of Vet  labs that  could  submit  AMR  data to  PAAF for  AMR  surveilla nce | 2.3.1.2.3. 1  List of  labs             | 2.3.1.2.3. 1  1  list/year | 2.3.1.2.3. 1  1 year  | 2.3.1.2.3. 1  PAAF                                   | 2.3.1.2.3. 1  PAAF  AMR  surveilla nce focal  Person | 2.3.1.2.3. 1  None           | 2.3.1.2.3. 1  None | 2.3.1.2.3. 1  List of  labs is  available  yearly |
|                                                                                                                                                  | 2.3.1.2.3. 2  Collect  data  from a  Sentinel                                                                | 2.3.1.2.3. 2  Yearly  data  collectio n | 2.3.1.2.3. 2  1/year       | 2.3.1.2.3. 2  2 years | 2.3.1.2.3. 2  PAAF                                   | 2.3.1.2.3. 2   PAAF/  AMR  surveilla                 | 2.3.1.2.3. 2  None           | 2.3.1.2.3. 2  None | 2.3.1.2.3. 2  Data is  yearly  collected          |

|                                                |                                           |                                                                                                          | of vet  hospitals  or labs  that  submit  data to  the  departm ent of  surveilla nce.  (They  belong to  the list).   |                                                                |                   |                   |                       | nce focal  person                                    |                 |                 |                                                        |
|------------------------------------------------|-------------------------------------------|----------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------|-------------------|-------------------|-----------------------|------------------------------------------------------|-----------------|-----------------|--------------------------------------------------------|
|                                                |                                           | 2.3.1.2.4  The focal  AMR  entity at  PAAF  submits  AMR  data to  the  Central  AMR  surveilla nce lab. |                                                                                                                        | 2.3.1.2.4  Data   Submitte d to  Central   AMR  office at  MOH | 2.3.1.2.4  1/year | 2.3.1.2.4  1 year | 2.3.1.2.4  PAAF/  MOH | 2.3.1.2.4  AMR  Surveilla nce focal  person at  PAAF | 2.3.1.2.4  None | 2.3.1.2.4  None | 2.3.1.2.4  Data  submitte d to  MOH  Central   Office. |
| 2.3.2  Collect  AMR  data  from  Environ ment. | 2.3.2.1  Map  available  data  from  KEPA | 2.3.2.1  Check  KEPA  Labs and  publicati ons  about  any AMR                                            |                                                                                                                        | 2.3.2.1  Search                                                | 2.3.2.1  1        | 2.3.2.1  3 months | 2.3.2.1  KEPA  labs   | 2.3.2.1  KEPA  focal  person  for AMR  surveilla nce | 2.3.2.1  None   | 2.3.2.1  None   | 2.3.2.1  Report is  issued                             |

|                                                                                      | data in  environ ment                                                                                                                           |                                                                                                                                                                       |                                                                                                                       |                             |                        |                                                    |                                                    |                    |                    |                                                                                                                                                |
|--------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|-----------------------------|------------------------|----------------------------------------------------|----------------------------------------------------|--------------------|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.3.2.2  Initiate  AMR  data  collectio n from  Environm ent By  research  projects. | 2.3.2.2.1  The  director  of the  office of  research  and  studies  puts  AMR  surveilla nce as  one of  the  priority  subjects  in  research | 2.3.2.2.1. 1  The plan  of  prioritizi ng AMR  surveilla nce in  Environm ent and  marine  environm ent re  and is  being  discussed  with  universiti es/institu tes | 2.3.2.2.1. 1  Minutes  of  discussio ns in  meetings  with  universiti es//instit utes  official  letters             | 2.3.2.2.1. 1  4/5           | 2.3.2.2.1. 1  6 months | 2.3.2.2.1. 1  KEPA   Research  office              | 2.3.2.2.1. 1  KEPA   Research  office              | 2.3.2.2.1. 1  None | 2.3.2.2.1. 1  None | 2.3.2.2.1. 1  % of  research  meetings  with  universiti es//instit utes  where  AMR is   requeste d to be  apriority  in  research  projects. |
|                                                                                      |                                                                                                                                                 | 2.3.2.2.1. 2  Call for  proposal  from  universiti es//instit utes                                                                                                    | 2.3.2.2.1. 2  Letter to  universiti es/institu tes from  KEPA  research  director  to send  projects  related  to AMR | 2.3.2.2.1. 2  1/univers ity | 2.3.2.2.1. 2  1 year   | 2.3.2.2.1. 2  KEPA  research  office  directora te | 2.3.2.2.1. 2  KEPA  research  office  directora te | 2.3.2.2.1. 2  None | 2.3.2.2.1. 2  None | 2.3.2.2.1. 2  Proportio n of  universiti es  /institute s that  send  projects  related  to AMR  in                                            |

<!-- image -->

|                                                                        |                                                                                                                                                                                                 | in  environ ment                                         |                        |                        |                                      |                                      |                    |                    | environm ent to  KEPA  research  office                                                            |
|------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------|------------------------|------------------------|--------------------------------------|--------------------------------------|--------------------|--------------------|----------------------------------------------------------------------------------------------------|
|                                                                        | 2.3.2.2.1. 3  The  director  of the  office of  research  and  studies  applies  for funds  from  KEPA for  projects  related  to AMR  surveilla nce in  Vet,  agricultu re, and  Environm ent. | 2.3.2.2.1. 3  Projects  and  funds                       | 2.3.2.2.1. 3  Multiple | 2.3.2.2.1. 3  6 months | 2.3.2.2.1. 3  KEPA  research  office | 2.3.2.2.1. 3  KEPA  research  office | 2.3.2.2.1. 3  None | 2.3.2.2.1. 3  None | 2.3.2.2.1. 3  % of  proposed  projects  related  to AMR  in  environm ent that  have  been  funded |
| 2.3.2.2.2  Increase  lab  capacity  of KEPA  Lab that  deals  with the | 2.3.2.2.2. 1  Letter  from  KEPA  Director  General  to                                                                                                                                         | 2.3.2.2.2. 1  Letter  from  KEPA   General  director  to | 2.3.2.2.2. 1  1        | 2.3.2.2.2. 1  3 months | 2.3.2.2.2. 1  KEPA                   | 2.3.2.2.2. 1  KEPA                   | 2.3.2.2.2. 1  None | 2.3.2.2.2. 1  None | 2.3.2.2.2. 1  KEPA Lab  starts  reporting  AMR  data                                               |

<!-- image -->

| quality of  coastal  water to  include  AMR  identifica tion and  surveilla nce in  water  and  sediment   | Technical  affairs  sector of   micro  labs  asking to  prepare  a project  with a  budget   that aims  at  expandin g their  work  from  only  identifica tion to  antibiogr am   |                                                                      | technical  affairs  sector       |                   |                          |                                               |                                               |                      |                      |                                                                                                   |
|------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------|----------------------------------|-------------------|--------------------------|-----------------------------------------------|-----------------------------------------------|----------------------|----------------------|---------------------------------------------------------------------------------------------------|
|                                                                                                            | testing  2.3.2.2.2. 2  KEPA   analytical  central  lab KEPA  prepare  road  map for  the labs  to be  able to  do  antibiogr                                                       | 2.3.2.2.2. 2.1  Identify  the  needed  machiner y and  their  budget | 2.3.2.2.2. 2.1  List and  budget | 2.3.2.2.2. 2.1  1 | 2.3.2.2.2. 2.1  6 months | 2.3.2.2.2. 2.1  KEPA  Analytica l Lab  center | 2.3.2.2.2. 2.1  KEPA  Analytica l Lab  center | 2.3.2.2.2. 2.1  None | 2.3.2.2.2. 2.1  None | 2.3.2.2.2. 2   Road  map  project  with  budget is  put to  extend  KEPA  microbiol ogy lab  from |

| am  testing                                                                            |                                                                        |                                       |                     |                          |                                    |                                    |                                                                |                      | bacterial  identifica tion to  include  also  antibiogr am  testing   |
|----------------------------------------------------------------------------------------|------------------------------------------------------------------------|---------------------------------------|---------------------|--------------------------|------------------------------------|------------------------------------|----------------------------------------------------------------|----------------------|-----------------------------------------------------------------------|
|                                                                                        | 2.3.2.2.2. 2.2  Put a  plan of  needed  extra  staffing                | 2.3.2.2.2. 2.2  Plan                  | 2.3.2.2.2. 2.2  1   | 2.3.2.2.2. 2.2  6 months | 2.3.2.2.2. 2.2  KEPA  Lab  council | 2.3.2.2.2. 2.2  KEPA  Lab  council | 2.3.2.2.2. 2.2  None                                           | 2.3.2.2.2. 2.2  None | See  above                                                            |
| 2.3.2.2.2. 3  KEPA    provides  the  related  budget                                   | 2.3.2.2.2. 3  Commun ication  between  KEPA and  ministry  of  finance | 2.3.2.2.2. 3  Letters                 | 2.3.2.2.2. 3  2     | 2.3.2.2.2. 3  2 years    | 2.3.2.2.2. 3  KEPA  MO  finance    | 2.3.2.2.2. 3  KEPA  MO  finance    | 2.3.2.2.2. 3  None                                             | 2.3.2.2.2. 3  None   | 2.3.2.2.2. 3  None                                                    |
| 2.3.2.2.2. 4  KEPA  microbiol ogy labs  start  generati ng  antibiogr am  results  for |                                                                        | 2.3.2.2.2. 4  Antibiogr am KEPA  LABS | 2.3.2.2.2. 4  1/LAB | 2.3.2.2.2. 4  3 years    | 2.3.2.2.2. 4  KEPA  Micro lab      | 2.3.2.2.2. 4  KEPA                 | 2.3.2.2.2. 4  Will be  determin ed in the   Road  map  project | 2.3.2.2.2. 4  KEPA   | 2.3.2.2.2. 4  KEPA   Marine  lab  actually  generate s   AMR  data    |

|                                                                                                                                                                                    |                                                                                                                           |                                                                         | priority  organism s   |                            |              |                    |                                    |                                                |                 |                 |                                    |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------|------------------------|----------------------------|--------------|--------------------|------------------------------------|------------------------------------------------|-----------------|-----------------|------------------------------------|
|                                                                                                                                                                                    |                                                                                                                           | 2.3.2.2.3  Generate  report  about  AMR  surveilla nce in  Environ ment |                        | 2.3.2.2.3  Report          | 2.3.2.2.3  1 | 2.3.2.2.3  4 years | 2.3.2.2.3  KEPA                    | 2.3.2.2.3  KEPA                                | 2.3.2.2.3  None | 2.3.2.2.3  None | 2.3.2.2.3  Yes/No                  |
| 2.3.3  The  national  AMR  Surveilla nce  Office at  MOH  gathers  data  from  KEPA,  PAAF and  PAFN  compiles  it with  Human  AMR  data and  generate s yearly  ONE  Health  AMR | 2.3.3.1  KEPA,  PAAF and  PAFN  submit  available  data to  Central  AMR  surveilla nce  office at  MOH on  yearly  basis | 2.3.3.1.1  Create a  digital  network  for data  sharing  with  MOH     |                        | 2.3.3.1.1  Digital  system | 2.3.3.1.1  1 | 2.3.3.1.1  5 years | 2.3.3.1.1  MOH,  KEPA,  PAAF  PAFN | 2.3.3.1.1  IT team  at MOH,  KEPA,  PAAF  PAFN | 2.3.3.1.1  none | 2.3.3.1.1  none | 2.3.3.1.1  Digital  System is  put |

| surveilla nce  report.                                                                                                          |                                                                                          |                                                                                                        |                                                                  |                                                                  |                                                                  |                                                                  |                                                                  |                                                                                 |                                                                  |                                                                                                                                               |
|---------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------|---------------------------------------------------------------------------------|------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                 |                                                                                          | 2.3.3.1.2  Add this  function  to the  TOR of  the focal  person at  PAAF and  KEPA and  food  safety. | 2.3.3.1.2  TOR                                                   | 2.3.3.1.2  3                                                     | 2.3.3.1.2  3 years                                               | 2.3.3.1.2  MOH/  KEPA/  PAAF/  PAFN                              | 2.3.3.1.2  MOH/  KEPA/  PAAF/   PAFN                             | 2.3.3.1.2  None                                                                 | 2.3.3.1.2  None                                                  | 2.3.3.1.2  TOR  includes  surveilla nce  function  detail.                                                                                    |
| Strategic objective 2.4: Create a National Reference Lab for AMR                                                                | Strategic objective 2.4: Create a National Reference Lab for AMR                         | Strategic objective 2.4: Create a National Reference Lab for AMR                                       | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR                | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR                                                                              |
| 2.4.1  To have   A Kuwaiti  Center of  Disease  Control  that will  be  overseei ng  bacterial  viral and  AMR  referenc e labs | 2.4.1.1  Project  of  referenc e lab  with its  budget  and  having it  endorsed  by MOH |                                                                                                        | 2.4.1.1  Project  endorsed  by MOH                               | 2.4.1.1  1                                                       | 2.4.1.1  Already  available                                      | 2.4.1.1  Kuwait  CDC Lab                                         | 2.4.1.1  MOH                                                     | 2.4.1.1  Included  in the  project,  already  approved  by  Minister  of Health | 2.4.1.1  MOH                                                     | 2.4.1.1  Kuwait  CDC  will  oversee  the  needs  and  functions  of all  referenc e  laborator ial,  including  viral,  bacterial  and   AMR. |

| 2.4.1.2  Kuwait  CDC  becomes  functiona l                                                                                                                                                                                  | 2.4.1.2  al   Kuwait  CDC        |   Function | 2.4.1.2  1   | 2.4.1.2  5 years   | 2.4.1.2  Kuwait  CDC     | 2.4.1.2  MOH/  Minister  of Health                               | 2.4.1.2  included  in the  approved  project  approved  by  minister  of health   | 2.4.1.2  Council  of  Ministers /MOH  and  Ministry  of  Finance.   | 2.4.1.2  Kuwait  CDC is  establish ed                                                                                                                                                                                      |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------|------------|--------------|--------------------|--------------------------|------------------------------------------------------------------|-----------------------------------------------------------------------------------|---------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.4.1.3  Write  and  approve  terms of  referenc e for a  national  AMR  referenc e  laborator y with  expertise  in  method  s for  confirmi ng and  character izing  specific  pathogen s, putting  guideline s, SOP  for | 2.4.1.3  TOR OF   Referenc e Lab |          1 | 2.4.1.3      | 2.4.1.3  3 months  | 2.4.1.3  Kuwait  CDC lab | 2.4.1.3  Kuwait  CDC/Min ister of  health/M edical  Lab.coun cil | 2.4.1.3  none                                                                     | 2.4.1.3  none                                                       | 2.4.1.3  TOR of   AMR  referenc e   Lab are  put.  They  include:  expertise  in  method  s for  confirmi ng and  character izing  specific  pathogen s, putting  guideline s, SOP  for  identifica tion and  antibiogr am |

<!-- image -->

| identifica tion and  antibiogr am  testing of  priority  organism s for  surveilla nce  training  accordin g to  guideline s, and  organizin g quality  assuranc e   |                                                           |            |                  |                      |                      |                                                      |                                                 | testing of  priority  organism s for  surveilla nce  training  accordin g to  guideline s, and  organizin g quality  assuranc e  schemes   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------|------------|------------------|----------------------|----------------------|------------------------------------------------------|-------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| 2.4.1.4  Prepare  a full  project  and  proposal  for the  referenc e lab                                                                                            | 2.4.1.4  Referenc e Lab  project  as part of  Kuwait  CDC | 2.4.1.4  1 | 2.4.1.4  5 years | 2.4.1.4  Kuwait  CDC | 2.4.1.4  Kuwait  CDC | 2.4.1.4  project  already  approved                  | 2.4.1.4  Kuwait  CDC  budget  already  approved | 2.4.1.4  Yes/No                                                                                                                            |
| 2.4.1.5  Prepare  a budget  for the  building,  equipme nt and                                                                                                       | 2.4.1.5  Budget                                           | 2.4.1.5  1 | 2.4.1.5  5 years | 2.4.1.5  Kuwait  CDC | 2.4.1.5  Kuwait  CDC | 2.4.1.5  Budget  within  the  budget  of Kuwait  CDC | 2.4.1.5  MOH/  Council  of  ministers /Ministry | 2.4.1.5  Budget  for AMR  lab is  approved                                                                                                 |

| man  power of  the  referenc e Lab         |                                          |            |                  |                      |                      |                                                      | of  Finance.                                                  |                                                   |
|--------------------------------------------|------------------------------------------|------------|------------------|----------------------|----------------------|------------------------------------------------------|---------------------------------------------------------------|---------------------------------------------------|
| 2.4.1.6  Executio n of the  Referenc e Lab | 2.4.1.6  Function al AMR  referenc e lab | 2.4.1.6  1 | 2.4.1.6  5 years | 2.4.1.6  Kuwait  CDC | 2.4.1.6  Kuwait  CDC | 2.4.1.6  Budget  within  the  budget  of Kuwait  CDC | 2.4.1.6  MOH/  Council  of  ministers /Ministry  of  Finance. | 2.4.1.6  Referenc e lab is  set and  functioni ng |

<!-- image -->

N.B. Refer to Annex 3 for AMR Surveillance Axis Strategic and Monitory plans

<!-- image -->

|                                                                                                                                                                   | referenc e lab.                                                                              |                                                                                    |                                                                                                                          |                                                                                                                           |                                                                     |                                                                     |                                                                     |                                                                     |                                                                     |                                                                     |                                                                     |                                                                                                                                                    |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------|---------------------------------------------------------------------|---------------------------------------------------------------------|---------------------------------------------------------------------|---------------------------------------------------------------------|---------------------------------------------------------------------|---------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------|
| Strategic objective 2.5: Unify AMR identification in all Micro labs                                                                                               | Strategic objective 2.5: Unify AMR identification in all Micro labs                          | Strategic objective 2.5: Unify AMR identification in all Micro labs                | Strategic objective 2.5: Unify AMR identification in all Micro labs                                                      | Strategic objective 2.5: Unify AMR identification in all Micro labs                                                       | Strategic objective 2.5: Unify AMR identification in all Micro labs | Strategic objective 2.5: Unify AMR identification in all Micro labs | Strategic objective 2.5: Unify AMR identification in all Micro labs | Strategic objective 2.5: Unify AMR identification in all Micro labs | Strategic objective 2.5: Unify AMR identification in all Micro labs | Strategic objective 2.5: Unify AMR identification in all Micro labs | Strategic objective 2.5: Unify AMR identification in all Micro labs | Strategic objective 2.5: Unify AMR identification in all Micro labs                                                                                |
| 2.5.1 Lab  audit by  lab  accredita tion body  accordin g to  microbiol ogist  consulta nt in  charge,  external  quality  control  and use  of CLSI  guideline s | 2.5.1.1  Accredita tion of  the  medical  Laborato ries  by  Medical  Laborato ries  Council | 2.5.1.1.1  Involve  all  laborator ies in  external  quality  assuranc e  programs | 2.5.1.1.1. 1  Mandate  that all  labs  including  all  private  should  be  accredite d and all  perform  external   QC. | 2.5.1.1.1. 1.1  List of  accredita tion  bodies  accepted  in  Kuwait,  all labs  should  be  accredite d by one  of them | 2.5.1.1.1. 1.1  List                                                | 2.5.1.1.1. 1.1  1                                                   | 2.5.1.1.1. 1.1  6 months                                            | 2.5.1.1.1. 1.1  Central  Labs/MO H/  Medical  Lab.coun cil          | 2.5.1.1.1. 1.1  Central  Labs/MO H/Medic al  Lab.coun cil           | 2.5.1.1.1. 1.1  None                                                | 2.5.1.1.1. 1.1  None                                                | 2.5.1.1.1. 1.1  Number  of  internati onal  accredita tion  bodies  that are  recomme nded in  Kuwait  for the  labs to  get their  accredita tion |

## Infection Prevention and Control Operational and Budget Plan

## Global action plan strategic objective 3: Reduce the incidence of infection through effective sanitation, hygiene and prevention measures.

<!-- image -->

| Strategic  intervent ions                                                                                                                                          | Activity                                                                                                                                               | Sub- activity                                                                                                                                          | Sub-sub-  activity                                                                                                                                     | Sub-sub- sub- activity                                                                                                                                 | Unit                                                                                                                                                                       | Quantity                                                                                                                                               | Date                                                                                                                                                   | Location                                                                                                                                               | Responsi ble  entity                                                                                                                                   | Cost                                                                                                                                                   | Source   Of  funding                                                                                                                                   | Indicator                                                                                                                                              |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels.             | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels.                     | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. |
| 3.1.1  Create a  formal  organizat ional  structure  to ensure  proper  develop ment  and use  of  infection  preventi on and  control  policies  and  strategie s | 3.1.1.1  Infection  Control  Organiza tional  structure  is already  establish ed and  functioni ng.                                                   | -                                                                                                                                                      | -                                                                                                                                                      | -                                                                                                                                                      | 3.1.1.1  IPC  Directora te in  MOH  that is a  central,  and  fulfills  the  criteria  of  National  IPC body  that  coordina tes and  organizes  IPC  activities  in HCF. | 3.1.1.1   1                                                                                                                                            | 3.1.1.1  Done  1980                                                                                                                                    | 3.1.1.1  MOH                                                                                                                                           | 3.1.1.1  MOH  /IPC  Directora te                                                                                                                       | 3.1.1.1  Done                                                                                                                                          | 3.1.1.1  none                                                                                                                                          | 3.1.1.1  Already  available                                                                                                                            |
|                                                                                                                                                                    | 3.1.1.2  To make  official  that IPC  is part of  the  organogr                                                                                        | 3.1.2.1  Decree  from  MOH  about  IPC  departm                                                                                                        |                                                                                                                                                        |                                                                                                                                                        | 3.1.2.1  Decree  from  MOH                                                                                                                                                 | 3.1.2.1  1                                                                                                                                             | 3.1.2.1  2 Months                                                                                                                                      | 3.1.2.1  MOH                                                                                                                                           | 3.1.2.1  MOH  /IPC  Directora te                                                                                                                       | 3.1.2.1  None                                                                                                                                          | 3.1.2.1  None                                                                                                                                          | 3.1.2.1  The  decree  was  issued.                                                                                                                     |

| am of  each  hospital  with  Terms of  Referenc e and  allocated  staff                                 | ent in  each  hospital  with  TOR, and  staffing  organizat ion                                           |                                                                                       |    |                                                                             |                                   |                                  |                                                                |                                                                 |                    |                       |                                                                                                      |
|---------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------|----|-----------------------------------------------------------------------------|-----------------------------------|----------------------------------|----------------------------------------------------------------|-----------------------------------------------------------------|--------------------|-----------------------|------------------------------------------------------------------------------------------------------|
| 3.1.1.3  IPC  departm ents in  hospitals  and they  work  closely  with the  central  IPC  Directora te | 3.1.1.3.1  To  impose  IPC  program s in all  hospitals                                                   | 3.1.1.3.1. 1  IPC  program  availabilit y is  checked  by  accredita tion  standard s |    | 3.1.1.3.1. 1  Recomm endation  availabilit y in  accredita tion  standard s | 3.1.1.3.1. 1  1                   | 3.1.1.3.1. 1  Already  available | 3.1.1.3.1. 1  MOH/  Quality  and  Accredita tion  Directora te | 3.1.1.3.1. 1  MOH /  Quality  and  Accredita tion  Directora te | 3.1.1.3.1. 1  None | 3.1.1.3.1. 1  No need | 3.1.1.3.1. 1  Exists  already                                                                        |
|                                                                                                         | 3.1.1.3.2  IPC  program s are  available  in all  hospitals  and they  work  under  the  umbrella  of the | -                                                                                     | -  | 3.1.1.3.2  IPC  Program/ Departm ent                                        | 3.1.1.3.2  One in  each  hospital | 3.1.1.3.2  Already  available    | 3.1.1.3.2  IPC  directora te/Hospit als                        | 3.1.1.3.2  MOH/IPC  directora te/Hospit als                     | 3.1.1.3.2  None    | 3.1.1.3.2  None       | 3.1.1.3.2  Number  of  Hospitals  with IPC  program s and  Total  number  of  hospital  departm ents |

|                                                                                               |                            | Central  IPC  directora te.                                                                     |                                                                                                                                                                    |    |                                   |                 |                        |                                     |                                      |                      |                      |                                                                             |
|-----------------------------------------------------------------------------------------------|----------------------------|-------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|----|-----------------------------------|-----------------|------------------------|-------------------------------------|--------------------------------------|----------------------|----------------------|-----------------------------------------------------------------------------|
| 3.1.2  Impleme nt laws  for  mandato ry  complian ce of the  facilities  with IPC  standard s | 3.1.2.1  Decree  from  MOH | 3.1.2.1.1  Decree  that  recomm ends that  all HCF  have to  abide by  IPC   Recomm endation s. | 3.1.2.1.1. 1 IPC   Directora te puts  the   detailed  IPC  measures  that  should  be  required  from  each  HCF, and  sent to  MOH to  be  included  in  ministry | -  | 3.1.2.1.1. 1 List of  measure s   | 3.1.2.1.1. 1 1  | 3.1.2.1.1. 1 2  months | 3.1.2.1.1. 1  MOH/IPC  directora te | 3.1.2.1.1. 1   MOH/IPC  directora te | 3.1.2.1.1. 1 No cost | 3.1.2.1.1. 1 No cost | 3.1.2.1.1. 1 List is  sent  from IPC  Directora te to  MOH  undersec retary |
|                                                                                               |                            |                                                                                                 | 3.1.2.1.1. 2 Decree  is issued  by MOH                                                                                                                             | -  | 3.1.2.1.1. 2 Decree               | 3.1.2.1.1. 2 1  | 3.1.2.1.1. 2 3  months | 3.1.2.1.1. 2 MOH                    | 3.1.2.1.1. 2 MOH                     | 3.1.2.1.1. 2 None    | 3.1.2.1.1. 2 None    | 3.1.2.1.1. 2 Decree  availabili ty and  dissemin ation                      |
|                                                                                               |                            | 3.1.2.1.2  Medical  responsi bilities.                                                          | 3.1.2.1.2. 1  Add  complian ce to IPC                                                                                                                              | -  | 3.1.2.1.2. 1  Update  of  medical | 3.1.2.1.2. 1  1 | 3.1.2.1.2. 1  3 months | 3.1.2.1.2. 1  MOH                   | 3.1.2.1.2. 1  IPC  Directora te/MOH  | 3.1.2.1.2. 1  None   | 3.1.2.1.2. 1  None   | 3.1.2.1.2. 1  The  Medical  responsi                                        |

|                                                                              |                                                                                                  | Add  details  IPC  standard  complian ce in  hospitals   | measures  and  recomme ndations  to the list  of  medical  responsi bilities of  hospitals  as listed  by MOH   |    | responsi bilities  list  issued by  MOH   |                                     |               |              |                                    |    |              | bility list  is  updated  and it  includes  the  statemen t about  IPC  measure s.   |
|------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|----------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|----|-------------------------------------------|-------------------------------------|---------------|--------------|------------------------------------|----|--------------|--------------------------------------------------------------------------------------|
| 3.1.3  WHO IPC  Core  compone nt based  guideline s are  establish ed in all | 3.1.3.1  Availabili ty of  endorsed  IPC  based on  WHO IPC  core  compone nts                   | -                                                        | -                                                                                                               | -  | 3.1.3.1   1  available  guideline s       | 3.1.3.1   1 Central  IPC  Guideline | 3.1.3.1  Done | 3.1.3.1  MOH | 3.1.3.1  MOH/  Directora te of IPC | -  | 3.1.3.1  MOH | 3.1.3.1  Available                                                                   |
| HCF                                                                          | 3.1.3.2  IPC  policies  and  procedur es are  included  in  hospital  accredita tion  standard s | -                                                        | -                                                                                                               | -  | 3.1.3.2   1  Available  list              | 3.1.3.2  1 list                     | 3.1.3.2  Done | 3.1.3.2  MOH | 3.1.3.2  MOH/  Directora te of IPC | -  | 3.1.3.2  MOH | 3.1.3.2  Available                                                                   |

| 3.1.3.3  IPC  policies  and  procedur es are  being  audited  regularly  by  accredita tion  bodies                                                                          | -                                                                                                                                  | -  -                                                           | 3.1.3.3   1 audit  tool  Available                                                                                                                               | 3.1.3.3  1 audit  tool   | 3.1.3.3  Done            | 3.1.3.3   MOH           | 3.1.3.3   MOH /  Quality  and  Accredita tion  Directora te   | -                | 3.1.3.3   MOH        | 3.1.3.3  Available                              |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|--------------------------|-------------------------|---------------------------------------------------------------|------------------|----------------------|-------------------------------------------------|
| 3.1.3.4  National  infection  control  policies  and  guideline s are  distribut ed and  periodica lly  updated   3.1.3.4.1  Regular  update  of  national  IPC  guideline s | 3.1.3.4.1. 1 On  going,  but  needs to  be  speeded  up by  increasin g  manpow er in IPC  nationwi de in  central  office  and in | -                                                              | 3.1.3.4.1. 1  Employin g new   Inspector s, MDs  and IPC  professio nals with  data  entry  personne l  3.1.3.4.1. 1 -10 MD  -4 data  entry  l  -15  inspector s | personne                 | 3.1.3.4.1. 1 2 years     | 3.1.3.4.1. 1 MOH  1 IPC | 3.1.3.4.1. directora te/MOH                                   | 3.1.3.4.1. 1 MOH | 3.1.3.4.1. 1 MOH     | 3.1.3.4.1. 1  Number  employe d/Numb er  needed |
|                                                                                                                                                                              | 3.1.3.4.2  A direct  channel  with                                                                                                 | 3.1.3.4.2. 1  Communi cate this  3.1.3.4.2. 1.1   Letter  from | 3.1.3.4.2. 1.1   Letter                                                                                                                                          | 3.1.3.4.2. 1.1   1       | 3.1.3.4.2. 1.1   1 month | 3.1.3.4.2. 1.1          | 3.1.3.4.2. 1.1   WCO                                          | 3.1.3.4.2. 1.1   | 3.1.3.4.2. 1.1   WHO | 3.1.3.4.2. 1.1   Number  of                     |

| WHO  consulta nt  regardin g few  queries  and new  recomm endation s     | need to  WHO  office in  Kuwait                                 | MOH/IPC  directora te to  WHO  office in  Kuwait  asking  for direct  channel  with a  consulta nt for  queries  wheneve r they  occur   |                                                                 |                                                 |                        | WHO  office  Kuwait              |                                                              | Will be  costed by  WHO              |                  | answere d queries  /Number  of  needed  consultat ions                                     |
|---------------------------------------------------------------------------|-----------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------|-------------------------------------------------|------------------------|----------------------------------|--------------------------------------------------------------|--------------------------------------|------------------|--------------------------------------------------------------------------------------------|
|                                                                           | 3.1.3.4.2. 2  Communi cate this  need to  Regional  WHO  office | 3.1.3.4.2. 2  Request  from  WCO to  Regional  office.                                                                                   | 3.1.3.4.2. 2 Letter                                             | 3.1.3.4.2. 2 1                                  | 3.1.3.4.2. 2 2  months | 3.1.3.4.2. 2 WHO  office  Kuwait | 3.1.3.4.2. 2 WCO                                             | 3.1.3.4.2. 2 Will be  costed by  WHO | 3.1.3.4.2. 2 WHO |                                                                                            |
| 3.1.3.4.3  Regular  update  of  National  IPC  policies  and  procedur es | 3.1.3.4.3. 1 Need  updating  +  speeding  up the  process       |                                                                                                                                          | 3.1.3.4.3. 1 provide  necessar y  manpow er as in  3.1.3.4.1. 1 | 3.1.3.4.3. 1 As  above  Manpow er  3.1.3.4.1. 1 | 3.1.3.4.3. 1  ongoing  | 3.1.3.4.3. 1   MOH               | 3.1.3.4.3. 1 Plan of  manpow er  Above   As in  3.1.3.4.1. 1 | 3.1.3.4.3. 1  Employe es  salaries   | 3.1.3.4.3. 1 MOH | 3.1.3.4.3. 1  Number  of  hospitals  with  updated  policies/ Total  number  of  hospitals |

| 3.1.3.5  National  IPC  Guideline s and  policies  are being  taught   | 3.1.3.5.1  TOT  periodica lly  performe d  nationall y                                           | -                                                                                                                                 | -                                                      | 3.1.3.5.1  Training  sessions                               | 3.1.3.5.1  Started   years  ago, and  running   | 3.1.3.5.1  Already  being  performe d   | 3.1.3.5.1  MOH/IPC  directora te/  Hospitals   | 3.1.3.5.1  IPC  Directora te          | 3.1.3.5.1  Already  budget is  available  and  being  performe d   | 3.1.3.5.1  MOH      | 3.1.3.5.1  Number  of IPC  professio nals  trained  annually  /total  number  of IPC  professio nals.   |
|------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|-------------------------------------------------------------|-------------------------------------------------|-----------------------------------------|------------------------------------------------|---------------------------------------|--------------------------------------------------------------------|---------------------|---------------------------------------------------------------------------------------------------------|
|                                                                        | 3.1.3.5.2  Continuo us   training  of HCW  about   IPC  policies    in  hospitals  is  available | 3.1.3.5.2. 1  Mandate  from  MOH   that it is  mandato ry   to all  HCW to  attend at  least 1  yearly  and 1  upon   employm ent |                                                        | 3.1.3.5.2. 1  Mandate                                       | 3.1.3.5.2. 1 1                                  | 3.1.3.5.2. 1 2  months                  | 3.1.3.5.2. 1 MOH                               | 3.1.3.5.2. 1 IPC  Directora te/ MOH   | 3.1.3.5.2. 1 None                                                  | 3.1.3.5.2. 1 None   | 3.1.3.5.2. 1 Decree  is done  and sent  to  hospitals .                                                 |
|                                                                        |                                                                                                  | 3.1.3.5.2. 2  Improve  attendan ce to  these                                                                                      | 3.1.3.5.2. 2.1  Attendan ce is  reported  to  hospital | 3.1.3.5.2. 2.1   Report  presente d to  hospital  directors | 3.1.3.5.2. 2.1  report/h ospital/y ear          | 3.1.3.5.2. 2.1   1 year                 | 3.1.3.5.2. 2.1   MOH/  Hospitals               | 3.1.3.5.2. 2.1   Hospital  IPC office | 3.1.3.5.2. 2.1   None                                              | 3.1.3.5.2. 2.1   No | 3.1.3.5.2. 2.1   Number  of HCW  attendee s /year                                                       |

|                                                                       |                                                                    | general  HCW   IPC  training  sessions                                                                                       | administr ators and  action  taken to  improve  attendan ce   |                                            |                                                                  |                                    |                                                                   |                       |                     |                                                                                 |
|-----------------------------------------------------------------------|--------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------|--------------------------------------------|------------------------------------------------------------------|------------------------------------|-------------------------------------------------------------------|-----------------------|---------------------|---------------------------------------------------------------------------------|
|                                                                       |                                                                    | 3.1.3.5.2. 2.2  Attendan ce  evidence  is  available  in yearly  Hospital  IPC  report  and  monitore d by IPC  Directora te | 3.1.3.5.2. 2.2   Report  presente d to IPC  directora te      | 3.1.3.5.2. 2.2   1  Report/h ospital/y ear | 3.1.3.5.2. 2.2   1 year                                          | 3.1.3.5.2. 2.2   IPC  Directora te | 3.1.3.5.2. 2.2   MOH/IPC  directora te/Hospit al  administr ators | 3.1.3.5.2. 2.2   None | 3.1.3.5.2. 2.2   No | 3.1.3.5.2. 2.2  none                                                            |
| 3.1.4  Monitor  and  evaluate  complian ce with  the IPC  guideline s | 3.1.4.1  Checklist s and  audit  tools are  prepared  and  applied | _  _                                                                                                                         | 3.1.4.1  documen ts  (checklist s and  audit  tools)          | 3.1.4.1  1                                 | 3.1.4.1    Started  years  ago, and  ongoing  for new  policies. | 3.1.4.1   MOH/IPC  Directora te    | 3.1.4.1   IPC  Directora te                                       | 3.1.4.1   none        | 3.1.4.1  none       | 3.1.4.1   Number  of  policies  with  audit  tools/Tot al  number  of  policies |

| 3.1.4.2  Regular  updates  of these  audit  tools   | new  policies if  they  have  their  audit  tools  prepared  and  dissemin ated and  check old                                                      | -   | -   | 3.1.4.2.1  Audit  tool            | 3.1.4.2.1  One/new  policy.  Then  total  review  once/yea r   | 3.1.4.2.1  Ongoing                 | 3.1.4.2.1  IPC  Directora te/  MOH   | 3.1.4.2.1  IPC  Directora te/  MOH   | 3.1.4.2.1  None   | 3.1.4.2.1  None   | 3.1.4.2.1  Number  of new  policies  with  audit  tool/Tota l number  of new  policies.   |
|-----------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|-----|-----|-----------------------------------|----------------------------------------------------------------|------------------------------------|--------------------------------------|--------------------------------------|-------------------|-------------------|-------------------------------------------------------------------------------------------|
| 3.1.4.3  Audit  plan  available  in  hospitals      | update  3.1.4.3.1  Audit  plan is  checked  in  standard s of the  National  Accredita tion  Program  applied  by the  Quality  and  Accredita tion | -   | -   | 3.1.4.3.1  checking  3.1.4.3.1  1 | 3.1.4.3.1  done  ongoing                                       | 3.1.4.3.1  IPC  Directora te/  MOH | 3.1.4.3.1  IPC  Directora te/  MOH   | 3.1.4.3.1  None                      |                   | 3.1.4.3.1  None   | 3.1.4.3.1  Done  and  ongoing                                                             |

|                                                    | Directora te                                                                                 |                                                  |              |                                                             |                            |                                       |                                          |                                              |                               |                                           |                                                                                   |
|----------------------------------------------------|----------------------------------------------------------------------------------------------|--------------------------------------------------|--------------|-------------------------------------------------------------|----------------------------|---------------------------------------|------------------------------------------|----------------------------------------------|-------------------------------|-------------------------------------------|-----------------------------------------------------------------------------------|
|                                                    | Central  audit  plan is  being  prepared  annually  and  distribut ed to all  hospitals      | -                                                | -            | 3.1.4.3.2  Audit  plan                                      | 3.1.4.3.2  1               | 3.1.4.3.2  Done  and  ongoing  yearly | 3.1.4.3.2  IPC  Directora te             | 3.1.4.3.2  IPC  Directora te /MOH            | 3.1.4.3.2  none               | 3.1.4.3.2  none                           | 3.1.4.3.2  Done  and  ongoing                                                     |
|                                                    | 3.1.4.3.3  Audit  report is  sent to  central  IPC  directora te with  correctiv e  actions. | -                                                | -            | 3.1.4.3.3   Report                                          | 3.1.4.3.3   one/  hospital | 3.1.4.3.3   Done  and  ongoing        | 3.1.4.3.3   Hospitals /IPC  directora te | 3.1.4.3.3   Hospitals /IPC  directora te/MOH | 3.1.4.3.3   None              | 3.1.4.3.3   None                          | 3.1.4.3.3   Done  and  ongoing                                                    |
| 3.1.4.4  Establish  national  process  indicator s | 3.1.4.4.1   1 st  set of  process  indicator s:  -CLABSI  -CAUTI  -VAP                       | 3.1.4.4.1. 1  Put the  basic  training  material | -            | 3.1.4.4.1. 1  Process  indicator s of the  Bundles  of care | 3.1.4.4.1. 13              | 3.1.4.4.1. 1Already   available       | 3.1.4.4.1.  IPC  directora te            | 3.1.4.4.1. 1  IPC  directora te              | 3.1.4.4.1. 1No  extra  budget | 3.1.4.4.1. 1  IPC  directora te  for both | 3.1.4.4.1. 1  Each one  of the 3  procedur es has its  own  bundle  establish ed. |
|                                                    |                                                                                              | 3.1.4.4.1. 2Update                               | 3.1.4.4.1. 2 | 3.1.4.4.1. 2New                                             | 3.1.4.4.1. 2               | 3.1.4.4.1. 2                          | 3.1.4.4.1. 2 IPC                         | 3.1.4.4.1. 2MOH/                             | 3.1.4.4.1. 2None              | 3.1.4.4.1. 2None                          | 3.1.4.4.1. 2Availabi                                                              |

| of the  already  available  bundle of  care in  each of  the  mentione d  bundles,  by  including  new  evidence-  based  items to  the  bundle   | Prepare  the  updated  bundles                           | bundle  definitio n and  checklist         | 3                                                             | 2 years                                           | directora te/MOH                      | IPC  directora te                      |                                                  |                      | lity of 3  updated  bundles                                             |
|---------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------|--------------------------------------------|---------------------------------------------------------------|---------------------------------------------------|---------------------------------------|----------------------------------------|--------------------------------------------------|----------------------|-------------------------------------------------------------------------|
| 3.1.4.4.1. 3  Train the  IPC  professio nals  nationwi de on the  updated  bundles                                                                | 3.1.4.4.1. 3.1  TOT  worksho ps                          | 3.1.4.4.1. 3.1  TOT  sessions              | 3.1.4.4.1. 3.1  2/year  centrally  Total=4                    | 3.1.4.4.1. 3.1  2 years                           | 3.1.4.4.1. 3.1  MOH/IPC  directora te | 3.1.4.4.1. 3.1  IPC  Directora te /MOH | 3.1.4.4.1. 3.1  No need  for  additiona l at MOH | 3.1.4.4.1. 3.1  MOH  | 3.1.4.4.1. 3.1  % IPC  professio nals  trained  about  the new  bundles |
| 3.1.4.4.1. 4 Engage  all HCW  with the  bundles  by  training,                                                                                    | 3.1.4.4.1. 4.1  Prepare  the  ground in  the  hospitals: | 3.1.4.4.1. 4.1  Letter for  CLABSI  bundle | 3.1.4.4.1. 4.1  1  dissemin ated to  all  hospital  directors | 3.1.4.4.1. 4.1  CLABSI  months  Each  bundle 1  y | 3.1.4.4.1. 4.1  IPC  Directora te/MOH | 3.1.4.4.1. 4.1  IPC  Directora te/MOH  | 3.1.4.4.1. 4.1  None                             | 3.1.4.4.1. 4.1  None | 3.1.4.4.1. 4.1  Letter  sent or  not                                    |

| audit and  feedback.                                                                                                         | Letter to  hospital  directors  about  the  bundles  project  its  importan ce and its  processe s   |                                                                                |                                              |                          |                                        |                                                   |                       |                        |                                                                              |
|------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|----------------------------------------------|--------------------------|----------------------------------------|---------------------------------------------------|-----------------------|------------------------|------------------------------------------------------------------------------|
| 3.1.4.4.1. 4.2   Update  the  material  to be  taught to  HCW by  IPC  professio nals,  accordin g to the  updated  bundles. | 3.1.4.4.1. 4.2   bundle                                                                              | Training  package  for each                                                    | 3.1.4.4.1. 4.2   3  (1/bundl e)              | 3.1.4.4.1. 4.2   2 years | 3.1.4.4.1. 4.2   IPC  Directora te/MOH | 3.1.4.4.1. 4.2   IPC  Directora te/MOH            | 3.1.4.4.1. 4.2   None | 33.1.4.4. 1.4.2   None | 3.1.4.4.1. 4.2   % of   material  directed  to HCW  that has  been  updated. |
| 4.3   In- hospital  training  sessions  by IPC  professio                                                                    | 3.1.4.4.1. nals to all                                                                               | 3.1.4.4.1. 4.3   Training  sessions  in  hospitals  to HCW  performe d by each | 3.1.4.4.1. 4.3   Multiple  in each  hospital | 3.1.4.4.1. 4.3   4 years | 3.1.4.4.1. 4.3   MOH/Ho spitals        | 3.1.4.4.1. 4.3   MOH/IPC  directora te/Hospit als | 3.1.4.4.1. 4.3   None | 3.1.4.4.1. 4.3   None  | 3.1.4.4.1. 4.3   Complian ce with  performa nce  indicator  for each  bundle |

<!-- image -->

| concerne d HCW.  Include  Bundle  training  in the  yearly  IPC  training  and in  peri-                                | employm ent  training.                                                                                     | hospital  's IPC  team   |                              |                         |                               |                                                  |                     |                     |                                                                                                                                                                           |
|-------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|--------------------------|------------------------------|-------------------------|-------------------------------|--------------------------------------------------|---------------------|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1.4.4.1. 4.4  Auditing  complian ce to  these  bundles  on  monthly  basis and  report to  IPC  directora te  monthly | 3.1.4.4.1. 4.4  Audit  activity/A udit  report.  (about  the  updated  bundles  and  updated  checklists ) | .4  l                    | .1.4.4.1.4 3/month s/hospita | 3.1.4.4.1. 4.4  5 years | .1.4.4.1.4 .4  MOH/Ho spitals | .1.4.4.1.4 .4  MOH/Ho spitals/IP C  Directora te | .1.4.4.1.4 .4  None | .1.4.4.1.4 .4  None | 3.1.4.4.1. 4.4  Process  Indicator  for each  of the 3  bundles:  For each  bundle:  %  Complian ce by the  specific  bundle  /opportu nities of  audit for  each  bundle |

| 3.1.4.4.2   Update  outcome  indicator s for the  3  bundles  above  (CLABSI,  CAUTI,  VAP)  accordin g to new  CDC/  guideline s   | 3.1.4.4.2. 1   Review  updated  CDC  outcome  indicator s and  update  already  measure d  bundles  outcome  indicator s  according ly   | -   | 3.1.4.4.2. 1   Reviewe d  outcome  indicator,  calculatio n and  benchma rking   | 3.1.4.4.2. 1   3   | 3.1.4.4.2. 1   6 months   | 3.1.4.4.2. 1   MOH/IPC  directora te   | 3.1.4.4.2. 1   MOH/IPC  directora te   | 3.1.4.4.2. 1   None   | 3.1.4.4.2. 1   MOH  budget   | 3.1.4.4.2. 1   Number  of  outcome  indicator  measure ments  and   benchma rk is  updated.   |
|-------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|-----|----------------------------------------------------------------------------------|--------------------|---------------------------|----------------------------------------|----------------------------------------|-----------------------|------------------------------|-----------------------------------------------------------------------------------------------|
| 3.1.4.4.3  Integrate  process  and  outcome  indicator s for  each  bundle,  and use  in the  analysis  and  correctiv e actions    | 3.1.4.4.3. 1  Put a  road map  for  integrati ng  analysis  of  outcome  and  process  indicator s related  to the  bundles              | -   | 3.1.4.4.3. 1  Protocol                                                           | 3.1.4.4.3. 1  3    | 3.1.4.4.3. 1  1 year      | 3.1.4.4.3. 1  MOH/IPC  directora te    | 3.1.4.4.3. 1  MOH/IPC  directora te    | 3.1.4.4.3. 1  None    | 3.1.4.4.3. 1  MOH  budget    | 3.1.4.4.3. 1  % of  bundles  whose  analysis   integrate s   process  and  outcome  data      |
| 3.1.4.4.4                                                                                                                           | 3.1.4.4.4. 1                                                                                                                             | -   | 3.1.4.4.4. 1                                                                     | 3.1.4.4.4. 1       | 3.1.4.4.4. 1              | 3.1.4.4.4. 1                           | 3.1.4.4.4. 1                           | 3.1.4.4.4. 1          | 3.1.4.4.4. 1                 | 3.1.4.4.4. 1                                                                                  |

| Introduc e   SSI  bundle   | preparati on of  material                       |                                                                                                      | Protocol,  Checklist,  teaching  material  for IPC  professio nals and  HCW   | 1 Central                         | 4 years                 | MOH/IPC  directora te                 | MOH/IPC  directora te                              | None                 | MOH  budget         | % of  material  that is  prepared                                                             |
|----------------------------|-------------------------------------------------|------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------|-----------------------------------|-------------------------|---------------------------------------|----------------------------------------------------|----------------------|---------------------|-----------------------------------------------------------------------------------------------|
|                            | 3.1.4.4.4. 2  Impleme ntation  of   SSI  bundle | 3.1.4.4.4. 2.1  Teaching  of IPC  professio nals by  central  IPC  directora te                      | 3.1.4.4.4. 2.1  Teaching  sessions  and  worksho ps                           | 3.1.4.4.4. 2.1  Central           | 3.1.4.4.4. 2.1  5 years | 3.1.4.4.4. 2.1  IPC  directora te/MOH | 3.1.4.4.4. 2.1  MOH/IPC  directora te  /Hospital s | 3.1.4.4.4. 2.1  None | 3.1.4.4.4. 2.1  MOH | 3.1.4.4.4. 2.1  %  hospitals  start  submitti ng  process  and  outcome  indicator s for SSI. |
|                            |                                                 | 3.1.4.4.4. 2.2  Teaching  of  healthcar e  providers  inside  the  hospitals  by IPC  professio nals | 3.1.4.4.4. 2.2  Teaching  sessions  and  worksho ps                           | 3.1.4.4.4. 2.2  2/y in  hospitals | 3.1.4.4.4. 2.2  5 years | 3.1.4.4.4. 2.2  MOH/Ho spitals        | 3.1.4.4.4. 2.2  MOH/IPC  directora te  /Hospital s | 3.1.4.4.4. 2.2  None | 3.1.4.4.4. 2.2  MOH | 3.1.4.4.4. 2.2  %  hospitals  start  submitti ng  process  and  outcome  indicator s for SSI. |
|                            |                                                 | 3.1.4.4.4. 2.3                                                                                       | 3.1.4.4.4. 2.3                                                                | 3.1.4.4.4. 2.3                    | 3.1.4.4.4. 2.3  5 years | 3.1.4.4.4. 2.3  Hospitals             | 3.1.4.4.4. 2.3                                     | 3.1.4.4.4. 2.3  None | 3.1.4.4.4. 2.3  MOH | 3.1.4.4.4. 2.3                                                                                |

|                                                                                                        |                                                                                                                                                                |                                                                                                                                                                   |                                                                                                                                                                                                                  | Data  collectio n   | Data  collectio n    | 1               |                        |                                                                | MOH/IPC  directora te  /Hospital s   |                  |                  | %  hospitals  start  submitti ng  process  and  outcome  indicator s for SSI.   |
|--------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|----------------------|-----------------|------------------------|----------------------------------------------------------------|--------------------------------------|------------------|------------------|---------------------------------------------------------------------------------|
| 3.1.5  IPC  programs /office in  LTCF  working  in close  cooperati on with  IPC  directora te in  MOH | 3.1.5.1  Mandate  from  MOH  that IPC  program/ with  employe e with  TOR and  specified  budget  are  available  in LTCF  the  central  and the  'branche s'. | 3.1.5.1.1  Commun ication  between  MOH  and  Public  Authorit y of  Disability  Affairs  regardin g IPC in  LTCF and  being  overseen  by the  IPC  directora te | 3.1.5.1.1. 1  Letter  from  MOH to  Public  Authority  of  Disability  Affairs  asking to  establish  IPC in  each  LTCF and  to have  the  personne l work  closely  with IPC  directora te  delegate  to LTCF. |                     | 3.1.5.1.1. 1  Letter | 3.1.5.1.1. 1  1 | 3.1.5.1.1. 1  2 months | 3.1.5.1.1. 1  MOH/  Public  Authority  of  Disability  Affairs | 3.1.5.1.1. 1  MOH/  Main  LTCF       | 3.1.5.1.1. 1  No | 3.1.5.1.1. 1  No | 3.1.5.1.1. 1  Present                                                           |

|                                                       | 3.1.5.1.1. 2  Letter  from  Public  Authority  of  Disability  Affairs to  LTCF that  recomme nds IPC in  each  LTCF and  organizes  the  communi cation  with  MOH   | 3.1.5.1.1. 2 Letter                              | 3.1.5.1.1. 2 1   | 3.1.5.1.1. 2 2  months   | 3.1.5.1.1. 2  Public  Authority  of  Disability  Affairs                     | 3.1.5.1.1. 2   Public  Authority  of  Disability  Affairs   | 3.1.5.1.1. 2 No    | 3.1.5.1.1. 2 No    | 3.1.5.1.1. 2 Letter  sent                                                                         |
|-------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------|------------------|--------------------------|------------------------------------------------------------------------------|-------------------------------------------------------------|--------------------|--------------------|---------------------------------------------------------------------------------------------------|
| 3.1.5.1.2  Establish ed  Guidelin es for IPC  in LTCF | 3.1.5.1.2. 1  Preparati on of the  LTCF  guideline s and  their  endorse ment by  Public  Authority  of  Disability  Affairs                                          | 3.1.5.1.2. 1  Guideline s  Policies  Procedur es | 3.1.5.1.2. 1  1  | 3.1.5.1.2. 1  1 year     | 3.1.5.1.2. 1  IPC  Directora te/  Public  Authority  of  Disability  Affairs | 3.1.5.1.2. 1  MOH/IPC  Directora te                         | 3.1.5.1.2. 1  None | 3.1.5.1.2. 1  None | 3.1.5.1.2. 1  Availabili ty of the  endorsed  guideline s and set  of  policies  and  procedur es |

|                                                                                                                         |                                                                                                                                                            | 3.1.5.1.2. 2  Dissemin ation of  LTCF  Policies  and  Procedur es                                                       | 3.1.5.1.2. 2.1  TOT of  LTCF IPC  focal  persons                                                                        | 3.1.5.1.2. 2  Worksho p once/y                                                                                          | 3.1.5.1.2. 2  1/year                                                                                                    | 3.1.5.1.2. 2  1.5 years                                                                                                 | 3.1.5.1.2. 2  Public  Authority  of  Disability  Affairs                                                                | 3.1.5.1.2. 2  MOH/  Public  Authority  of  Disability  Affairs                                                          | 3.1.5.1.2. 2  20,000  KD                                                                                                | 3.1.5.1.2. 2  MOH/  Public  Authority  of  Disability  Affairs                                                          | 3.1.5.1.2. 2  % focal  IPC  persons  in LTCF   trained  on the  guideline s/total  number  of LTCF  IPC focal  persons.   |
|-------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report                                    | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic Objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report   |
| 3.2.1  Software  for  hospital  data  entry,  analysis  and  generati ng both  hospital  and  national  reports         | 3.2.1.1  Subcom mittee  from IPC  directora te sends  a letter  to   Informati on  system  departm ent at  MOH  explainin g what is  required  and  asking |                                                                                                                         | 3.2.1.1  Letter                                                                                                         |                                                                                                                         | 3.2.1.1  1                                                                                                              | 3.2.1.1  2 months                                                                                                       | 3.2.1.1  MOH                                                                                                            | 3.2.1.1  MOH/  IPC  directora te                                                                                        | 3.2.1.1  None                                                                                                           | 3.2.1.1  None                                                                                                           | 3.2.1  Software  develope d and  working                                                                                  |

| for the  software                                                                                                       |                               |            |                           |                                                                       |                                                  |                                         |               |            |
|-------------------------------------------------------------------------------------------------------------------------|-------------------------------|------------|---------------------------|-----------------------------------------------------------------------|--------------------------------------------------|-----------------------------------------|---------------|------------|
| 3.2.1.2  Informati on  system  dep.  presents  projects  (either  in-house,  or ready  to buy)  with  budget  providing | 3.2.1.2  Project              | 3.2.1.2  1 | 3.2.1.2  12  months       | 3.2.1.2  MOH                                                          | 3.2.1.2  MOH/  Informati on  system  departm ent | 3.2.1.2  To be  determin ed             | 3.2.1.2  MOH  | See  above |
| 3.2.1.3  Agreeme nt  between  IPC  directora te and  informati on  system  dep. to  choose  one  system                 | 3.2.1.3  Agreeme nt letter    | 3.2.1.3  1 | 3.2.1.3  1 year 3  months | 3.2.1.3  MOH  directora te/Healt h  Informati on  system  departm ent | 3.2.1.3  MOH/  IPC                               | 3.2.1.3  None                           | 3.2.1.3  None | See  above |
| 3.2.1.4  Apply the  system in  the  hospitals                                                                           | 3.2.1.4  System  applicati on | 3.2.1.4  1 | 3.2.1.4  1 year 9  months | 3.2.1.4  Hospitals                                                    | 3.2.1.4  MOH/  IPC  directora te/  Informati     | 3.2.1.4  To be  determin ed by the  MOH | 3.2.1.4  MOH  | See  above |

|                                                                                     |                                                                                                                                            |                                      |    |                               |                                 |                                        |                                               | on  system  departm ent/Hosp itals                                                                                         |                                                          |                 |                            |
|-------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------|----|-------------------------------|---------------------------------|----------------------------------------|-----------------------------------------------|----------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------|-----------------|----------------------------|
|                                                                                     | 3.2.1.5  Apply the  Digital   HAI/AMR   System  for  National  data  collectio n from  individua l  hospitals  to  central  IPC  directora | from                                 | -  | 3.2.1.5  System  applicati on | 3.2.1.5  1                      | 3.2.1.5  2 years  3.2.2.1.1   2 months | 3.2.1.5  Hospitals  3.2.2.1.1  MOH/Ho spitals | 3.2.1.5  MOH/  IPC  directora te/Infor mation  system  departm ent/Hosp itals  3.2.2.1.1  MOH/  Informati on  system  dep. | 3.2.1.5  To be  determin ed by the  MOH  3.2.2.1.1  None | 3.2.1.5  MOH    | See  above                 |
| 3.2.2 To  Shift all  hospital  informati on  system  from  paper to  digital  mode. | te  3.2.2.1  MOH  recomme nds from  hospitals  to have  an  electroni c patient  and data  informati on  system.                           | 3.2.2.1.1  Letter  MOH to  hospitals |    | 3.2.2.1.1  Letter             | 3.2.2.1.1   1 to each  hospital |                                        |                                               |                                                                                                                            |                                                          | 3.2.2.1.1  None | 3.2.2.1.1  Letter is  sent |

|                                                                                   | 3.2.2.2  Increase  the  number  of  hospitals  that have   digitalize d their  medical  informati on                         | -                                                                                                                 | -   | -   | 3.2.2.2  Digital  informati on  system in  each  hospital   | 3.2.2.2  1/hospit al                                                | 3.2.2.2   5 years    | 3.2.2.2  Hospitals   | 3.2.2.2  Hospitals /MOH/  Informati on  system  dep.   | 3.2.2.2   to be  determin ed by  MOH   | 3.2.2.2  Private  hospitals:  the  hospitals  themselv es  Public  hospitals:  MOH   | 3.2.2.2   %  hospitals  with  digital  informati on  system                |
|-----------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-----|-----|-------------------------------------------------------------|---------------------------------------------------------------------|----------------------|----------------------|--------------------------------------------------------|----------------------------------------|--------------------------------------------------------------------------------------|----------------------------------------------------------------------------|
| 3.2.3  Connect  Infection  Control  Departm ents to  electroni c medical  records | system  3.2.3.1  Connect  Infection  Control  departm ents in all  hospitals  with the  HIS and  LIS at the  hospital  level | 3.2.3.1.1  Letter  from  MOH to  ask all  hospitals  to  connect  IC dep.  with HIS  and LIS  at the  hospital  - | -   |     | 3.2.3.1.1  Letter                                           | 3.2.3.1.1  all  private  hospitals  all  governm ental  hospitals   | 3.2.3.1.1   2 months | 3.2.3.1.1  MOH       | 3.2.3.1.1  Hospitals  MOH/Inf ormation  system  dep.   | 3.2.3.1.1  None                        | 3.2.3.1.1  None                                                                      | 3.2.3.1.1  % IC dep  connecte d with  HIS/LIS in  hospitals                |
|                                                                                   |                                                                                                                              | 3.2.3.1.2  Decree  from  MOH to  all  hospitals  who  have an  electroni                                          | -   | -   | 3.2.3.1.2  Letter                                           | 3.2.3.1.2  all  private  hospitals /  all  governm ental  hospitals | 3.2.3.1.2   4 months | 3.2.3.1.2  MOH       | 3.2.3.1.2  MOH                                         | 3.2.3.1.2  No                          | 3.2.3.1.2  Hospitals                                                                 | 3.2.3.1.2   % IC dep  connecte d with  electroni c AMR  data in  hospitals |

|                                                                                                            | c Health  informati on  system  to link  their Lab  AMR  data to  the  Hospital  system   |                                                                                  |         |             |                   |                         |                                                  |                                      |              |                                                                                 |
|------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|---------|-------------|-------------------|-------------------------|--------------------------------------------------|--------------------------------------|--------------|---------------------------------------------------------------------------------|
| 3.2.3.2  Develop  electroni c  outbreak  reporting  system  for data  entry,  analysis  and    generati ng |                                                                                           | 3.2.3.2  electroni c  outbreak  reporting  system                                | 3.2.3.2 | 1 central   | 3.2.3.2   3 years | 3.2.3.2  MOH            | 3.2.3.2  MOH  /Informa tion  system  departm ent | 3.2.3.2   to be  determin ed by  MOH | 3.2.3.2  MOH | 3.2.3.2  electroni c  outbreak  reporting  system  available                    |
| 3.2.3.3  Develop  electroni c  reporting  system  for data  entry,  analysis  and                          |                                                                                           | 3.2.3.3  Electroni c system  for data  collectio n  analysis  and    generati ng |         | 3.2.3.3   1 | 3.2.3.3   3 years | 3.2.3.3  MOH/Ho spitals | 3.2.3.3  MOH  /Informa tion  system  departm ent | 3.2.3.3   to be  determin ed by  MOH | 3.2.3.3  MOH | 3.2.3.3  Bundles  data  collectio n,  analysis  and  generati on of  hospital / |

|                                                                                                 | generati ng  hospital/ national  reports  for  bundles  of care.                                                                           |                                                                                                                      |                                                                                                 |                                                                                                 | hospitals  /national  reports  for  bundles  process  and  outcome  indicator s                 |                                                                                                 |                                                                                                 |                                                                                                 |                                                                                                 |                                                                                                 |                                                                                                 | national   reports is  done  through.  an  electroni c  advance d system  Yes/No                        |
|-------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|
|                                                                                                 | 3.2.3.4  Develop  electroni c  infection  preventi on and  control  system  capable  of self- identifyin g HAI  and  detecting  outbreak s | 3.2.3.4.1  Electroni c system  has a  function  for self  diagnosis  of HAIs  and  automati cally  detects  outbreak |                                                                                                 |                                                                                                 | 3.2.3.4.1  Function  in the  electroni c system                                                 | 3.2.3.4.1   1                                                                                   | 3.2.3.4.1    5 years                                                                            | 3.2.3.4.1  MOH/Ho spitals                                                                       | 3.2.3.4.1  MOH/  Informati on  system  departm ent                                              | 3.2.3.4.1  to be  determin ed by  MOH                                                           | 3.2.3.4.1  MOH                                                                                  | 3.2.3.4.1  % of HAIs  and  outbreak s   in  hospitals  are  automati cally  detected  by the IT  system |
| Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW.                                            | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW.                      | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW.         |
| 3.3.1  Include  IPC as a  core  element  in  educatio n and                                     | 3.3.1.1  Include  infection  control in  undergra duate  curricula  for                                                                    | 3.3.1.1.1  Prepare  module  about  IPC and  AMR to  be  included                                                     | -                                                                                               | -                                                                                               | 3.3.1.1.1  Educatio nal IPC  module                                                             | 3.3.1.1.1   1                                                                                   | 3.3.1.1.1   2 years                                                                             | 3.2.1.1.1   MOH                                                                                 | 3.3.1.1.1   MOH/IPC  directora te                                                               | 3.3.1.1.1   None                                                                                | 3.3.1.1.1   MOH                                                                                 | 3.3.1.1.1   Module  is  available                                                                       |

| training  of  healthcar e  professio nals   | health  care  students  (medical,  nursing,  dental  and  pharmac eutical).   | in all  health  specialtie s in  universiti es/PAAE T.                                                                                            |    |    |                                                            |               |                      |                          |                                  |                 |               |                                                               |
|---------------------------------------------|-------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------|----|----|------------------------------------------------------------|---------------|----------------------|--------------------------|----------------------------------|-----------------|---------------|---------------------------------------------------------------|
|                                             |                                                                               | 3.3.1.1.2  MOH  letter to  MOHE  and  PAAET to  ask to  include  this  modules  into the  undergra ds and  graduate  health  students'  curricula | -  | -  | 3.3.1.1.2  1 letter  to MOHE   and  Letter to  PAAET       | 3.3.1.1.2   2 | 3.3.1.1.2   2 years  | 3.2.1.1.2  MOH           | 3.3.1.1.2  MOH/IPC  Directora te | 3.3.1.1.2  None | 3.3.1.1.2  No | 3.3.1.1.2  Letters  sent                                      |
|                                             |                                                                               | 3.3.1.1.3  Modules  sent to  Kuwait  universit y/ PAAET  to  include it  in  curricula                                                            |    |    | 3.3.1.1.3  Module  sent to  Kuwait  Universit y and  PAAET | 3.3.1.1.3   1 | 3.3.1.1.3  2.5 years | 3.3.1.1.3  MOHE /  PAAET | 3.3.1.1.3  MOHE /  PAAET         | 3.3.1.1.3  None | 3.3.1.1.3  No | 3.3.1.1.3  % health  specialtie s that  include   IPC  module |

| 3.3.2  Enhance  IPC  educatio n among    undergra duates  and  higher  educatio n health  students   | 3.3.2.1  Include  infection  control in  continuin g  educatio n of  healthcar e  workers  and  mandato ry  prerequis ite for  promotio n   | 3.3.2.1.1  Provide  IPC  courses  with CE  credits in  universiti es,  hospitals , MOH,  PAAET  PAAF  Include  CME  Credit   10% IPC   | 3.3.2.1.1  IPC  courses   | 3.3.2.1.1  At least  once/yea r in  universiti es /IPC  directora te and  PAAF   | 3.3.2.1.1   2 years   | 3.3.2.1.1  Universiti es/  Hospitals /  IPC  Directora te/  PAAET  PAAF   | 3.3.2.1.1  IPC  directora te/MOHE  / PAAET /  PAAF   | 3.3.2.1.1  No  extra   | 3.3.2.1.1  Universiti es/  Hospitals / PAAET /  PAAF   | 3.3.2.1.1  Number  of IPC  courses/  year                                          |
|------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------|---------------------------|----------------------------------------------------------------------------------|-----------------------|---------------------------------------------------------------------------|------------------------------------------------------|------------------------|--------------------------------------------------------|------------------------------------------------------------------------------------|
|                                                                                                      |                                                                                                                                             | 3.3.2.1.2  Request  that  when CE  credits  for  physician s, nurses,  or  pharmaci                                                    | 3.3.2.1.2  Decree         | 3.3.2.1.2   -1 for  physician s  -1 for  Nurses  -1 for  pharmaci sts.           | 3.3.2.1.2   3 months  | 3.3.2.1.2  MOH                                                            | 3.3.2.1.2  MOH/IPC  Directora te                     | 3.3.2.1.2  None        | 3.3.2.1.2  None                                        | 3.3.2.1.2  %  professio nals have  10% of  their CE  credits  are  related  to IPC |

|                                                                                      | sts is  needed,  10% of  these  credits  should  be about  IPC.                                              |                                                                                       |                                   |                                                 |                                                    |                            |                           |                                         |                        |                        |                                                                                                                              |
|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------|-----------------------------------|-------------------------------------------------|----------------------------------------------------|----------------------------|---------------------------|-----------------------------------------|------------------------|------------------------|------------------------------------------------------------------------------------------------------------------------------|
|                                                                                      | 3.3.2.1.3  In  hospitals , yearly  and  upon  employm ent,  mandato ry  attendan ce of IPC  lectures         | -                                                                                     | -                                 | 3.3.2.1.3  Letter  from  MOH to  all  hospitals | 3.3.2.1.3   1 to each  hospital                    | 3.3.2.1.3   3 months       | 3.3.2.1.3  MOH/Ho spitals | 3.3.2.1.3  MOH/Ho spitals               | 3.3.2.1.3  None        | 3.3.2.1.3  None        | 3.3.2.1.3  %  hospitals  that  mandate d that all  employe e get IPC  training  upon  employm ent and  yearly  IPC  lecture. |
| 3.3.2.2  Hygiene  and IPC  educatio n  provided  outside  formal  teaching  programs | 3.3.2.2.1  Require  IPC  educatio n by drug  compani es,  hospitals , LTCFs,  FAO, and  medical/ veterinar y | 3.3.2.2.1. 1  Request  to  include  few  topics  about IPC  in  conferen ces  agendas | 3.3.2.2.1. 11  Letter to  be sent | 3.3.2.2.1. 11  letter                           | 3.3.2.2.1. 1  1   letter  /associati on or  entity | 3.3.2.2.1. 1  1   6 months | 3.3.2.2.1. 1  1   MOH     | 3.3.2.2.1. 1  1   MOH/Dir ectorate  IPC | 3.3.2.2.1. 1  1   None | 3.3.2.2.1. 1  1   None | 3.3.2.2.1. 1  1   Yes/No                                                                                                     |

<!-- image -->

|                                                                                                                       |                                                                 | associati ons                                                   |                                                                 |                                                                 |                                                                                                                      |                                                                 |                                                                 |                                                                 |                                                                 |                                                                 |                                                                 |                                                                 |
|-----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|
| Strategic Objective 3.4 Prevent occupational infections in HCWs                                                       | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs                                                      | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs |
| 3.4.1  Develop  a  compreh ensive  program  of  vaccinati on to  protect  HCWs  from  vaccine  preventa ble  diseases | -                                                               | -                                                               | -                                                               | -                                                               | 3.4.1   HCW  vaccinati on  program                                                                                   | 3.4.1   1 all  inclusive                                        | 3.4.1   Available  And  applied                                 | 3.4.1   MOH                                                     | 3.4.1   MOH/Pu blic  Health  directora te                       | 3.4.1   Price of  vaccines                                      | 3.4.1   MOH                                                     | 3.4.1   % of  HCWs  professio nals that  are  vaccinate d       |
| 3.4.2  Develop  policies  and  procedur es to  protect  healthcar e  workers  from  occupati onal  exposure  to       | -                                                               | -                                                               | -                                                               | -                                                               | 3.4.2   policies  and  procedur es to  protect  healthcar e  workers  from  occupati onal  exposure  to  infection s | 3.4.2  1                                                        | 3.4.2  Available   And  applied                                 | 3.4.2  MOH                                                      | 3.4.2   MOH                                                     | 3.4.2   None                                                    | 3.4.2  None                                                     | 3.4.2  Yes/No                                                   |

<!-- image -->

| infection s.                                                                                                                      |                                                                                       |                                                                |                                                                |                                                                |                                                                |                                                                |                                                                |                                                                |                                                                |                                                                                         |                                                                                  |
|-----------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|-----------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|
| 3.4.3  Availabili ty of  Airborne  Isolation   Rooms in  all  hospitals                                                           | g   mapping   and  updating  the  recomme ndations  accordin g to the  expected  need | -                                                              | - -                                                            | 3.4.3.1  Mapping  and   Updated  recomme ndations              | 3.4.3.1  1/1                                                   | 3.4.3.1   5 years                                              | 3.4.3.1  MOH/Ho spitals                                        | 3.4.3.1  MOH/En gineering  Directora te                        | 3.4.3.1  None                                                  | 3.4.3.1  MOH for   Public  hospitals  private  hospitals:  the  hospitals  themselv es. | 3.4.3.1  Yes/No                                                                  |
| 3.4.4  Mandate  to  hospitals  to  provide  airborne  isolation  rooms  (AII)  available  as per  the   updated  recomme ndations | -                                                                                     | -                                                              | -  -                                                           | 3.4.4  Mandate                                                 | 3.4.4  1/hospit al                                             | 3.4.4   5 years                                                | 3.4.4  MOH                                                     | 3.4.4   MOH                                                    | 3.4.4  none                                                    | 3.4.4  none                                                                             | 3.4.4  Percent  hospitals  have  enough  AII  rooms as  per MOH  recomm endation |
| Strategic Objective 3.5 Adequate waste management in hospitals                                                                    | Strategic Objective 3.5 Adequate waste management in hospitals                        | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals                          | Strategic Objective 3.5 Adequate waste management in hospitals                   |
| 3.5.1                                                                                                                             | 3.5.1.1                                                                               | 3.5.1.1.1                                                      | 3.5.1.1.1. 1  -                                                | 3.5.1.1.1. 1                                                   | 3.5.1.1.1. 1                                                   | 3.5.1.1.1. 1                                                   | 3.5.1.1.1. 1                                                   | 3.5.1.1.1. 1                                                   | 3.5.1.1.1. 1                                                   | 3.5.1.1.1. 1                                                                            | 3.5.1.1.1. 1                                                                     |

| Put  National  Guideline s   | National  policies,  strategie s and  plans for  healthcar e waste  manage ment is  in place   | Unify  recomm endation s  between  KEPA  and  MOH   | Create a  committe e from  MOH and  KEPA  that  unifies  the  recomme ndation  and the  road map  of all  types of  waste  that are  generate d in  healthcar e   | Committ ee             | 1               | 6 months             | MOH/KE PA          | MOH                | None               | None               | Committ ee  members  are  nominat ed                                                                                                    |
|------------------------------|------------------------------------------------------------------------------------------------|-----------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------|-----------------|----------------------|--------------------|--------------------|--------------------|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------|
|                              |                                                                                                |                                                     | 3.5.1.1.1. 2  The  committe e reviews  waste  policies  that are  related  to HCF  and  unifies  recomme ndations  and  provides                                  | 3.5.1.1.1. 2  Revision | 3.5.1.1.1. 2  1 | 3.5.1.1.1. 2  1 year | 3.5.1.1.1. 2  KEPA | 3.5.1.1.1. 2  KEPA | 3.5.1.1.1. 2  None | 3.5.1.1.1. 2  None | 3.5.1.1.1. 2  Percent  chapters  that  represen t conflict  between  recomm endation s of the 2  ministrie s  that have  been  reviewed |

|                                                                  |                                                                                                   |    | the  proper  ways of  supervisi on   |    |                      |            |                                  |               |                    |                             |               | and  unified                                                           |
|------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|----|--------------------------------------|----|----------------------|------------|----------------------------------|---------------|--------------------|-----------------------------|---------------|------------------------------------------------------------------------|
| 3.5.2  Supervisi on of  waste  disposal  from  public  hospitals | 3.5.2.1  Create a  committ ee for  the  supervisi on of  waste  disposal  from  public  hospitals | -  | -                                    | -  |                      |            | 3.5.2.1  Available  and  ongoing |               |                    |                             |               | 3.5.2.1  Available  and  ongoing                                       |
| 3.5.3  Supervisi on of  waste  disposal  in private  hospitals   | 3.5.3.1  Create a  committ ee for  the  supervisi on of  waste  disposal  in private              | -  | -                                    | -  | 3.5.3.1  Committ ee  | 3.5.3.1  1 | 3.5.3.1  1 year                  | 3.5.3.1  KEPA | 3.5.3.1  MOH/KE PA | 3.5.3.1  None               | 3.5.3.1  None | 3.5.3.1  Yes/No                                                        |
| 3.5.4  Waste  policies  are being  audited  by KEPA              | 3.5.4.1  Organiza tion of  supervisi on of  waste  disposal                                       | -  | -                                    | -  | 3.5.4.1  Audit  plan | 3.5.4.1  1 | 3.5.4.1  1.5 years               | 3.5.4.1  KEPA | 3.5.4.1  KEPA      | 3.5.4.1  1  employe e  KEPA | 3.5.4.1  KEPA | 3.5.4.1  % Public  hospitals  are being  audited  for waste  disposal. |

|                                                                                                                     | inside  and from  private  hospitals                                                                                |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     |
|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|
|                                                                                                                     | 3.5.4.2  Designat e 1 unit  at KEPA  to  oversee  the  waste in  hospitals                                          |                                                                                                                     | -                                                                                                                   | -                                                                                                                   | 3.5.4.2  1 Unit  At KEPA                                                                                            | 3.5.4.2  1                                                                                                          | 3.5.4.2  1 year                                                                                                     | 3.5.4.2  KEPA                                                                                                       | 3.5.4.2  MOH/KE PA                                                                                                  | 3.5.4.2  to be  determin ed                                                                                         | 3.5.4.2  KEPA/Pri vate  hospitals /MOH                                                                              | 3.5.4.2  % Private  hospitals  where  waste  manage ment is  being  supervise d                                     |
| Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings |
| 3.6.1  Availabili ty of IPC  guideline s in  veterinar y  practices                                                 | 3.6.1.1  Impleme ntation  of OIE  guideline s  regarding  IPC in  veterinar y field                                 | PAAF  that  regularly  checks  updates  in OIE  guideline s  regardin g IPC in  veterinar y field,                  | -                                                                                                                   | -                                                                                                                   | 3.6.1.1.1  IPC  Committ ee in  PAAF                                                                                 | 3.6.1.1.1  1                                                                                                        | 3.6.1.1.1  6 months                                                                                                 | 3.6.1.1.1  PAAF                                                                                                     | 3.6.1.1.1  PAAF                                                                                                     | 3.6.1.1.1  None                                                                                                     | 3.6.1.1.1  None                                                                                                     | 3.6.1.1.1  Committ ee is  formed                                                                                    |

|                                               |                                                                                                                          | accordin gly                                                                                                             |                                      |                                       |                               |              |                     |                 |                                     |                 |                 |                                                                            |
|-----------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|--------------------------------------|---------------------------------------|-------------------------------|--------------|---------------------|-----------------|-------------------------------------|-----------------|-----------------|----------------------------------------------------------------------------|
|                                               |                                                                                                                          | 3.6.1.1.2  Overseei ng the  impleme ntation  of  national  IPC  guideline s in Vet  field and  OIE good  practices       | 3.6.1.1.2  Regular  audits to  farms | 3.6.1.1.2  Put a  yearly  audit  plan | 3.6.1.1.2  Plan               | 3.6.1.1.2  1 | 3.6.1.1.2  1 year   | 3.6.1.1.2  PAAF | 3.6.1.1.2  PAAF                     | 3.6.1.1.2  none | 3.6.1.1.2  none | 3.6.1.1.2  % Farms  that are  being  audited  yearly  for IPC  measure s.  |
| 3.6.2  Include  IPC in  licensing  of Vets    | 3.6.2.1  Include  question s about  OIE IPC  guideline s and  vaccinati ons in all  vets  licensing  exams or  interview | 3.6.2.1.1  Prepare  a set of  question s related  to IPC in  Vets to  be  included  in  licensing  exams  and  interview | -                                    | -                                     | 3.6.2.1.1  Set of  question s | 3.6.2.1.1  1 | 3.6.2.1.1  6 months | 3.6.2.1.1  PAAF | 3.6.2.1.1  IPC  Committ ee in  PAAF | 3.6.2.1.1  none | 3.6.2.1.1  none | 3.6.2.1.1  Availabili ty of IPC  question s in  licensing  exams  (Yes/No) |
| 3.6.3  Include  IPC in  Continuo us  educatio | 3.6.3.1  Prepare  a slide  bank  related  to IPC in                                                                      | -                                                                                                                        | -                                    | -                                     | 3.6.3.1  IPC slide  bank      | 3.6.3.1  1   | 3.6.3.1  6 months   | 3.6.3.1  PAAF   | 3.6.3.1  PAAF                       | 3.6.3.1  none   | 3.6.3.1  none   | 3.6.3.1  Yes/No                                                            |

<!-- image -->

| n of Vets  and  professio nals in  Agricultu re          | vet and  agricultu re, to be  given to  drug  compani es that  usually  do the  continuo us  educatio n                            |    |                                                            |            |                   |               |                    |               |               |                                                         |
|----------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------|----|------------------------------------------------------------|------------|-------------------|---------------|--------------------|---------------|---------------|---------------------------------------------------------|
|                                                          | 3.6.3.2  Mandate  that all  drug  company  events or  seminars  include a  specific  number  of slides  related  to IPC  and  AMR. | -  | 3.6.3.2  Mandate                                           | 3.6.3.2  1 | 3.6.3.2  9 months | 3.6.3.2  PAAF | 3.6.3.2  PAAF      | 3.6.3.2  None | 3.6.3.2  None | 3.6.3.2  Mandate  available  or not                     |
| 3.6.4  Include  hygiene  and  infection  preventi on and | 3.6.4.1  Close  communi cation  between.  FAO and  PAAF to                                                                         | -  | 3.6.4.1  Yearly  educatio n plan  that  targets  vaccinati | 3.6.4.1  1 | 3.6.4.1  1 year   | 3.6.4.1  PAAF | 3.6.4.1  PAAF/FA O | 3.6.4.1  None | 3.6.4.1  None | 3.6.4.1  Joint  educatio n plan  between  FAO and  PAAF |

N.B. Refer to Annex 4 for IPC Axis Strategic and Monitory plans

<!-- image -->

| control  as core  content  in  training  of  veterinar y  professio nals.   | put a  joint  yearly  plan of  educatio n  activities  related  to IPC.                                                                               |    | on and  IPC           |           |                     |                                      |                                           |                 |                 | that  includes  IPC- related  training   |
|-----------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|----|-----------------------|-----------|---------------------|--------------------------------------|-------------------------------------------|-----------------|-----------------|------------------------------------------|
|                                                                             | 3.6.4.2  Include  hygiene  and  infection  preventi on and  control  as  mandato ry  prerequis ite for  promotio n of for  the  veterinar y  workers. | -  | 3.6.4.2.1  Mandate  1 | 3.6.4.2.1 | 3.6.4.2.1  6 months | 3.6.4.2.1  Veterinar y  associati on | 3.6.4.2.1  PAAF/Ve terinary  associati on | 3.6.4.2.1  None | 3.6.4.2.1  None | 3.6.4.2.1  Mandate  available  or not    |

## Antimicrobial Use Operational and Budget Plan

## Global action plan strategic objective 4: Optimize the use of antimicrobial medicines in human and animal health.

| Activity                                                                                                           | Sub- activity                                                                                                      | Sub-sub- activity                                                                                                  | Unit                                                                                                               | Quantity                                                                                                           | Date                                                                                                               | Location                                                                                                           | Responsibl e entity                                                                                                | Cost                                                                                                               | Source   Of funding                                                                                                | Indicator                                                                                                          |
|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar |
| 4.1.1  Identify  who will be  the ABX  arm pillar  focal point  in each  ministry  /authority  and assign  the TOR |                                                                                                                    |                                                                                                                    |                                                                                                                    |                                                                                                                    | 4.1.1   6 months                                                                                                   |                                                                                                                    | MOH  -PAAF  -KEPA  -PAFN                                                                                           | 4.1.1  Already  available                                                                                          | 4.1.1 None                                                                                                         | 4.1.1  available                                                                                                   |
| 4.1.2  Prepare  clear TOR  of the focal  person for  ABX in each  ministry/au thority                              |                                                                                                                    |                                                                                                                    | 4.1.2  TOR                                                                                                         | 4.1.2  1                                                                                                           | 4.1.2  2 months                                                                                                    | 4.1.2  MOH                                                                                                         | 4.1.2  AMR  committee  that  reports to  secretary                                                                 | 4.1.2  None                                                                                                        | 4.1.2  None                                                                                                        | 4.1.2  Yes/No                                                                                                      |
| 4.1.3  Assign the  job to a  defined  person/pos ition in  each  ministry/au thority,                              |                                                                                                                    |                                                                                                                    | 4.1.3  Letter of  assignment  of duties                                                                            | 4.1.3  1/each  ministry                                                                                            | 4.1.3  3 months                                                                                                    | 4.1.3  -MOH  -PAAF  -KEPA  PAFN                                                                                    | 4.1.3  AMR   Inter- ministerial/ authorities  executive  committee                                                 | 4.1.3  None                                                                                                        | 4.1.3  None                                                                                                        | 4.1.3  Proportion  of  ministries/ authorities  where ABX  arm focal  person is  assigned                          |

| and  nomination  by each  ministry/au thority                                               |                                                                                             |                                                                                             |                                                                                             |                                                                                                                 |                                                                                             |                                                                                             |                                                                                             |                                                                                             |
|---------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|
| 4.1.4  Put TOR   And   reimburse ment plan  for  the  different   tasks.                    | 4.1.4  TOT/  Reimburse ment   plan                                                          | 4.1.4  1                                                                                    | 4.1.4  3 months                                                                             | 4.1.4  MOH                                                                                                      | 4.1.4  NMCG/  Focal  person                                                                 | 4.1.4  None                                                                                 | 4.1.4  None                                                                                 | 4.1.4  Yes/No                                                                               |
| 4.1.5  Nominate  the  stakeholde rs for the  task force  of the pillar                      | 4.1.5  Decree  with names  of  stakeholde rs                                                | 4.1.5  1                                                                                    | 4.1.5  4 months                                                                             | 4.1.5  MOH  PAAF  KEPA PAFN                                                                                     | 4.1.5  MOH  PAAF  KEPA   PAFN                                                               | 4.1.5  None                                                                                 | 4.1.5  None                                                                                 | 4.1.5  ABX use  task force   group is  formed   Yes/No                                      |
| Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines                     | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines |
|                                                                                             | 4.2 Already  available                                                                      |                                                                                             | 4.2 System  is in place                                                                     | ( Pharmace utical and  Herbal  Medicines  Registratio n and  Control  Administrat ion/Drug  Inspection  Control |                                                                                             |                                                                                             |                                                                                             | 4.2 Already  available                                                                      |
| 4.2.1 Put  clear  criteria for                                                              |                                                                                             |                                                                                             | 4.2.1  System is in  place                                                                  |                                                                                                                 |                                                                                             |                                                                                             |                                                                                             | 4.2.1  System is in  place                                                                  |

| standards  of quality  safety   and  efficiency  of ABX                                                                                                                           |                                                                                                                |                                  |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|----------------------------------|
| 4.2.2 Put a  system of  controlling  that all  available  ABX in the  country  should    meet the  internation al  standards  listed  above  otherwise  they are  not  allowed to | 4.2.2  Already  available,  Only ABX  that are  licensed by  WHO,  EMEA or  FDA,   are allowed  in the  market | 4.2.2  Already  available        |
| 4.2.3 All  ABX should  be tested  by a system  that  identifies  counterfeit  prior to  licensing.                                                                                | 4.2.3  Available                                                                                               | 4.2.3  System  already in  place |
| 4.2.4 Put  regulations                                                                                                                                                            | 4.2.4  Available                                                                                               | 4.2.4  System                    |

| that  prohibit  the sale of  counterfeit  products                                                                                                    |                  | already in  place                 |
|-------------------------------------------------------------------------------------------------------------------------------------------------------|------------------|-----------------------------------|
| 4.2.5 The  system that  controls  quality  assurance  of ABX has  the  authority  to stop  counterfeit  products  from being  licensed  and  marketed | 4.2.5  available | 4.2.5  System  already   In place |

## Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics

| 4.3.1  Develop  and  implement  national  essential  medicine  list guided  by the  WHO  Model List  of Essential  Medicines   | 4.3.1.1  Finalize the  essential  medicine  list that is   being  prepared at  MOH   | 4.3.1.1  National   list issued  and   endorsed  by MOH  director  general   | 4.3.1.1   1   | 4.3.1.1   6 months   | 4.3.1.1  MOH   | 4.3.1.1  Central  Medical  Stores  Directorate   | 4.3.1.1 No  need   Then  accordingly  might need  new need  antibiotics  that may  need a  budget   | 4.3.1.1 No  need   | 4.3.1.1 List  is issued   Yes/No   |
|--------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|------------------------------------------------------------------------------|---------------|----------------------|----------------|--------------------------------------------------|-----------------------------------------------------------------------------------------------------|--------------------|------------------------------------|
| 4.3.2  Mandate                                                                                                                 |                                                                                      | 4.3.2  Mandate                                                               | 4.3.2   1     | 4.3.2   6 months     | 4.3.2   MOH    | 4.3.2 MOH  Undersecre                            | 4.3.2   None                                                                                        | 4.3.2 None         | 4.3.2  Yes/No                      |

| that every  institution  has an  essential  medicine  list                                                                                                                        |                                                                                                                                                                                         |                                                                                                             |                      |               |                      |                | tary  general/  ABX focal  person                            |                 |                 |                                                                                          |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------|----------------------|---------------|----------------------|----------------|--------------------------------------------------------------|-----------------|-----------------|------------------------------------------------------------------------------------------|
| 4.3.3 Each  institution  has an  essential  medicine  list and this  is checked  in  accreditati on  standards  include  checking  the  availability  of the  essential  medicine | 4.3.3.1  Mandate  from MOH  that once  the   national  essential  medicine  list is  available,  all hospitals  including  public and  private  hospitals  should  formulate  their own |                                                                                                             | 4.3.3.1  Mandate     | 4.3.3.1   1   | 4.3.3.1   8 months   | 4.3.3.1   MOH  | 4.3.3.1   MOH  Undersecre tary  general /  Abx focal  person | 4.3.3.1   None  | 4.3.3.1   None  | 4.3.3.1   Yes/No                                                                         |
|                                                                                                                                                                                   | 4.3.3.2  Include   the  availability  of essential  medicine  list into   the license  renewal                                                                                          | 4.3.3.2.1  Private  hospital  renewal  license   checklist  should  include the  availability  of essential | 4.3.3.2.1  Checklist | 4.3.3.2.1   1 | 4.3.3.2.1   8 months | 4.3.3.2.1  MOH | 4.3.3.2.1  Medical  Licensing  Dep/  MOH                     | 4.3.3.2.1  None | 4.3.3.2.1  None | 4.3.3.2.1  Licensing  checklist  includes  the item of  essential  medicine  list or not |

|                                                                                                                                                                          | conditions  of private  hospitals                                                    | medicine  list                                                  |                                                                                                   |                                                                 |                                                                 |                                                                 |                                                                 |                                                                 |                                                                 |                                                                                      |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|-----------------------------------------------------------------|---------------------------------------------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|--------------------------------------------------------------------------------------|
| 4.3.4 Re  imburseme nt plan is  based on   essential  medicine  list    in public   and private  hospitals                                                               |                                                                                      |                                                                 | 4.3.4   After   issuing the  essential  medicine  list,  Mandate  from   Undersecre tary  General | 4.3.4   1                                                       | 4.3.4   8 months                                                | 4.3.4   MOH                                                     | 4.3.4 MOH/  Undersecre tary  General /  NMCG                    | 4.3.4   None                                                    | 4.3.4   None                                                    | 4.3.4   %  of  reimbursed  ABX   that are  listed in the   essential  medicine  list |
| Strategic Objective 4.4 Start AMS program in primary Healthcare                                                                                                          | Strategic Objective 4.4 Start AMS program in primary Healthcare                      | Strategic Objective 4.4 Start AMS program in primary Healthcare | Strategic Objective 4.4 Start AMS program in primary Healthcare                                   | Strategic Objective 4.4 Start AMS program in primary Healthcare | Strategic Objective 4.4 Start AMS program in primary Healthcare | Strategic Objective 4.4 Start AMS program in primary Healthcare | Strategic Objective 4.4 Start AMS program in primary Healthcare | Strategic Objective 4.4 Start AMS program in primary Healthcare | Strategic Objective 4.4 Start AMS program in primary Healthcare | Strategic Objective 4.4 Start AMS program in primary Healthcare                      |
| 4.4.1  Create a  technical  group that  puts  national  ABX use  guidelines  for  outpatient  care based  on  Internation al  guidelines  and   National  AMR  profiles: | 4.4.1.1 Put  TOR and   renewal   conditions  of the   focal group  of  stakeholde rs |                                                                 | 4.4.1.1   TOR                                                                                     | 4.4.1.1   1                                                     | 4.4.1.1   3 months                                              | 4.4.1.1  MOH                                                    | 4.4.1.1  MOH/  National  Committee  of proper  ABX use.         | 4.4.1.1  None                                                   | 4.4.1.1  None                                                   | 4.4.1.1 TOR  put   Yes or no                                                         |

| can be a  subcommit tee  from   the  national  task force  for the ABX  pillar for  proper use  of ABX   |                                                                                 |                             |                        |                    |               |                                                                                                     |                |                |                                         |
|----------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|-----------------------------|------------------------|--------------------|---------------|-----------------------------------------------------------------------------------------------------|----------------|----------------|-----------------------------------------|
|                                                                                                          | 4.4.1.2  Assign the  members  of this  committee                                | 4.4.1.2  Committee  members | 4.4.1.2   1  committee | 4.4.1.2   3 months | 4.4.1.2  MOH  | 4.4.1.2  MOH/  National  Committee  of proper  ABX use.                                             | 4.4.1.2  None  | 4.4.1.2  None  | 4.4.1.2 TOR  put   Yes or no            |
|                                                                                                          | 4.4.1.3 Put  TOR and  official   renewal  time   for the  guidelines  committee | 4.4.1.3   TOR               | 4.4.1.3   1            | 4.4.1.3   3 months | 4.4.1.3   MOH | 4.4.1.3   MOH/  National  Committee  of proper  ABX use.                                            | 4.4.1.3   None | 4.4.1.3   None | 4.4.1.3   TOR put   Yes or no           |
| 4.4.2  Guidelines  in primary  healthcare  are  available  and are  regularly  updated                   |                                                                                 | 4.4.2  Guidelines           | 4.4.2   1              | 4.4.2   6 months   | 4.4.2   MOH   | 4.4.2  Primary  Healthcare  Directorate  / technical  committee /  National  Committee  for ABX use | 4.4.2  None    | 4.4.2 MOH      | 4.4.2  Guidelines  available  Yes or no |

|                                                                                                                      | 4.4.2.1  Training  workshop  about ABX  guidelines  in primary  healthcare               |                                               | 4.4.2.1  Workshop                   | 4.4.2.1  Once/year                                     | 4.4.2.1   5 years    | 4.4.2.1  MOH                                       | 4.4.2.1  Primary  Health care  Directorate /   technical  committee   | 4.4.2.1   None                                                      | 4.4.2.1  MOH    | 4.4.2.1  Proportion  of primary  healthcare  physician  who attend  every year                  |
|----------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|-----------------------------------------------|-------------------------------------|--------------------------------------------------------|----------------------|----------------------------------------------------|-----------------------------------------------------------------------|---------------------------------------------------------------------|-----------------|-------------------------------------------------------------------------------------------------|
| /4.4.3  Apply   AMS   in primary  healthcare:  Monitoring  ABX  consumpti on and   Link  prescriptio n to  diagnoses | 4.4.3.1  Project ABX  consumpti on  documenta tion and   surveillanc e in  primary  care | 4.4.3.1.1  Put a  proposal  for this  project | 4.4.3.1.1  Proposal                 | 4.4.3.1.1   1                                          | 4.4.3.1.1   8 months | 4.4.3.1.1  Primary  Health care                    | 4.4.3.1.1  AMR  committee  /Primary  Health care  Directorate         | 4.4.3.1.1  COST:  No need  for extra  manpower                      | 4.4.3.1.1  None | 4.4.3.1.1  Project is  put                                                                      |
|                                                                                                                      | 4.4.3.2  Start  collecting  data and  link it to  diagnosis                              |                                               | 4.4.3.2  Data  collection           | 4.4.3.2  Same  number as  primary  healthcare  centers | 4.4.3.2   10 months  | 4.4.3.2  Primary  healthcare  centers              | 4.4.3.2  Primary  Healthcare  Directorate /Informatio n system  dep.  | 4.4.3.2   No                                                        | 4.4.3.2  No     | 4.4.3.2  Proportion  of primary  Healthcare  centers  that are  feeding  data into  the project |
|                                                                                                                      | 4.4.3.3  Data  analysis   and  feedback to  prescribers                                  |                                               | 4.4.3.3  Report   of analyzed  data | 4.4.3.3  Once/year                                     | 4.4.3.3   1 year     | 4.4.3.3  Central  primary  Heath care  Directorate | 4.4.3.3   Clinical  Pharmacist  in primary  Healthcare.               | 4.4.3.3  Employ 1   Clinical  pharmacist  in charge of  the project | 4.4.3.3  MOH    | 4.4.3.3  Proportion  of    primary  Healthcare  centers                                         |

|                                                                                                |                                                                                                                   |                                                      |                                                            |                       |                                              |                                                    | in primary  healthcare                    |                | that  receive  annual  report with  feedback  about ABX  prescriptio n                                |
|------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|------------------------------------------------------|------------------------------------------------------------|-----------------------|----------------------------------------------|----------------------------------------------------|-------------------------------------------|----------------|-------------------------------------------------------------------------------------------------------|
| 4.4.3.4  Employ  more   pharmacist s in primary  healthcare                                    |                                                                                                                   | 4.4.3.4  New  employed   Pharmacist s                | 4.4.3.4  According  to the  needed  clinical  pharmacist s | 4.4.3.4   1 year      | 4.4.3.4  Primary  Health  care/  MOH         | 4.4.3.4   Pharmaceu tical  Services  Directorate   | 4.4.3.4  Salaries for   new  pharmacist s | 4.4.3.4  MOH   | 4.4.3.4  Number of  pharmacist s that are  employed                                                   |
| 4.4.3.5  Improve  manpower  with  professiona ls for the  AMS  project in  primary  healthcare | 4.4.3.5.1  Train  available  pharmacist s on AMS  and clinical   pharmacy  principles                             | 4.4.3.5.1  Workshops /Courses                        | 4.4.3.5.1   To be  assessed                                | 4.4.3.5.1   18 months | 4.4.3.5.1  Primary  Health care  directorate | 4.4.3.5.1   ABX use  taskforce  group              | 4.4.3.5.1  30,000  KD/  workshop          | 4.4.3.5.1  MOH | 4.4.3.5.1  Number of  pharmacist s in primary  Health care  who have a  certificate  in AMS  training |
|                                                                                                | 4.4.3.5.2  Employ  new   clinical  pharmacist  specialized  in AMS and  1 full time  clinical  microbiolo gist in | 4.4.3.5.2  Clinical  pharmacist  specialized  in AMS | 4.4.3.5.2   2                                              | 4.4.3.5.2 1  8 months | 4.4.3.5.2  Primary  Healthcare  directorate  | 4.4.3.5.2   Pharmaceu tical  Services  Directorate | 4.4.3.5.2  Salary x2                      | 4.4.3.5.2  MOH | 4.4.3.5.2  Clinical  pharmacist s are  employed,  Yes/No                                              |

|                                                                                                                                                                        |                                                                                                    | primary  healthcare  directorate                                  |                                                                              |                                                                   |                                                                   |                                                                   |                                                                                    |                                                                        |                                                                   |                                                                   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|------------------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------------------------------------------------|------------------------------------------------------------------------------------|------------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------------------------------------------------|
| 4.4.4  Update the   digital  system   that is   available  in primary  healthcare  to  integrate   the ABX  guidelines   into the   electronic  system in  the form of |                                                                                                    |                                                                   | 4.4.4   ABX  guidelines  integrated  in primary  Heath care  digital  system | 4.4.4   1                                                         | 4.4.4   2 years                                                   | 4.4.4   Primary  Healthcare  directorate                          | 4.4.4   MOH/Prim ary  Healthcare / technical  committee /Informatio n System  Dep. | 4.4.4   To be  determined                                              | 4.4.4   MO                                                        | 4.4.4   updated  electronic  system  available                    |
| Strategic Objective 4.5 Apply AMS In Public and Private hospitals                                                                                                      | Strategic Objective 4.5 Apply AMS In Public and Private hospitals                                  | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals            | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals                  | Strategic Objective 4.5 Apply AMS In Public and Private hospitals      | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals |
| 4.5.1  Improve  and  measure  appropriat e use of  antimicrobi al agents in  healthcare                                                                                | 4.5.1.1  Nominate  who will be  the AMS   focal  person  (Could be  the ABX  pillar focal  person) |                                                                   | 4.5.1.1  Decree                                                              | 4.5.1.1  1                                                        | 4.5.1.1  3 months                                                 | 4.5.1.1  MOH                                                      | 4.5.1.1  MOH  Undersecre tary r  general  /NMCG                                    | 4.5.1.1  Already  employed  in MOH   No cost  (The Abx  focal  person) | 4.5.1.1  None                                                     | 4.5.1.1  AMS focal  person is  nominated                          |
| 4.5.2  Identify the  National                                                                                                                                          | 4.5.2.1  AMS  technical                                                                            |                                                                   | 4.5.2.1  Group of  specialists                                               | 4.5.2.1  1                                                        | 4.5.2.1  3 months                                                 | 4.5.2.1  MOH                                                      | 4.5.2.1  MOH/                                                                      | 4.5.2.1  Cost/Activit y /                                              | 4.5.2.1  MOH                                                      | 4.5.2.1  AMS                                                      |

| AMS Task  force  (Could be a  subcommit tee of the  ABX pillar  Task force)  the  National  AMS  Technical  team   | group is  assigned   (subgroup  from the  ABX  technical  committee.  +other  specialists  like IT, etc)                                                                                                           |              |            |                   |              | ABX  taskforce  group /  AMS Focal  person                                             | professiona l   |               | Technical  Task force  members  are  nominated  Yes/No   |
|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------------|--------------|----------------------------------------------------------------------------------------|-----------------|---------------|----------------------------------------------------------|
|                                                                                                                    | 4.5.2.2  TOR of the  technical  groups   are well  defined   They  include:  -guidelines  for  inpatient  and  outpatient  care.  -put or  endorse   diagnostic  pathways,  treatment  and  national  AMS  targets | 4.5.2.2  TOR | 4.5.2.2  1 | 4.5.2.2  3 months | 4.5.2.2  MOH | 4.5.2.2  ABX Pillar   Task force /  ABX focal  person/  MOH  Undersecre tary  general. | 4.5.2.2  None   | 4.5.2.2  None | 4.5.2.2  TOR put                                         |

| 4.5.3  Put  national  guidelines  eithe r de  novo  or  Endorse  existing  internation al  guidelines  with  regular   updates   | 4.5.3.1  MOH puts  national  guidelines  for  common  community  acquired  infections  (CAI)                                                                                                        |                                                                                                                                                     | 4.5.3.1  National  guidelines  for  common  CAI   | 4.5.3.1  1   | 4.5.3.1  6 months   | 4.5.3.1  MOH   | 4.5.3.1  AMS   Task force  Group                     | 4.5.3.1  none   | 4.5.3.1  MOH         | 4.5.3.1  CAI  guidelines   developed  Yes/No   |
|----------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------|--------------|---------------------|----------------|------------------------------------------------------|-----------------|----------------------|------------------------------------------------|
|                                                                                                                                  | 4.5.3.2  Hospitals  put  institutiona l guidelines  for  treatment  of  Healthcare  associated  infections  (HAI)  according  to their  local  epidemiolo gy, with the  help of  taskforce  members | 4.5.3.2.1  Mandate  for  hospitals to  issue HAI  treatment  guidelines  based on  local  epidemiolo gy and   with the  help of  taskforce  members | 4.5.3.2.1  Mandate                                | 4.5.3.2.1  1 | 4.5.3.2.1  6 months | 4.5.3.2.1  MOH | 4.5.3.2.1  MOH  Undersecre tary  General/Ta sk Force | 4.5.3.2.1  None | 4.5.3.2.1  None      | 4.5.3.2.1  Mandate   Yes/No                    |
|                                                                                                                                  |                                                                                                                                                                                                     | 4.5.3.2.2                                                                                                                                           | 4.5.3.2.2                                         | 4.5.3.2.2  1 | 4.5.3.2.2  8 months | 4.5.3.2.2      | 4.5.3.2.2  Task force                                | 4.5.3.2.2       | 4.5.3.2.2  Hospitals | 4.5.3.2.2                                      |

|                                                                                                       | Organize  the work of  taskforce  members  with the  different  hospitals to  assist in  putting  their own   HAI  guidelines       | Organizatio nal plan  and   distribution  of the  hospitals to  the  different  taskforce  members   |                                 |                        | MOH/  Hospitals           |                                               | To be  determined                          |                            | Proportion  of hospitals  that have  HAI   guidelines  based on  their own  epidemiolo gy.   |
|-------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------|---------------------------------|------------------------|---------------------------|-----------------------------------------------|--------------------------------------------|----------------------------|----------------------------------------------------------------------------------------------|
|                                                                                                       | 4.5.3.2.3  HAI  treatment  guidelines  should be  reviewed  every year                                                              | 4.5.3.2.3  Revision                                                                                  | 4.5.3.2.3  1                    | 4.5.3.2.3  once / year | 4.5.3.2.3  Hospitals/ MOH | 4.5.3.2.3  Hospitals/ MOH/  Taskforce         | 4.5.3.2.3  None                            | 4.5.3.2.3  None            | 4.5.3.2.3  Proportion  of hospitals  that have   guidelines   updated                        |
| 4.5.3.3  Disseminati on and  implement ation of  these  treatment  guidelines  in hospital  practice. | 4.5.3.3.1  Workshops  for  discussion  and   endorseme nt of these  guidelines  with  practicing  physicians  all over the  country | 4.5.3.3.1  Workshops                                                                                 | 4.5.3.3.1  Number of  hospitals | 4.5.3.3.1  1 year      | 4.5.3.3.1  MOH/Hosp itals | 4.5.3.3.1  MOH/  Taskforce/ ABX Focal  person | 4.5.3.3.1  Number of  workshops  X 5000 KD | 4.5.3.3.1  MOH             | 4.5.3.3.1  Number of  hospitals  where  guidelines  workshops  have been  performed          |
|                                                                                                       | 4.5.3.3.2  Distributio n of                                                                                                         | 4.5.3.3.2  Material                                                                                  | 4.5.3.3.2                       | 4.5.3.3.2  1 year      | 4.5.3.3.2  MOH/Hosp itals | 4.5.3.3.2  MOH/Hosp itals                     | 4.5.3.3.2  To be  determined               | 4.5.3.3.2  MOH/  Hospitals | 4.5.3.3.2  Proportion  of hospitals                                                          |

| educational  material in  the form of  booklets,  brochures,  posters,  &pocket  cards, or  equivalent  softcopies  available  on mobile  phones   |                        | 1 for  national  CAI  guidelines  1 for HAI  guidelines  in each  hospital   |                           |                      |                                                              |                              |                      | that have  the  softcopies  available  on the  mobile  phones of  staff                                      |
|----------------------------------------------------------------------------------------------------------------------------------------------------|------------------------|------------------------------------------------------------------------------|---------------------------|----------------------|--------------------------------------------------------------|------------------------------|----------------------|--------------------------------------------------------------------------------------------------------------|
| 4.5.3.3.3  Post the  guidelines  on the  MOH  website  and  integrate  them into  the  intranet of  each  hospital                                 | 4.5.3.3.3  IT project  | 4.5.3.3.3  1/Hospital                                                        | 4.5.3.3.3  1yr, 3  months | 4.5.3.3.3  Hospitals | 4.5.3.3.3  Hospitals/I nformation  System  Dep./Hospi tal IT | 4.5.3.3.3  To be  determined | 4.5.3.3.3  Hospitals | 4.5.3.3.3  Proportion  of hospitals  that have  the  guidelines  posted on  their  intranet                  |
| 4.5.3.3.4  Integrate   the  guidelines   into the   electronic  medical  record, in  the form of  pop-ups                                          | 4.5.3.3.4  IT  Project | 4.5.3.3.4  1/hospital                                                        | 4.5.3.3.4  2 years        | 4.5.3.3.4  Hospitals | 4.5.3.3.4  Hospitals/I nformation  System  Dep/  Hospital IT | 4.5.3.3.4  To be  determined | 4.5.3.3.4  Hospitals | 4.5.3.3.4  Proportion  of hospitals  that have  guidelines  recommen dations  integrated  in the  electronic |

|                                                                                               |                                                                                      |                                                                                                                                         |                                                                                      |                                                                                      |                                                                                      |                                                                                      |                                                                                      |                                                                                      |                                                                                      | medical  records  system                                                                                       |
|-----------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|
| 4.5.4  Make AMS  programs  mandatory  in each  hospital  (presence  of AMS  team/  committee) | 4.5.4.1  Mandate  by MOH for  this issue                                             |                                                                                                                                         | 4.5.4.1  Mandate                                                                     | 4.5.4.1  1                                                                           | 4.5.4.1  1 y 6  months                                                               | 4.5.4.1  MOH                                                                         | 4.5.4.1  MOH  Undersecre tary  General/  AMS Task  force.                            | 4.5.4.1  None                                                                        | 4.5.4.1  None                                                                        | 4.5.4.1  Mandate  issued  Yes/No                                                                               |
|                                                                                               | 4.5.4.2  Build AMS  manpower                                                         | 4.5.4.2.1  Train  microbiolo gists,  clinical  pharmacist s and  Infectious  Disease  specialists  on AMS  through  national  workshops | 4.5.4.2.1  Workshops                                                                 | 4.5.4.2.1  Depends  on the  REGIONS                                                  | 4.5.4.2.1  1 y 6  months                                                             | 4.5.4.2.1  Hospitals/  Universities /  MOH                                           | 4.5.4.2.1  Task force                                                                | 4.5.4.2.1  30,000 KD x  number of  workshops                                         | 4.5.4.2.1  MOH                                                                       | 4.5.4.2.1  Percent  microbiolog ists and  clinical  pharmacist s that have  attended at  least 1 AMS  workshop |
| Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants          | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                                                    | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                           |
| 4.6 ABX  used in the  agriculture/  veterinary   are under  the same  control as              |                                                                                      |                                                                                                                                         |                                                                                      |                                                                                      | 4.6 Already  available                                                               |                                                                                      |                                                                                      |                                                                                      |                                                                                      | 4.6 Already  available                                                                                         |

those used in humans

Pharmaceu tical and

Herbal

Medicines

Registratio n and

Control

Administrat ion/The

Dug

Inspection

Control

## Strategic Objective 4.7 Restrict the use of critically important ABX to human health in the veterinary field

| 4.7.1  Establish  the list of  critically  important  antibiotics  for humans  in the  animal  sector.   | 4.7.1  List   | 4.7.1  1   | 4.7.1  3 months   | 4.7.1  MOH      | 4.7.1  ABX   Task force   | 4.7.1  None   | 4.7.1  None   | 4.7.1  List put  Yes/No   |
|----------------------------------------------------------------------------------------------------------|---------------|------------|-------------------|-----------------|---------------------------|---------------|---------------|---------------------------|
| 4.7.2  Determine  from this  list which  antibiotics  should be  restricted  for use to                  | 4.7.2  List   | 4.7.2  1   | 4.7.2  3 months   | 4.7.2  PAAF/MOH | 4.7.2  ABX   Task force   | 4.7.2  None   | 4.7.2  None   | 4.7.2  List put  Yes/No   |
| 4.7.3                                                                                                    | 4.7.3  Decree | 4.7.3  1   | 4.7.3  6 months   | 4.7.3  PAAF     | 4.7.3                     | 4.7.3  None   | 4.7.3  None   | 4.7.3                     |

| Issue a  decree that  the  critically  important  ABX to  human  health are  not to be  used in  animals  whether in  individual  treatment  or in herd  therapy   |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                                      | ABX Task  force/  ABX Focal  person/  PAAF                                                                           |                                                                                                                      |                                                                                                                      | Decree  issued   Yes /No                                                                                             |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|
| 4.7.4  Prohibit  the  importatio n of these  critically   important  ABX for   vet use                                                                             | 4.7.4.1  Decree  that  prohibits  the   importatio n and sale  of these  ABX in the  vet field                       | 4.7.4.1  Decree                                                                                                      | 4.7.4.1  1                                                                                                           | 4.7.4.1  6 months                                                                                                    | 4.7.4.1  PAAF                                                                                                        | 4.7.4.1  PAAF                                                                                                        | 4.7.4.1  None                                                                                                        | 4.7.4.1  None                                                                                                        | 4.7.4.1  Decree is  issued   Yes/No                                                                                  |
| Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture.                                               | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. |
| 4.8.1  Put (or  endorse)  guidelines  regarding  the use of  ABX in  animals                                                                                       |                                                                                                                      | 4.8.1  Guidelines                                                                                                    | 4.8.1  1                                                                                                             | 4.8.1  8 months                                                                                                      | 4.8.1  PAAF/MOH                                                                                                      | 4.8.1  ABX Task  force  /PAAF  Focal  person                                                                         | 4.8.1  Bonus for  the  members                                                                                       | 4.8.1  PAAF/  MOH                                                                                                    | 4.8.1  Guidelines  are  established   Yes/No                                                                         |

| and  agriculture                                                                                           |                                                                                                                                  |                                               |                  |                    |               |                                          |                                           |               |                                                                                              |
|------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------|------------------|--------------------|---------------|------------------------------------------|-------------------------------------------|---------------|----------------------------------------------------------------------------------------------|
| 4.8.2  Disseminat e these  guidelines  among  veterinaria ns                                               | 4.8.2.1  Booklets/  Brochures/ app that  summarize  the key  points in  these  guidelines.                                       | 4.8.1.1  -Booklets  -Brochures  - Application | 4.8.1.1  3       | 4.8.1.1  18 months | 4.8.1.1  PAAF | 4.8.1.1  PAAF focal  person/PA AF        | 4.8.1.1  To be  determined                | 4.8.1.1  PAAF | 4.8.1.1  Proportion  of Vet  clinics   that have  easy access  to these  updated  guidelines |
|                                                                                                            | 4.8.2.1  Regular  workshops  for  veterinary  specialists  regarding  the  application  of these  guidelines                     | 4.8.2.1  Workshop                             | 4.8.2.1  2*/year | 4.8.2.1  1 year    | 4.8.2.1  PAAF | 4.8.2.1  PAAF                            | 4.8.2.1  7000 to  10000 KD  per  workshop | 4.8.2.1  PAAF | 4.8.2.1  proportion  of  veterinary  specialists  attending  these  workshops                |
| 4.8.3  Restrict  selling ABX  for animal  and  agriculture  health to  exclusively  prescriptio ns by vets | 4.8.3.1  Decree that  vet  pharmacies  should  dispense  ABX only  according  to vet  prescriptio ns, and  should  submit  these | 4.8.3.1  Decree                               | 4.8.3.1  1       | 4.8.3.1  2 years   | 4.8.3.1  PAAF | 4.8.3.1  ABX focal  person /  PAAF/  MOH | 4.8.3.1  None                             | 4.8.3.1  None | 4.8.3.1  Decree is  issued   Yes/No                                                          |

|                                                                                                                  | prescriptio ns with the  evidence of  selling to  PAAF.                                                    |                                                                                   |                                                                                   |                                                                                   |                                                                                   |                                                                                   |                                                                                   |                                                                                   |                                                                                   |
|------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|
| 4.8.4  Control the  use of ABX  in animals                                                                       | 4.8.4.1.  Detection  of the ABX  residues in  milk, meat,  poultry and  eggs                               | 4.8.4.1.  Already  available                                                      |                                                                                   | 4.8.4.1.  system in  place                                                        | PAAF/MOH  public  Health Lab                                                      |                                                                                   |                                                                                   |                                                                                   | 4.8.4.1.  Already  available                                                      |
| Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR                                | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR                          | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR |
| 4.9.1  Provide  training  courses for  vets for  ABX use   according  to  guidelines  and  provide  certificate. |                                                                                                            | 4.9.1  Workshop                                                                   | 4.9.1  2/year                                                                     | 4.9.1  2 years                                                                    | 4.9.1  PAAF                                                                       | 4.9.1  PAAF                                                                       | 4.9.1   5 ,000 KD X  2 /YR                                                        | 4.9.1 PAAF                                                                        | 4.9.1  Proportion  of vets that  have a  yearly  certificate                      |
| 4.9.2 Study   baseline  consumpti on  imported  antibiotics  in this field                                       | 4.9.2.1   Pharmaceu tical Dep in  PAAF  Committee   that will  study and  document  this  consumpti on and | 4.9.2.1   Report                                                                  | 4.9.2.1   1/year                                                                  | 4.9.2.1   2 years                                                                 | 4.9.2.1   PAAF                                                                    | 4.9.2.1   PAAF                                                                    | 4.9.2.1   None                                                                    | 4.9.2.1   PAAF                                                                    | 4.9.2.1   Report  issued   Yes/No                                                 |

## Kuwait national action plan on antimicrobial resistance 2022

compare it

to

internation

al

benchmark

N.B. Refer to Annex 5 for Antimicrobial Use Axis Strategic and Monitory plans

## References

- 1. No  time  to  wait:  securing  the  future  from  drug-resistant  infections.  report  to  the  secretarygeneral of the united nations April 2019.
- 2. WHO Global Strategy for Containment of Antimicrobial Resistance.2001.
- 3. Global action plan on antimicrobial resistance. WHO 2015.
- 4. Taqi  M,  Jamal  W,  Rotimi    VO  .Proportion  of  positive  blood  cultures  that  yielded  extendedspectrum β -lactamase (ESBL) and carbapenem-resistant Enterobacteriaceae (CRE) isolates in a Teaching Hospital in Kuwait over a 2-year period.. ID week 2017, 4-8 October, 2017, San Diego, USA.
- 5. Al Sweih N, Moghnia O, Rotimi VO. Explosive Emergence of Colistin-resistant and Carbapenemresistant Enterobacteriaceae (CRE) Among Community Food- handlers in Kuwait. ID week 2017, 4-8 October, 2017, San Diego, USA
- 6. Jamal W, Salama M, Shahin M, Rotimi. The Burden of Acinetobacter baumannii in the Intensive Care Unit of a Teaching Hospital in Kuwait Over a 3-Year Period. ID week 2017, 4-8 October, 2017, San Diego, USA.
- 7. Kuwait National Healthcare- associated Infection Surveillance System (KNHSS) 2019 data report.
- 8. Kuwait National Healthcare- associated Infection Surveillance System (KNHSS) 2020 data report.
- 9. Mokaddas, E.,  Ahmad  S,  ,Samir  I.  Secular  trends  in  susceptibility  patterns  of  Mycobacterium tuberculosis isolates in Kuwait,1996 -2005. Int. J. Tuberc. Lung Dis. 12, 319 -325 (2008).
- 10. Ahmad S, Mokaddas, E, Al-Mutairi, NM. Epidemiology of tuberculosis and multidrug-resistant tuberculosis in the Middle East Region. Expert Rev. Anti Infect. Ther. 16, 709 -721 (2018).
- 11. Abal AT, Ahmad S, Mokaddas E. Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Microb Drug Resist. 2002;8:99 -105.
- 12.  Ahmad  S,  Mokaddas  E,  Fares  E.  Characterization  of  rpoB  mutations  in  rifampin  resistant Mycobacterium  tuberculosis  isolates  from  Kuwait  and    Dubai.  Diagn  Microbiol  Infect  Dis. 2002;44:245 -52.
- 13.  Ahmad  S,  Mokaddas  E.  The  occurrence  of  rare rpoB  mutations  in rifampicin-resistant Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents. 2005;26:205 -12.

- 14. Ahmad S, Al-Mutairi NM, Mokaddas E. Variations in the occurrence of specific rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis strains isolated from patients of different ethnic groups in Kuwait. Indian J Med Res. 2012; 135:756 -62.
- 15. Al-Mutairi  N,  Ahmad    S  ,  Mokaddas  E.  Molecular  characterization  of  multidrug resistant -Mycobacterium tuberculosis (MDR TB) isolates identifies local transmission of infection in Kuwait, -a country with a low incidence of TB and MDR TB. Eur J Med Res (2019) 24:38. -
- 16. Chehadeh W, Albaksami O, John SE, et al. Drug resistance-associated mutations in antiretroviral treatment-naive and -experienced patients in Kuwait. Acta Virol 2018; 62: 259 -65.
- 17. .Aly N, Omar A , Badawy D, Al-Mousa H, Sadek A. Audi t of Physicians' Adherence to the Antibiotic Policy Guidelines in Kuwait. Med Princ Pract 2012; 21:310 -17.
- 18. Ramchurrena  K,  Balakrishnab  Y,  Mahomedc  S.  Patients'  knowledge,  attitudes  and  practices regarding antibiotic use at a regional hospital in KwaZulu-Natal, South Africa 2017.
- 19. Schechner V, Temkin E, Harbarth S, et al. Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev 2013; 26:289 -307.
- 20. Van de Sande-Bruinsma N, Grundmann H, Verloo D, et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008;14: 1722 -30.
- 21. Awad AS, Aboud EA. Knowledge, attitude and practice towards antibiotic use among the public in Kuwait. PLoS ONE 2015; 10(2): e0117910
- 22. Assessment of the the level of knowledge, attitudes and practices towards antibiotic use among public attending Kuwait MOH Healthcare facilities 2019.
- 23. United  Nations  Environment  Programme  2022.    Environmental  Dimensions  of  Antimicrobial Resistance. Summary for Policymakers.
- 24. Al-Bahry, S N, Mahmoud IY, Al-Belushi K I, et al. Coastal sewage discharge and its impact on fish with reference to antibiotic resistant enteric bacteria and enteric pathogens as bio-indicators of pollution. Chemosphere 2009; 77(11): 1534-9.
- 25. Al-Bahry S N, Mahmoud I Y, Al-Zadjali M, et al. Antibiotic resistant bacteria as bio-indicator of polluted effluent in the green turtles, Chelonia mydas in Oman. Marine Environmental Research 2011;71(2): 139-44.
- 26. Al-Bahry, S N, Al-Zadjali, M A, Mahmoud I Y et al. Biomonitoring marine habitats in reference to antibiotic  resistant  bacteria  and  ampicillin  resistance  determinants  from oviductal fluid of the nesting green sea turtle, Chelonia mydas. Chemosphere 2012; 87(11): 1308-15.

- 27. Light E, Baker-Austin C, Card M.R et al. Establishing a marine monitoring programme to assess antibiotic resistance: a case study from the Gulf Cooperation Council (GCC) region 2022.medRxiv2022.02.04.22270466.Available at: https://doi.org/10.1101/2022.02.04.22270466 (accessed March 10, 2022).
- 28. Al-Sarawi, HA, Jha AN, Baker-Austin C, et al. Baseline screening for the presence of antimicrobial resistance  in E.  coli isolated  from  Kuwait's  marine  environment.  Marine  Pollution  Bulletin 2018;129 (2): 893-8.

Kuwait national action plan on antimicrobial resistance 2022

## Annexes

## Annex 1

## A. Governance Strategic Plan

| Activity                                                                                                                                                                                                                                                                                                                         | Sub-activity                                                                                                      | Sub-sub- activity                                                                                                                        | Sub-sub-sub-activity                                                                                              | Milestone                                                                                                         |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|
| Strategic Objective G1. National coordination between focal points in the different sectors and different pillars                                                                                                                                                                                                                | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars                        | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars |
| G1.1 Identify the needed  AMR focal points in human  health, animal health,  welfare, and production,  food safety and security,  Plants and agriculture, and  environment.  The TOR should include  coordination among the  different ministries and  authorities along with a  yearly meeting of the  different focal persons. | G1.1.1  Define the TOR of focal  points in each of these  sectors                                                 |                                                                                                                                          |                                                                                                                   | G1.  6 months                                                                                                     |
|                                                                                                                                                                                                                                                                                                                                  | G1.1.2  Employ and assign the   functions of a focal person  for each pillar and for AMR  in general              | G1.1.2.1  Assign AMR focal points for  each pillar in human health                                                                       | G1.1.2.1.1  one focal point for each of  the following pillars:  IPC, Surveillance, ABX,  Awareness               |                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                  |                                                                                                                   | G1.1.2.2  Assign the general focal   Person in MOH                                                                                       | G1.1.2.2.1  Dr. Abeer Aly  pending assignment/  New employee                                                      |                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                  |                                                                                                                   | G1.1.2.3  Assign 1 focal person in  animal health and  agriculture fields for all  pillars including IPC,  Surveillance,  ABX, Awareness | G1.1.2.3.1  Representative in NMCG   is the focal person   or authorities appoint a  person                       |                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                  |                                                                                                                   | G1.1.2.4                                                                                                                                 | G1.1.2.4.1                                                                                                        |                                                                                                                   |

|                                                                                                                        |                                                                                                                                                 | Assign 1 focal person in KEPA  for all pillars including IPC,  Surveillance, ABX,  Awareness                           | Representative in NMCG   is the focal person   or authorities appoint a  person                                        |                                                                                                                        |
|------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                        |                                                                                                                                                 | G1.1.2.5  Assign 1 Focal person in food  safety regarding IPC,  Surveillance, ABX,  Awareness                          | G1.1.2.5.1  leave the   decision to  ministries/authorities                                                            |                                                                                                                        |
|                                                                                                                        | G1.1.2  Include inter-ministerial  communication and  coordination with the  general AMR focal person in  the TOR of the focal points           |                                                                                                                        |                                                                                                                        |                                                                                                                        |
| Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan                          | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan |
| G2.1 Form inter-ministerial  NMCG committee                                                                            | G2.1.1  Nominate the members and  have a ministerial decree  about their appointment                                                            |                                                                                                                        |                                                                                                                        | G2.   3 months                                                                                                         |
|                                                                                                                        | G2.1.2  Write the TOR of the NMCG  that include:  to facilitate and oversee  implementation, monitoring  and evaluation of the AMR  action plan |                                                                                                                        |                                                                                                                        |                                                                                                                        |
|                                                                                                                        | G2.1.3  The NMCG  has dedicated funds for   administrative costs.                                                                               | G2.1.3.1  NMCG puts a budget for  administrative costs                                                                 |                                                                                                                        |                                                                                                                        |
| Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                          | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                                                   | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                          | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                          | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                          |
| G3.1 Technical groups for  specific activities are created                                                             | G3.1.1                                                                                                                                          |                                                                                                                        |                                                                                                                        | G3.  3 months                                                                                                          |

| when needed from all  sectors                                                                                       | Mapping of professionals  throughout the country from  public and private sectors  that could be part of  technical groups when  needed.                                      |                                                                                                                     |
|---------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|
| Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR                                                           | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR |
| G4.1 Formulate or endorse  guidelines for the different  topics, along with tools                                   | G4.1.1  Each technical group for  each pillar will agree on  existing guidelines or  producing new guidelines or  endorsing international  guidelines and make them  national | G4.  1 year                                                                                                         |

## B. Governance Monitoring Plan

<!-- image -->

| Activity                                                                                                                                                                                                                                                            | Sub- activity                                                                                                     | Sub-sub-  activity                                                                                                | Sub-sub- sub- activity                                                                                            | Indicator                                                                                                         | Purpose                                                                                                           | Calculation                                                                                                       | Frequency                                                                                                         | Data  source                                                                                                      | Method                                                                                                            | Baseline                                                                                                          |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|
| Strategic Objective G1. National coordination between focal points in the different sectors and different pillars                                                                                                                                                   | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars | Strategic Objective G1. National coordination between focal points in the different sectors and different pillars |
| G1.1  Identify the  needed  AMR focal  points in  human  health,  animal  health,  welfare,  and  production,  food safety  and  security,  Plants and  agriculture,  and  environme nt.  The TOR  should  include  coordinatio n among  the  different  ministries | G1.1.1  Define the  TOR of  focal points  in each of  these  sectors                                              |                                                                                                                   |                                                                                                                   | G1.1.1  TOR are  put                                                                                              |                                                                                                                   |                                                                                                                   |                                                                                                                   |                                                                                                                   |                                                                                                                   |                                                                                                                   |

| and  authorities  along with  a yearly  meeting of  the  different  focal  persons.   |                                                                                                           |                                                              |                                                                                                           |                                                                                                                                      |                                                                                                                                          |                |              |             |                  |                              |
|---------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|--------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|----------------|--------------|-------------|------------------|------------------------------|
|                                                                                       | G1.1.2  Employ and  assign the   functions  of a focal  person for  each pillar  and for  AMR in  general | Assign AMR  focal points  for each  pillar in  human  health | G1.1.2.1.1  one focal  point for  each of the  following  pillars:  IPC,  Surveillanc e,  ABX,  Awareness | G1.1.2  Focal  persons for  each pillar  at MOH are  assigned.  Focal  points in  PAAF, and  KEPA, and   food safety   are  assigned | G1.1.2  Oversee  the  implement ation of  different  activities in  the NAP  and ensure  communica tion  between  different  authorities | G1.1.2  Yes/No | G1.1.2  Once | G1.1.2  MOH | G1.1.2  Checking | G1.1.2  Partially  available |
|                                                                                       |                                                                                                           | G1.1.2.2  Assign the  general  focal   person  in MOH        | G1.1.2.2.1  Dr. Abeer  Aly  pending  assignment /  New  employee                                          |                                                                                                                                      |                                                                                                                                          |                |              |             |                  |                              |
|                                                                                       |                                                                                                           | G1.1.2.3  Assign 1  focal  person in  animal                 | G1.1.2.3.1  Representa tive in  NMCG                                                                      |                                                                                                                                      |                                                                                                                                          |                |              |             |                  |                              |

|                                     | health and  agriculture  fields for all  pillars  including  IPC,  Surveillanc e,  ABX,  Awareness            | is the focal  person   or  authorities  appoint a  person                                        |              |
|-------------------------------------|---------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|--------------|
|                                     | G1.1.2.4  Assign 1  focal  person in  KEPA for all  pillars  including  IPC,  Surveillanc e,  ABX,  Awareness | G1.1.2.4.1  Representa tive in  NMCG   is the focal  person   or  authorities  appoint a  person |              |
|                                     | G1.1.2.5  Assign 1  Focal  person in  food safety  IPC:  Surveillanc e:  ABX  Awareness                       | G1.1.2.5.1  leave the   decision to  ministries/ authorities                                     |              |
| G1.1.2  Include  inter- ministerial |                                                                                                               |                                                                                                  | G1.1.2  None |

|                                                                                                                        | communica tion and  coordinatio n with the  general  AMR focal  person in  the TOR of  the focal  points                                                |                                                                                                                        |                                                                                                                        |
|------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan                                  | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan | Strategic Objective G2. Provide legal and ministerial support for the realization of the activities listed in the plan |
| G2.1  Form inter- ministerial  NMCG  committee                                                                         | G2.1.1  Nominate  the  members  and have a  ministerial  decree  about their  appointme nt                                                              | G2.1.1  Already  available                                                                                             |                                                                                                                        |
|                                                                                                                        | G2.1.2  Write the  TOR of the  NMCG that  include:  to facilitate  and  oversee  implement ation,  monitoring  and  evaluation  of the AMR  action plan | G2.1.2  Already  available                                                                                             |                                                                                                                        |

|                                                                                                                     | G2.1.3  The NMCG  has  dedicated  funds for   administrat ive costs.                                                                                     | G2.1.3.1  NMCG puts  a budget  for  administrat ive costs                                                           | G2.1.3.1  A budget is  put and  provided                                                                            |                                                                                                                     | G2.1.3.1  Yes/No                                                                                                    | G2.1.3.1  Once                                                                                                      | G2.1.3.1  NMCG                                                                                                      | G2.1.3.1  Checking                                                                                                  | G2.1.3.1  Partially  available                                                                                      |
|---------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|
| Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                       | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                                                            | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                       | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                       | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                       | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                       | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                       | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                       | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                       | Strategic Objective G3. The plan is based on evidence-based medicine and put by professionals                       |
| G3.1  Technical  groups for  specific  activities  are created  when  needed  from all  sectors                     | G3.1.1  Mapping of  professiona ls  throughout  the country  from public  and private  sectors that  could be  part of  technical  groups  when  needed. |                                                                                                                     | G3.1.1  Technical  groups are  formed for  each pillar,  including  representat ive of One  Health  approach        | G3.1.1  Ensure  proper  implement ation and  monitoring  of the  activities of  the NAP                             | G3.1.1  Yes/No                                                                                                      | G3.1.1  Once                                                                                                        | G3.1.1  NMCG/  MOH  Undersecre tary  general  /Director  General in  PAAF/KEPA  /PAFN                               | G3.1.1  Checking                                                                                                    | G3.1.1  Partially  available in  MOH                                                                                |
| Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR                                      | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR | Strategic Objective G4. Provide guidance and tools to form a basis for preparation of a national action plan on AMR |
| G4.1  Formulate  or endorse  guidelines   for the  different  topics,  along with  tools                            | G4.1.1  Each  technical  group for  each pillar  will agree  on existing  guidelines  or  producing  new  guidelines                                     |                                                                                                                     | G4.1.1  Guidelines  are  available  when  needed                                                                    | G4.1.1  Standardize  practice  related to  AMR in  different  sectors                                               | G4.1.1  Yes/No                                                                                                      | G4.1.1  Once/year                                                                                                   | G4.1.1  Technical  groups/  Focal  persons of  each pillar                                                          | G4.1.1  Checking                                                                                                    | G4.1.1  Partially  available                                                                                        |

## Kuwait national action plan on antimicrobial resistance 2022

or

endorsing internation

al

guidelines and make them national

## Annex 2

## A. Awareness Strategic Plan

| Activity                                                                                                                                                                | Sub-activity                                                                                                                                | Sub-sub- activity                                                                                                           | Sub-sub-sub-activity                                                                                                        | Date                                                                                                                        | Milestone                                                                                                                   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up                                                                              | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up                                                  | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up                                  | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up                                  | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up                                  | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up                                  |
| 1.1.1 To designate a  specific employee or  post that is responsible  of realizing the plan, do  the proper  communications and  follow up on the  progress of the plan | 1.1.1 Assign one  employee/post to  overlook these  activities in MOH,  KEPA, PAAF, food  safety                                            |                                                                                                                             |                                                                                                                             | 1.1.1   3 months                                                                                                            | 1.1   8 months                                                                                                              |
|                                                                                                                                                                         | 1.1.2 Put TOR of  employment                                                                                                                |                                                                                                                             |                                                                                                                             | 1.1.2   2 months                                                                                                            |                                                                                                                             |
|                                                                                                                                                                         | 1.1.3 Letter of  employment or  assignment of   Responsibilities of focal  persons in the 4  ministries/authorities                         |                                                                                                                             |                                                                                                                             | 1.1.3   3 months                                                                                                            |                                                                                                                             |
| Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs                                             | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs                 | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs |
| 1.2.1 Establish an  evidence-based public  communications  program targeting the  general public in the  community                                                      | 1.2.1.1 Estimate the  knowledge, attitude  and practice of general  public regarding AMR  in humans, animals,  agriculture and  environment |                                                                                                                             |                                                                                                                             | 1.2.1.1 Done                                                                                                                | 1.2   5 years                                                                                                               |
|                                                                                                                                                                         | 1.2.1.2 Conduct  national public  awareness campaigns  based on the One  health approach                                                    | 1.2.1.2.1 Preparation of  material regarding the  awareness campaign  based on the One  health approach                     | 1.2.1.2.1.1 Assign a  team   to formulate and  design the public  communication                                             | 1.2.1.2.1.1 Done                                                                                                            |                                                                                                                             |

|                                                                                                                                                                                     | material regarding  AMR                                                                                                                                       |                        |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------|
|                                                                                                                                                                                     | 1.2.1.2.1.2 Produce the   public communication  material regarding  AMR                                                                                       | 1.2.1.2.1.1 Done       |
|                                                                                                                                                                                     | 1.2.1.2.1.3 Update the  communication  material to cover all  aspects of the One  health approach:  Animal Health,  Agriculture, food safety  and environment | 1.2.1.2.1.3   6 months |
| 1.2.1.2.2  Put a yearly plan on  broadcasting and  posting the public  communication  material on AMR                                                                               | 1.2.1.2.2.1  Broadcasting is all year  long, not only during  the AMR awareness  week  (specific   timing, place)                                             | 1.2.1.2.2.1  6 months  |
|                                                                                                                                                                                     | 1.2.1.2.2.2  Prepare costing of the  plan                                                                                                                     | 1.2.1.2.2.2  8 months  |
| 1.2.1.2.3  Launch the  broadcasting plan                                                                                                                                            |                                                                                                                                                               | 1.2.1.2.3  1 year      |
| 1.2.1.2.4  Engage different types  of media including  social media in AMR  awareness such as  putting material/ads  periodically on  ministry/governmental  websites, social media |                                                                                                                                                               | 1.2.1.2.4  1 year      |

|                                                                                                     |                                                                                                     | accounts like Facebook,  Twitter, Instagram, etc.                                                                                                                                                  |                                                                                                                                                                  |                                                                                                     |                                                                                                     |
|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|
|                                                                                                     |                                                                                                     | 1.2.1.2.5  Involve a public figure  like   Dr. Abdallah Al-Sanad  (spokesperson MOH) in  delivering AMR  messages, like tweets  on twitter or messages  in Talk Shows or  through TV ads/News  bar |                                                                                                                                                                  | 1.2.1.2.5  3 months                                                                                 |                                                                                                     |
|                                                                                                     |                                                                                                     | 1.2.1.2.6  Discuss AMR in TV talk  shows                                                                                                                                                           | 1.2.1.2.6.1  MOH sends a letter to  Ministry of Information  asking to host  professionals in AMR to  discuss this issue on TV  and thus raise public  awareness | 1.2.1.2.6.1  2 months                                                                               |                                                                                                     |
|                                                                                                     |                                                                                                     | 1.2.1.2.7  Involve Non-  Governmental  Organizations (NGOs)  in AMR awareness  campaign                                                                                                            | 1.2.1.2.7.1  Contact FAO and OIE  and   ask about their  communications  program regarding  AMR and communicate  with them the NAP on  AMR                       | 1.2.1.2.7.1  2 months                                                                               |                                                                                                     |
| Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools                                                                                                | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools                                                              | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools | Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools |
| 1.3.1 Include basic AMR  education in school  curricula                                             | 1.3.1.1 MOH sends a  letter with key facts  about AMR, antibiotics,  hygiene and IPC basics         |                                                                                                                                                                                                    |                                                                                                                                                                  | 1.3.1.1   2 months                                                                                  | 1.3   2 years                                                                                       |

|                                                                                                                                                                        | through the School  Health Administration  asking to include  material related to  these topics in school  curricula     |                                                                                                                                                                                                                    |                                                                                                          |                                                                                                          |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                        | 1.3.1.2 Prepare a  module/Add material  related to basic AMR  knowledge, antibiotics,  hygiene and IPC in the  curricula | 1.3.1.2.1 Create a  committee of  comprising of AMR  professional and  education professionals  to create a module  about basic AMR  knowledge, antibiotics,  hygiene and IPC to be  included in school  curricula | 1.3.1.2.1   2 months                                                                                     |                                                                                                          |
|                                                                                                                                                                        |                                                                                                                          | 1.3.1.2.2 Include this  module in secondary  school education                                                                                                                                                      | 1.3.1.2.2   8 months                                                                                     |                                                                                                          |
|                                                                                                                                                                        |                                                                                                                          | 1.3.1.2.3 Yearly AMR  module workshops  involving teachers                                                                                                                                                         | 1.3.1.2.3 1 year                                                                                         |                                                                                                          |
| Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach                                                               | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach                 | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach                                                                                                           | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach |
| 1.4.1 Establish an  evidence-based  communication  program targeting the  healthcare providers  for human health,  animal health,  agriculture and  environment sector | 1.4.1.1 Estimate  knowledge, attitudes  and practices related to  AMR among healthcare  workers                          | 1.4.1.1.1 Prepare a  survey to estimate this  knowledge among  healthcare workers and  identify the gaps                                                                                                           | 1.4.1.1.1 Done                                                                                           | 1.4   3 years                                                                                            |
|                                                                                                                                                                        | 1.4.1.2 Conduct  awareness program                                                                                       | 1.4.1.2.1 MOH  mandates to all                                                                                                                                                                                     | 1.4.1.2.1   2 months                                                                                     |                                                                                                          |

| within hospitals,  primary healthcare,  among physicians,  nurses, pharmacists,  dentists,  physiotherapists, and  other HC providers                                                | hospitals and primary  health care centers to  provide mandatory  sessions about AMR to  all employees who are  subject to  contract/license  renewal   |                     |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|
| 1.4.1.3  AMR mandatory  courses for pharmacists  in private practice who  are subject to contract/  license renewal                                                                  | 1.4.1.3.1  Letter from MOH to  Drug Inspection Control  to  request   evidence of AMR   course attendance  about AMR   upon license  renewal            | 1.4.1.3.1  6 months |
| 1.4.1.4   Link  of AMR course  attendance to hospital  pharmacists' and  primary Health care   pharmacists'  promotion.                                                              | 1.4.1.4.1  MOH recommends  yearly attendance for  promotion                                                                                             | 1.4.1.4.1  1 year   |
| 1.4.1.5  Preparation of a bank  of presentations, films,  articles, etc. diffused to  these syndicates and  hospitals to be used as  material in their AMR  communication  programs. | 1.4.1.5.1  Toolkit for   AMR communication  program   to be used in hospital  and syndicates                                                            | 1.4.1.5.1  1 year   |

|                                                                                                                                                                                | 1.4.1.6  Syndicates and  hospitals send yearly  report to MOH about  this activity                                                                                                                         |                                                                                                                                                                                    | 1.4.1.6  Yearly starting 1 year  from starting the plan                                                                                                   |                                                                                                                                                           |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach                      | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach                                                  | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach                          | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach |
| 1.5.1 Conduct an  awareness program  among veterinarians,  agriculture  professionals,  environmental  workers, in addition to  professionals in PAAF,  KEPA, and food safety. | 1.5.1.1 Prepare AMR  awareness toolkit  including slide sets,  short films,  lectures,  posters for these  professionals                                                                                   |                                                                                                                                                                                    | 1.5.1.1   6 months                                                                                                                                        | 1.5  3 years                                                                                                                                              |
|                                                                                                                                                                                | 1.5.1.2 Integrate AMR  awareness in  continuous education  programs of  veterinarians,  agriculture  professionals,  environmental  workers, in addition to  professionals in PAAF,  KEPA, and food safety | 1.5.1.2.1   The focal person in  each ministry/authority  checks educational  activities in their  facilities and   Includes   AMR   awareness as a topic of  continuous education | 1.5.1.2.1   1 year                                                                                                                                        |                                                                                                                                                           |
|                                                                                                                                                                                |                                                                                                                                                                                                            | 1.5.1.2.2   Mandate that   all drug  companies'  educational activities  should include AMR  awareness                                                                             | 1.5.1.2.2   6 months                                                                                                                                      |                                                                                                                                                           |

| 1.5.2 Country  participates the  regional/international  AMR awareness  campaign                                                                                                                   | 1.5.2.1 Participate  actively in WHO  regional AMR campaign   and FAO  and  OIE   activities related to  AMR                                                                                                          | 1.5.2.1.1 Register  Kuwait  ministries/authorities  (KEPA, PAAF, MOH) to  participate in the yearly  schedule of AMR  activities in WHO, FAO,  OIE   And encourage  individual healthcare  professionals,  veterinarians,  agriculture  professionals,  environmental workers  to participate   | 1.5.2.1.1   1 year                                                                                                                                                                                 |                                                                                                                                                                                                    |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                    | 1.5.2.2 Participate in  GCC activities related  to AMR                                                                                                                                                                | 1.5.2.2.1 Kuwait is part  of GCC AMR Group                                                                                                                                                                                                                                                      | 1.5.2.2.1 Done                                                                                                                                                                                     |                                                                                                                                                                                                    |
|                                                                                                                                                                                                    |                                                                                                                                                                                                                       | 1.5.2.2.2 Kuwait  participates in all the  AMR activities GCC                                                                                                                                                                                                                                   | 1.5.2.2.2 Done                                                                                                                                                                                     |                                                                                                                                                                                                    |
| Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties.                    | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties.                                                                                              | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. |
| 1.6.1 Include AMR and  related topics based on  the One Health  approach as a core  component of  professional   education, training,  certification                                               | 1.6.1.1 Include AMR  and related topics  based on the One  Health approach in  undergraduate  curricula for human  health (medical,  nursing, dental and  pharmaceutical),  agriculture, veterinary  food safety, and | 1.6.1.1.1 preparation of   modules for these  specialties                                                                                                                                                                                                                                       | 1.6.1.1.1   6 months                                                                                                                                                                               | 1.6  1.5 years                                                                                                                                                                                     |

|                                                   | environment related  specialties.                                                                                                                           |                                                                                                                                                                                                                                   |                                      |                     |          |
|---------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------|---------------------|----------|
|                                                   |                                                                                                                                                             | 1.6.1.1.2  Letter from MOH,  PAAF, PAFN and  KEPA to Ministry of  Higher Education to  impose on  universities/authorities  to include these  modules in the  corresponding                                                       |                                      | 1.6.1.1.2  6 months |          |
|                                                   | 1.6.1.2   AMR and related topics  based on the One  Health approach  included in the  licensing procedure for  nurses, dentists,  physicians,  pharmacists, | education programs.  1.6.1.2.1  Letter from MOH,  PAAF, PAFN and KEPA  to licensing   bodies of these  professionals to include  AMR and its related  topics   in licensing exams and  interviews or in the  evaluation procedure |                                      | 1.6.1.2.1  3 months |          |
|                                                   | veterinarians and other                                                                                                                                     |                                                                                                                                                                                                                                   |                                      |                     |          |
|                                                   | professionals for which                                                                                                                                     |                                                                                                                                                                                                                                   |                                      |                     |          |
|                                                   |                                                                                                                                                             |                                                                                                                                                                                                                                   |                                      | 1.7.1.1             | 1.7      |
|                                                   |                                                                                                                                                             |                                                                                                                                                                                                                                   |                                      | 3 months            | 9 months |
|                                                   | licensing is required.                                                                                                                                      |                                                                                                                                                                                                                                   |                                      |                     |          |
|                                                   |                                                                                                                                                             | for license renewal                                                                                                                                                                                                               |                                      |                     |          |
|                                                   | 1.7.1.1 Letter from                                                                                                                                         | Strategic Objective Include 1.7 AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food                                                                          |                                      |                     |          |
|                                                   | MOH to accreditation  bodies to include AMR                                                                                                                 |                                                                                                                                                                                                                                   |                                      |                     |          |
|                                                   | surveillance and  implementation of  antimicrobial                                                                                                          |                                                                                                                                                                                                                                   |                                      |                     |          |
|                                                   |                                                                                                                                                             |                                                                                                                                                                                                                                   | chain and environment                |                     |          |
|                                                   | stewardship programs                                                                                                                                        |                                                                                                                                                                                                                                   |                                      |                     |          |
|                                                   |                                                                                                                                                             |                                                                                                                                                                                                                                   | 1.7.1 IPC, AMR  surveillance and AMS |                     |          |
|                                                   | as part of accreditation                                                                                                                                    |                                                                                                                                                                                                                                   |                                      |                     |          |
| accreditation standards  of healthcare facilities |                                                                                                                                                             |                                                                                                                                                                                                                                   |                                      |                     |          |
| are included in the                               |                                                                                                                                                             |                                                                                                                                                                                                                                   |                                      |                     |          |
|                                                   | standards in all                                                                                                                                            |                                                                                                                                                                                                                                   |                                      |                     |          |

|                                                                                                                                                              | healthcare facilities as  well as in the licensing  renewal procedures of  private healthcare  facilities  IPC is already part of  these standards                           |                                                                                                               |                     |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------|---------------------|
| 1.7.2 IPC and rational  use of antimicrobials is  checked in the  procedure of licensing  farms, animal  husbandry, agriculture,  aquatic and marine  fields | 1.7.2.1 Review of   large animal/poultry  farms   licensing policies and  procedures,   to include   IPC and proper ABX use  and prevention of ABX  use as growth  promoters | 1.7.2.1.1  Mandate that ABX are  not to be used as  growth promoters                                          | 1.7.2.1.1  3 months |
|                                                                                                                                                              |                                                                                                                                                                              | 1.7.2.1.2  Letter from PAAF  Director General to  licensing office to  include these points in  the standards | 1.7.2.1.2  3 months |

## B. Awareness Monitoring Plan

| Activity                                                                                                                                                               | Sub- activity                                                                                         | Sub-sub-  activity                                                                         | Sub-sub- sub- activity                                                                     | Indicator                                                                                  | Purpose                                                                                    | Calculation                                                                                | Frequency                                                                                  | Data  source                                                                               | Method                                                                                     | Baseline                                                                                   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|
| Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up                                                                             | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up            | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up | Strategic Objective 1.1 Organize the activities of this axis and ensure a proper follow up |
| 1.1.1 To  designate a  specific  employee  or post that  is  responsible  of realizing  the plan,  do the  proper  communica tions and  follow up  on the  progress of | 1.1.1  Assign one  employee/ post to  overlook  these  activities in  MOH,  KEPA,  PAAF, food  safety |                                                                                            |                                                                                            | 1.1.1  Awareness  Focal  person  assigned                                                  | 1.1.1  Oversee  activities of  this pillar                                                 | 1.1.1  Yes/No                                                                              | 1.1.1 Once                                                                                 | 1.1.1 MOH  KEPA,  PAAF, PAFN                                                               | 1.1.1  Checking                                                                            | 1.1.1 Not  available                                                                       |
|                                                                                                                                                                        | 1.1.2 Put  TOR of  employme nt                                                                        |                                                                                            |                                                                                            | 1.1.2 TOR is  put  for all 4  focal  persons.                                              | 1.1.2  Organize  work in this  pillar                                                      | 1.1.2  Yes/No                                                                              | 1.1.2 Once                                                                                 | 1.1.2 MOH                                                                                  | 1.1.2  Checking                                                                            | 1.1.2 Not  available                                                                       |
|                                                                                                                                                                        | 1.1.3 Letter  of  employme nt or  assignment  of   Responsibil ities of                               |                                                                                            |                                                                                            | 1.1.3 Letter  of  employme nt or  assignment  of duties to   specific  focal               | 1.1.3  Oversee  activities in  this pillar                                                 | 1.1.3  Yes/No                                                                              | 1.1.3 Once                                                                                 | 1.1.3 MOH,  KEPA,  PAAF, PAFN                                                              | 1.1.3  Checking                                                                            | 1.1.3 Not  available                                                                       |

<!-- image -->

|                                                                                                                             | focal  persons in  the 4  ministries/ authorities                                                                                                     |                                                                                                                             |                                                                                                                             | persons in  the 4  ministries/ authorities  is done                                                                         |                                                                                                                             |
|-----------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs                           | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs | Strategic Objective 1.2 Increase national public awareness of AMR as per One health approach through communication programs |
| 1.2.1  Establish  an  evidence- based  public  communica tions  program  targeting  the general  public in  the  community  | 1.2.1.1  Estimate  the  knowledge,  attitude  and  practice of  general  public  regarding  AMR in  humans,  animals,  agriculture  and  environme nt |                                                                                                                             |                                                                                                                             | 1.2.1.1  Done                                                                                                               | 1.2.1.1  Done                                                                                                               |
|                                                                                                                             | 1.2.1.2  Conduct  national  public  awareness  campaigns  based on  the One  health  approach                                                         | 1.2.1.2.1  Preparation  of material  regarding  the  awareness  campaign  based on  the One  health  approach               | 1.2.1.2.1.1  Assign a  team   to  formulate  and design  the public  communica tion  material  regarding  AMR               | 1.2.1.2.1.1  Done                                                                                                           | 1.2.1.2.1.1  Done                                                                                                           |

|                                                                                          | 1.2.1.2.1.2  Produce  the   public  communica tion  material  regarding  AMR                                                                                           | 1.2.1.2.1.1  Done                                                                                 |                                                                                        |                     |                   |                                                                                |                       | 1.2.1.2.1.1  Done                 |
|------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------|---------------------|-------------------|--------------------------------------------------------------------------------|-----------------------|-----------------------------------|
|                                                                                          | 1.2.1.2.1.3  Update the  communica tion  material to  cover all  aspects of  the One  health  approach:  Animal  Health,  Agriculture,  food safety  and  environme nt | 1.2.1.2.1.3  The  communica tion  material  covers all  fields of  One Health  approach  (Yes/No) | 1.2.1.2.1.3  Highlight  the effect  of AMR on  all fields  not just the  human  health | 1.2.1.2.1.3  Yes/No | 1.2.1.2.1.3  Once | 1.2.1.2.1.3  The  awareness  technical  task force  from  MOH/PAAF /KEPA/PAF N | 1.2.1.2.1.3  Checking | 1.2.1.2.1.3  Partially  available |
| 1.2.1.2.2  Put a yearly  plan on  broadcastin g and  posting the  public  communica tion | 1.2.1.2.2.1  Broadcastin g is all year  long, not  only during  the AMR  awareness  week  (specific                                                                    | 1.2.1.2.2.1  Schedule is  put   (Yes/No)                                                          | 1.2.1.2.2.1  Organize  the  diffusion of  AMR  related  messages  all yearlong         | 1.2.1.2.2.1  Yes/No | 1.2.1.2.2.1  Once | 1.2.1.2.2.1  MOH/  Media  Office                                               | 1.2.1.2.2.1  Checking | 1.2.1.2.2.1  Partially  available |

| material on  AMR                                                                                                                                                                         | timing,  place)                            |                                                                           |                                                                                                             |                                                              |                           |                                  |                       |                                 |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------|---------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------|---------------------------|----------------------------------|-----------------------|---------------------------------|
|                                                                                                                                                                                          | 1.2.1.2.2.2  Prepare  costing of  the plan | 1.2.1.2.2.2  Costing  plan is  finalized                                  | 1.2.1.2.2.2  Organize  the  diffusion of  AMR  related  messages  all yearlong                              | 1.2.1.2.2.2  Yes/No                                          | 1.2.1.2.2.2  Once         | 1.2.1.2.2.2  MOH/  Media  Office | 1.2.1.2.2.2  Checking | 1.2.1.2.2.2  Not  available     |
| 1.2.1.2.3  Launch the  broadcastin g plan                                                                                                                                                |                                            | 1.2.1.2.3  Proportion  of the plan  that was  put on  schedule            | 1.2.1.2.3  Diffusion of  AMR  messages  all year  long                                                      | 1.2.1.2.3  Number of  broadcasts  related to  AMR per  month | 1.2.1.2.3  Once per  year | 1.2.1.2.3  MOH                   | 1.2.1.2.3  Counting   | 1.2.1.2.3  Partially  available |
| 1.2.1.2.4  Engage  different  types of  media  including  social  media in  AMR  awareness  such as  putting  material/ad s  periodically  on  ministry/go vernmental  websites,  social |                                            | 1.2.1.2.4  Types of  media or  social  media   that   mention  AMR/mont h | 1.2.1.2.4  Relevant  informatio n on AMR  and related  topics  reaches to  the public  as much as  possible | 1.2.1.2.4  Yes/No                                            | 1.2.1.2.4  Once           | 1.2.1.2.4  MOH/  Media  Office   | 1.2.1.2.4  Checking   | 1.2.1.2.4  Not  available       |

| media  accounts  like  Facebook,  Twitter,  Instagram,  etc.                                                                                                                                                   |                                                                                |                                                                                      |                                                                          |                                                                                |                        |                                                         |                               |                                 |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------|--------------------------------------------------------------------------------|------------------------|---------------------------------------------------------|-------------------------------|---------------------------------|
| 1.2.1.2.5  Involve a  public  figure like   Dr.  Abdallah   Al Sanad  (spokesper son MOH)  in  delivering  AMR  messages,  like tweets  on twitter  or  messages  in Talk  Shows or  through TV  ads/News  bar |                                                                                | 1.2.1.2.5  Public  figure (Dr.  Abdulla Al- Sanad)  sending  message  regarding  AMR | 1.2.1.2.5  The public  figure  influences  the public  awareness  on AMR | 1.2.1.2.5  Yes/No                                                              | 1.2.1.2.5  Once        | 1.2.1.2.5  MOH/Medi a Office/  Awareness  focal  person | 1.2.1.2.5  Checking           | 1.2.1.2.5  Partially  available |
| 1.2.1.2.6  Discuss  AMR in TV  talk shows                                                                                                                                                                      | 1.2.1.2.6.1  MOH sends  a letter to  Ministry of  Informatio n asking to  host | 1.2.1.2.6.1  Proportion  of talk  shows  episodes  that discuss  AMR                 | 1.2.1.2.6.1  enhance  public  knowledge  about the  dangers of  AMR      | 1.2.1.2.6.1  Number of  talk show  episodes  that target  AMR/total  number of | 1.2.1.2.6.1  Once/year | 1.2.1.2.6.1  MOH                                        | 1.2.1.2.6.1  Data  collection | 1.2.1.2.6.1  Not  available     |

|                                                                                             | professiona ls in AMR  to discuss  this issue  on TV and  thus raise  public  awareness                                                           |                   | episodes*1 00   |
|---------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------|-------------------|-----------------|
| 1.2.1.2.7  Involve  Non-  Governmen tal  Organizatio ns (NGOs)  in AMR  awareness  campaign | 1.2.1.2.7.1  Contact  FAO and  OIE and   ask about  their  communica tions  program  regarding  AMR and  communica te with  them the  NAP on  AMR | 1.2.1.2.7.1  None |                 |

## Strategic Objective 1.3 Include AMR education as per One health approach at an early age in schools

1.3.1.1

MOH sends a letter

with key facts about

AMR, antibiotics,

hygiene and IPC

basics and to School

1.3.1

Include basic AMR

education in school

curricula

1.3.1.1

Letter sent

Yes or No

1.3.1.1

Improve

AMR

awareness starting in

young age

1.3.1.1

Yes/No

1.3.1.1

Once

1.3.1.1

MOH

1.3.1.1

Checking

1.3.1.1 Not available

| Health  Administrat ion  asking to  include  material  related to  these  topics in  school  curricula                         |                                                                                                                                                                                                                              |                                     |                                                              |                                |                      |                                                                              |                              |                           |
|--------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------------------------|--------------------------------|----------------------|------------------------------------------------------------------------------|------------------------------|---------------------------|
| 1.3.1.2  Prepare a  module/Ad d material  related to  basic AMR  knowledge,  antibiotics,  hygiene  and IPC in  the  curricula | 1.3.1.2.1  Create a  committee  of  comprising  of AMR  professiona l and  education  professiona ls to create  a module  about basic  AMR  knowledge,  antibiotics,  hygiene  and IPC to  be included  in school  curricula | 1.3.1.2.1  Module  prepared  Yes/No | 1.3.1.2.1  Standardize  AMR  education  at the  school level | 1.3.1.2.1  Yes/No              | 1.3.1.2.1  Once      | 1.3.1.2.1  MOH/  Awareness  Focal  person/  awareness  technical  task force | 1.3.1.2.1  Checking          | 1.3.1.2.1  Not  available |
|                                                                                                                                | 1.3.1.2.2  Include this  module in                                                                                                                                                                                           | 1.3.1.2.2  Percent of  schools      | 1.3.1.2.2   Enhance  the                                     | 1.3.1.2.2   Number of  schools | 1.3.1.2.2  Once/year | 1.3.1.2.2   MOH/  School                                                     | 1.3.1.2.2   Data  collection | 1.3.1.2.2  Not  available |

|                                                                                                                                   |                                                                                                          | secondary  school  education                                                                                    | that teach  the AMR  module   in their  secondary  school  curricula                                     | education  and  knowledge  about the  dangers of  AMR  starting  from a  young age                       | that teach  AMR  module/To tal number  of  schools*10 0                                                  |                                                                                                          | Health  Administrat ion/  Ministry of  Education                                                         |                                                                                                          |                                                                                                          |
|-----------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|
|                                                                                                                                   |                                                                                                          | 1.3.1.2.3  Yearly AMR  module  workshops  involving  teachers                                                   | 1.3.1.2.3  Proportion  of teachers  who attend  these  workshops                                         | 1.3.1.2.3   Standardize  AMR  teaching in  schools                                                       | 1.3.1.2.3   Number of  teachers  who attend  these  modules/T otal  number of  teachers*1 00             | 1.3.1.2.3   Once/year                                                                                    | 1.3.1.2.3  MOH/  School  Health  Administrat ion/Health  promotion  Departmen t/  Ministry of  Education | 1.3.1.2.3   Data  collection                                                                             | 1.3.1.2.3 `  Not  available                                                                              |
| Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach                          | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach        | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach | Strategic Objective 1.4 Raise awareness of healthcare workers about AMR based on the One Health approach |
| 1.4.1  Establish  an  evidence- based  communica tion  program  targeting  the  healthcare  providers  for human  health,  animal | 1.4.1.1  Estimate  knowledge,  attitudes  and  practices  related to  AMR  among  healthcare  workers    | 1.4.1.1.1  Prepare a  survey to  estimate  this  knowledge  among  healthcare  workers  and  identify the  gaps | 1.4.1.1.1  Done                                                                                          |                                                                                                          |                                                                                                          |                                                                                                          |                                                                                                          |                                                                                                          | 1.4.1.1.1  Done                                                                                          |

| health,  agriculture  and  environme nt sector   |                                                                                                                                                                                    |                                                                                                                                                                                                |                                                                                                                                                              |                                                                                                                 |                                                                                                                                                                       |                      |                 |                              |                            |
|--------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|-----------------|------------------------------|----------------------------|
|                                                  | 1.4.1.2  Conduct  awareness  program  within  hospitals,  primary  Health  care,  among  physicians,  nurses,  pharmacist s dentists,  physiother apists, and  other HC  providers | 1.4.1.2.1  MOH  mandates  to all  hospitals  and  primary  Healthcare  centers to  provide  mandatory  sessions  about AMR  to all  employees  who are  subject to  contract/lic ense  renewal | 1.4.1.2.1  Proportion  of hospitals  and  primary  Health care  centers  that   provide  and  request  yearly  attendance  of   AMR  conference s  /sessions | 1.4.1.2.1  AMR and  related  topics are  an  important  elements  education  and  practice                      | 1.4.1.2.1   Number of  healthcare  facilities  that   provide  and  request  yearly  attendance  of   AMR  conference s/Total  number of  healthcare  facilities*1 00 | 1.4.1.2.1  Once/year | 1.4.1.2.1   MOH | 1.4.1.2.1   Data  collection | 1.4.1.2.1   Not  available |
|                                                  | 1.4.1.3  AMR  mandatory  courses for  pharmacist s in private  practice  who are  subject to  contract/                                                                            | 1.4.1.3.1  Letter from  MOH to  Drug  Inspection  Control to  request   evidence of  AMR                                                                                                       | 1.4.1.3.1  Letter is   issued                                                                                                                                | 1.4.1.3.1  Make sure  that AMR  education/ CE is  mandatory  for license  renewal in  the human  health  sector | 1.4.1.3.1  Yes/No                                                                                                                                                     | 1.4.1.3.1  Once      | 1.4.1.3.1  MOH  | 1.4.1.3.1  Checking          | 1.4.1.3.1  Not  available  |

| license  renewal                                                                                                                                                              | course  attendance  about AMR   upon  license  renewal                                           |                               |                                                                                                       |                   |                 |                                                               |                     |                           |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|-------------------------------|-------------------------------------------------------------------------------------------------------|-------------------|-----------------|---------------------------------------------------------------|---------------------|---------------------------|
| 1.4.1.4   Link  of AMR  course  attendance  to hospital  pharmacist s' and  primary  care   pharmacist s'  promotion.                                                         | 1.4.1.4.1  MOH  recommen ds yearly  attendance  for  promotion                                   | 1.4.1.4.1  Mandate is  issued | 1.4.1.4.1  Emphasize  the  importance  of AMR  education  and  practice in  the human  health  sector | 1.4.1.4.1  Yes/No | 1.4.1.4.1  Once | 1.4.1.4.1  MOH  Undersecre tary  general /  AMR Focal  person | 1.4.1.4.1  Checking | 1.4.1.4.1  Not  available |
| 1.4.1.5  Preparation  of a bank of  presentatio ns, films,  articles,  etc.  diffused to  these  syndicates  and  hospitals to  be used as  material in  their AMR  communica | 1.4.1.5.1  Toolkit for   AMR  communica tion  program   to be used  in hospital  and  syndicates | 1.4.1.5.1  Toolkit  available | 1.4.1.5.1  Standardize  AMR CE  and  knowledge  in the  human  health  sector                         | 1.4.1.5.1  Yes/No | 1.4.1.5.1  Once | 1.4.1.5.1  NMCG/  Awareness  Technical  task force            | 1.4.1.5.1  Checking | 1.4.1.5.1  Not  available |

|                                                                                                                                                                                          | tion  programs.                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |                                                                                                                                                           |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                          | 1.4.1.6  Syndicates  and  hospitals  send yearly  report to  MOH about  this activity                                                                     | 1.4.1.6  Proportion  of hospitals  that send  report   about AMR   Awareness  activities to  MOH                                                          | 1.4.1.6  Keep track  of AMR  activities in  hospitals                                                                                                     | 1.4.1.6  Number of  hospitals  that send  report   about AMR   Awareness  activities to  MOH/Total  number of  hospitals*1 00                             | 1.4.1.6  Once/year                                                                                                                                        | 1.4.1.6  MOH                                                                                                                                              | 1.4.1.6  Data  collection                                                                                                                                 | 1.4.1.6  Not  available                                                                                                                                   |
| Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach                                | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach | Strategic Objective 1.5 Raise awareness of veterinarians, agriculture professionals and environmental workers about AMR based on the One Health  approach |
| 1.5.1  Conduct an  awareness  program  among  veterinaria ns,  agriculture  professiona ls,  environme ntal  workers, in  addition to  professiona ls in PAAF,  KEPA, and  food  safety. | 1.5.1.1  Prepare  AMR  awareness  toolkit  including  slide sets,  short films,  lectures,  posters for  these  professiona ls                            | 1.5.1.1   AMR  toolkit   is available                                                                                                                     | 1.5.1.1   Standardize  AMR CE  and  knowledge  in the non- human  health  sector                                                                          | 1.5.1.1   Yes/No                                                                                                                                          | 1.5.1.1   Once                                                                                                                                            | 1.5.1.1   Awareness  Technical  Task force  PAAF  KEPA  PAFN                                                                                              | 1.5.1.1   Checking                                                                                                                                        | 1.5.1.1   Not  available                                                                                                                                  |

| 1.5.1.2  Integrate  AMR  awareness  in  continuous  education  programs  of  veterinaria ns,  agriculture  professiona ls,  environme ntal  workers, in  addition to  professiona ls in PAAF,  KEPA, and  food safety   | 1.5.1.2.1   The focal  person in  each  ministry/au thority  checks  educational  activities in  their  facilities  and   Includes   AMR   awareness  as a topic  of  continuous  education   | 1.5.1.2.1   Number of  AMR   Awareness  sessions  per year in  each   Ministry/au thority                                     | 1.5.1.2.1   Enhance  AMR  knowledge  and facing  its dangers  on the  official/gov ernmental  level                     | 1.5.1.2.1   Number of  sessions                                                                                                     | 1.5.1.2.1   Once/year   | 1.5.1.2.1   PAAF  KEPA-PAFN                                                | 1.5.1.2.1   Counting        | 1.5.1.2.1   Not  available   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|-------------------------|----------------------------------------------------------------------------|-----------------------------|------------------------------|
|                                                                                                                                                                                                                         | 1.5.1.2.2   Mandate  that   all drug  companies'  educational  activities  should  include  AMR  awareness                                                                                    | 1.5.1.2.2   Proportion  of  promotion al activities  by drug  companies  in  these fields  that  include  messages  about AMR | 1.5.1.2.2   Engage  drug  companies  in  improving  AMR  awareness  among  veterinaria ns,  agriculture  professiona ls | 1.5.1.2.2   Number of  activities  held by  drug  companies  that  include  messages  on  AMR/Total  number of  activities  held by | 1.5.1.2.2   Once/year   | 1.5.1.2.2   PAAF  Awareness  focal  person /   Director  General of   PAAF | 1.5.1.2.2  Data  collection | 1.5.1.2.2   Not  available   |

<!-- image -->

|                                                                                      |                                                                                                                   |                                                                                                                                                                                                                                                                                                               |                                                                                        |                                                                                                     | these  companies *100                                                                                                              |                       |                                                               |                              |                            |
|--------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------|-----------------------|---------------------------------------------------------------|------------------------------|----------------------------|
| 1.5.2  Country  participates  the  regional/int ernational  AMR  awareness  campaign | 1.5.2.1  Participate  actively in  WHO  regional  AMR  campaign   and FAO  and  OIE   activities  related to  AMR | 1.5.2.1.1  Register  Kuwait  ministries  /authorities  (KEPA,  PAAF,  MOH) to  participate  in the  yearly  schedule of  AMR  activities in  WHO, FAO,  OIE   And  encourage  individual  healthcare  professiona ls,  veterinaria ns,  agriculture  professiona ls,  environme ntal  workers to  participate | 1.5.2.1.1  Proportion  of events  related to  AMR in  which the  country  participates | 1.5.2.1.1   Engage the  country as  a whole in  the  regional  and  internation al fighting  of AMR | 1.5.2.1.1   Number of  events  related to  AMR  attended  by the  country/To tal number  of events  attended  by the  country*10 0 | 1.5.2.1.1   Once/year | 1.5.2.1.1   MOH  PAAF  KEPA  Awareness  Technical  Task force | 1.5.2.1.1   Data  collection | 1.5.2.1.1   Not  available |
|                                                                                      | 1.5.2.2  Participate                                                                                              | 1.5.2.2.1  Kuwait is                                                                                                                                                                                                                                                                                          | 1.5.2.2.1  Done                                                                        |                                                                                                     |                                                                                                                                    |                       |                                                               |                              | 1.5.2.2.1  Done            |

|                                                                                                                                                                                                    | in GCC  activities  related to  AMR                                                                                                                                                                                          | part of GCC  AMR Group                                                                                                                                                                             |                                                                                                                                                                                                    |                                                                                                                                                                                                    |                                                                                                                                                                                                    |                                                                                                                                                                                                    |                                                                                                                                                                                                    |                                                                                                                                                                                                    |                                                                                                                                                                                                    |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                    |                                                                                                                                                                                                                              | 1.5.2.2.2  Kuwait  participates  in all the  AMR  activities  GCC                                                                                                                                  | 1.5.2.2.2  Done                                                                                                                                                                                    |                                                                                                                                                                                                    |                                                                                                                                                                                                    |                                                                                                                                                                                                    |                                                                                                                                                                                                    |                                                                                                                                                                                                    | 1.5.2.2.2  Done                                                                                                                                                                                    |
| Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties.                           | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. | Strategic Objective 1.6 Include AMR teaching in higher education/post-graduate studies in all human health specialties, agriculture, veterinary food  safety, and environment related specialties. |
| 1.6.1  Include  AMR and  related  topics  based on  the One  Health  approach  as a core  component  of  professiona l   education,  training,  certificatio n                                     | 1.6.1.1  Include  AMR and  related  topics  based on  the One  Health  approach in  undergradu ate  curricula  for human  health  (medical,  nursing,  dental and  pharmaceu tical), food  safety, and  environme nt related | 1.6.1.1.1  preparatio n of   modules  for these  specialties                                                                                                                                       | 1.6.1.1.1  Modules  prepared  yes/no                                                                                                                                                               | 1.6.1.1.1  Standardize  AMR  education  and  knowledge  based on  the One  Health  Approach                                                                                                        | 1.6.1.1.1  Yes/No                                                                                                                                                                                  | 1.6.1.1.1  Once                                                                                                                                                                                    | 1.6.1.1.1  Awareness  focal  persons in  all  ministries/ authorities  /Awarenes s technical  task force                                                                                           | 1.6.1.1.1  Checking                                                                                                                                                                                | 1.6.1.1.1  Not  available                                                                                                                                                                          |

|                                                                                                                                                                  | 1.6.1.1.2  Letter from  MOH,  PAFN and  KEPA to  Ministry of  Higher  Education  to impose  on  universities /authorities  to include  these  modules in  the  correspond ing  education  programs.   | 1.6.1.1.2  Letter sent   Yes/No   | 1.6.1.1.2  Standardize  AMR  knowledge  based on  the One  Health  Approach   | 1.6.1.1.2  Yes/No   | 1.6.1.1.2  Once   | 1.6.1.1.2  Awareness  focal  persons in  all  ministries/ authorities  /awareness  technical   Task force   | 1.6.1.1.2  Checking   | 1.6.1.1.2  Not  available   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------|-------------------------------------------------------------------------------|---------------------|-------------------|-------------------------------------------------------------------------------------------------------------|-----------------------|-----------------------------|
| 1.6.1.2   AMR and  related  topics  based on  the One  Health  approach  included in  the  licensing  procedure  for nurses,  dentists,  physicians,  pharmacist | 1.6.1.2.1  Letter from  MOH,  PAAF, PAFN  and KEPA  to licensing   bodies of  these  professiona ls to  include  AMR and  its related  topics   in licensing  exams and                               | 1.6.1.2.1  Letters sent  Yes/No   | 1.6.1.2.1  Standardize  AMR  knowledge  based on  the One  Health  Approach   | 1.6.1.2.1  Yes/No   | 1.6.1.2.1  Once   | 1.6.1.2.1  MOH,  PAAF,PAFN  and KEPA  /AMR focal  persons in  all  authorities                              | 1.6.1.2.1  Checking   | 1.6.1.2.1  Not  available   |

|                                                                                                                                                                                 | s,  veterinaria ns and  other  professiona ls for which  licensing is  required.                                                                                                                                                               | interviews  or in the  evaluation  procedure  for license  renewal                                                                                                              |                                                                                                                                                                                 |                                                                                                                                                                                 |                                                                                                                                                                                 |                                                                                                                                                                                 |                                                                                                                                                                                 |                                                                                                                                                                                 |                                                                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment | Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment                                                                | Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment | Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment | Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment | Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment | Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment | Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment | Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment | Strategic Objective 1.7 Include AMR and related topics in quality assurance and accreditation programs in human health, animal health, agriculture, food  chain and environment |
| 1.7.1 IPC,  AMR  surveillanc e and AMS   are  included in  the  accreditati on  standards  of  healthcare  facilities                                                           | 1.7.1.1  Letter from   MOH to  accreditati on bodies  to include  AMR  surveillanc e and  implement ation of  antimicrobi al  stewardshi p programs  as part of  accreditati on  standards  in all  healthcare  facilities as  well as in  the |                                                                                                                                                                                 | 1.7.1.1  AMR  surveillanc e and AMS  programs  are  included in  the  accreditati on and  license  renewal  standards  for  healthcare  facilities                              | 1.7.1.1   Standardize  quality  assurance  practices  related to  AMR  including  surveillanc e and  stewardshi p in  healthcare  facilities                                    | 1.7.1.1   Yes/No                                                                                                                                                                | 1.7.1.1   Once                                                                                                                                                                  | 1.7.1.1   MOH                                                                                                                                                                   | 1.7.1.1   Checking                                                                                                                                                              | 1.7.1.1   Not  available                                                                                                                                                        |

|                                                                                                                                                                       | procedures  of private  healthcare  facilities  IPC is  already  part of  these  standards                                                                                          |                                                                                   |                                                                            |                                                                                       |                   |                 |                                                                            |                     |                           |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|----------------------------------------------------------------------------|---------------------------------------------------------------------------------------|-------------------|-----------------|----------------------------------------------------------------------------|---------------------|---------------------------|
| 1.7.2 IPC  and  rational use  of  antimicrobi als is  checked in  the  procedure  of licensing  farms,  animal  husbandry,  agriculture,  aquatic and  marine  fields | 1.7.2.1  Review of   large  animal/pou ltry farms   licensing  policies and  procedures ,   to include   IPC and  proper ABX  use and  prevention  of ABX use  as growth  promoters | 1.7.2.1.1  Mandate  that ABX  are not to  be used as  growth  promoters           | 1.7.2.1.1  Mandate  issued                                                 | 1.7.2.1.1  Put a legal  frame for  the control  of ABX use  in the non- human  sector | 1.7.2.1.1  Yes/No | 1.7.2.1.1  Once | 1.7.2.1.1  PAAF/  PAAF  Director  General  /PAAF  awareness  focal  person | 1.7.2.1.1  Checking | 1.7.2.1.1  Not  available |
|                                                                                                                                                                       |                                                                                                                                                                                     | 1.7.2.1.2  Letter from  PAAF  Director  General to  licensing  office to  include | 1.7.2.1.2  AMR- related  topics   are  included in  licensing  conditions. | 1.7.2.1.2  Emphasize  on the  importance  of AMR and  related  topics in  the non-    | 1.7.2.1.2  Yes/No | 1.7.2.1.2  Once | 1.7.2.1.2  PAAF/  Director  General of  PAAF                               | 1.7.2.1.2  Checking | 1.7.2.1.2  Not  available |

## Kuwait national action plan on antimicrobial resistance 2022

these points in the standards

human sector

## Annex 3

## A. Surveillance Strategic Plan

| Strategic  interventions                                                                                                        | Activity                                                                                                                                                                                                                                                                      | Sub-activity                                                                                                              | Sub-sub- activity                                                                                                         | Sub-sub-sub- activity                                                                                                     | Date                                                                                                                      | Milestone for  strategic objective                                                                                        |
|---------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach       | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach                                                                                                                                                     | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach |
| 2.1.1 Establish a  national  coordination  structure for AMR  surveillance in  humans, veterinary  agriculture and  environment | 2.1.1.1 Write and  approve terms of  reference for a  national  coordinating  committee for  AMR surveillance  with the mandate  to oversee the  AMR surveillance  program, including  AMR surveillance  in Humans,  Veterinary,  agriculture,  environment and  Food safety. |                                                                                                                           |                                                                                                                           |                                                                                                                           | 2.1.1   6 months                                                                                                          | 2.1  3 years                                                                                                              |
|                                                                                                                                 | 2.1.1.2. Write and  approve terms of  reference for a   central office that  executes the  National  surveillance in  humans and  receives data from  other AMR offices  in PAAF, KEPA and  food safety                                                                       | 2.1.1.2.1 Write  terms of reference  of the AMR office  at MOH                                                            |                                                                                                                           |                                                                                                                           | 2.1.1.2.1   3 months                                                                                                      |                                                                                                                           |

| 2.1.1.2.2 Create  the AMR  coordinating office  at MOH.                                                                           | 2.1.1.2.2.1 Include  the already existing  Glass team into the  MOH National AMR  office for Human  sector at MOH.                            | 2.1.1.2.2.1.1 Add 2  employees with a  support from IT at  MOH to be able to  handle nationwide  data  (to do the  functions of the  central office).   | 2.1.1.2.2.1.1   6 months   |
|-----------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|
|                                                                                                                                   | 2.1.1.2.2.2 Mandate  that each MOH  hospital has an AMR  surveillance focal  person that  coordinates with  Central AMR  surveillance office. |                                                                                                                                                         | 2.1.1.2.2.2   3 months     |
| 2.1.1.2.3  Inform PAAF, PAFN  and KEPA about  the need for AMR  surveillance in their  respective fields.                         |                                                                                                                                               |                                                                                                                                                         | 2.1.1.2.3  1 month         |
| 2.1.1.2.4  Nominate AMR  focal persons in  PAAF, KEPA, and  Food safety                                                           |                                                                                                                                               |                                                                                                                                                         | 2.1.1.2.4  3 months        |
| 2.1.1.2.5  Write the job  description of  these focal  persons. The job  description would  be to collect AMR  data and supply it |                                                                                                                                               |                                                                                                                                                         | 2.1.1.2.5  3 months        |

|                                                                                                                                                                                            | to the Central AMR  office and full  coordination with  the Central AMR  office at MOH.                                                                                                                                |                                                                                                                                                                                                        |                      |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|
| 2.1.1.3 Identify  priority organisms  for the purpose of  national AMR  surveillance in  human sector,  animal sector,  plants and  Environment.                                           |                                                                                                                                                                                                                        |                                                                                                                                                                                                        | 2.1.1.3   3 months   |
| 2.1.1.4  Systematically  collect, analyze and  report data on  AMR in humans in  order to inform  decision-making at  national and  international levels  (Choose sentinel  group of labs) | 2.1.1.4.1   Choose a list of  labs (dealing with  specimen from  humans) that can  provide reliable  AMR data will form  a sentinel for  starting AMR data  collection that will  be submitted to  AMR central office. |                                                                                                                                                                                                        | 2.1.1.4.1   3 months |
|                                                                                                                                                                                            | 2.1.1.4.2  Increase the  number of labs  that are included in  the list on yearly  basis until it  becomes  representative of  the national data.                                                                      | 2.1.1.4.2.1  Establish close  communication  between central AMR  OFFICE that also  collects data for glass  with the lab council to  have a list of labs that  are accredited by the  council, and to | 2.1.1.4.2.1  1 year  |

|                                                                                            |                                                                                                 |                                                                                                                                           | include them in the  list of labs eligible to  submit data to GLASS  and  National AMR  surveillance                                    |                          |
|--------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|--------------------------|
|                                                                                            | 2.1.1.5  Establish an  antimicrobial  resistance  surveillance  network for  human health       | 2.1.1.5.1 integrate  all MOH  laboratories in  network with the  national reference  Lab.                                                 | 2.1.1.5.1.1  Training of hospital  AMR Surveillance  focal persons for data  cleaning and data  entry into the MOH  surveillance system | 2.1.1.5.1.1  1 year      |
|                                                                                            |                                                                                                 | 2.1.1.5.2  Generate yearly  report about AMR  in humans in  general and mainly  priority organisms  in humans by the  MOH central office. |                                                                                                                                         | 2.1.1.5.2  2 years       |
| 2.1.2 Participate in  Global  Antimicrobial  Resistance  Surveillance  System (GLASS- AMR) | 2.1.2.1 Nominate a  hospital ad a team  for GLASS reporting  with TOR                           |                                                                                                                                           |                                                                                                                                         | 2.1.2.1   Already done   |
|                                                                                            | 2.1.2.2 Give the  GLASS team the  authority to  request and collect  data from labs  nationwide |                                                                                                                                           |                                                                                                                                         | 2.1.2.2   Already done   |
|                                                                                            |                                                                                                 | 2.1.2.2.1 The team  initiates data                                                                                                        |                                                                                                                                         | 2.1.2.2.1   Started 2021 |

|                                                                                                                                                  |                                                                                                                                                  | collection from a  sentinel of labs                                                                                                                                                      |                                                                                                                                                  |                                                                                                                                                  |                                                                                                                                                  |                                                                                                                                                  |
|--------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                  | 2.1.2.3  Send yearly report  to glass with  increasing number  of contributing labs                                                              | 2.1.2.3.1  Central GLASS focal  group (Part of AMR  central office),  chooses from the  list of eligible  accredited labs  submitted by  central entity of  medical labs to  AMR office, | 2.1.2.3.1  1  Yearly training of  GLASS focal persons  on GLASS data  collection,  management and  entry                                         | 2.1.2.3.1.1.1  Central workshops  yearly                                                                                                         | 2.1.2.3.1.1.1  2 years                                                                                                                           |                                                                                                                                                  |
|                                                                                                                                                  |                                                                                                                                                  | 2.1.2.3.2  Yearly lab report is  sent to GLASS with  increasing number  of contributing labs  every year.                                                                                |                                                                                                                                                  |                                                                                                                                                  | 2.1.2.3.2  Started already                                                                                                                       |                                                                                                                                                  |
| Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance                                         | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance |
| activities in human,  2.2.1  Lab in Hospitals  become CAP  certified (College of  American  pathologists)                                        | 2.2.1.1  Pilot with 2 labs                                                                                                                       |                                                                                                                                                                                          |                                                                                                                                                  |                                                                                                                                                  | 2.2.1.1  1 year                                                                                                                                  | 2.2  5 years                                                                                                                                     |
|                                                                                                                                                  | 2.2.1.2  Increase the  number of labs  that are CAP  members                                                                                     | 2.2.1.2.1  Lab council puts a  plan for sequential  recruitment of labs  into the CAP                                                                                                    |                                                                                                                                                  |                                                                                                                                                  | 2.2.1.2.1  1 year                                                                                                                                |                                                                                                                                                  |
|                                                                                                                                                  |                                                                                                                                                  | 2.2.1.2.2  Sequential  recruitment of labs  into CAP                                                                                                                                     |                                                                                                                                                  |                                                                                                                                                  | 2.2.1.2.2  5 years                                                                                                                               |                                                                                                                                                  |

| 2.2.2  Improve private  labs capacity to be  eligible for  submitting data to  GLASS and National  AMR   | 2.2.2.1  Reinforce the  accreditation  activity of the lab  council that audits  labs according to  availability of  qualified  microbiologist,  results of External  QC and abidance to  guidelines   | 2.2.2.1.1  Mandate from  MOH that each  private lab should  pass the  accreditation by  the Lab council                                                      |                                                                             | 2.2.2.1.1  12-24 months                                                     |                                                                             |
|----------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|
|                                                                                                          |                                                                                                                                                                                                        | 2.2.2.1.2  Accreditation of  the lab council  includes the  availability of  qualified  microbiologist,  results of External  QC and abidance to  guidelines |                                                                             | 2.2.2.1.2  6 months                                                         |                                                                             |
| Strategic objective 2.3: Collect data from Vet, Agriculture and Environment                              | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment                                                                                                                            | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment                                                                                  | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment |
| 2.3.1  Collect AMR data  from Vets                                                                       | 2.3.1.1  Map available data  On AMR in vet and  agriculture in the  country.                                                                                                                           | 2.3.1.1.1  Agriculture and  Environment focal  persons collect  available info  about AMR in the  country and issue a  report                                | 2.3.1.1.1.1  Map PAAF labs and  the type of AMR data  that is generated.    | 2.3.1.1.1.1  6 months                                                       | 2.3  5 years                                                                |
|                                                                                                          |                                                                                                                                                                                                        |                                                                                                                                                              | 2.3.1.1.1.2  Collect available data  about AMR in  PAAF/PAFN                | 2.3.1.1.1.2  6 months                                                       |                                                                             |
|                                                                                                          | 2.3.1.2                                                                                                                                                                                                | 2.3.1.2.1                                                                                                                                                    | 2.3.1.2.1.1                                                                 | 2.3.1.2.1.1                                                                 |                                                                             |

| Improve vet lab  capacity in a way  they generate data  about AMR vets  and agriculture   | Establish quality  control of Vet  Microbiology labs                                                                                     | Assign expert to   establish a system for  quality control and  put a plan                           | 1 year                 |
|-------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------|------------------------|
|                                                                                           |                                                                                                                                          | 2.3.1.2.1.2  Execute the plan of  quality control in Vet  labs                                       | 2.3.1.2.1.2  2 year    |
|                                                                                           | 2.3.1.2.2  Extend Vet Micro  Labs to identify  priority organisms     antibiogram                                                        | 2.3.1.2.2  1  Increase man power                                                                     | 2.3.1.2.2  1  6 months |
|                                                                                           |                                                                                                                                          | 2.3.1.2.2.2  Road map and full  project                                                              | 2.3.1.2.2.2  1 year    |
|                                                                                           |                                                                                                                                          | 2.3.1.2.2.3  Workshops for  training about  antibiogram                                              | 2.3.1.2.2.3  1 year    |
|                                                                                           | 2.3.1.2.3  Implement  national  surveillance for  antibiogram  priority animal  pathogens,  zoonotic and  commensal  bacterial isolates. | 2.3.1.2.3.1  Choose a number of  Vet labs that could  submit AMR data to  PAAF for AMR  surveillance | 2.3.1.2.3.1  1 year    |
|                                                                                           |                                                                                                                                          | 2.3.1.2.3.2  Collect data from a  Sentinel of vet  hospitals or labs that  submit data to the        | 2.3.1.2.3.2  2 years   |

|                                            |                                                                                 |                                                                                                                                       | department of  surveillance. (They  belong to the list).                                                                                                                          |                       |
|--------------------------------------------|---------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------|
|                                            |                                                                                 | 2.3.1.2.4  The focal AMR  entity at PAAF  submits AMR data  to the Central AMR  surveillance lab.                                     |                                                                                                                                                                                   | 2.3.1.2.4  1 year     |
| 2.3.2  Collect AMR data  from Environment. | 2.3.2.1  Map available data  from KEPA                                          | 2.3.2.1  Check KEPA Labs  and publications  about any AMR   data in  environment                                                      |                                                                                                                                                                                   | 2.3.2.1  3 months     |
|                                            | 2.3.2.2  Initiate AMR data  collection from  Environment By  research projects. | 2.3.2.2.1  The director of the  office of research  and studies puts  AMR surveillance  as one of the  priority subjects in  research | 2.3.2.2.1.1  The plan of  prioritizing AMR  surveillance in  Environment and  marine environment  re and is being  discussed with  universities/institutes.                       | 2.3.2.2.1.1  6 months |
|                                            |                                                                                 |                                                                                                                                       | 2.3.2.2.1.2  Call for proposal from  universities/institutes                                                                                                                      | 2.3.2.2.1.2  1 year   |
|                                            |                                                                                 |                                                                                                                                       | 2.3.2.2.1.3  The director of the  office of research and  studies applies for  funds from KEPA for  projects related to  AMR surveillance in  Vet, agriculture, and  Environment. | 2.3.2.2.1.3  6 months |

| 2.3.2.2.2  Increase lab  capacity of KEPA  Lab that deals with  the quality of  coastal water to  include AMR  identification and  surveillance in  water and  sediment   | 2.3.2.2.2.1  Letter from KEPA  Director General to  Technical affairs  sector of micro labs  asking to prepare a  project with a budget   that aims at  expanding their work  from only  identification to  antibiogram testing   |                                                                   | 2.3.2.2.2.1  3 months   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------|
|                                                                                                                                                                           | 2.3.2.2.2.2  KEPA   analytical central lab  KEPA  prepare  road map for the labs  to be able to do  antibiogram testing                                                                                                           | 2.3.2.2.2.2.1  Identify the needed  machinery and  their budget   | 2.3.2.2.2.2.1  6 months |
|                                                                                                                                                                           |                                                                                                                                                                                                                                   | 2.3.2.2.2.2.2  Put a plan of  needed extra  staffing              | 2.3.2.2.2.2.2  6 months |
|                                                                                                                                                                           | 2.3.2.2.2.3  KEPA    provides the related  budget                                                                                                                                                                                 | 2.3.2.2.2.3  Communication  between KEPA and  ministry of finance | 2.3.2.2.2.3  2 years    |
|                                                                                                                                                                           | 2.3.2.2.2.4  KEPA microbiology  labs start generating  antibiogram results  for priority organisms                                                                                                                                |                                                                   | 2.3.2.2.2.4  3 years    |
| 2.3.2.2.3  Generate report  about AMR                                                                                                                                     |                                                                                                                                                                                                                                   |                                                                   | 2.3.2.2.3  4 years      |

|                                                                                                                                                                                             |                                                                                                                    | surveillance in  Environment                                                                      |                                                                  |                                                                  |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------|
| 2.3.3  The national AMR  Surveillance Office  at MOH gathers  data from KEPA,  PAAF and PAFN  compiles it with  Human AMR data  and generates  yearly ONE Health  AMR surveillance  report. | 2.3.3.1  KEPA, PAAF and  PAFN submit  available data to  Central AMR  surveillance office  at MOH on yearly  basis | 2.3.3.1.1  Create a digital  network for data  sharing with MOH                                   | 2.3.3.1.1  5 years                                               |                                                                  |
|                                                                                                                                                                                             |                                                                                                                    | 2.3.3.1.2  Add this function  to the TOR of the  focal person at  PAAF and KEPA and  food safety. | 2.3.3.1.2  3 years                                               |                                                                  |
| Strategic objective 2.4: Create a National Reference Lab for AMR                                                                                                                            | Strategic objective 2.4: Create a National Reference Lab for AMR                                                   | Strategic objective 2.4: Create a National Reference Lab for AMR                                  | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR |
| 2.4.1  To have   A Kuwaiti  Center of Disease  Control that will  be overseeing  bacterial ,viral and  AMR reference labs                                                                   | 2.4.1.1  Project of  reference lab with  its budget and  having it endorsed  by MOH                                |                                                                                                   | 2.4.1.1  Already available                                       | 2.4  5 years                                                     |
|                                                                                                                                                                                             | 2.4.1.2  Kuwait CDC  becomes functional                                                                            |                                                                                                   | 2.4.1.2  5 years                                                 |                                                                  |
| .                                                                                                                                                                                           | 2.4.1.3  Write and approve  terms of reference  for a national                                                     |                                                                                                   | 2.4.1.3  3 months                                                |                                                                  |

|                                                       | AMR reference  laboratory with  expertise in  method  s for confirming  and characterizing  specific pathogens,  putting  guidelines, SOP for  identification and  antibiogram testing  of priority  organisms for  surveillance  training according  to guidelines, and  organizing quality  assurance schemes   |                                                                         |                              |
|-------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------|------------------------------|
|                                                       | 2.4.1.4  Prepare a full  project and  proposal for the  reference lab                                                                                                                                                                                                                                             |                                                                         | 2.4.1.4  5 years             |
|                                                       | 2.4.1.5  Prepare a budget  for the building,  equipment and  man power of the  reference Lab                                                                                                                                                                                                                      |                                                                         | 2.4.1.5  5 years             |
|                                                       | 2.4.1.6  Execution of the  Reference Lab                                                                                                                                                                                                                                                                          |                                                                         | 2.4.1.6  5 years             |
| 2.4.2  Delegate the  function of  surveillance of the | 2.4.2.1  Identify institution  affiliated to MOH  that will host the                                                                                                                                                                                                                                              | 2.4.2.1.1  A letter from MOH  to all labs that asks  them to coordinate | 2.4.2.1.1  Already available |

| Reference Lab  pending its  readiness                                                                                                                   | manpower and  activities of the  AMR Surveillance  office   for the actual work  on the National  and GLASS AMR  reports pending  the finalization of  the reference lab.   | with the GLASS lab  by delivering AMR  data   for the purpose of  AMR Surveillance   |                                                                                                                  |                                                                                                                    |                                                                     |                                                                     |
|---------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------|---------------------------------------------------------------------|
| Strategic objective 2.5: Unify AMR identification in all Micro labs                                                                                     | Strategic objective 2.5: Unify AMR identification in all Micro labs                                                                                                         | Strategic objective 2.5: Unify AMR identification in all Micro labs                  | Strategic objective 2.5: Unify AMR identification in all Micro labs                                              | Strategic objective 2.5: Unify AMR identification in all Micro labs                                                | Strategic objective 2.5: Unify AMR identification in all Micro labs | Strategic objective 2.5: Unify AMR identification in all Micro labs |
| 2.5.1 Lab audit by  lab accreditation  body according to  microbiologist  consultant in  charge, external  quality control and  use of CLSI  guidelines | 2.5.1.1  Accreditation of  the medical  Laboratories  by Medical  Laboratories  Council                                                                                     | 2.5.1.1.1  Involve all  laboratories in  external quality  assurance  programs       | 2.5.1.1.1.1  Mandate that all labs  including all private  should be accredited  and all perform  external   QC. | 2.5.1.1.1.1.1  List of  accreditation  bodies accepted in  Kuwait, all labs  should be  accredited by one  of them | 2.5.1.1.1.1.1  6 months                                             | 2.5  5 years                                                        |

## B. Surveillance Monitoring Plan

<!-- image -->

| Strategic  interventi ons                                                                                                              | Activity                                                                                                                                                                                                               | Sub- activity                                                                                                             | Sub-sub-  activity                                                                                                        | Sub-sub- sub- activity  Indicator                                                                                         | Purpose                                                                                                                   | Calculatio n                                                                                                              | Frequenc y                                                                                                                | Data  source                                                                                                              | Method                                                                                                                    | Baseline                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach              | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach                                                                                              | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach | Strategic Objective 2.1:  Set up a national surveillance system for antimicrobial resistance based on One Health Approach |
| 2.1.1  Establish a  national  coordinati on  structure  for AMR  surveillan ce in  humans,  veterinary  agricultur e and  environm ent | Write and  approve  terms of  reference  for a  national  coordinati ng  committe e for AMR  surveillan ce with  the  mandate  to oversee  the AMR  surveillan ce  program,  including  AMR  surveillan ce in  Humans, |                                                                                                                           |                                                                                                                           | 2.1.1  Committe e is  formed  yes/No                                                                                      | 2.1.1  To  oversee  and  coordinat e  surveillan ce  activities   in  Humans,  Vets,  Agricultur e and  Environm ent.     | 2.1.1  Yes/No                                                                                                             | 2.1.1  Once                                                                                                               | 2.1.1  MOH                                                                                                                | 2.1.1  Checking                                                                                                           | 2.1.1  Not  formed                                                                                                        |

<!-- image -->

| ent and  Food  safety.                                                                                                                                                                                      |                                                                    |                                                                                   |                                                                                    |                                                             |                                                                         |                                                                |                       |                                                             |                           |                                 |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|-----------------------------------------------------------------------------------|------------------------------------------------------------------------------------|-------------------------------------------------------------|-------------------------------------------------------------------------|----------------------------------------------------------------|-----------------------|-------------------------------------------------------------|---------------------------|---------------------------------|
| 2.1.1.2.  Write and  approve  terms of  reference  for a   central  office that  executes  the  National  surveillan ce in  humans  and  receives  data from  other  AMR  offices in  PAAF,  KEPA and  food | 2.1.1.2.1  Write  terms of  reference  of the  AMR  office at  MOH |                                                                                   |                                                                                    | 2.1.1.2.1  TOR  written                                     | 2.1.1.2.1  To  organize  and frame  the work  of this  committe e       | 2.1.1.2.1  Yes/No                                              | 2.1.1.2.1  Once       | 2.1.1.2.1  MOH                                              | 2.1.1.2.1  Checking       | 2.1.1.2.1  Not  written  yet    |
|                                                                                                                                                                                                             | 2.1.1.2.2  Create the  AMR  coordinati ng office  at MOH.          | 2.1.1.2.2.1  Include  the  already  existing  Glass  team into  the MOH  National | 2.1.1.2.2.1 .1   Add 2  employee s with a  support  from IT at  MOH to  be able to | 2.1.1.2.2.1 .1   2 extra  employee s are  employed.  Yes/No | 2.1.1.2.2.1 .1   To  execute  all the  Human  AMR  surveillan ce and to | 2.1.1.2.2.1 .1   Office  with  employed  personnel  is formed. | 2.1.1.2.2.1 .1   Once | 2.1.1.2.2.1 .1   MOH/  Informati on system  administr ation | 2.1.1.2.2.1 .1   Checking | 2.1.1.2.2. 1.1   Not  available |

|                                                                                           | AMR  office for  Human  sector at  MOH.                                                                                                                | handle  nationwid e data  (to do the  functions  of the  central  office).   |                                      | collect  data from  the Vet  and  Agricultur e and  KEPA  Surveillan ce.   |                     |                   |                  |                       |                             |
|-------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------|--------------------------------------|----------------------------------------------------------------------------|---------------------|-------------------|------------------|-----------------------|-----------------------------|
|                                                                                           | 2.1.1.2.2.2  Mandate  that each  MOH  hospital  has an  AMR  surveillan ce focal  person  that  coordinat es with  Central  AMR  surveillan ce office. |                                                                              | 2.1.1.2.2.2  Mandate  issued  Yes/No | 2.1.1.2.2.2  Mandate  is issued                                            | 2.1.1.2.2.2  Yes/No | 2.1.1.2.2.2  Once | 2.1.1.2.2.2  MOH | 2.1.1.2.2.2  Checking | 2.1.1.2.2. 2 Not  available |
| 2.1.1.2.3  Inform  PAAF,PAF N and  KEPA  about the  need for  AMR  surveillan ce in their |                                                                                                                                                        |                                                                              | 2.1.1.2.3  Letter  sent              |                                                                            |                     |                   |                  |                       |                             |

| respective  fields.                                                                                                                                       |                                                                                  |                                                                                                                                                                   |                   |                                     |                                  |                     |                                                                                                                                           |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------|-------------------------------------|----------------------------------|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| 2.1.1.2.4  Nominate  AMR focal  persons in  PAAF,  KEPA, and  Food  safety                                                                                | 2.1.1.2.4  AMR  surveillan ce focal  persons  appointed  in all 3   authoritie s | 2.1.1.2.4  To start  the  activities  that lead  to data  collection  and  ultimately  do the  surveillan ce data  collection  in their  respective  authoritie s | 2.1.1.2.4  Yes/No | 2.1.1.2.4  ONCE in  each  authority | 2.1.1.2.4  MOH  PAAF  KEPA  PAFN | 2.1.1.2.4  Checking | 2.1.1.2.4  Only  GLASS  focal  person is  employed  at MOH.  No  national  surveillan ce job  descriptio n.   None in  PAAF,  KEPA,  PAFN |
| 2.1.1.2.5  Write the  job  descriptio n of these  focal  persons.  The job  descriptio n would  be to  collect  AMR data  and  supply it  to the  Central | 2.1.1.2.5  TOR  are set                                                          | 2.1.1.2.5  To  organize  the job  and reach  the goal  of  surveillan ce                                                                                          | 2.1.1.2.5  Yes/No | 2.1.1.2.5  Once in  each  authority | 2.1.1.2.5  MOH  PAAF  KEPA  PAFN | 2.1.1.2.5  Checking | 2.1.1.2.5  Not  available                                                                                                                 |

|                                                                                                                                                           | AMR  office and  full  coordinati on with  the  Central  AMR  office at  MOH.   |                                                                       |                                                                                                               |                               |                       |                 |                      |                                                           |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|-----------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------|-------------------------------|-----------------------|-----------------|----------------------|-----------------------------------------------------------|
| 2.1.1.3  Identify  priority  organisms  for the  purpose  of  national  AMR  surveillan ce in  human  sector,  animal  sector,  plants and  Environm ent. |                                                                                 | 2.1.1.3  List is  available  and  includes  all listed  sectors.      | 2.1.1.3   To focus  surveillan ce on the  most  important  AMR  trends  that are of  interest in  all sectors | 2.1.1.3  List is put   Yes/No | 2.1.1.3  Once         | 2.1.1.3  MOH    | 2.1.1.3  Checking    | Not  available.                                           |
| 2.1.1.4  Systemati cally  collect,  analyze  and  report  data on                                                                                         | 2.1.1.4.1   Choose a  list of labs  (dealing  with  specimen  from  humans)     | 2.1.1.4.1   List is  chosen(8  Labs  submitted  GLASS  data for  2021 | 2.1.1.4.1   To include  only data  that is  microbiol ogically  brought  according                            | 2.1.1.4.1   Yes/No            | 2.1.1.4.1   Once/year | 2.1.1.4.1   MOH | 2.1.1.4.1   Checking | 2.1.1.4.1   List for  GLASS  data has  been put  for 2022 |

| AMR in  humans in  order to  inform  decision- making at  national  and  internatio nal levels  (Choose  sentinel  group of  labs)   | that can  provide  reliable  AMR data  will form a  sentinel  for  starting  AMR data  collection  that will  be  submitted  to AMR  central  office.     |                                                                                                                                                                                                  | -Amiri  -Adan  -Mubarak  Alkhabeer  -Jaber  -Farwania  -Jahra  -Chest  -Ibn Sina)   | to  recogniza ble   microbiol ogy  guidelines  like   CLSI or  EUCAST                    |                                                                   |                        |                                         |                       |                                                                   |
|--------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|-------------------------------------------------------------------|------------------------|-----------------------------------------|-----------------------|-------------------------------------------------------------------|
|                                                                                                                                      | 2.1.1.4.2  Increase  the  number of  labs that  are  included  in the list  on yearly  basis until  it  becomes  represent ative of  the  national  data. | 2.1.1.4.2.1  Establish  close  communic ation  between  central  AMR  OFFICE  that also  collects  data for  glass with  the lab  council to  have a list  of labs  that are  accredited  by the | 2.1.1.4.2.1  Proportio n of labs  in the  country  that are  included  in the list  | 2.1.1.4.2.1  To have   surveillan ce data  that is  represent ative of all  the  country | 2.1.1.4.2.1  Number  of labs in  the  list/total  number of  labs | 2.1.1.4.2.1  Once/year | 2.1.1.4.2.1  MOH/  Surveillan ce office | 2.1.1.4.2.1  Checking | 2.1.1.4.2. 1  10 labs  will be  included  in 2022  in GLASS  data |

<!-- image -->

|                                                                                                |                                                                                               | council,  and to  include  them in  the list of  labs  eligible to  submit  data to  GLASS and  National  AMR  surveillan ce                   |                                                    |                                                                                                                                  |                                       |                        |                                      |                       |                                                     |
|------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|------------------------|--------------------------------------|-----------------------|-----------------------------------------------------|
| 2.1.1.5  Establish  an  antimicro bial  resistance  surveillan ce  network  for  human  health | 2.1.1.5.1  integrate  all MOH  laboratori es in  network  with the  national  reference  Lab. | 2.1.1.5.1.1  Training  of hospital  AMR  Surveillan ce focal  persons  for data  cleaning  and data  entry into  the MOH  surveillan ce system | 2.1.1.5.1.1  Yearly  workshop  performe d   Yes/No | 2.1.1.5.1.1  To  provide  adequate  training  about  data  managem ent in a  unanimou s way  throughou t all the  included  labs | 2.1.1.5.1.1  Workshop  done   Yes /No | 2.1.1.5.1.1  Once/year | 2.1.1.5.1.1  MOH                     | 2.1.1.5.1.1  Checking | 2.1.1.5.1. 1  Only  GLASS  focal is  being  trained |
|                                                                                                | 2.1.1.5.2  Generate  yearly  report  about  AMR in  humans in                                 |                                                                                                                                                | 2.1.1.5.2  Yearly  human  AMR  report is  issued   | 2.1.1.5.2  To direct  empiric  therapy  and  strategic  plan in                                                                  | 2.1.1.5.2  Yes/No                     | 2.1.1.5.2  Once/Year   | 2.1.1.5.2  MOH  Surveillan ce office | 2.1.1.5.2  Checking   | 2.1.1.5.2  GLASS  report  started  2021             |

|                                                                                                |                                                                                                     | general  and  mainly  priority  organisms  in humans  by the  MOH  central  office.   |                          | treatment  and  preventio n and  antibiotic  use in  humans.   |                          |
|------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------|--------------------------|----------------------------------------------------------------|--------------------------|
| 2.1.2  Participat e in  Global  Antimicro bial  Resistance  Surveillan ce System  (GLASS- AMR) | 2.1.2.1  Nominate  a hospital  ad a team  for GLASS  reporting  with TOR                            |                                                                                       | 2.1.2.1  Already  done   |                                                                | Already  available.      |
|                                                                                                | 2.1.2.2  Give the  GLASS  team the  authority  to request  and  collect  data from  labs  nationwid |                                                                                       | 2.1.2.2   Already  done  |                                                                | 2.1.2.2   Already  done  |
|                                                                                                |                                                                                                     | 2.1.2.2.1  The team  initiates                                                        | 2.1.2.2.1  Started  2021 |                                                                | 2.1.2.2.1  Started  2021 |

|                                                                                         | data  collection  from a  sentinel of  labs                                                                                                                                                         |                                                                                                               |                                            |                                                                                                                          |                                                                                 |                        |                                                      |                                                     |                          |                                                                    |
|-----------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------|--------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|------------------------|------------------------------------------------------|-----------------------------------------------------|--------------------------|--------------------------------------------------------------------|
| 2.1.2.3  Send  yearly  report to  glass with  increasing  number of  contributi ng labs | 2.1.2.3.1  Central  GLASS  focal  group  (Part of  AMR  central  office),  chooses  from the  list of  eligible  accredited  labs  submitted  by central  entity of  medical  labs to  AMR  office, | 2.1.2.3.1  1  Yearly  training of  GLASS  focal  persons  on GLASS  data  collection,  managem ent and  entry | 2.1.2.3.1.1 .1  Central  workshop s yearly | 2.1.2.3.1.1 .1  Workshop  done,  yes/No  have 10- 20 %  increase  in number  of  participati ng labs in  GLASS  annually | 2.1.2.3.1.1 .1  To do  proper  data   entry into  GLASS                         | 2.1.2.3.1.1 .1  Yes/No | 2.1.2.3.1.1 .1  Once/Year  (and for  new  employee ) | 2.1.2.3.1.1 .1  Surveillan ce/GLASS  office at  MOH | 2.1.2.3.1.1 .1  Checking | 2.1.2.3.1. 1.1  Not being  done on  yearly  basis  systemati cally |
|                                                                                         | 2.1.2.3.2  Yearly lab  report is  sent to  GLASS  with  increasing  number of  contributi                                                                                                           |                                                                                                               |                                            | 2.1.2.3.2  Data is  available  in the  yearly  GLASS  report                                                             | 2.1.2.3.2  To be  included  in the  global  AMR map  and to  evaluate  benchmar | 2.1.2.3.2  Yes/No      | 2.1.2.3.2  Once/Year                                 | 2.1.2.3.2  GLASS  Report                            | 2.1.2.3.2  Checking      | 2.1.2.3.2  Started  2021                                           |

<!-- image -->

|                                                                                                                                                                        | ng labs  every  year.                                                                                                                                                  |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        | k with  other  countries                                                                                                                                               |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, | Strategic Objective 2.2:  Build laboratory capacity to produce high-quality microbiological data for patient management and support surveillance  activities in human, |
|                                                                                                                                                                        | 2.2.1  Lab in  Hospitals  become  CAP  certified  (College  of  American  pathologis ts)                                                                               | 2.2.1.1  Pilot with  2 labs                                                                                                                                            |                                                                                                                                                                        | 2.2.1.1  Started  already                                                                                                                                              | 2.2.1.1  To check  feasibility                                                                                                                                         |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |
|                                                                                                                                                                        |                                                                                                                                                                        | 2.2.1.2  Increase  the  number of  labs that  are CAP  members                                                                                                         | 2.2.1.2.1  Lab  council  puts a  plan for  sequential  recruitme nt of labs  into the  CAP                                                                             | 2.2.1.2.1  List is put  already                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        |
|                                                                                                                                                                        |                                                                                                                                                                        |                                                                                                                                                                        | 2.2.1.2.2  Sequential  recruitme nt of labs  into CAP                                                                                                                  | 2.2.1.1  Proportio n of Labs  that are  CAP  affiliated                                                                                                                | 2.2.1.1  To   ensure  high  standard  lab work  and                                                                                                                    | 2.2.1.1  Number  of labs  that are  CAP   Members/ Total labs                                                                                                          | 2.2.1.1  Once/Year                                                                                                                                                     | 2.2.1.1  MOH  Central  laboratori es                                                                                                                                   | 2.2.1.1  Checking                                                                                                                                                      |

|                                                                                                             |                                                                                                                                                                                                                 |                                                                                                              |                                                                                                         | get  internatio nal  scientific  support                 |                                                                                                                                  |                    |                                                                            |                   |                                                                                                                                                         |
|-------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|----------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------|--------------------|----------------------------------------------------------------------------|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.2.2  Improve  private  labs  capacity  to be  eligible for  submittin g data to  GLASS and  National  AMR | 2.2.2.1  Reinforce  the  accreditati on activity  of the lab  council  that  audits  labs  according  to  availabilit y of  qualified  microbiol ogist,  results of  External  QC and  abidance  to  guidelines | 2.2.2.1.1  Mandate  from  MOH that  each  private  lab should  pass the  accreditati on by the  Lab  council | 2.2.2.1  Proportio n of labs  that are  functional  and that  have  passed  the  accreditati on testing | 2.2.2.1  To have  quality   AMR data  from all  the labs | 2.2.2.1  Number  of  of labs  that are  functional  and that  have  passed  the  accreditati on  testing/to tal  number of  labs | 2.2.2.1  Once/Year | 2.2.2.1  Central  Medical  laboratory  council/   Medical  Licensing  Dep. | 2.2.2.1  Checking | 2.2.2.1  All   governme ntal labs  are  accredite d  Not all  private  labs are  accredite d and  many do  not pass  the  accreditat ion check  yearly. |
|                                                                                                             |                                                                                                                                                                                                                 | 2.2.2.1.2  Accreditat ion of the  lab  includes  the  availabilit y of                                       | 2.2.2.1.2  Updated  accreditati on  standards  of Labs  prepared  or not                                | To  improve  private  lab  capacity  for  detecting  AMR | Update  done  yes/No                                                                                                             | once               | Central  Medical  laboratory  council                                      | checking          | available  in MOH  Labs                                                                                                                                 |

|                                                                             |                                                                                  |                                                                                                                                     |                                                                               | qualified  microbiol ogist,  results of  External  QC and  abidance  to  guidelines   |                                                                                               |                                                                                                                  |                                                                             |                                                                             |                                                                             |                                                                             |                                                                             |
|-----------------------------------------------------------------------------|----------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------|---------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------|
| Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment      | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment                                                         | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment   | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment           | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment                   | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment                                      | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment | Strategic objective 2.3: Collect data from Vet, Agriculture and Environment |
| 2.3.1  Collect  AMR data  from Vets                                         | 2.3.1.1  Map  available  data On  AMR in  vet and  agricultur e in the  country. | 2.3.1.1.1  Agricultur e and  Environm ent focal  persons  collect  available  info about  AMR in  the  country  and issue  a report | 2.3.1.1.1.1  Map PAAF  labs and  the type  of AMR  data that  is  generated . |                                                                                       | 2.3.1.1.1.1  Report is   Submitted  to central  AMR  surveillan ce office                     | 2.3.1.1.1.1  To check  the  available   Situation  regarding  AMR  identificat ion and  reporting  in Vet  labs. | 2.3.1.1.1.1  Report  done  Yes/No                                           | 2.3.1.1.1.1  Once                                                           | 2.3.1.1.1.1  Vet Labs  PAAF                                                 | 2.3.1.1.1.1  Data  collection  according  to a  checklist                   | 2.3.1.1.1. 1  Unknown                                                       |
|                                                                             |                                                                                  |                                                                                                                                     | 2.3.1.1.1.2  Collect  available  data  about  AMR in  PAAF/PAF N              |                                                                                       | 2.3.1.1.1.2  AMR  Vets/food  reports  are    submitted  to central  AMR  Surveillan ce office | 2.3.1.1.1.2  To collect  available  AMR data                                                                     | 2.3.1.1.1.2  AMR  report   from   PAAF/PAF N                                | 2.3.1.1.1.2  Once/year                                                      | 2.3.1.1.1.2  Vet  Labs/PAF N                                                | 2.3.1.1.1.2  Data  collection                                               | 2.3.1.1.1. 2  Not  available                                                |
|                                                                             | 2.3.1.2                                                                          | 2.3.1.2.1                                                                                                                           | 2.3.1.2.1.1                                                                   |                                                                                       | 2.3.1.1.1.1                                                                                   | 2.3.1.1.1.1                                                                                                      | 2.3.1.1.1.1  Yes/No                                                         | 2.3.1.1.1.1  Once                                                           | 2.3.1.1.1.1  PAAF                                                           | 2.3.1.1.1.1  Checking                                                       | 2.3.1.1.1. 1                                                                |

| Improve  vet lab  capacity  in a way  they  generate  data  about  AMR vets  and  agricultur e   | Establish  quality  control of  Vet  Microbiol ogy labs                                      | Assign  expert to   establish a  system for  quality  control  and put a  plan   | Profession al is  assigned                                                                           | To put a  plan with  a defined  budget   for Vet  labs to   start  generatin g  adequate   AMR data   |                                                                                                                                   |                        |                             |                       | The Vet  labs  generate  only   microorga nism  identificat ion data,  no AMR  data is  generated   |
|--------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|------------------------|-----------------------------|-----------------------|-----------------------------------------------------------------------------------------------------|
|                                                                                                  |                                                                                              | 2.3.1.2.1.2  Execute  the plan  of quality  control in  Vet labs                 | 2.3.1.2.1.2  Proportio n of VET  Labs that   Participat e in  external  quality  control  activities | 2.3.1.2.1.2  To  provide   periodic  check up  on the   accuracy  of AMR  detection  in vet  labs.    | 2.3.1.2.1.2  Number  of  of VET  Labs that   participat e in  external  quality  control  activities/ Total  number of  vet labs. | 2.3.1.2.1.2  once/year | 2.3.1.2.1.2  Vet  labs/PAAF | 2.3.1.2.1.2  Checking | 2.3.1.2.1. 2  Not  available                                                                        |
|                                                                                                  | 2.3.1.2.2  Extend  Vet Micro  Labs to  identify  priority  organisms     power  antibiogra m | 2.3.1.2.2  1  Increase  man                                                      | 2.3.1.2.2  1  None                                                                                   |                                                                                                       |                                                                                                                                   |                        |                             |                       |                                                                                                     |

| 2.3.1.2.2.2  Road map  and full  project                                                                                                                                                                                | 2.3.1.2.2.2  The  project is  put with  specified  budget  and ready  for   | execution                                                                                         | 2.3.1.2.2.2  To  upgrade  Vet labs  to  become  able to  generate  AMR   data       | 2.3.1.2.2.2  Yes/No    | 2.3.1.2.2.2  Once   | 2.3.1.2.2.2  PAAF   | 2.3.1.2.2.2  Checking   | 2.3.1.2.2. 2  Not  available   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|------------------------|---------------------|---------------------|-------------------------|--------------------------------|
| 2.3.1.2.2.3  Workshop s for  training  about  antibiogra m                                                                                                                                                              | 2.3.1.2.2.3  Workshop  is  performe d.                                      | 2.3.1.2.2.3  To train  microbiol ogists and  technician  in Vet labs  about  AMR  IDENTIFIC ATION | 2.3.1.2.2.3  Proportio n of vet  labs that  are  represent ed in  these  workshop s | 2.3.1.2.2.3  Once/year | 2.3.1.2.2.3  PAAF   | Checking            | 2.3.1.2.2.3             | 2.3.1.2.2. 3  Not  available   |
| Implemen t national  surveillan ce for  antibiogra m priority  animal  pathogens , zoonotic  and  commens al  2.3.1.2.3.1  Choose a  number of  Vet labs  that could  submit  AMR data  to PAAF  for AMR  surveillan ce | 2.3.1.2.3.1  List of labs  is  available  yearly                            | 2.3.1.2.3.1  To collect   Microbiol ogically  sound  AMR data  from Vet  Labs.                    | 2.3.1.2.3.1  Yes/No                                                                 | 2.3.1.2.3.1  Once/Year | PAAF                | 2.3.1.2.3.1         | 2.3.1.2.3.1  Checking   | 2.3.1.2.3. 1  Not  available   |

|       |         |                                                                                                        | 2.3.1.2.3.2  Collect  data from  a Sentinel  of vet  hospitals  or labs  that  submit  data to  the  departme nt of  surveillan ce. (They  belong to  the list).   | 2.3.1.2.3.2  Data is  yearly  collected               | 2.3.1.2.3.2  To  generate   AMR data  from Vets  and  Agricultur e and  correlate  it with  Human  AMR and   decide  upon ABX  use in  agricultur e and  vets.   | 2.3.1.2.3.2  Yes/No   | 2.3.1.2.3.2  Once/Year   | 2.3.1.2.3.2  PAAF  Vets Lab                       | 2.3.1.2.3.2  Checking   | 2.3.1.2.3. 2  Not  available.   |
|-------|---------|--------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------|--------------------------|---------------------------------------------------|-------------------------|---------------------------------|
|       |         | 2.3.1.2.4  The focal  AMR  entity at  PAAF  submits  AMR data  to the  Central  AMR  surveillan ce lab |                                                                                                                                                                    | 2.3.1.2.4  Data  submitted  to MOH  Central   Office. | 2.3.1.2.4  To pool  data into  the  central  national  One  Health  AMR  office, to  generate  decisions  related to  ABX in all  sectors of  One  Health.       | 2.3.1.2.4  Yes/No     | 2.3.1.2.4  Once/Year     | 2.3.1.2.4  MOH   Central  AMR One  Health  office | 2.3.1.2.4  Checking     | 2.3.1.2.4  Not  available       |
| 2.3.2 | 2.3.2.1 | 2.3.2.1                                                                                                |                                                                                                                                                                    | 2.3.2.1                                               | 2.3.2.1                                                                                                                                                          | 2.3.2.1               | 2.3.2.1                  | 2.3.2.1                                           | 2.3.2.1                 | 2.3.2.1                         |

| Collect  AMR data  from  Environm ent.   | Map  available  data from  KEPA                                                     | Check  KEPA Labs  and  publicatio ns about  any AMR   data in  environm ent                                                                  |                                                                                                                                                                      | Report is  issued                                                                                                                           | To collect  available  baseline  informatio n about  AMR in  the  environm ent.                                          | Yes/No                                                                                                                                                                       | Once                      | Publicatio ns from  Kuwait             | Checking              | Not  available.              |
|------------------------------------------|-------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------|----------------------------------------|-----------------------|------------------------------|
|                                          | 2.3.2.2  Initiate  AMR data  collection  from  Environm ent By  research  projects. | 2.3.2.2.1  The  director of  the office  of  research  and  studies  puts AMR  surveillan ce as one  of the  priority  subjects in  research | 2.3.2.2.1.1  The plan  of  prioritizin g AMR  surveillan ce in  Environm ent and  marine  environm ent re and  is being  discussed  with  universitie s/institute s. | 2.3.2.2.1.1  % of  research  meetings  with  universitie s/institute s where  AMR is   requested  to be  apriority  in  research  projects. | 2.3.2.2.1.1  To   prioritize   AMR in  environm ent as  research   target,  and    attract  related  projects  and funds | 2.3.2.2.1.1  Number  of  research  meetings  with  universitie s where  AMR is   requested  to be a  priority in  research  projects/  total  number of  research  meetings. | 2.3.2.2.1.1  Twice  /year | 2.3.2.2.1.1  KEPA/  Universiti es/KISR | 2.3.2.2.1.1  Checking | 2.3.2.2.1. 1  Not  available |
|                                          |                                                                                     |                                                                                                                                              | 2.3.2.2.1.2  Call for  proposal  from  universitie s/institute s                                                                                                     | 2.3.2.2.1.2  Proportio n of  universitie s that  send  projects  related to  AMR in                                                         | 2.3.2.2.1.2  To   increase  the  number of  research  projects  about                                                    | 2.3.2.2.1.2  Number  of  universitie s that  send  projects  related to  AMR in                                                                                              | 2.3.2.2.1.2  Twice/yea r  | 2.3.2.2.1.2  KEPA   Research  office   | 2.3.2.2.1.2  Checking | 2.3.2.2.1. 2  Not  available |

|                                                                                                                                                                                          | ent to  KEPA  research  office                                                                  | environm                                                                              | AMR in  the  environm ent.                                                                                                                                               | environm ent to  KEPA  research  office/Tot al number  of  universitie s.   |                                     |                       |                       |                              |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|-------------------------------------|-----------------------|-----------------------|------------------------------|
| 2.3.2.2.1.3  The  director of  the office  of  research  and  studies  applies for  funds  from KEPA  for  projects  related to  AMR  surveillan ce in Vet,  agricultur e, and  Environm | 2.3.2.2.1.3  % of  proposed  projects  related to  AMR in  environm ent that  have been  funded | 2.3.2.2.1.3  To secure  funds for  the  projects in  order for  them to  be  realized | 2.3.2.2.1.3  Number  of  proposed  projects  related to  AMR in  environm ent that  have been  funded/to tal  number of  projects  related to  AMR that  were  proposed. | 2.3.2.2.1.3  Once/6  months                                                 | 2.3.2.2.1.3  KEPA  Research  office | Checking              | 2.3.2.2.1.3           | 2.3.2.2.1. 3  Almost  none   |
| 2.3.2.2.2  Increase  lab  capacity  of KEPA  Lab that  2.3.2.2.2.1  Letter  from KEPA  Director  General to  Technical                                                                   | 2.3.2.2.2.1  KEPA Lab  starts  reporting  AMR data                                              | the  from                                                                             | 2.3.2.2.2.1  To expand  capacity  of the lab                                                                                                                             | 2.3.2.2.2.1  Yes/No                                                         | 2.3.2.2.2.1  Once/year              | 2.3.2.2.2.1  KEPA lab | 2.3.2.2.2.1  Checking | 2.3.2.2.2. 1  Not  available |

<!-- image -->

| deals with  the  quality of  coastal  water to  include  AMR  identificat ion and  surveillan ce in  water and  sediment   | affairs  sector  of  micro labs  asking to  prepare a  project  with a  budget   that aims  at  expanding  their work  from only  identificat ion to  antibiogra m testing   |                                                                     |                                                                                                                                                                      | microorga nism  identificat ion to  AMR  detection                                                         |                       |                              |                                             |                        |                                                                                        |
|----------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|-----------------------|------------------------------|---------------------------------------------|------------------------|----------------------------------------------------------------------------------------|
|                                                                                                                            | 2.3.2.2.2.2  KEPA   analytical  central lab  KEPA  prepare  road map  for the  labs to be  able to do  antibiogra m testing                                                  | 2.3.2.2.2.2 .1  Identify  the  needed  machinery  and their  budget | 2.3.2.2.2.2   Road map  project  with  budget is  put to  extend  KEPA  microbiol ogy lab  from   bacterial  identificat ion to  include  also  antibiogra m testing | 2.3.2.2.2.2   To put a  plan for  how to  reach the  target of  making  KEPA lab   (marine…)  detect  AMR. | 2.3.2.2.2.2   Yes /No | 2.3.2.2.2.2   Once/6  months | 2.3.2.2.2.2   KEPA   Analytical  Lab center | 2.3.2.2.2.2   Checking | 2.3.2.2.2. 2   KEPA  marine  lab  identifies  microorga nisms,  does not  detect  AMR. |

|       |         |                                                                         |                                                                                                           | 2.3.2.2.2.2 .2  Put a plan  of needed  extra  staffing               | See above                                                       |                                                             |                     |                        |                                |                       |                              |
|-------|---------|-------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------|-----------------------------------------------------------------|-------------------------------------------------------------|---------------------|------------------------|--------------------------------|-----------------------|------------------------------|
|       |         |                                                                         | 2.3.2.2.2.3  KEPA    provides  the  related  budget                                                       | 2.3.2.2.2.3  Communi cation  between  KEPA and  ministry  of finance | 2.3.2.2.2.3  None                                               |                                                             |                     |                        |                                |                       |                              |
|       |         |                                                                         | 2.3.2.2.2.4  KEPA  microbiol ogy labs  start  generatin g  antibiogra m results  for  priority  organisms |                                                                      | 2.3.2.2.2.4  KEPA   Marine  lab  actually  generates   AMR data | 2.3.2.2.2.4  To have  AMR   data from  marine  environm ent | 2.3.2.2.2.4  Yes/No | 2.3.2.2.2.4  Once/Year | 2.3.2.2.2.4  KEPA  marine  lab | 2.3.2.2.2.4  Checking | 2.3.2.2.2. 4  Not  available |
|       |         | 2.3.2.2.3  Generate  report  about  AMR  surveillan ce in  Environm ent |                                                                                                           |                                                                      | 2.3.2.2.3  Yes/No                                               |                                                             |                     |                        |                                |                       |                              |
| 2.3.3 | 2.3.3.1 | 2.3.3.1.1                                                               |                                                                                                           |                                                                      | 2.3.3.1.1                                                       | 2.3.3.1.1                                                   | 2.3.3.1.1  Yes/No   | 2.3.3.1.1              | 2.3.3.1.1  MOH                 | 2.3.3.1.1  Checking   | 2.3.3.1.1                    |

<!-- image -->

| The  national  AMR  Surveillan ce Office  at MOH  gathers  data from  KEPA,  PAAF, and  PAFN  compiles  it with  Human  AMR data  and  generates  yearly  ONE  Health  AMR  surveillan   | KEPA,  PAAF ,  and PAFN  submit  available  data to  Central  AMR  surveillan ce office  at MOH  on yearly  basis   | Create a  digital  network  for data  sharing  with MOH                                                | Digital  System is  put                                          | To  facilitate  AMR data  collection  in health  approach  by making  it digital   |                                                                  | Once/6  months                                                   |                                                                  |                                                                  | Not  available                                                   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------|
|                                                                                                                                                                                          |                                                                                                                     | 2.3.3.1.2  Add this  function  to the  TOR of  the focal  person at  PAAF and  KEPA and  food  safety. | 2.3.3.1.2  TOR  includes  surveillan ce  function  detail.       |                                                                                    |                                                                  |                                                                  |                                                                  |                                                                  |                                                                  |
| Strategic objective 2.4: Create a National Reference Lab for AMR                                                                                                                         | Strategic objective 2.4: Create a National Reference Lab for AMR                                                    | Strategic objective 2.4: Create a National Reference Lab for AMR                                       | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR                   | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR | Strategic objective 2.4: Create a National Reference Lab for AMR |
| 2.4.1                                                                                                                                                                                    | 2.4.1.1                                                                                                             |                                                                                                        | 2.4.1.1                                                          | 2.4.1.1                                                                            | 2.4.1.1                                                          | 2.4.1.1                                                          | 2.4.1.1                                                          | 2.4.1.1                                                          | 2.4.1.1                                                          |

| To have   A Kuwaiti  Center of  Disease  Control  that will  be  overseein g  bacterial,  viral and  AMR  reference  labs   | Project of  reference  lab with  its budget  and  having it  endorsed  by MOH   | CDC  will  oversee  the needs  and  functions  of all  reference  laboratori al,  including  viral,  bacterial  and   AMR.   | To  centralize  all the  reference  labs                  | Yes/No          | Once/year          | MOH                                               | Checking          | Project is  already  under the  umbrella  of  Minister  of Health  and under  serious  considera tion.                   |
|-----------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------|-----------------|--------------------|---------------------------------------------------|-------------------|--------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                             | 2.4.1.2  Kuwait  CDC  becomes  functional                                       | 2.4.1.2  Kuwait  CDC is  establishe d                                                                                        | 2.4.1.2  To put the  project of  Kuwait  CDC into  action | 2.4.1.2  Yes/No | 2.4.1.2  Once/Year | 2.4.1.2  MOH                                      | 2.4.1.2  Checking | 2.4.1.2  The  Minister  of Health  has put  the  project  among his  priorities  and has  provided  the  budget  for it. |
| .                                                                                                                           | 2.4.1.3  Write and  approve  terms of  reference  for a  national               | 2.4.1.3  TOR of   AMR  reference   Lab are  put.                                                                             | 2.4.1.3  To define  the  functions  and fulfill  them     | 2.4.1.3  Yes/No | 2.4.1.3  Once      | 2.4.1.3  MOH/  Kuwait  CDC/Medi cal  Lab.Counc il | 2.4.1.3  Checking | 2.4.1.3  Not done  yet                                                                                                   |

<!-- image -->

| AMR  reference  laboratory  with  expertise  in method  s for  confirmin g and  characteri zing  specific  pathogens , putting  guidelines , SOP for  identificat ion and  antibiogra m testing  of priority  organisms  for  surveillan ce training  according  to  guidelines , and  organizing  quality  assurance  schemes   | They  include:  expertise  in method  s for  confirmin g and  characteri zing  specific  pathogens , putting  guidelines , SOP for  identificat ion and  antibiogra m testing  of priority  organisms  for  surveillan ce training  according  to  guidelines , and  organizing  quality  assurance  schemes   |         |                 |               |                          |                   |                  |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------|-----------------|---------------|--------------------------|-------------------|------------------|
| 2.4.1.4  Prepare a  full                                                                                                                                                                                                                                                                                                         | 2.4.1.4  Yes/No                                                                                                                                                                                                                                                                                                | 2.4.1.4 | 2.4.1.4  Yes/No | 2.4.1.4  Once | 2.4.1.4  Kuwait  CDC/MOH | 2.4.1.4  checking | 2.4.1.4  Not yet |

|                                                                                   | project  and  proposal  for the  reference  lab                                                    |                                                                                                  |                                                                               | To put the  full road  map and   define the  budget  and  submit it  for  funding        |                 |                    |                            |                   |                                                                                |
|-----------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|-----------------|--------------------|----------------------------|-------------------|--------------------------------------------------------------------------------|
|                                                                                   | 2.4.1.5  Prepare a  budget for  the  building,  equipmen t and man  power of  the  reference  Lab  |                                                                                                  | 2.4.1.5  Budget for  AMR lab is  approved  within the  budget of  Kuwait  CDC | 2.4.1.5  To  provide  the  needed  budget for   Manpowe r and  equipmen t                | 2.4.1.5  Yes/No | 2.4.1.5  Once/year | 2.4.1.5  Kuwait  CDC/  MOH | Checking          | Not yet                                                                        |
|                                                                                   | 2.4.1.6  Execution  of the  Reference  Lab                                                         |                                                                                                  | 2.4.1.6  Reference  lab is set  and  functionin g                             | 2.4.1.6  To fulfill  the  functions  listed in  the TOR                                  | 2.4.1.6  Yes/no | 2.4.1.6  Once/year | 2.4.1.6  Kuwait  CDC       | 2.4.1.6  Checking | 2.4.1.6  Not yet                                                               |
| 2.4.2  Delegate  the  function  of  surveillan ce of the  reference  Lab  pending | 2.4.2.1  Identify  institution  affiliated  to MOH  that will  host the  manpowe r and  activities | 2.4.2.1.1  A letter  from  MOH to  all labs  that asks  them to  coordinat e with the  GLASS lab | 2.4.2.1.1  Already  available                                                 | 2.4.2.1.1  To start  surveillan ce while  waiting  for the  reference  lab, which  might |                 |                    |                            |                   | 2.4.2.1.1  AMR  surveillan ce is being  submitted  to GLASS  National  AMR not |

<!-- image -->

| its  readiness                                                                                                                                                  | of the  AMR  Surveillan ce office   for the  actual  work on  the  National  and GLASS  AMR  reports  pending  the  finalizatio n of the  reference   | by  delivering  AMR data   for the  purpose  of AMR  Surveillan ce               |                                                                                                                       |                                                                                                                        |                                                                                                                                                  | take few  years                                                                                                                                  |                                                                           |                                                                           |                                                                           |                                                                           | finalized  yet  A plan is  put above                                      |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------|---------------------------------------------------------------------------|---------------------------------------------------------------------------|---------------------------------------------------------------------------|---------------------------------------------------------------------------|
| lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs                                                                                       | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs                                                                             | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs        | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs                                             | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs                                              | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs                                                                        | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs                                                                        | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs | lab.  Strategic objective 2.5: Unify AMR identification in all Micro labs |
| 2.5.1 Lab  audit by  lab  accreditati on body  according  to  microbiol ogist  consultant  in charge,  external  quality  control  and use of  CLSI  guidelines | 2.5.1.1  Accreditat ion of the  medical  Laboratori es  by  Medical  Laboratori es Council                                                            | 2.5.1.1.1  Involve all  laboratori es in  external  quality  assurance  programs | 2.5.1.1.1.1  Mandate  that all  labs  including  all private  should be  accredited  and all  perform  external   QC. | 2.5.1.1.1.1 .1  List of  accreditati on bodies  accepted  in Kuwait,  all labs  should be  accredited  by one of  them | 2.5.1.1.1.1 .1  Number  of  internatio nal  accreditati on bodies  that are  recomme nded in  Kuwait for  the labs to  get their  accreditati on | 2.5.1.1.1.1 .1  To  identify  internatio nal  accreditati on bodies  to  perform  accreditati on of the  labs in  Kuwait  and not to  be limited | 2.5.1.1.1.1 .1  Number                                                    | 2.5.1.1.1.1 .1  Once/Year                                                 | 2.5.1.1.1.1 .1  MOH/  Reference  lab/  Medical  Lab.counc il              | 2.5.1.1.1.1 .1  Checking                                                  | 2.5.1.1.1. 1.1  CAP                                                       |

to the local accreditati on activity

## Annex 4

## A. IPC Strategic Plan

| Strategic  interventions                                                                                                                                 | Activity                                                                                                                                               | Sub-activity                                                                                                                                           | Sub-sub- activity                                                                                                                                      | Sub-sub-sub- activity                                                                                                                                  | Date                                                                                                                                                   | Milestone                                                                                                                                              |
|----------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| Strategic objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels.   | Strategic objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. |
| 3.1.1 Create a  formal  organizational  structure to ensure  proper  development and  use of infection  prevention and  control policies and  strategies | 3.1.1.1 Infection  Control  Organizational  structure is already  established and  functioning.                                                        | -                                                                                                                                                      | -                                                                                                                                                      | -                                                                                                                                                      | 3.1.1.1 Done 1980                                                                                                                                      | 3.1  5 years                                                                                                                                           |
|                                                                                                                                                          | 3.1.1.2 To make  official that IPC is  part of the  organogram of  each hospital with  Terms of Reference  and allocated staff                         | 3.1.2.1 Decree from  MOH about IPC  department in each  hospital with TOR,  and staffing  organization                                                 |                                                                                                                                                        |                                                                                                                                                        | 3.1.2.1  2 Months                                                                                                                                      |                                                                                                                                                        |
|                                                                                                                                                          | 3.1.1.3  IPC departments in  hospitals and they  work closely with  the central IPC  Directorate                                                       | 3.1.1.3.1  To impose IPC  programs in all  hospitals                                                                                                   | 3.1.1.3.1.1  IPC program  availability is  checked by  accreditation  standards                                                                        |                                                                                                                                                        | 3.1.1.3.1.1  Already available                                                                                                                         |                                                                                                                                                        |
|                                                                                                                                                          |                                                                                                                                                        | 3.1.1.3.2  IPC programs are  available in all  hospitals and they  work under the                                                                      | -                                                                                                                                                      | -                                                                                                                                                      | 3.1.1.3.2  Already available                                                                                                                           |                                                                                                                                                        |

|                                                                                        |                                                                                          | umbrella of the  Central IPC  directorate.                                                 |                                                                                                                                                        |                        |
|----------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------|
| 3.1.2 Implement  laws for mandatory  compliance of the  facilities with IPC  standards | 3.1.2.1 Decree from  MOH                                                                 | 3.1.2.1.1 Decree  that recommends  that all HCF have to  abide by IPC   Recommendations.   | 3.1.2.1.1.1 IPC   Directorate puts  the   detailed IPC  measures that  should be required  from each HCF, and  sent to MOH to be  included in ministry | 3.1.2.1.1.1   2 months |
|                                                                                        |                                                                                          |                                                                                            | 3.1.2.1.1.2 Decree  is issued by MOH                                                                                                                   | 3.1.2.1.1.2   3 months |
|                                                                                        |                                                                                          | 3.1.2.1.2  Medical  responsibilities.  Add details IPC  standard  compliance in  hospitals | 3.1.2.1.2.1  Add compliance to  IPC measures and  recommendations  to the list of  medical  responsibilities of  hospitals as listed  by MOH           | 3.1.2.1.2.1  3 months  |
| 3.1.3 WHO IPC Core  component based  guidelines are  established in all  HCF           | 3.1.3.1 Availability  of endorsed IPC  based on WHO IPC  core components                 | -                                                                                          | -                                                                                                                                                      | 3.1.3.1 Done           |
|                                                                                        | 3.1.3.2 IPC policies  and procedures are  included in hospital  accreditation  standards | -                                                                                          | -                                                                                                                                                      | 3.1.3.2 Done           |
|                                                                                        | 3.1.3.3 IPC policies  and procedures are  being audited                                  | -                                                                                          | -                                                                                                                                                      | 3.1.3.3 Done           |

| regularly by  accreditation  bodies                                                                       |                                                                                                    |                                                                                                                                     |                                                                                                                                                             |                                    |
|-----------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------|
| 3.1.3.4 National  infection control  policies and  guidelines are  distributed and  periodically  updated | 3.1.3.4.1 Regular  update of national  IPC guidelines                                              | 3.1.3.4.1.1 On  going, but needs to  be speeded up by  increasing  manpower in IPC  nationwide in  central office and in  hospitals | -                                                                                                                                                           | 3.1.3.4.1.1   2 years              |
|                                                                                                           | 3.1.3.4.2  A direct channel  with WHO  consultant  regarding few  queries and new  recommendations | 3.1.3.4.2.1  Communicate this  need to WHO office  in Kuwait                                                                        | 3.1.3.4.2.1.1   Letter from  MOH/IPC  directorate to WHO  office in Kuwait  asking for direct  channel with a  consultant for  queries whenever  they occur | 3.1.3.4.2.1.1   1 month            |
|                                                                                                           |                                                                                                    | 3.1.3.4.2.2  Communicate this  need to Regional  WHO office                                                                         | 3.1.3.4.2.2 Request  from WCO to  Regional office.                                                                                                          | 3.1.3.4.2.2   2 months             |
|                                                                                                           | 3.1.3.4.3  Regular update of  National IPC  policies and  procedures                               | 3.1.3.4.3.1 Need  updating +  speeding up the  process                                                                              |                                                                                                                                                             | 3.1.3.4.3.1  ongoing               |
| 3.1.3.5 National IPC  Guidelines and  policies are being  taught                                          | 3.1.3.5.1 TOT  periodically  performed  nationally                                                 | -                                                                                                                                   | -                                                                                                                                                           | 3.1.3.5.1 Already  being performed |

|                                                                  |                                                                | 3.1.3.5.2  Continuous   training of HCW  about   IPC policies    in hospitals is  available                                         | 3.1.3.5.2.1  Mandate from  MOH   that it is mandatory   to all HCW to  attend at least 1  yearly and 1 upon   employment   |                                                                                                                     | 3.1.3.5.2.1   2 months                                        |
|------------------------------------------------------------------|----------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------|
|                                                                  |                                                                |                                                                                                                                     | 3.1.3.5.2.2 Improve  attendance to  these general HCW   IPC training  sessions                                             | 3.1.3.5.2.2.1  Attendance is  reported to hospital  administrators and  action taken to  improve  attendance        | 3.1.3.5.2.2.1   1 year                                        |
|                                                                  |                                                                |                                                                                                                                     |                                                                                                                            | 3.1.3.5.2.2.2  Attendance  evidence is  available in yearly  Hospital IPC report  and monitored by  IPC Directorate | 3.1.3.5.2.2.2   1 year                                        |
| 3.1.4 Monitor and  evaluate  compliance with  the IPC guidelines | 3.1.4.1 Checklists  and audit tools are  prepared and  applied | _                                                                                                                                   | _                                                                                                                          | _                                                                                                                   | 3.1.4.1    Started years ago,  and ongoing for  new policies. |
|                                                                  | 3.1.4.2 Regular  updates  of these audit tools                 | 3.1.4.2.1 Check  new policies if they  have their audit  tools prepared and  disseminated and  check old tools if  they need update | -                                                                                                                          | -                                                                                                                   | 3.1.4.2.1 Ongoing                                             |
|                                                                  | 3.1.4.3 Audit plan  available in  hospitals                    | 3.1.4.3.1 Audit plan  is checked in  standards of the                                                                               | -                                                                                                                          | -                                                                                                                   | 3.1.4.3.1  done ongoing                                       |

|                                                 | National  Accreditation  Program applied by  the Quality and  Accreditation  Directorate     |                                                                                                                                                         |                                           |                                     |
|-------------------------------------------------|----------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------|-------------------------------------|
|                                                 | 3.1.4.3.2 Central  audit plan is being  prepared annually  and distributed to  all hospitals | -                                                                                                                                                       | -                                         | 3.1.4.3.2  Done and ongoing  yearly |
|                                                 | 3.1.4.3.3 Audit  report is sent to  central IPC  directorate with  corrective actions.       | -                                                                                                                                                       | -                                         | 3.1.4.3.3   Done and ongoing        |
| 3.1.4.4 Establish  national process  indicators | 3.1.4.4.1   1 st  set of process  indicators:  -CLABSI  -CAUTI  -VAP                         | 3.1.4.4.1.1Put the  basic training  material                                                                                                            | -                                         | 3.1.4.4.1.1Already   available      |
|                                                 |                                                                                              | 3.1.4.4.1.2Update  of the already  available bundle of  care in each of the  mentioned bundles,  by including new  evidence- based  items to the bundle | 3.1.4.4.1.2 Prepare  the updated  bundles | 3.1.4.4.1.2  2 years                |
|                                                 |                                                                                              | 3.1.4.4.1.3Train the  IPC professionals  nationwide on the  updated bundles                                                                             | 3.1.4.4.1.3.1  TOT workshops              | 3.1.4.4.1.3.1  2 years              |
|                                                 |                                                                                              | 3.1.4.4.1.4 Engage  all HCW with the                                                                                                                    | 3.1.4.4.1.4.1                             | 3.1.4.4.1.4.1  CLABSI months        |

|                                                  | bundles by training,  audit and feedback.   | Prepare the ground  in the hospitals:  Letter to hospital  directors about the  bundles project its  importance and its  processes                                                    | Each bundle 1 y         |
|--------------------------------------------------|---------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------|
|                                                  |                                             | 3.1.4.4.1.4.2   Update the  material to be  taught to HCW by  IPC professionals,  according to the  updated bundles.                                                                  | 3.1.4.4.1.4.2   2 years |
|                                                  |                                             | 3.1.4.4.1.4.3   In-hospital training  sessions by IPC  professionals to all  concerned HCW.  Include Bundle  training in the  yearly IPC training  and in peri- employment  training. | 3.1.4.4.1.4.3   4 years |
|                                                  |                                             | 3.1.4.4.1.4.4  Auditing  compliance to  these bundles on  monthly basis and  report to IPC  directorate  monthly                                                                      | 3.1.4.4.1.4.4  5 years  |
| 3.1.4.4.2   Update outcome  indicators for the 3 | 3.1.4.4.2.1   Review updated  CDC outcome   | -                                                                                                                                                                                     | 3.1.4.4.2.1   6 months  |

|                                                                                                 |                                                                                     | bundles above  (CLABSI, CAUTI,  VAP) according to  new CDC/  guidelines                                                  | indicators and  update already  measured bundles  outcome indicators  accordingly                                  |                                                                                               |                        |
|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|------------------------|
|                                                                                                 |                                                                                     | 3.1.4.4.3  Integrate process  and outcome  indicators for each  bundle, and use in  the analysis and  corrective actions | 3.1.4.4.3.1  Put a road map for  integrating analysis  of outcome and  process indicators  related to the  bundles | -                                                                                             | 3.1.4.4.3.1  1 year    |
|                                                                                                 |                                                                                     | 3.1.4.4.4  Introduce   SSI bundle                                                                                        | 3.1.4.4.4.1  preparation of  material                                                                              | -                                                                                             | 3.1.4.4.4.1  4 years   |
|                                                                                                 |                                                                                     |                                                                                                                          | 3.1.4.4.4.2  Implementation of   SSI bundle                                                                        | 3.1.4.4.4.2.1  Teaching of IPC  professionals by  central IPC  directorate                    | 3.1.4.4.4.2.1  5 years |
|                                                                                                 |                                                                                     |                                                                                                                          |                                                                                                                    | 3.1.4.4.4.2.2  Teaching of  healthcare  providers inside the  hospitals by IPC  professionals | 3.1.4.4.4.2.2  5 years |
|                                                                                                 |                                                                                     |                                                                                                                          |                                                                                                                    | 3.1.4.4.4.2.3  Data collection                                                                | 3.1.4.4.4.2.3  5 years |
| 3.1.5  IPC programs/office  in LTCF working in  close cooperation  with IPC directorate  in MOH | 3.1.5.1  Mandate from  MOH that IPC  program/with  employee with TOR  and specified | 3.1.5.1.1  Communication  between MOH and  Public Authority of  Disability Affairs  regarding IPC in                     | 3.1.5.1.1.1  Letter from MOH to  Public Authority of  Disability Affairs  asking to establish  IPC in each LTCF    |                                                                                               | 3.1.5.1.1.1  2 months  |

|                                                                                                                         | budget are  available in LTCF  the central and the  'branches'.                                                                      | LTCF and being  overseen by the IPC  directorate                                                                        | and to have the  personnel work  closely with IPC  directorate  delegate to LTCF.                                                                        |                                                                                                                         |                                                                                                                         |                                                                                                                         |
|-------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                         |                                                                                                                                      |                                                                                                                         | 3.1.5.1.1.2Letter  from Public  Authority of  Disability Affairs to  LTCF that  recommends IPC in  each LTCF and  organizes the  communication  with MOH |                                                                                                                         | 3.1.5.1.1.2   2 months                                                                                                  |                                                                                                                         |
|                                                                                                                         |                                                                                                                                      | 3.1.5.1.2  Established  Guidelines for IPC  in LTCF                                                                     | 3.1.5.1.2.1  Preparation of the  LTCF guidelines and  their endorsement  by Public Authority  of Disability Affairs                                      | -                                                                                                                       | 3.1.5.1.2.1  1 year                                                                                                     |                                                                                                                         |
|                                                                                                                         |                                                                                                                                      |                                                                                                                         | 3.1.5.1.2.2  Dissemination of  LTCF Policies and  Procedures                                                                                             | 3.1.5.1.2.2.1  TOT of LTCF IPC  focal persons                                                                           | 3.1.5.1.2.2  1.5 years                                                                                                  |                                                                                                                         |
| Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report              | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report                                  | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report |
| 3.2.1  Software for  hospital data entry,  analysis and  generating both  hospital and  national reports                | 3.2.1.1  Subcommittee from  IPC directorate  sends a letter to   Information system  department at  MOH explaining  what is required |                                                                                                                         |                                                                                                                                                          |                                                                                                                         | 3.2.1.1  2 months                                                                                                       | 3.2  5 years                                                                                                            |

|                                                                                | and asking for the  software                                                                                                        |                                          |    |    |                          |
|--------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------|----|----|--------------------------|
|                                                                                | 3.2.1.2  Health Information  system dep.  presents projects  (either in-house, or  ready to buy) with  budget providing             |                                          |    |    | 3.2.1.2  12 months       |
|                                                                                | 3.2.1.3  Agreement  between IPC  directorate and  information system  dep. to choose one  system                                    |                                          |    |    | 3.2.1.3  1 year 3 months |
|                                                                                | 3.2.1.4  Apply the system in  the hospitals                                                                                         |                                          |    |    | 3.2.1.4  1 year 9 months |
|                                                                                | 3.2.1.5  Apply the Digital   HAI/AMR   System for National  data collection  from individual  hospitals to central  IPC directorate |                                          |    |    | 3.2.1.5  2 years         |
| 3.2.2 To Shift all  hospital  information system  from paper to  digital mode. | 3.2.2.1 MOH  recommends from  hospitals to have an  electronic patient  and data  information  system.                              | 3.2.2.1.1 Letter  from MOH to  hospitals | -  | -  | 3.2.2.1.1   2 months     |

|                                                                                | 3.2.2.2 Increase the  number of hospitals  that have   digitalized their  medical  information system                                                            | -                                                                                                                                                    | -   | -   | 3.2.2.2   5 years    |
|--------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|-----|-----|----------------------|
| 3.2.3  Connect Infection  Control  Departments to  electronic medical  records | 3.2.3.1 Connect  Infection Control  departments in all  hospitals with the  Heath information  system and  Laboratory  information system  at the hospital level | 3.2.3.1.1 Letter  from MOH to ask all  hospitals to  connect IC dep.  With HIS system  and LIS at the  hospital level                                | -   | -   | 3.2.3.1.1   2 months |
|                                                                                |                                                                                                                                                                  | 3.2.3.1.2 Decree  from MOH to all  hospitals who have  an electronic  Health information  system to link their  Lab AMR data to  the Hospital system | -   | -   | 3.2.3.1.2   4 months |
|                                                                                | 3.2.3.2 Develop  electronic outbreak  reporting system  for data entry,  analysis and    generating reports.                                                     |                                                                                                                                                      |     |     | 3.2.3.2   3 years    |
|                                                                                | 3.2.3.3 Develop  electronic reporting  system for data  entry, analysis and    generating  hospital/national                                                     |                                                                                                                                                      |     |     | 3.2.3.3   3 years    |

|                                                                                                 | reports for bundles  of care.                                                                                                               |                                                                                                                                                                                                                          |                                                                                                 |                                                                                                 |                                                                                                 |                                                                                                 |
|-------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|
|                                                                                                 | 3.2.3.4  Develop electronic  infection  prevention and  control system  capable of self- identifying HAI and  detecting outbreaks           | 3.2.3.4.1 Electronic  system has a  function for self- diagnosis of HAIs  and automatically  detects outbreak                                                                                                            |                                                                                                 |                                                                                                 | 3.2.3.4.1   5 years                                                                             |                                                                                                 |
| Strategic objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic objective 3.3 Enhance IPC education in all health- related specialties and among HCW.                                             | Strategic objective 3.3 Enhance IPC education in all health- related specialties and among HCW.                                                                                                                          | Strategic objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic objective 3.3 Enhance IPC education in all health- related specialties and among HCW. |
| 3.3.1 Include IPC as  a core element in  education and  training of  healthcare  professionals  | 3.3.1.1 Include  infection control in  undergraduate  curricula for health  care students  (medical, nursing,  dental and  pharmaceutical). | 3.3.1.1.1 Prepare  module about IPC  and AMR to be  included in all  health specialties in  universities/PAAET.                                                                                                          | -                                                                                               | -                                                                                               | 3.3.1.1.1   2 years                                                                             | 3.3  5 years                                                                                    |
|                                                                                                 |                                                                                                                                             | 3.3.1.1.2 MOH  letter to Ministry of  higher education  and  The Public  Authority for  Applied Education  and Training to ask  to include these  modules into the  undergrads and  graduate health  students' curricula | -                                                                                               | -                                                                                               | 3.3.1.1.2   2 years                                                                             |                                                                                                 |

|                                                                                              |                                                                                                                                 | 3.3.1.1.3 Modules  sent to Kuwait  university/   The Public  Authority for  Applied Education  and Training to  include it in  curricula   |    |    | 3.3.1.1.3   2.5 years   |
|----------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|----|----|-------------------------|
| 3.3.2 Enhance IPC  education among    undergraduates  and higher  education health  students | 3.3.2.1 Include  infection control in  continuing  education of  healthcare workers  and mandatory  prerequisite for  promotion | 3.3.2.1.1 Provide  IPC courses with CE  credits in  universities,  hospitals, MOH,  PAAET, PAAF  Include CME Credit   10% IPC              |    |    | 3.3.2.1.1   2 years     |
|                                                                                              |                                                                                                                                 | 3.3.2.1.2 Request  that when CE  credits for  physicians, nurses,  or pharmacists is  needed, 10% of  these credits  should be about  IPC. |    |    | 3.3.2.1.2   3 months    |
|                                                                                              |                                                                                                                                 | 3.3.2.1.3 In  hospitals, yearly  and upon  employment,  mandatory  attendance of IPC  lectures                                             | -  | -  | 3.3.2.1.3   3 months    |

|                                                                                                                      | 3.3.2.2 Hygiene and  IPC education  provided outside  formal teaching  programs                                     | 3.3.2.2.1  Require IPC  education by drug  companies,  hospitals, LTCFs,  FAO, and  medical/veterinary  associations   | 3.3.2.2.1.1  Request to include  few topics about  IPC in conferences  agendas   | 3.3.2.2.1.1  Letter to be sent                                  | 3.3.2.2.1.1  6 months                                           |                                                                 |
|----------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|
| Strategic objective 3.4 Prevent occupational infections in HCWs                                                      | Strategic objective 3.4 Prevent occupational infections in HCWs                                                     | Strategic objective 3.4 Prevent occupational infections in HCWs                                                        | Strategic objective 3.4 Prevent occupational infections in HCWs                  | Strategic objective 3.4 Prevent occupational infections in HCWs | Strategic objective 3.4 Prevent occupational infections in HCWs | Strategic objective 3.4 Prevent occupational infections in HCWs |
| 3.4.1 Develop a  comprehensive  program of  vaccination to  protect HCWs from  vaccine preventable  diseases         | -                                                                                                                   | -                                                                                                                      | -                                                                                | -                                                               | 3.4.1   Available  And applied                                  | 3.4  5 years                                                    |
| 3.4.2 Develop  policies and  procedures to  protect healthcare  workers from  occupational  exposure to  infections. | -                                                                                                                   | -                                                                                                                      | -                                                                                | -                                                               | 3.4.2  Available   And applied                                  |                                                                 |
| 3.4.3 Availability of  Airborne  Isolation   Rooms in all  hospitals                                                 | 3.4.3.1 screening   mapping   and updating the  recommendations  according to the  expected need  according to need | -                                                                                                                      | -                                                                                | -                                                               | 3.4.3.1   5 years                                               |                                                                 |
| 3.4.4 Mandate to  hospitals to provide  airborne isolation  rooms (AII)                                              | -                                                                                                                   | -                                                                                                                      | -                                                                                | -                                                               | 3.4.4   5 years                                                 |                                                                 |

| available as per the  updated  recommendations                 |                                                                                                  |                                                                |                                                                                                                                                                   |                                                                |                                                                |                                                                |
|----------------------------------------------------------------|--------------------------------------------------------------------------------------------------|----------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|
| Strategic objective 3.5 Adequate waste management in hospitals | Strategic objective 3.5 Adequate waste management in hospitals                                   | Strategic objective 3.5 Adequate waste management in hospitals | Strategic objective 3.5 Adequate waste management in hospitals                                                                                                    | Strategic objective 3.5 Adequate waste management in hospitals | Strategic objective 3.5 Adequate waste management in hospitals | Strategic objective 3.5 Adequate waste management in hospitals |
| 3.5.1  Put National  Guidelines                                | 3.5.1.1  National policies,  strategies and plans  for healthcare  waste management  is in place | 3.5.1.1.1  Unify  recommendations  between KEPA and  MOH       | 3.5.1.1.1.1  Create a committee  from MOH and  KEPA that unifies  the  recommendation  and the road map  of all types of waste  that are generated  in healthcare | -                                                              | 3.5.1.1.1.1  6 months                                          | 3.5  5 years                                                   |
|                                                                |                                                                                                  |                                                                | 3.5.1.1.1.2  The committee  reviews waste  policies that are  related to HCF and  unifies  recommendations  and provides the  proper ways of  supervision         | -                                                              | 3.5.1.1.1.2  1 year                                            |                                                                |
| 3.5.2  Supervision of  waste disposal from  public hospitals   | 3.5.2.1  Create a committee  for the supervision  of waste disposal  from public  hospitals      | -                                                              | -                                                                                                                                                                 | -                                                              | 3.5.2.1  Available and  ongoing                                |                                                                |
| 3.5.3  Supervision of  waste disposal in  private hospitals    | 3.5.3.1  Create a committee  for the supervision  of waste disposal in  private hospitals        | -                                                              | -                                                                                                                                                                 | -                                                              | 3.5.3.1  1 year                                                |                                                                |

| 3.5.4  Waste policies are  being audited by  KEPA                                                                   | 3.5.4.1  Organization of  supervision of  waste disposal  inside and from  private hospitals                        | -                                                                                                                                                              | -                                                                                                                   | -                                                                                                                   | 3.5.4.1  1.5 years                                                                                                  |                                                                                                                     |
|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|
|                                                                                                                     | 3.5.4.2  Designate 1 unit at  KEPA to oversee  the waste in  hospitals                                              |                                                                                                                                                                | -                                                                                                                   | -                                                                                                                   | 3.5.4.2  1 year                                                                                                     |                                                                                                                     |
| Strategic objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings                                            | Strategic objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings |
| 3.6.1  Availability of IPC  guidelines in  veterinary practices                                                     | 3.6.1.1  Implementation of  OIE guidelines  regarding IPC in  veterinary field                                      | 3.6.1.1.1  Committee in PAAF  that regularly  checks updates in  OIE guidelines  regarding IPC in  veterinary field,  and updates the  guidelines  accordingly | -                                                                                                                   | -                                                                                                                   | 3.6.1.1.1  6 months                                                                                                 | 3.6  5 years                                                                                                        |
|                                                                                                                     |                                                                                                                     | 3.6.1.1.2  Overseeing the  implementation of  national IPC  guidelines in Vet  field and OIE good  practices                                                   | 3.6.1.1.2  Regular audits to  farms                                                                                 | 3.6.1.1.2  Put a yearly audit  plan                                                                                 | 3.6.1.1.2  1 year                                                                                                   |                                                                                                                     |
| 3.6.2  Include IPC in  licensing of Vets                                                                            | 3.6.2.1  Include questions  about OIE IPC  guidelines and                                                           | 3.6.2.1.1  Prepare a set of  questions related  to IPC in Vets to be                                                                                           | -                                                                                                                   | -                                                                                                                   | 3.6.2.1.1  6 months                                                                                                 |                                                                                                                     |

|                                                                                                                            | vaccinations in all  vets licensing  exams or  interviews.                                                                                                      | included in  licensing exams and  interviews.                          |    |    |                     |
|----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------|----|----|---------------------|
| 3.6.3  Include IPC in  Continuous  education of Vets  and professionals in  Agriculture                                    | 3.6.3.1  Prepare a slide  bank related to IPC  in vet and  agriculture, to be  given to drug  companies that  usually do the  continuous  education activities. | -                                                                      | -  | -  | 3.6.3.1  6 months   |
|                                                                                                                            | 3.6.3.2  Mandate that all  drug company  events or seminars  include a specific  number of slides  related to IPC and  AMR.                                     | -                                                                      | -  | -  | 3.6.3.2  9 months   |
| 3.6.4  Include hygiene and  infection  prevention and  control as core  content in training  of veterinary  professionals. | 3.6.4.1  Close  communication  between. FAO and  PAAF to put a joint  yearly plan of  education activities  related to IPC.                                     | -                                                                      | -  | -  | 3.6.4.1  1 year     |
|                                                                                                                            | 3.6.4.2  Include hygiene and  infection  prevention and  control as                                                                                             | 3.6.4.2.1  IPC credits  mandatory for  promotion in Vet.  Associations | -  | -  | 3.6.4.2.1  6 months |

mandatory prerequisite for promotion of for the veterinary workers.

## B.  IPC Monitoring Plan

| Strategic  interventi ons                                                                                                                              | Activity                                                                                                                                               | Sub- activity                                                                                                                                          | Sub-sub-  activity                                                                                                                                     | Sub-sub- sub- activity                                                                                                                                 | Indicator                                                                                                                                              | Purpose                                                                                                                                                | Calculatio n                                                                                                                                           | Frequenc y                                                                                                                                             | Data  source                                                                                                                                           | Method                                                                                                                                                 | Baseline                                                                                                                                               |
|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. | Strategic Objective 3.1 Emphasize the national infection prevention and control program in healthcare at the National and Health care facility levels. |
| 3.1.1  Create a  formal  organizati onal  structure  to ensure  proper  developm ent and  use of  infection  preventio n and  control  policies  and   | 3.1.1.1  Infection  Control  Organizati onal  structure  is already  establishe d and  functionin g.                                                   | -                                                                                                                                                      | -                                                                                                                                                      | -                                                                                                                                                      | 3.1.1.1  Already  available                                                                                                                            |                                                                                                                                                        |                                                                                                                                                        |                                                                                                                                                        |                                                                                                                                                        |                                                                                                                                                        | 3.1.1.1  Already  available                                                                                                                            |
|                                                                                                                                                        | 3.1.1.2 To  make  official  that IPC is  part of                                                                                                       | 3.1.2.1  Decree  from  MOH  about IPC                                                                                                                  |                                                                                                                                                        |                                                                                                                                                        | 3.1.2.1  The  decree  was  issued.                                                                                                                     |                                                                                                                                                        |                                                                                                                                                        |                                                                                                                                                        |                                                                                                                                                        |                                                                                                                                                        | 3.1.2.1  Already  available                                                                                                                            |

<!-- image -->

| the  organogra m of each  hospital  with  Terms of  Reference  and  allocated  staff                    | departme nt in each  hospital  with TOR,  and  staffing  organizati on                                                                      |                                                |                                     |
|---------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|-------------------------------------|
| 3.1.1.3  IPC  departme nts in  hospitals  and they  work  closely  with the  central  IPC  Directorat e | 3.1.1.3.1  To impose  IPC  programs  in all  hospitals  3.1.1.3.1.1  IPC  program  availabilit y is  checked  by  accreditati on  standards | 3.1.1.3.1.1  already  exists                   | 3.1.1.3.1. 1  Already  establishe d |
|                                                                                                         | programs  are  available  in all  hospitals  and they  work  under the  umbrella  -                                                         | 3.1.1.3.2  % of  Hospitals  with IPC  programs | 3.1.1.3.1. 2  Already  establishe d |

|                                                                                             |                            | Central  IPC  directorat e.                                                                    |                                                                                                                                                                |                                                                               |                                                                                  |                     |                                                          |                                     |                       |                                                                    |
|---------------------------------------------------------------------------------------------|----------------------------|------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------|----------------------------------------------------------------------------------|---------------------|----------------------------------------------------------|-------------------------------------|-----------------------|--------------------------------------------------------------------|
| 3.1.2  Implemen t laws for  mandator y  complianc e of the  facilities  with IPC  standards | 3.1.2.1  Decree  from  MOH | 3.1.2.1.1  Decree  that  recomme nds that  all HCF  have to  abide by  IPC   Recomme ndations. | 3.1.2.1.1.1  IPC   Directorat e puts the   detailed  IPC  measures  that  should be  required  from each  HCF, and  sent to  MOH to  be  included  in ministry | 3.1.2.1.1.1  List is sent  from IPC  Directorat e to MOH  Director            |                                                                                  | 3.1.2.1.1.1  Yes/No | 3.1.2.1.1.1  Once                                        | 3.1.2.1.1.1  IPC  Directorat e/ MOH | 3.1.2.1.1.1  Checking | 3.1.2.1.1. 1 Not  available                                        |
|                                                                                             |                            |                                                                                                | 3.1.2.1.1.2  Decree is  issued by  MOH                                                                                                                         | 3.1.2.1.1.2  Decree  availabilit y and  dissemina tion                        | 3.1.2.1.1.2  Abiding by  IPC  standards  is a must  in  hospitals                | 3.1.2.1.1.2  Yes/No | 3.1.2.1.1.2  once                                        | 3.1.2.1.1.2  IPC  Directorat e/ MOH | 3.1.2.1.1.2  Checking | 3.1.2.1.1. 2 Not  available                                        |
|                                                                                             |                            | 3.1.2.1.2  Medical  responsibi lities.  Add  details IPC  standard                             | 3.1.2.1.2.1  Add  complianc e to IPC  measures  and  recomme ndations                                                                                          | 3.1.2.1.2.1  The  Medical  responsibi lity list is  updated  and it  includes | 3.1.2.1.2.1  To make it  official  through  medical   Decisions  that  obedience | 3.1.2.1.2.1  Yes/No | 3.1.2.1.2.1  Once  /year until  they  appear in  the law | 3.1.2.1.2.1  IPC  Directorat e/ MOH | 3.1.2.1.2.1  Checking | 3.1.2.1.2. 1  IPC exists  in  hospitals  and  centrally  but there |

|                                                                                   |                                                                                               | complianc e in  hospitals   | to the list  of medical  responsibi lities of  hospitals  as listed  by MOH   |    | the  statement  about IPC  measures.   | to IPC  measures  is a must  in  Hospitals   | is no law,  so far,  that  enforces  it in the  hospitals.   |
|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------|-------------------------------------------------------------------------------|----|----------------------------------------|----------------------------------------------|--------------------------------------------------------------|
| 3.1.3  WHO IPC  Core  compone nt based  guidelines  are  establishe d in all  HCF | 3.1.3.1  Availabilit y of  endorsed  IPC based  on WHO  IPC core  compone nts                 | -                           | -                                                                             | -  | 3.1.3.1  Available                     |                                              | 3.1.3.1  Available                                           |
|                                                                                   | 3.1.3.2 IPC  policies  and  procedure s are  included  in hospital  accreditati on  standards | -                           | -                                                                             | -  | 3.1.3.2  Available                     |                                              | 3.1.3.2  Available                                           |
|                                                                                   | 3.1.3.3 IPC  policies  and  procedure s are  being  audited  regularly  by                    | -                           | -                                                                             | -  | 3.1.3.3  Available                     |                                              | 3.1.3.3  Available                                           |

| accreditati on bodies                                                                                          |                                                                                                        |                                                                                                                                            |                                                                                                                                                                     |                                                                                        |                                                                                                                                                                 |                                                                                              |                                                         |                                      |                       |                                                                                                             |
|----------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------|---------------------------------------------------------|--------------------------------------|-----------------------|-------------------------------------------------------------------------------------------------------------|
| 3.1.3.4  National  infection  control  policies  and  guidelines  are  distribute d and  periodicall y updated | 3.1.3.4.1  Regular  update of  national  IPC  guidelines                                               | 3.1.3.4.1.1  On going,  but needs  to be  speeded  up by  increasing  manpowe r in IPC  nationwid e in  central  office and  in  hospitals | -                                                                                                                                                                   | 3.1.3.4.1.1  Proportio n of staff  that is  needed  that has  been  actually  employed | 3.1.3.4.1.1  speed up  the  process of  updating  policies  and  guidelines                                                                                     | 3.1.3.4.1.1  Number  of newly  employed  in IPC.  /Number  needed  X 100                     | 3.1.3.4.1.1  Once /6  months  until all  are  employed. | 3.1.3.4.1.1  IPC  Directorat e / MOH | 3.1.3.4.1.1  Checking | 3.1.3.4.1. 1 The  request  has been  sent to  MOH and  approval  was given,  employm ent still in  process. |
|                                                                                                                | 3.1.3.4.2  A direct  channel  with WHO  consultant  regarding  few  queries  and new  recomme ndations | 3.1.3.4.2.1  Communi cate this  need to  WHO  office in  Kuwait                                                                            | 3.1.3.4.2.1 .1   Letter  from  MOH/IPC  directorat e to WHO  office in  Kuwait  asking for  direct  channel  with a  consultant  for  queries  whenever  they occur | 3.1.3.4.2.1 .1   Percent of  queries to  WHO that  have been  timely  answered.        | 3.1.3.4.2.1  To have a  direct  channel  with a  WHO  consultant  that helps  giving  answers  to   questions  based on  WHO  guidelines  and  recomme ndations | 3.1.3.4.2.1  Number  of timely  answered  queries  /Number  of needed  consultati ons  X 100 | 3.1.3.4.2.1  Once/year                                  | 3.1.3.4.2.1  MOH/WH O                | 3.1.3.4.2.1  Checking | 3.1.3.4.2. 1 Not  available                                                                                 |

|                                                                      |                                                                          |                                                                |                                                       |                                                                                            | that might  arise                                                              |                                                                                                                               |                        |                                                       |                       |                                                    |
|----------------------------------------------------------------------|--------------------------------------------------------------------------|----------------------------------------------------------------|-------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|------------------------|-------------------------------------------------------|-----------------------|----------------------------------------------------|
|                                                                      |                                                                          | 3.1.3.4.2.2  Communi cate this  need to  Regional  WHO  office | 3.1.3.4.2.2  Request  from WCO  to  Regional  office. |                                                                                            |                                                                                |                                                                                                                               |                        |                                                       |                       |                                                    |
|                                                                      | 3.1.3.4.3  Regular  update of  National  IPC  policies  and  procedure s | 3.1.3.4.3.1  Need  updating  +  speeding  up the  process      |                                                       | 3.1.3.4.3.1   % of  hospitals  that have  polices  updated  in the last  2 years or  less. |                                                                                | 3.1.3.4.3.1  Number  of  hospitals  with  updated  policies in  the last 2  years or  less/Total  number of  hospitals  X 100 | 3.1.3.4.3.1  Once/Year | 3.1.3.4.3.1  Hospitals  /  Central  IPC  Directorat e | 3.1.3.4.3.1  Checking | 3.1.3.4.3. 1 Partially  available                  |
| 3.1.3.5  National  IPC  Guidelines  and  policies  are being  taught | 3.1.3.5.1  TOT  periodicall y  performe d  nationally                    | -                                                              | -                                                     | 3.1.3.5.1   % IPC  profession als that  are  trained  annually                             | 3.1.3.5.1   To have a  unified  centralize d training  of IPC  profession als. | 3.1.3.5.1  Number  of IPC  profession als trained  annually  /total  number of  IPC  profession als X100                      | 3.1.3.5.1  Once/year   | 3.1.3.5.1  MOH/  Central  IPC  Directorat e           | 3.1.3.5.1  Checking   | 3.1.3.5.1  Ongoing,  Exact  numbers  are  unknown. |
|                                                                      | 3.1.3.5.2  Continuou s                                                   | 3.1.3.5.2.1  Mandate                                           |                                                       | 3.1.3.5.2.1  Decree is  done and                                                           |                                                                                |                                                                                                                               |                        |                                                       |                       | 3.1.3.5.2. 1 Yes/no                                |

| training of  HCW  about   IPC  policies    in  hospitals  is  available   | from  MOH   that it is  mandator y   to all HCW  to attend  at least 1  yearly and  1 upon   employm ent   |                                                                                                                     | sent to  hospitals.                                                     |                                                                                 |                            |                                                        |                                   |                                                                                        |
|---------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------|---------------------------------------------------------------------------------|----------------------------|--------------------------------------------------------|-----------------------------------|----------------------------------------------------------------------------------------|
|                                                                           | 3.1.3.5.2.2  Improve  attendanc e to these  general  HCW   IPC  training  sessions                         | 3.1.3.5.2.2 .1  Attendanc e is  reported  to  hospital  administr ators and  action  taken to  improve  attendanc e | 3.1.3.5.2.2 .1   % of HCW  that  attend the  training  sessions  yearly | 3.1.3.5.2.2 .1   Number  of HCW  attendees  /total  number of  HCW  /year  X100 | 3.1.3.5.2.2 .1   Once/year | 3.1.3.5.2.2 .1   Hospitals/ Central  IPC  Directorat e | 3.1.3.5.2.2 .1   Data  collection | 3.1.3.5.2. 2.1   Training is  recomme nded and  provided,  attendanc e is  suboptim al |
|                                                                           |                                                                                                            | 3.1.3.5.2.2 .2  Attendanc e  evidence  is  available  in yearly  Hospital  IPC report                               |                                                                         |                                                                                 |                            |                                                        |                                   |                                                                                        |

|                                                                      |                                                                   |                                                                                                                          |    | and  monitored  by IPC  Directorat e   |                                                                                        |                                                                                                                                                          |                                                                                                  |                                    |                                            |                                   |                                               |
|----------------------------------------------------------------------|-------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|----|----------------------------------------|----------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|------------------------------------|--------------------------------------------|-----------------------------------|-----------------------------------------------|
| 3.1.4  Monitor  and  evaluate  complianc e with the  IPC  guidelines | 3.1.4.1  Checklists  and audit  tools are  prepared  and  applied | _                                                                                                                        | _  | _                                      | 3.1.4.1  and  3.1.4.2    Percent of  policies  that have  correspon ding audit  tools. | 3.1.4.1  and  3.1.4.2    To make  audit  tools  unified  nationally  and  readily  available  and to  facilitate   National  data  collection  if needed | 3.1.4.1  and  3.1.4.2    Number  of policies  with audit  tools/Tota l number  of policies  X100 | 3.1.4.1  and  3.1.4.2    Once/year | 3.1.4.1  and  3.1.4.2    IPC  directorat e | 3.1.4.1  and  3.1.4.2    Checking | 3.1.4.1  and  3.1.4.2    Partially  available |
|                                                                      | 3.1.4.2  Regular  updates  of these  audit  tools                 | 3.1.4.2.1  Check  new  policies if  they have  their audit  tools  prepared  and  dissemina ted and  check old  tools if | -  | -                                      |                                                                                        |                                                                                                                                                          |                                                                                                  |                                    |                                            |                                   |                                               |

<!-- image -->

|                                               | they need  update                                                                                 |    |    |                              |                                                                                                                    |                                                                                                                                         |                       |                                                        |                              |                                   |
|-----------------------------------------------|---------------------------------------------------------------------------------------------------|----|----|------------------------------|--------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|-----------------------|--------------------------------------------------------|------------------------------|-----------------------------------|
| 3.1.4.3  Audit plan  available  in  hospitals | of the  National  Accreditat ion  Program  applied by  the  Quality  and  Accreditat              | -  | -  | 3.1.4.3.1  Done and  ongoing |                                                                                                                    |                                                                                                                                         |                       |                                                        |                              | 3.1.4.3.1  Done and  ongoing      |
|                                               | 3.1.4.3.2  Central  audit plan  is being  prepared  annually  and  distribute d to all  hospitals | -  | -  | 3.1.4.3.2  Done and  ongoing | 3.1.4.3.2   % of  hospitals  that  perform  audit  according  to the  centralize d audit  plan and  audit.  tools. | 3.1.4.3.2   Number  of  hospitals  that  perform  audit  according  to the  centralize d audit  plan and  audit  tools/total  number of | 3.1.4.3.2   Once/year | 3.1.4.3.2   Hospitals/  Digital  central  IPC  program | 3.1.4.3.2   Data  collection | 3.1.4.3.2   Partially  performe d |

|                                                   |                                                                                             |                                                                                                           |                                             |                                                                                 |                                                                                                            | hospitals  X100                                                                                                           |                                                    |                                                        |                              |                                                   |
|---------------------------------------------------|---------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|---------------------------------------------|---------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------|--------------------------------------------------------|------------------------------|---------------------------------------------------|
|                                                   | 3.1.4.3.3  Audit  report is  sent to  central  IPC  directorat e with  corrective  actions. | -                                                                                                         | -                                           | 3.1.4.3.3   Done and  ongoing                                                   | 3.1.4.3.3   % of  hospitals  that  report the  results of  their  audits to  IPC                           | 3.1.4.3.3   Number  of  hospitals   that  report the  results of  their  audits to  IPC/Total  number of  hospitals  X100 | 3.1.4.3.3   Once/year                              | 3.1.4.3.3   Hospitals/  Digital  central  IPC  program | 3.1.4.3.3   Data  collection | 3.1.4.3.3   Partially  performe d                 |
| 3.1.4.4  Establish  national  process  indicators | 3.1.4.4.1   1 st  set of  process  indicators:  -CLABSI  -CAUTI  -VAP                       | 3.1.4.4.1.1 Put the  basic  training  material                                                            | -                                           | 3.1.4.4.1.1  Each one  of the 4  procedure s has its  own  bundle  establishe d | 3.1.4.4.1.1  To  improve  quality of  care by  using the  bundle  approach  in all HCF                     | 3.1.4.4.1.1  Yes/No                                                                                                       | 3.1.4.4.1.1  Checking                              | 3.1.4.4.1.1  MOH/  IPC  directorat e                   | 3.1.4.4.1.1  Checking        | 3.1.4.4.1. 1  Not  available                      |
|                                                   |                                                                                             | 3.1.4.4.1.2 Update of  the  already  available  bundle of  care in  each of  the  mentione d bundles,  by | 3.1.4.4.1.2  Prepare  the  updated  bundles | 3.1.4.4.1.2  Availabilit y of 3  updated  bundles                               | 3.1.4.4.1.2  To make  quality of  care up- to-date  regarding  the 3  procedure s and to  improve  outcome | 3.1.4.4.1.2  Yes or no  x 3  (For each  bundle)                                                                           | 3.1.4.4.1.2  Once /6  months  until  availabilit y | 3.1.4.4.1.2  IPC  directorat e                         | 3.1.4.4.1.2  Checking        | 3.1.4.4.1. 2  Old  version of  bundles  available |

| including  new  evidence-  based  items to  the  bundle                              |                                                                                                                                      |                                                                    |                                                                                             |                                                                                                                        |                        |                                           |                               |                                                                                               |
|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|---------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------|-------------------------------------------|-------------------------------|-----------------------------------------------------------------------------------------------|
| 3.1.4.4.1.3 Train the  IPC  profession als  nationwid e on the  updated  bundles     | 3.1.4.4.1.3 .1  TOT  workshop s                                                                                                      | 3.1.4.4.1.3 % IPC  profession als trained  about the  new  bundles | 3.1.4.4.1.3  To  dissemina te the  updated  bundles to  all IPC  profession als  nationally | 3.1.4.4.1.3  Number  of  IPC  profession als trained  about the  new  bundles  /Total  number of  IPC  profession als. | 3.1.4.4.1.3  Once/year | 3.1.4.4.1.3  IPC  directorat e/Hospital s | 3.1.4.4.1.3  Data  collection | 3.1.4.4.1. 3 IPC  profession als have  been  trained on  the older  version of  the  bundles. |
| 3.1.4.4.1.4  Engage all  HCW with  the  bundles  by  training,  audit and  feedback. | 3.1.4.4.1.4 .1  Prepare  the  ground in  the  hospitals:  Letter to  hospital  directors  about the  bundles  project its  importanc | 3.1.4.4.1.4 .1  Letter  sent or  not                               |                                                                                             | 3.1.4.4.1.4 .1  Yes /No                                                                                                | 3.1.4.4.1.4 .1  Once   | 3.1.4.4.1.4 .1  IPC  directorat e/  MOH   | 3.1.4.4.1.4 .1  Checking      | 3.1.4.4.1. 4.1  Not  available                                                                |

| e and its  processes                                                                                                                                       |                                                                              |                                                                                                                                                      |                                                                                         |                            |                                                                 |                           |                                                                                                       |
|------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|----------------------------|-----------------------------------------------------------------|---------------------------|-------------------------------------------------------------------------------------------------------|
| 3.1.4.4.1.4 .2   Update  the  material  to be  taught to  HCW by  IPC  profession als,  according  to the  updated  bundles.                               | 3.1.4.4.1.4 .2   % of   material  directed  to HCW  that has  been  updated  | 3.1.4.4.1.4 .2   To  synchroni ze the  teaching  of the IPC  bundle  material  with the  training of  the HCW  other  than the  IPC  profession als. | 3.1.4.4.1.4 .2   Updated  bundle  material  directed  to  HCW/Nu mber of  bundles  x100 | 3.1.4.4.1.4 .2   Once/Year | 3.1.4.4.1.4 .2   IPC  directorat e/Hospital  training  material | 3.1.4.4.1.4 .2   Checking | 3.1.4.4.1. 4.2   The  material  to be  taught to  HCW is  based on.  the  classical  bundle  training |
| 3.1.4.4.1.4 .3   In- hospital  training  sessions  by IPC  profession als to all  concerned  HCW.  Include  Bundle  training in  the yearly  IPC  training | 3.1.4.4.1.4 .3   Complianc e with  performa nce  indicator  for each  bundle | 3.1.4.4.1.4 .3   To  increase  the  complianc e to  bundles to  prevent  HAI and  improve  the  quality of  care                                     |                                                                                         | 3.1.4.4.1.4 .3   Once/Year | 3.1.4.4.1.4 .3   Hospitals                                      | 3.1.4.4.1.4 .3   Checking | 3.1.4.4.1. 4.3   The  material  to be  taught to  HCW is  based on.  the  classical  bundle  training |

|                                                                                            |                                                                                         | and in  peri- employm ent  training.                                                                                  |                                                                                                                                                                           |                                                                                                                         |                                                                                                                                                                        |                                                           |                                                         |                                  |                                                                                         |
|--------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------|---------------------------------------------------------|----------------------------------|-----------------------------------------------------------------------------------------|
|                                                                                            |                                                                                         | 3.1.4.4.1.4 .4  Auditing  complianc e to these  bundles  on  monthly  basis and  report to  IPC  directorat e monthly | 3.1.4.4.1.4 .4  Process  Indicator  for each  of the 3  bundles:  For each  bundle:  %  Complianc e by the  specific  bundle  /opportun ities of  audit for  each  bundle | 3.1.4.4.1.4 .4  To  increase  the  complianc e with the  updated  bundles  and  improve  the  related  quality of  care | 3.1.4.4.1.4 .4  % of  auditing  opportuni ties that  are  compliant  with the  bundle  checklist/t otal  number of  audited  complianc e with  updated  bundle   X 100 | 3.1.4.4.1.4 .4  twice/yea r                               | 3.1.4.4.1.4 .4  Hospitals  Central  Digital IPC  system | 3.1.4.4.1.4 .4  Data  collection | 3.1.4.4.1. 4.4  There are  already  process  indicators   related to   the old  bundles |
| 3.1.4.4.2   Update  outcome  indicators  for the 3  bundles  above  (CLABSI,  CAUTI,  VAP) | 3.1.4.4.2.1   Review  updated  CDC  outcome  indicators  and  update  already  measured | -                                                                                                                     | 3.1.5.4.2.1   Number  of  outcome  indicator  tools and   benchmar k is  updated.                                                                                         | 3.1.5.4.2.1   To be in  line with  internatio nal data  benchmar k.                                                     | 3.1.5.4.2.1   Number  of  updates  outcome  bundles                                                                                                                    | 3.1.5.4.2.1   Once until  all 3  indicators  are  updates | 3.1.5.4.2.1   IPC  Directorat e                         | 3.1.5.4.2.1   Checking           | 3.1.5.4.2. 1   Outcome  bundles  methodol ogy need  revision  and  update               |

| according  to new  CDC/  guidelines                                                                                             | bundles  outcome  indicators  accordingl y                                                                               |                                                                                 |                                                                                                  |                                                                                                |                                                                                                     |                             |                                           |                                                                 |                                                                                           |
|---------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|-----------------------------|-------------------------------------------|-----------------------------------------------------------------|-------------------------------------------------------------------------------------------|
| 3.1.4.4.3  Integrate  process  and  outcome  indicators  for each  bundle,  and use in  the  analysis  and  corrective  actions | 3.1.4.4.3.1  Put a road  map for  integratin g analysis  of  outcome  and  process  indicators  related to  the  bundles | -                                                                               | 3.1.5.4.3.1  Proportio n of  bundles  whose  analysis   integrates   process  and  outcome  data | 3.1.5.4.3.1  To use all  the  available  data and  means to  improve  outcome  results         | 3.1.5.4.3.1  Number  of   bundles  whose  analysis   integrates   process  and  outcome  data/3     | 3.1.5.4.3.1  Once/6  months | 3.1.5.4.3.1  IPC    Directorat e          | 3.1.5.4.3.1  Data  collection                                   | 3.1.5.4.3. 1  Process  and  outcome  bundles  are not  being  interprete d  together  yet |
| 3.1.4.4.4  Introduce   SSI bundle                                                                                               | 3.1.4.4.4.1  preparatio n of  material                                                                                   | -                                                                               | 3.1.5.4.4.1  material  that is  prepared                                                         | 3.1.5.4.4.1  To track  and  minimize  SSI                                                      | 3.1.5.4.4.1  Yes/no                                                                                 | 3.1.5.4.4.1  Once           | 3.1.5.4.4.1  IPC  Directorat e            | 3.1.5.4.4.1  Literature  search  WHO/Inte rnational  literature | 3.1.5.4.4. 1  Not done                                                                    |
|                                                                                                                                 | 3.1.4.4.4.2  Implemen tation of   SSI bundle                                                                             | 3.1.4.4.4.2 .1  Teaching  of IPC  profession als by  central  IPC  directorat e | 3.1.5.4.4.2  %  hospitals  start  submittin g process  and  outcome  indicators  for SSI.        | 3.1.5.4.4.2  To  measure  SSI  complianc e to  bundles  elements  and to  track SSI  incidence | 3.1.5.4.4.2  Number  of   hospitals  start  submittin g process  and  outcome  indicators  for SSI/ | 3.1.5.4.4.2  Once/Year      | 3.1.5.4.4.2  Hospitals/ IPC  directorat e | 3.1.5.4.4.2  Checking                                           | 3.1.5.4.4. 2  Not  available                                                              |

<!-- image -->

|                                                                                                       |                                                                                                                           |                                                                                                                                       |                                                                                                                                          |                                                                                                     |                      | Total  number of  hospitals  x100   |
|-------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------|----------------------|-------------------------------------|
|                                                                                                       |                                                                                                                           |                                                                                                                                       |                                                                                                                                          | 3.1.4.4.4.2 .2  Teaching  of  healthcar e  providers  inside the  hospitals  by IPC  profession als |                      |                                     |
|                                                                                                       |                                                                                                                           |                                                                                                                                       |                                                                                                                                          | 3.1.4.4.4.2 .3  Data  collection                                                                    |                      |                                     |
| 3.1.5  IPC  programs/ office in  LTCF  working in  close  cooperati on with  IPC  directorat e in MOH | 3.1.5.1  Mandate  from  MOH that  IPC  program/ with  employee  with TOR  and  specified  budget  are  available  in LTCF | 3.1.5.1.1  Communi cation  between  MOH and  Public  Authority  of  Disability  Affairs  regarding  IPC in  LTCF and  being  overseen | 3.1.5.1.1.1  Letter  from  MOH to  Public  Authority  of  Disability  Affairs  asking to  establish  IPC in  each LTCF  and to  have the |                                                                                                     | 3.1.5.1.1.1  Present |                                     |

| the  central  and the  'branches '.   | by the IPC  directorat e                              | personnel  work  closely  with IPC  directorat e delegate  to LTCF.                                                                                              |                                                                                                 |                                                       |                      |                   |                  |                       |                                     |
|---------------------------------------|-------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------|----------------------|-------------------|------------------|-----------------------|-------------------------------------|
|                                       |                                                       | 3.1.5.1.1.2 Letter  from  Public  Authority  of  Disability  Affairs to  LTCF that  recomme nds IPC in  each LTCF  and  organizes  the  communic ation with  MOH | 3.1.5.1.1.2  Letter  sent                                                                       |                                                       | 3.1.5.1.1.2  Yes /No | 3.1.5.1.1.2  Once | 3.1.5.1.1.2  MOH | 3.1.5.1.1.2  Checking | 3.1.5.1.1. 2   Partially  available |
|                                       | 3.1.5.1.2  Establishe d  Guidelines  for IPC in  LTCF | 3.1.5.1.2.1  Preparatio n of the  LTCF  guidelines  and their  endorsem ent by  Public  Authority                                                                | 3.1.5.1.2.1  Availabilit y of the  endorsed  guidelines  and set of  policies  and  procedure s | 3.1.5.1.2.1  Proper  unified  IPC  practices  at LTCF | 3.1.5.1.2.1  Yes /No | 3.1.5.1.2.1  Once | 3.1.5.1.2.1  MOH | 3.1.5.1.2.1  Checking | 3.1.5.1.2. 1  Not  available        |

|                                                                                                                         |                                                                                                                                                                                    | of  Disability  Affairs                                                                                                 |                                                                                                                         |                                                                                                                         |                                                                                                                         |                                                                                                                         |                                                                                                                         |                                                                                                                         |                                                                                                                         |                                                                                                                         |
|-------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                         |                                                                                                                                                                                    | 3.1.5.1.2.2  Dissemina tion of  LTCF  Policies  and  Procedure s                                                        | 3.1.5.1.2.2 .1  TOT of  LTCF IPC  focal  persons                                                                        | 3.1.5.1.2.2  % focal  IPC  persons in  LTCF   trained on  the  guidelines /total  number of  LTCF IPC  focal  persons.  | 3.1.5.1.2.1  Proper  unified  IPC  practices  at LTCF                                                                   | 3.1.5.1.2.1  Number  of focal  persons  trained  /total  number of  focal  persons  *100                                | 3.1.5.1.2.1  Once/year                                                                                                  | 3.1.5.1.2.1  MOH                                                                                                        | 3.1.5.1.2.1  Checking                                                                                                   | 3.1.5.1.2. 1  Not  available                                                                                            |
| Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report                                                            | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report | Strategic objective 3.2 To have the HAI and AMR information digitalized and sent to IPC directorate as a digital report |
| 3.2.1  Software  for  hospital  data  entry,  analysis  and  generatin g both  hospital  and  national  reports         | 3.2.1.1  Subcommi ttee from  IPC  directorat e sends a  letter to   Informati on system  departme nt at MOH  explaining  what is  required  and asking  for the  software  3.2.1.2 |                                                                                                                         |                                                                                                                         | 3.2.1  Software  developed  and  working                                                                                | 3.2.1  Simplify  the  follow-up  on  tracking  AMR/HAI  data by  MOH IPC  directorat e                                  | 3.2.1  Yes/No                                                                                                           | 3.2.1  Once                                                                                                             | 3.2.1  MOH/ IPC  directorat e                                                                                           | 3.2.1  Checking                                                                                                         | 3.2.1  Not  available                                                                                                   |
|                                                                                                                         |                                                                                                                                                                                    |                                                                                                                         |                                                                                                                         | See above                                                                                                               |                                                                                                                         |                                                                                                                         |                                                                                                                         |                                                                                                                         |                                                                                                                         |                                                                                                                         |

<!-- image -->

| Informati on system  dep.  presents  projects  (either in- house, or  ready to  buy) with  budget  providing   |           |
|----------------------------------------------------------------------------------------------------------------|-----------|
| 3.2.1.3  Agreemen t between  IPC  directorat e and  informatio n system  dep. to  choose  one  system          | See above |
| 3.2.1.4  Apply the  system in  the  hospitals                                                                  | See above |
| 3.2.1.5  Apply the  Digital   HAI/AMR   System  for  National  data                                            | See above |

|                                                                                    | collection  from  individual  hospitals  to central  IPC  directorat e                                     |                                            |    |    |                                                            |                                                    |                                                                                                        |                      |                                                |                     |                                                     |
|------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|--------------------------------------------|----|----|------------------------------------------------------------|----------------------------------------------------|--------------------------------------------------------------------------------------------------------|----------------------|------------------------------------------------|---------------------|-----------------------------------------------------|
| 3.2.2 To  Shift all  hospital  informatio n system  from  paper to  digital  mode. | 3.2.2.1  MOH  recomme nds from  hospitals  to have an  electronic  patient  and data  informatio n system. | 3.2.2.1.1  Letter  from  MOH to  hospitals | -  | -  | 3.2.2.1.1  Letter is  sent                                 |                                                    | 3.2.2.1.1   Yes /No                                                                                    | 3.2.2.1.1  Once      | 3.2.2.1.1  MOH                                 | 3.2.2.1.1  Checking | 3.2.2.1.1  Partially  available  in some  hospitals |
|                                                                                    | 3.2.2.2  Increase  the  number of  hospitals  that have   digitalized  their  medical  informatio n system | -                                          | -  | -  | 3.2.2.2   %  hospitals  with  digital  informatio n system | 3.2.2.2   improving  all aspects  of patient  care | 3.2.2.2   Number  of  hospitals  with  electronic  medical  records/T otal  number of  hospitals  *100 | 3.2.2.2   Once/year  | 3.2.2.2   Hospitals                            | 3.2.2.2   Checking  | 3.2.2.2   Partially  available  in some  hospitals  |
| 3.2.3  Connect  Infection  Control                                                 | 3.2.3.1  Connect  Infection  Control  departme                                                             | 3.2.3.1.1  Letter  from  MOH to  ask all   | -  | -  | 3.2.3.1.1   % IC dep  connected  with                      | 3.2.3.1.1  proper  HAI  surveillan ce and          | 3.2.3.1.1  Number  of IC dep  connected  with                                                          | 3.2.3.1.1  Once/year | 3.2.3.1.1  Hospitals/  IPC  directorat e / MOH | 3.2.3.1.1  Checking | 3.2.3.1.1  partially  available  in some  hospitals |

| Departme nts to  electronic  medical  records   | nts in all  hospitals  with the  Heath  informatio n system  and  Laborator y  informatio n system  at the  hospital   | hospitals  to  connect IC  dep. with  HIS and  LIS at the  hospital  level                                                                          |    | HIS/LIS in  hospitals                                                          | preventio n thus  improving  patient  care                            | HIS/LIS in  hospitals  /Total  number of  hospitals  *100                                                              |                      |                                                |                     |                           |
|-------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|----|--------------------------------------------------------------------------------|-----------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|----------------------|------------------------------------------------|---------------------|---------------------------|
|                                                 | level                                                                                                                  | Decree  from  MOH to  all  hospitals  who have  an  electronic  Health  informatio n system  to link  their Lab  AMR data  to the  Hospital  system | -  | 3.2.3.1.2   % of IC  dep  connected  with  electronic  AMR data  in  hospitals | 3.2.3.1.2  Better HAI  and AMR  surveillan ce on the  national  level | 3.2.3.1.2  number of  IC dep  connected  with  electronic  AMR data  in  hospitals  /Total  number of  hospitals  *100 | 3.2.3.1.2  Once/year | 3.2.3.1.2  Hospitals/  IPC  directorat e/  MOH | 3.2.3.1.2  Checking | 3.2.3.1.2  Not  available |
|                                                 | 3.2.3.2  Develop  electronic                                                                                           |                                                                                                                                                     |    | 3.2.3.2  electronic  outbreak                                                  | 3.2.3.2  Better  managem                                              | 3.2.3.2  Yes/No                                                                                                        | 3.2.3.2   Once       | 3.2.3.2  Hospitals                             | 3.2.3.2  Checking   | 3.2.3.2  Not  available   |

| outbreak  reporting  system for  data  entry,  analysis  and    generatin                                                                             |                                                                                    | reporting  system  available                                                                                                                                  |                                                                            | ent and  control of  outbreaks                                                          |                      |                                        |                                          |                     |                           |
|-------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|----------------------|----------------------------------------|------------------------------------------|---------------------|---------------------------|
| 3.2.3.3  Develop  electronic  reporting  system for  data  entry,  analysis  and    generatin g  hospital/n ational   reports  for  bundles of  care. |                                                                                    | 3.2.3.3  Bundles  data  collection,  analysis  and    generatin g  hospitals  /national  reports is  done  through.  an  electronic  advanced  system  Yes/No | 3.2.3.3  Better  monitorin g and  auditing  of bundles  of care            | 3.2.3.3  Yes/No                                                                         | 3.2.3.3  Once        | 3.2.3.3  Hospitals  /IPC  directorat e | 3.2.3.3                                  | Checking            | 3.2.3.3  Not  available   |
| 3.2.3.4  Develop  electronic  infection  preventio n and  control  system  capable of                                                                 | 3.2.3.4.1   Electronic  system  has a  function  for self  diagnosis  of HAIs  and | 3.2.3.4. %  of HAIs  and  outbreaks   in  hospitals  are  automatic ally                                                                                      | 3.2.3.4.1  Better  tracking  and  managem ent of  HAIs and  outbreaks  and | 3.2.3.4.1  Number  HAIs and  outbreaks  detected/ Total  number of  HAIs and  outbreaks | 3.2.3.4.1  Once/year |                                        | 3.2.3.4.1  IPC  directorat e/  Hospitals | 3.2.3.4.1  Checking | 3.2.3.4.1  Not  available |

|                                                                                                       | self- identifyin g HAI and  detecting  outbreaks                                                                                                    | automatic ally  detects  outbreak                                                                                      |                                                                                                 |                                                                                                 | detected  by the IT  system                                                                     | preventin g spread                                                                                                                    |                                                                                                 |                                                                                                 |                                                                                                 |                                                                                                 |                                                                                                 |
|-------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|
| Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW.       | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW.                                                     | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW.                        | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW.                                       | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. | Strategic Objective 3.3 Enhance IPC education in all health- related specialties and among HCW. |
| 3.3.1  Include  IPC as a  core  element  in  education  and  training of  healthcar e  profession als | 3.3.1.1  Include  infection  control in  undergrad uate  curricula  for health  care  students  (medical,  nursing,  dental  and  pharmace utical). | 3.3.1.1.1  Prepare  module  about IPC  and AMR  to be  included  in all  health  specialties  in  universitie s/PAAET. | -                                                                                               | -                                                                                               | 3.3.1.1.1   Module is  available                                                                | 3.3.1.1.1   To  provide all  health  specialties  with IPC  material  to be  taught in  undergrad uate and  post  graduate  education | 3.3.1.1.1   Yes/No                                                                              | 3.3.1.1.1   Once                                                                                | 3.3.1.1.1   IPC  Directorat e                                                                   | 3.3.1.1.1   Checking                                                                            | 3.3.1.1.1   Not  available                                                                      |
|                                                                                                       |                                                                                                                                                     | 3.3.1.1.2  MOH  letter to  MOHE  and  PAAET to  ask to  include  this  modules  into the  undergrad s and  graduate    | -                                                                                               | -                                                                                               | 3.3.1.1.2  Letters  sent                                                                        | 3.3.1.1.2   To make it  official  and   speed up  the  inclusion  of these  modules  into the  curricula                              | 3.3.1.1.2   Yes/No                                                                              | 3.3.1.1.2   Once                                                                                | 3.3.1.1.2   IPC  Directorat e                                                                   | 3.3.1.1.2   Checking                                                                            | 3.3.1.1.2   Not sent  yet                                                                       |

|                                                                                                   |                                                                                                                                         | health  students'  curricula                                                                                               |                                                               |                                                                                                                                        |                                                                                                                     |                                                                          |                                       |                              |                                 |
|---------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------|---------------------------------------|------------------------------|---------------------------------|
|                                                                                                   |                                                                                                                                         | 3.3.1.1.3  Modules  sent to  Kuwait  university / PAAET  to include  it in  curricula                                      | 3.3.1.1.3  % health  specialties  that  include   IPC  module | 3.3.1.1.3  To  incorporat e IPC  training in  all health  specialties  including  dentistry                                            | 3.3.1.1.3  Health  specialties  programs  that  include   IPC  module/T otal  health  specialties  programs   X 100 | 3.3.1.1.3  Once/6  months  until all  programs  do include  IPC  modules | 3.3.1.1.3  Universiti es/PAAET        | 3.3.1.1.3  Data  collection  | 3.3.1.1.3  Partially  available |
| 3.3.2  Enhance  IPC  education  among    undergrad uates and  higher  education  health  students | 3.3.2.1  Include  infection  control in  continuing  education  of  healthcar e workers  and  mandator y  prerequisi te for  promotio n | 3.3.2.1.1  Provide  IPC  courses  with CE  credits in  universitie s,  hospitals,  MOH,  PAAET  PAAF  Include  CME  Credit | 3.3.2.1.1  Number  of IPC  courses/  year                     | 3.3.2.1.1   To  provide  opportuni ty of IPC  education   among  non-IPC  HCW and  to  promote  IPC as a  job among  students  and HCW | 3.3.2.1.1   Number/  year                                                                                           | 3.3.2.1.1   Once/year                                                    | 3.3.2.1.1   Universiti es/PAAET  KIMS | 3.2.2.1.1   Data  collection | 3.3.2.1.1   Not  available      |

|                                                | 10% IPC   3.3.2.1.2  Request  that when  CE credits  for  physicians , nurses,  or  pharmacis ts is  needed,  10% of  these  credits  should be   |                                                         |                                    | 3.3.2.1.2  %  profession als have  10% of  their CE  credits are  related to  IPC                                           | 3.3.2.1.2   To  provide  IPC  education  to all  HCW, and  not to IPC  profession als alone   | 3.3.2.1.2   Number  of   HC  profession als that  have CE  related to  IPC/Total  number of  profession als who  are  requested  to have CE   | 3.3.2.1.2   Once/year            | 3.3.2.1.2   Syndicates  of HC  profession als (MDs,  nurses,  pharmacis ts,  dentists,  physiothe rapists,  technician s)   | 3.3.2.1.2   Data  collection   | 3.3.2.1.2   Not  available      |
|------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------|------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------|--------------------------------|---------------------------------|
|                                                | 3.3.2.1.3  In  hospitals,  yearly and  upon  employm ent,  mandator y  attendanc e of IPC  lectures                                               | -                                                       | -                                  | 3.3.2.1.3  %  hospitals  that  mandated  that all  employee  get IPC  training  upon  employm ent and  yearly IPC  lecture. | 3.3.2.1.3  To update  and  remind  and  engage  HCW with  IPC                                 | 3.3.2.1.3  Number  of  hospitals  that have  this  program  /total  number of  hospitals                                                      | 3.3.2.1.3  Once/year             | 3.3.2.1.3  Hospitals                                                                                                        | 3.3.2.1.3  Data  collection    | 3.3.2.1.3  Partially  available |
| 3.3.2.2  Hygiene  and IPC  education  provided | 3.3.2.2.1  Require  IPC  education  by drug                                                                                                       | 3.3.2.2.1.1  Request  to include  few topics  about IPC | 3.3.2.2.1.1 .1  Letter to  be sent | 3.3.2.2.1.1 .1  Yes/No                                                                                                      |                                                                                               | 3.3.2.2.1.1 .1  Yes/No                                                                                                                        | 3.3.2.2.1.1 .1  Once/conf erence | 3.3.2.2.1.1 .1  conferenc e  organizers                                                                                     | 3.3.2.2.1.1 .1  Checking       | 3.3.2.2.1. 1.1  Not  available  |

|                                                                                                         | outside  formal  teaching  programs                             | companie s,  hospitals,  LTCFs,  FAO, and  medical/v eterinary  associatio ns   | in  conferenc es  agendas                                       |                                                                 |                                                                 |                                                                      |                                                                        |                                                                 |                                                                 |                                                                 |                                                                 |
|---------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------|---------------------------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|----------------------------------------------------------------------|------------------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|
| Strategic Objective 3.4 Prevent occupational infections in HCWs                                         | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs                 | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs      | Strategic Objective 3.4 Prevent occupational infections in HCWs        | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs | Strategic Objective 3.4 Prevent occupational infections in HCWs |
| 3.4.1  Develop a  comprehe nsive  program  of  vaccinatio n to  protect  HCWs  from  vaccine  preventab | -                                                               | -                                                                               | -                                                               | -                                                               | 3.4.1   % of  HCWs  profession als that  are  vaccinate d       | 3.4.1   Prevent  vaccine  preventab le  diseases                     | 3.4.1   Number  of HCW  who are  vaccinate d/Total  number of  HCW*100 | 3.4.1  Once/year                                                | 3.4.1   MOH  Hospitals/ Public  Health  Directorat e            | 3.4.1   Checking                                                | 3.4.1  Partially  available                                     |
| 3.4.2  Develop  policies  and  procedure s to  protect  healthcar e workers  from                       | -                                                               | -                                                                               | -                                                               | -                                                               | 3.4.2  Yes/No                                                   | 3.4.2   Prevent  occupatio nal  exposure  to  infections  among  HCW | 3.4.2   Yes/No                                                         | 3.4.2   Once                                                    | 3.4.2   Hospitals                                               | 3.4.2   Checking                                                | 3.4.2   Partially  available                                    |

| occupatio nal  exposure  to  infections.                                                                                        |                                                                                                                   |                                                                |                                                                |                                                                |                                                                                  |                                                                                         |                                                                                          |                                                                |                                                                |                                                                |                                                                |
|---------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------|
| 3.4.3  Availabilit y of  Airborne  Isolation   Rooms in  all  hospitals                                                         | 3.4.3.1  screening   mapping   and  updating  the  recomme ndations  according  to the  expected  need  according | -                                                              | -                                                              | -                                                              | 3.4.3.1  Yes/No                                                                  | 3.4.3.1  proper  managem ent of  airborne  infections  and  improving  quality of  care | 3.4.3.1  Yes/No                                                                          | 3.4.3.1  Once                                                  | 3.4.3.1  Hospitals                                             | 3.4.3.1  Checking                                              | 3.4.3.1  Partially  available                                  |
| 3.4.4  Mandate  to  hospitals  to provide  airborne  isolation  rooms  (AII)  available  as per the   updated  recomme ndations | -                                                                                                                 | -                                                              | -                                                              | -                                                              | 3.4.4  Percent  hospitals  have  enough  AII rooms  as per  MOH  recomme ndation | 3.4.4  Prevent  spread of  airborne  infections  plus  proper  managem ent              | 3.4.4  Number  of  hospitals  with  enough  AII rooms  /total  number of  hospitals* 100 | 3.4.4  Once/year                                               | 3.4.4  MOH  Hospitals                                          | 3.4.4  Checking                                                | 3.4.4  Partially  available                                    |
| Strategic Objective 3.5 Adequate waste management in hospitals                                                                  | Strategic Objective 3.5 Adequate waste management in hospitals                                                    | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals                   | Strategic Objective 3.5 Adequate waste management in hospitals                          | Strategic Objective 3.5 Adequate waste management in hospitals                           | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals | Strategic Objective 3.5 Adequate waste management in hospitals |
| 3.5.1                                                                                                                           | 3.5.1.1                                                                                                           | 3.5.1.1.1                                                      | 3.5.1.1.1.1                                                    | -                                                              | 3.5.1.1.1.1                                                                      |                                                                                         | 3.5.1.1.1.1  Yes/No                                                                      | 3.5.1.1.1.1  Once                                              | 3.5.1.1.1.1  MOH                                               | 3.5.1.1.1.1  Checking                                          | 3.5.1.1.1. 1                                                   |

| Put  National  Guidelines   | National  policies,  strategies  and plans  for  healthcar e waste  managem ent is in  place   | Unify  recomme ndations  between  KEPA and  MOH   | Create a  committe e from  MOH and  KEPA that  unifies the  recomme ndation  and the  road map  of all  types of  waste that  are  generated  in  healthcar e   | Committe e  members  are  nominate d                                                                                                                |                                                                                  |                                                                            |                   | KEPA                   |                       | Not  available               |
|-----------------------------|------------------------------------------------------------------------------------------------|---------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|----------------------------------------------------------------------------|-------------------|------------------------|-----------------------|------------------------------|
|                             |                                                                                                |                                                   | 3.5.1.1.1.2  The  committe e reviews  waste  policies  that are  related to  HCF and  unifies  recomme ndations  and  provides  the  proper  ways of            | 3.5.1.1.1.2  Percent  chapters  that  represent  conflict  between  recomme ndations  of the 2  ministries  that have  been  reviewed  and  unified | 3.5.1.1.1.2  Unify  recomme ndation  and thus  proper  methods  of  supervisio n | 3.5.1.1.1.2  number of  chapters  edited  /total  number of  chapters* 100 | 3.5.1.1.1.2  Once | 3.5.1.1.1.2  MOH  KEPA | 3.5.1.1.1.2  Checking | 3.5.1.1.1. 2  Not  available |

|                                                                 |                                                                                                  |    | supervisio n   |    |                                                                        |                                                                                               |                                                                           |                    |                             |                   |                         |
|-----------------------------------------------------------------|--------------------------------------------------------------------------------------------------|----|----------------|----|------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|---------------------------------------------------------------------------|--------------------|-----------------------------|-------------------|-------------------------|
| 3.5.2  Supervisio n of waste  disposal  from  public  hospitals | 3.5.2.1  Create a  committe e for the  supervisio n of waste  disposal  from  public  hospitals  | -  | -              | -  | 3.5.2.1  Available  and  ongoing                                       |                                                                                               |                                                                           |                    |                             |                   |                         |
| 3.5.3  Supervisio n of waste  disposal in  private  hospitals   | 3.5.3.1  Create a  committe e for the  supervisio n of waste  disposal in  private  hospitals    | -  | -              | -  | 3.5.3.1  Yes/No                                                        | 3.5.3.1  overseein g proper  waste  disposal                                                  | 3.5.3.1  Yes/No                                                           | 3.5.3.1  Once      | 3.5.3.1  private  hospitals | 3.5.3.1  Checking | 3.5.3.1  Not  available |
| 3.5.4  Waste  policies  are being  audited  by KEPA             | 3.5.4.1  Organizati on of  supervisio n of waste  disposal  inside and  from  private  hospitals | -  | -              | -  | 3.5.4.1  % Public  hospitals  are being  audited  for waste  disposal. | 3.5.4.1  Ensure  proper  waste  managem ent and  preventio n of  environm ent  contamin ation | 3.5.4.1  Number  of audited  hospitals/ total  number of  hospitals  *100 | 3.5.4.1  Once/year | 3.5.4.1  KEPA               | 3.5.4.1  Checking | 3.5.4.1  Not  available |
|                                                                 | 3.5.4.2                                                                                          |    | -              | -  | 3.5.4.2                                                                |                                                                                               | 3.5.4.2  Yes/No                                                           | 3.5.4.2  Once      | 3.5.4.2  KEPA               | 3.5.4.2  Checking | 3.5.4.2                 |

|                                                                                                                     | Designate  1 unit at  KEPA to  oversee  the waste  in  hospitals                                                    |                                                                                                                                                                        |                                                                                                                     |                                                                                                                     | % Private  hospitals  where  waste  managem ent is  being  supervise d                                              |                                                                                                                                            |                                                                                                                     |                                                                                                                     |                                                                                                                     |                                                                                                                     | Not  available                                                                                                      |
|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings                                                    | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings                        | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings | Strategic Objective 3.6 To enhance infection prevention and control programs in veterinary and agriculture settings |
| 3.6.1  Availabilit y of IPC  guidelines  in  veterinary  practices                                                  | 3.6.1.1  Implemen tation of  OIE  guidelines  regarding  IPC in  veterinary  field                                  | 3.6.1.1.1  Committe e in PAAF  that  regularly  checks  updates in  OIE  guidelines  regarding  IPC in  veterinary  field, and  updates  the  guidelines  accordingl y | -                                                                                                                   | -                                                                                                                   | 3.6.1.1.1  Committe e is  formed                                                                                    | 3.6.1.1.1  To have  up-to- date  guidelines  and to   have local  responsibl e bodies  involved  rather  than  internatio nal NGOs  alone. | 3.6.1.1.1  Guidelines  availabilit y and   Update at  least  once/3  years                                          | 3.6.1.1.1  Once/year                                                                                                | 3.6.1.1.1  PAAF                                                                                                     | 3.6.1.1.1  Checking  the  guidelines .                                                                              | 3.6.1.1.1  Guideline s  available,  need  improved  governanc e                                                     |
|                                                                                                                     |                                                                                                                     | 3.6.1.1.2  Overseein g the  implemen tation of  national  IPC  guidelines                                                                                              | 3.6.1.1.2  Regular  audits to  farms                                                                                | 3.6.1.1.2  Put a  yearly  audit plan                                                                                | 3.6.1.1.2  % Farms  that are  being  audited  yearly for  IPC  measures.                                            | 3.6.1.1.2  To check  the  applicatio n of IPC  guidance  in farms                                                                          | 3.6.1.1.2  Number  of   farms that  are being  audited  yearly for  IPC                                             | 3.6.1.1.2  Once/year                                                                                                | 3.6.1.1.2  Farms                                                                                                    | 3.6.1.1.2  Data  collection                                                                                         | 3.6.1.1.2  Not  performe d                                                                                          |

|                                                                                               |                                                                                                                             | in Vet  field and  OIE good  practices                                                                                        |    |                                                                            |                                                                                                                  | measures/ Total  number of  farms   X 100   |                   |                                  |                     |                           |
|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|----|----------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------|---------------------------------------------|-------------------|----------------------------------|---------------------|---------------------------|
| 3.6.2  Include  IPC in  licensing  of Vets                                                    | 3.6.2.1  Include  questions  about OIE  IPC  guidelines  and  vaccinatio ns in all  vets  licensing  exams or  interviews . | 3.6.2.1.1  Prepare a  set of  questions  related to  IPC in Vets  to be  included  in  licensing  exams  and  interviews .  - | -  | 3.6.2.1.1  Availabilit y of IPC  questions  in  licensing  exams  (Yes/No) | 3.6.2.1.1T o promote  revision of  IPC  practices  in  preparatio n for pre- employm ent  interviews  and  exams | 3.6.2.1.1  Yes/No                           | 3.6.2.1.1  Yearly | 3.6.2.1.1  PAAF   Exam  material | 3.6.2.1.1  Checking | 3.6.2.1.1  Not  available |
| 3.6.3  Include  IPC in  Continuou s  education  of Vets  and  profession als in  Agricultur e | slide bank  related to  IPC in vet  and  agricultur e, to be  given to  drug  companie s that  usually do  the              | -  -                                                                                                                          | -  | 3.6.3.1  Yes/No                                                            | 3.6.3.1  Improve  IPC  knowledg e among  profession als in  vet/agricu lture  fields                             | 3.6.3.1  Yes/No                             | 3.6.3.1  Once     | 3.6.3.1  PAAF                    | 3.6.3.1  Checking   | 3.6.3.1  Not  available   |

|                                                                                                                                  | education  activities.                                                                                                            |           |    |    |                                                                                                 |                                                                                                                               |                                   |                    |                    |                     |                         |
|----------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|-----------|----|----|-------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|-----------------------------------|--------------------|--------------------|---------------------|-------------------------|
|                                                                                                                                  | 3.6.3.2  Mandate  that all  drug  company  events or  seminars  include a  specific  number of  slides  related to  IPC and  AMR. | -         | -  | -  | 3.6.3.2  Mandate  available  or not                                                             | 3.6.3.2  To oblige  drug  companie s that are  almost  the only  provider  of CE, to  include  IPC in  their  presentati ons. | 3.6.3.2  Mandate  issued:  Yes/No | 3.6.3.2  Once      | 3.6.3.2  PAAF      | 3.6.3.2  Checking   | 3.6.3.2  Not  available |
| 3.6.4  Include  hygiene  and  infection  preventio n and  control as  core  content in  training of  veterinary  profession als. | 3.6.4.1  Close  communic ation  between.  FAO and  PAAF to  put a joint  yearly  plan of  education  activities  related to  IPC. | -         | -  | -  | 3.6.3.2  Joint  education  plan  between  FAO and  PAAF  that  includes  IPC- related  training | To  provide  CE by  nonprofit  organizati ons to  eliminate  the  possibility  of  commerci al bias  while  teaching  IPC     | 3.6.3.2  Plan  available:  Yes/No | 3.6.3.2  Once/year | 3.6.3.2  PAAF  FAO | 3.6.3.2  Checking   | 3.6.3.2  Not  available |
|                                                                                                                                  | 3.6.4.2                                                                                                                           | 3.6.4.2.1 | -  | -  | 3.6.4.2.1                                                                                       | 3.6.4.2.1                                                                                                                     | 3.6.4.2.1                         | 3.6.4.2.1  Once    | 3.6.4.2.1          | 3.6.4.2.1  Checking | 3.6.4.2.1               |

## Annex 5

## A. Antimicrobial Use Strategic Plan

| Activity                                                                                                                            | Sub-activity                                                                                                       | Sub-sub-activity                                                                                                   | Date                                                                                                               | Milestone for strategic  objective                                                                                 |
|-------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar                  | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar |
| 4.1.1 Identify who will be the  ABX arm pillar focal point in  each ministry/authority and  assign the TOR                          |                                                                                                                    |                                                                                                                    | 4.1.1   6 months                                                                                                   | 4.1  2 years                                                                                                       |
| 4.1.2 Prepare clear TOR of  the focal person for ABX in  each ministry/ authority                                                   |                                                                                                                    |                                                                                                                    | 4.1.2  2 months                                                                                                    |                                                                                                                    |
| 4.1.3 Assign the job to a  defined person/position in  each ministry/ authority, and  nomination by the director  of each ministry. |                                                                                                                    |                                                                                                                    | 4.1.3  3 months                                                                                                    |                                                                                                                    |
| 4.1.4 Put TOR and  reimbursement plan for the  different tasks.                                                                     |                                                                                                                    |                                                                                                                    | 4.1.4  3 months                                                                                                    |                                                                                                                    |
| 4.1.5 Nominate the  stakeholders for the task  force of the pillar                                                                  |                                                                                                                    |                                                                                                                    | 4.1.5  4 months                                                                                                    |                                                                                                                    |
| Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines                                         | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines                        | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines                        | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines                        | Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines                        |
| 4.2.1 Put clear criteria for  standards of quality safety    and efficiency of ABX                                                  |                                                                                                                    |                                                                                                                    | 4.2.1 System is in place                                                                                           | 4.2 Available                                                                                                      |
| 4.2.2 Put a system of  controlling that all available  ABX in the country should    meet the international  standards listed above  |                                                                                                                    |                                                                                                                    | 4.2.2 Already available,  Only ABX that are licensed  by WHO, EMEA or FDA,   are allowed in the market             |                                                                                                                    |

| otherwise they are not  allowed to be in the market.                                                                                                                        |                                                                                                                                                                                   |                                                                                                                                          |                                                                                                                                          |                                                                                                                                          |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| 4.2.3 All ABX should be  tested by a system that  identifies counterfeit prior to  licensing.                                                                               |                                                                                                                                                                                   |                                                                                                                                          | 4.2.3 Available                                                                                                                          |                                                                                                                                          |
| 4.2.4 Put regulations that  prohibit the sale of  counterfeit products                                                                                                      |                                                                                                                                                                                   |                                                                                                                                          | 4.2.4 Available                                                                                                                          |                                                                                                                                          |
| 4.2.5 The system that  controls quality assurance of  ABX has the authority to  stop counterfeit products  from being licensed and  marketed                                |                                                                                                                                                                                   |                                                                                                                                          | 4.2.5 available                                                                                                                          |                                                                                                                                          |
| Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics                                    | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics                                          | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics |
| 4.3.1 Develop and  implement national essential  medicine list guided by the  WHO Model List of Essential  Medicines                                                        | 4.3.1.1 Finalize the essential  medicine list that is   being prepared at MOH                                                                                                     |                                                                                                                                          | 4.3.1.1   6 months                                                                                                                       | 4.3  4 years                                                                                                                             |
| 4.3.2 Mandate that every  institution has an essential  medicine list                                                                                                       |                                                                                                                                                                                   |                                                                                                                                          | 4.3.2   6 months                                                                                                                         |                                                                                                                                          |
| 4.3.3 Each institution has an  essential medicine list and  this is checked in  accreditation standards  include checking the  availability of the essential  medicine list | 4.3.3.1 Mandate from MOH  that once the   national essential medicine  list is available,  all hospitals including public  and private hospitals should  formulate their own list |                                                                                                                                          | 4.3.3.1   8 months                                                                                                                       |                                                                                                                                          |
|                                                                                                                                                                             | 4.3.3.2 Include   the availability of essential  medicine list into   the license renewal                                                                                         | 4.3.3.2.1 Private hospital  renewal license                                                                                              | 4.3.3.2.1   8 months                                                                                                                     |                                                                                                                                          |

|                                                                                                                                                                                                                                                            | conditions of private  hospitals                                                        | checklist should include the  availability of essential  medicine list   |                                                                 |                                                                 |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|--------------------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|
| 4.3.4 Re imbursement plan is  based on   essential medicine list    in public   and private hospitals                                                                                                                                                      |                                                                                         |                                                                          | 4.3.4   8 months                                                |                                                                 |
| Strategic Objective 4.4 Start AMS program in primary healthcare                                                                                                                                                                                            | Strategic Objective 4.4 Start AMS program in primary healthcare                         | Strategic Objective 4.4 Start AMS program in primary healthcare          | Strategic Objective 4.4 Start AMS program in primary healthcare | Strategic Objective 4.4 Start AMS program in primary healthcare |
| 4.4.1 Create a technical  group that puts national ABX  use guidelines for outpatient  care based on International  guidelines and National AMR  profiles: can be a  subcommittee  from the national task force  for the ABX pillar for proper  use of ABX | 4.4.1.1 Put TOR and   renewal conditions of the   focal group of stakeholders           |                                                                          | 4.4.1.1   3 months                                              | 4.4  5 years                                                    |
|                                                                                                                                                                                                                                                            | 4.4.1.2 Assign the members  of this committee                                           |                                                                          | 4.4.1.2   3 months                                              |                                                                 |
|                                                                                                                                                                                                                                                            | 4.4.1.3 Put TOR and official   renewal time for the  guidelines committee               |                                                                          | 4.4.1.3   3 months                                              |                                                                 |
| 4.4.2 Guidelines in primary  healthcare are available and  are regularly updated                                                                                                                                                                           |                                                                                         |                                                                          | 4.4.2   6 months                                                |                                                                 |
|                                                                                                                                                                                                                                                            | 4.4.2.1 Training workshop  about ABX guidelines in  primary healthcare                  |                                                                          | 4.4.2.1   5 years                                               |                                                                 |
| 4.4.3 Apply AMS in primary  healthcare: Monitoring ABX  consumption and Link  prescription to diagnoses                                                                                                                                                    | 4.4.3.1 Project ABX  consumption documentation  and surveillance in primary  healthcare | 4.4.3.1.1 Put a proposal for  this project                               | 4.4.3.1.1   8 months                                            |                                                                 |

|                                                                                                                                                                          | 4.4.3.2 Start collecting data  and link it to diagnosis                                       |                                                                                                                                              | 4.4.3.2   10 months                                               |                                                                   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------------------------------------------------|
|                                                                                                                                                                          | 4.4.3.3 Data analysis   and feedback to prescribers                                           |                                                                                                                                              | 4.4.3.3   1 year                                                  |                                                                   |
|                                                                                                                                                                          | 4.4.3.4 Employ  more pharmacists in primary  healthcare                                       |                                                                                                                                              | 4.4.3.4   1 year                                                  |                                                                   |
|                                                                                                                                                                          | 4.4.3.5 Improve manpower  with professionals for the  AMS project in primary  healthcare      | 4.4.3.5.1 Train available  pharmacists on AMS and  clinical pharmacy principles                                                              | 4.4.3.5.1   18 months                                             |                                                                   |
|                                                                                                                                                                          |                                                                                               | 4.4.3.5.2 Employ new   clinical pharmacist  specialized in AMS and 1 full  time  clinical microbiologist in  primary healthcare  directorate | 4.4.3.5.2   18 months                                             |                                                                   |
| 4.4.4 Update the   digital system   that is   available  in primary healthcare to  integrate   the ABX guidelines   into the   electronic system in the  form of pop-ups |                                                                                               |                                                                                                                                              | 4.4.4   2 years                                                   |                                                                   |
| Strategic Objective 4.5 Apply AMS In Public and Private hospitals                                                                                                        | Strategic Objective 4.5 Apply AMS In Public and Private hospitals                             | Strategic Objective 4.5 Apply AMS In Public and Private hospitals                                                                            | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals |
| 4.5.1 Improve and measure  appropriate use of  antimicrobial agents in  healthcare                                                                                       | 4.5.1.1 Nominate who will  be the AMS   focal person  (Could be the ABX pillar focal  person) |                                                                                                                                              | 4.5.1.1  3 months                                                 | 4.5  5 years                                                      |

| 4.5.2 Identify the National  AMS Task force (Could be a  subcommittee of the ABX  pillar Task force) the  National AMS Technical  team   | 4.5.2.1 AMS technical group  is assigned   (subgroup from the ABX  technical committee. +other  specialists like IT, etc)                                                                             |                                                                                                                                             | 4.5.2.1  3 months   |
|------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|---------------------|
|                                                                                                                                          | 4.5.2.2  TOR of the technical groups   are well defined   They include:  -guidelines for inpatient and  outpatient care.  -put or endorse   diagnostic pathways,  treatment and  national AMS targets |                                                                                                                                             | 4.5.2.2  3 months   |
| 4.5.3 Put national guidelines  either  de novo  or Endorse  existing international  guidelines with regular   updates                    | 4.5.3.1 MOH puts national  guidelines for common  community acquired  infections (CAI)                                                                                                                |                                                                                                                                             | 4.5.3.1  6 months   |
|                                                                                                                                          | 4.5.3.2 Hospitals put  institutional guidelines for  treatment of   Healthcare associated (HAI)  according to their local  epidemiology, with the help  of taskforce members                          | 4.5.3.2.1  Mandate for hospitals to  issue HAI treatment  guidelines based on local  epidemiology and   with the help of taskforce  members | 4.5.3.2.1  6 months |
|                                                                                                                                          |                                                                                                                                                                                                       | 4.5.3.2.2  Organize the work of  taskforce members with the  different hospitals to assist  in putting their own   HAI guidelines           | 4.5.3.2.2  8 months |
|                                                                                                                                          |                                                                                                                                                                                                       | 4.5.3.2.3                                                                                                                                   | 4.5.3.2.3           |

|                                                                                         |                                                                                                  | HAI treatment guidelines  should be reviewed every  year                                                                                                             | once/ year               |
|-----------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|
|                                                                                         | 4.5.3.3  Dissemination and  implementation of these  treatment guidelines in  hospital practice. | 4.5.3.3.1  Workshops for discussion  and   endorsement of these  guidelines with practicing  physicians all over the  country                                        | 4.5.3.3.1  1 year        |
|                                                                                         |                                                                                                  | 4.5.3.3.2  Distribution of educational  material in the form of  booklets, brochures, posters,  &pocket cards, or equivalent  softcopies available on  mobile phones | 4.5.3.3.2  1 year        |
|                                                                                         |                                                                                                  | 4.5.3.3.3  Post the guidelines on the  MOH website and integrate  them into the intranet of  each hospital                                                           | 4.5.3.3.3  1yr, 3 months |
|                                                                                         |                                                                                                  | 4.5.3.3.4  Integrate   the guidelines   into the   electronic medical record, in  the form of pop-ups                                                                | 4.5.3.3.4  2 years       |
| 4.5.4 Make AMS programs  mandatory in each hospital  (presence of AMS team/  committee) | 4.5.4.1 Mandate by MOH for  this issue                                                           |                                                                                                                                                                      | 4.5.4.1  1 y 6 months    |
|                                                                                         | 4.5.4.2 Build AMS manpower                                                                       | 4.5.4.2.1  Train microbiologists, clinical  pharmacists and Infectious                                                                                               | 4.5.4.2.1  1 y 6 months  |

|                                                                                                                                                                                                               |                                                                                                              | Disease specialists on AMS  through national workshops                                                       |                                                                                                              |                                                                                                              |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|
| Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                                                                                                                          | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                         | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                         | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                         | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                         |
| 4.6 ABX used in the  agriculture/ veterinary   are under the same control  as those used in humans  Pharmaceutical and Herbal  Medicines Registration and  Control Administration/The  Dug Inspection Control |                                                                                                              |                                                                                                              | 4.6 Already available                                                                                        | 4.6 available                                                                                                |
| Strategic Objective 4.7 Restrict the use of critically important ABX to human health in the veterinary field                                                                                                  | Strategic Objective 4.7 Restrict the use of critically important ABX to human health in the veterinary field | Strategic Objective 4.7 Restrict the use of critically important ABX to human health in the veterinary field | Strategic Objective 4.7 Restrict the use of critically important ABX to human health in the veterinary field | Strategic Objective 4.7 Restrict the use of critically important ABX to human health in the veterinary field |
| 4.7.1                                                                                                                                                                                                         | 4.7.1                                                                                                        | 4.7.1                                                                                                        | 4.7.1                                                                                                        | 4.7.1                                                                                                        |
| Establish the list of  critically important  antibiotics for humans in the  animal sector.                                                                                                                    |                                                                                                              |                                                                                                              | 4.7.1  3 months                                                                                              | 4.7  2 years                                                                                                 |
| 4.7.2  Determine from this list  which antibiotics should be  restricted for use to humans                                                                                                                    |                                                                                                              |                                                                                                              | 4.7.2  3 months                                                                                              |                                                                                                              |
| 4.7.3  Issue a decree that the  critically important ABX to  human health are not to be  used in animals whether in  individual treatment or in  herd therapy                                                 |                                                                                                              |                                                                                                              | 4.7.3  6 months                                                                                              |                                                                                                              |
| 4.7.4  Prohibit the importation of  these critically   important ABX for   vet use                                                                                                                            | 4.7.4.1  Decree  that prohibits the   importation and sale of  these ABX in the vet field                    |                                                                                                              | 4.7.4.1  6 months                                                                                            |                                                                                                              |

| Put (or endorse) guidelines  regarding the use of ABX in  animals and agriculture                        |                                                                                                                                                                                | 4.8.1                                                                             | 4.8.1  8 months                                                                   | 4.8  5 years                                                                      |
|----------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|
| 4.8.2  Disseminate these guidelines  among veterinarians                                                 | 4.8.2.1  Booklets/  Brochures/app that  summarize the key points in  these guidelines.                                                                                         |                                                                                   | 4.8.1.1  18 months                                                                |                                                                                   |
|                                                                                                          | 4.8.2.1  Regular workshops for  veterinary specialists  regarding the application of  these guidelines                                                                         |                                                                                   | 4.8.2.1  1 year                                                                   |                                                                                   |
| 4.8.3  Restrict selling ABX for  animal and agriculture  health to exclusively  prescriptions by vets    | 4.8.3.1  Decree that vet pharmacies  should dispense ABX only  according to vet  prescriptions, and should  submit these prescriptions  with the evidence of selling  to PAAF. |                                                                                   | 4.8.3.1  2 years                                                                  |                                                                                   |
| 4.8.4  Control the use of ABX in  animals                                                                | 4.8.4.1. Detection of the ABX  residues in milk, meat,  poultry and eggs                                                                                                       |                                                                                   | 4.8.4.1. Already available                                                        | 4.8.4.1. Already available                                                        |
| Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR                        | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR                                                                                              | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR |
| 4.9.1 Provide training  courses for vets for ABX use   according to guidelines and  provide certificate. |                                                                                                                                                                                |                                                                                   | 4.9.1   2 years                                                                   | 4.9  4 years                                                                      |
| 4.9.2 Study   baseline consumption  imported antibiotics in this  field                                  | 4.9.2.1   Pharmaceutical Dep in PAAF  Committee   that will study and  document this consumption                                                                               |                                                                                   | 4.9.2.1   2 years                                                                 |                                                                                   |

and compare it to international benchmark

## B. Antimicrobial Use Monitoring Plan

| Activity                                                                                                           | Sub-activity                                                                                                       | Sub-sub- activity                                                                                                  | Indicator                                                                                                          | Purpose                                                                                                            | Calculation                                                                                                        | Frequency                                                                                                          | Data source                                                                                                        | Method                                                                                                             | Baseline                                                                                                           |
|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar | Strategic Objective 4.1 Ensure governance of antibiotic axis pillar and follow up of the activities of this pillar |
| 4.1.1 Identify  who will be  the ABX arm  pillar focal  point in each  ministry  /authority  and assign  the TOR   |                                                                                                                    |                                                                                                                    | 4.1.1  available                                                                                                   |                                                                                                                    |                                                                                                                    |                                                                                                                    |                                                                                                                    |                                                                                                                    |                                                                                                                    |
| 4.1.2  Prepare  clear TOR of  the focal  person for  ABX in each  ministry  authority                              |                                                                                                                    |                                                                                                                    | 4.1.2  Yes/No                                                                                                      | 4.1.2 proper  organization  and follow- up on the  work in this  pillar                                            | 4.1.2  Yes/No                                                                                                      | 4.1.2  Once                                                                                                        | 4.1.2  AMR  committee                                                                                              | 4.1.2  Checking                                                                                                    | 4.1.2  Not available                                                                                               |
| 4.1.3  Assign the  job to a  defined  person/posit ion in each                                                     |                                                                                                                    |                                                                                                                    | 4.1.3  Proportion  of  ministries/au thorities  where ABX                                                          | 4.1.3 proper  monitoring  and  surveillance  on the work  in this pillar                                           | 4.1.3  number of  ministries /  authorities  with  assigned                                                        | 4.1.3 once                                                                                                         | 4.1.3  AMR   Inter- ministerial  executive  committee                                                              | 4.1.3  checking                                                                                                    | 4.1.3  not available                                                                                               |

ministry

authority,

and

nomination

by the

director of

each

ministry/

authority.

arm focal

person is

assigned

focal

persons/tota

l number of

concerned

ministries/au

thorities*10

0

4.1.4

Put TOR

And

reimbursem

ent plan for

the different

tasks.

4.1.4

Yes/No

4.1.4 proper

organization

and follow-

up on the

work of this

axis

4.1.4

Yes/No

4.1.4

Once

4.1.4

MOH

NMCG/

Focal person

4.1.4

Checking

4.1.4

Not available

4.1.5

Nominate

the

stakeholders

for the task

force of the

pillar

4.1.5

ABX use task

force

group is

formed

Yes/No

4.1.5

assign

responsibiliti

es to specific

persons

regarding

the work in

this pillar

4.1.5

Yes/No

4.1.5

Once

4.1.5

MOH

PAAF

KEPA

PAFN

4.1.5

Checking

4.1.5

Not available

## Strategic Objective 4.2 Ensure uninterrupted access to high-quality antimicrobial medicines

4.2.1 Put

clear criteria

for

standards of

quality

safety   and

efficiency of

ABX

4.2.1 System

is in place

4.2.2 Put a

system of

controlling

4.2.2 Already

available

| that all  available  ABX in the  country  should    meet the  international  standards  listed above  otherwise  they are not  allowed to  be in the  market.   |                                  |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------|
| 4.2.3 All ABX  should be  tested by a  system that  identifies  counterfeit  prior to  licensing.                                                               | 4.2.3 System  already in  place  |
| 4.2.4 Put  regulations  that prohibit  the sale of  counterfeit  products                                                                                       | 4.2.4 System  already in  place  |
| 4.2.5 The  system that  controls  quality  assurance of  ABX has the  authority to  stop                                                                        | 4.2.5 System  already   In place |

| counterfeit  products  from being  licensed and  marketed                                                                                |                                                                                                                                          |                                                                                                                                          |                                                                                                                                          |                                                                                                                                          |                                                                                                                                          |                                                                                                                                          |                                                                                                                                          |                                                                                                                                          |
|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics | Strategic Objective 4.3 Develop and enforce legislation and regulations on prescription and dispensing of medicine including antibiotics |
| 4.3.1  Develop and  implement  national  essential  medicine list  guided by  the WHO  Model List of  Essential  Medicines               | 4.3.1.1  Finalize the  essential  medicine list  that is   being  prepared at  MOH                                                       | 4.3.1.1 List is  issued   Yes/No                                                                                                         | 4.3.1.1   regulate  prescription  and  dispensing of  medications  including  antimicrobial s                                            | 4.3.1.1   Yes/No                                                                                                                         | 4.3.1.1   Once                                                                                                                           | 4.3.1.1   MOH  Central  Medical  Stores  Directorate                                                                                     | 4.3.1.1   Checking                                                                                                                       | 4.3.1.1  task in  progress                                                                                                               |
| 4.3.2  Mandate  that every  institution  has an  essential  medicine list                                                                |                                                                                                                                          | 4.3.2 Yes/No                                                                                                                             | 4.3.2   regulate  prescription  and  dispensing of  medications  including  antimicrobial s on the  facility level                       | 4.3.2   Yes/No                                                                                                                           | 4.3.2   Once                                                                                                                             | 4.3.2   MOH  Undersecret ary general  ABX focal  person                                                                                  | 4.3.2   Checking                                                                                                                         | 4.3.2   Not available                                                                                                                    |
| 4.3.3 Each  institution  has an  essential  medicine list  and this is  checked in  accreditation  standards                             | 4.3.3.1  Mandate  from MOH  that once  the   national  essential  medicine list  is available,                                           | 4.3.3.1   Yes/No                                                                                                                         | 4.3.3.1   put a legal  frame for  the  prescription  and  dispensing of  medicines  including                                            | 4.3.3.1   Yes/No                                                                                                                         | 4.3.3.1   Once                                                                                                                           | 4.3.3.1   MOH  Undersecret ary general  ABX focal  person                                                                                | 4.3.3.1   Checking                                                                                                                       | 4.3.3.1   Not available                                                                                                                  |

| include  checking the  availability  of the  essential  medicine list                                     | all hospitals  including  public and  private  hospitals  should  formulate  their own list                                       |                                                                                                                            |                                                                                          | antimicrobial s                                                                                                      |                                                                                          |                                                                 |                                                                 |                                                                 |                                                                 |
|-----------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|-----------------------------------------------------------------|
|                                                                                                           | 4.3.3.2  Include   the  availability  of essential  medicine list  into   the license  renewal  conditions of  private  hospitals | 4.3.3.2.1  Private  hospital  renewal  license   checklist  should  include the  availability  of essential  medicine list | 4.3.3.2.1  Licensing  checklist  includes the  item of  essential  medicine list  or not | 4.3.3.2.1  having an  essential list  is an  obligation  and  represents a  standard of  good  practice of  medicine | 4.3.3.2.1   Yes/No                                                                       | 4.3.3.2.1  Once                                                 | 4.3.3.2.1   MOH/  Medical  Licensing  Dep                       | 4.3.3.2.1  Checking                                             | 4.3.3.2.1   Not available                                       |
| 4.3.4 Re  imbursemen t plan is  based on   essential  medicine list    in public   and private  hospitals |                                                                                                                                   |                                                                                                                            | 4.3.4   %  of  reimbursed  ABX   that are  listed in the   essential  medicine list      | 4.3.4   making  essential list  an obligation  as a  standard of  good  practice of  medicine                        | 4.3.4   number of  reimbursed  antibiotics/t otal number  of available  antibiotics*1 00 | 4.3.4   once/year                                               | 4.3.4   MOH                                                     | 4.3.4   data  collection                                        | 4.3.4   Not available                                           |
| Strategic Objective 4.4 Start AMS program in primary healthcare                                           | Strategic Objective 4.4 Start AMS program in primary healthcare                                                                   | Strategic Objective 4.4 Start AMS program in primary healthcare                                                            | Strategic Objective 4.4 Start AMS program in primary healthcare                          | Strategic Objective 4.4 Start AMS program in primary healthcare                                                      | Strategic Objective 4.4 Start AMS program in primary healthcare                          | Strategic Objective 4.4 Start AMS program in primary healthcare | Strategic Objective 4.4 Start AMS program in primary healthcare | Strategic Objective 4.4 Start AMS program in primary healthcare | Strategic Objective 4.4 Start AMS program in primary healthcare |
| 4.4.1 Create  a technical  group that  puts national  ABX use  guidelines                                 | 4.4.1.1 Put  TOR and   renewal   conditions of  the                                                                               |                                                                                                                            | 4.4.1.1 TOR  put   Yes or no                                                             | 4.4.1.1  organize the  AMS work  that this  taskforce is                                                             | 4.4.1.1   Yes/No                                                                         | 4.4.1.1   Once                                                  | 4.4.1.1   MOH/  National  Committee  of proper  ABX use         | 4.4.1.1   Checking                                              | 4.4.1.1  Not available                                          |

| for  outpatient  care based  on  International  guidelines  and   National  AMR  profiles:  can be a  subcommitte e  from   the national  task force for  the ABX  pillar for  proper use   | focal group  of  stakeholders                                                  |                               | responsible  for                           |                  |                |                                                         |                    |                         |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|-------------------------------|--------------------------------------------|------------------|----------------|---------------------------------------------------------|--------------------|-------------------------|
|                                                                                                                                                                                             | 4.4.1.2  Assign the  members of  this  committee                               | 4.4.1.2 TOR  put   Yes or no  | 4.4.1.2  oversee AMS  work in this  sector | 4.4.1.2   Yes/No | 4.4.1.2   Once | 4.4.1.2  MOH  National  Committee  of proper  ABX use.  | 4.4.1.2   Checking | 4.4.1.2   Not available |
|                                                                                                                                                                                             | 4.4.1.3 Put  TOR and  official   renewal time   for the  guidelines  committee | 4.4.1.3   TOR put   Yes or no | 4.4.1.3   oversee  guideline  developmen t | 4.4.1.3  Yes/No  | 4.4.1.3   Once | 4.4.1.3   MOH  National  Committee  of proper  ABX use. | 4.4.1.3   Checking | 4.4.1.3  Not available  |
| 4.4.2  Guidelines in  primary                                                                                                                                                               |                                                                                | 4.4.2  Guidelines  available  | 4.4.2   ensure  judicious                  | 4.4.2   Yes/No   | 4.4.2   Once   | 4.4.2   Primary  Healthcare                             | 4.4.2   Checking   | 4.4.2   Not available   |

| healthcare  are  available  and are  regularly  updated                                                           |                                                                                              |                                              | Yes or no                                                                      | antimicrobial  use in  primary  healthcare                                      |                                                                                                                                            |                     | Directorate/  technical  committee/   National  Committee  of proper  ABX use.   |                           |                          |
|-------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------|----------------------------------------------|--------------------------------------------------------------------------------|---------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|---------------------|----------------------------------------------------------------------------------|---------------------------|--------------------------|
|                                                                                                                   | 4.4.2.1  Training  workshop  about ABX  guidelines in  primary  healthcare                   |                                              | 4.4.2.1  Proportion  of primary  healthcare  physician  who attend  every year | 4.4.2.1  primary care  physicians  rationally  prescribe  antimicrobial s       | 4.4.2.1   number of  primary care  physicians  who attend  the training  workshops/t otal number  of primary  healthcare  physicians  *100 | 4.4.2.1   Once/year | 4.4.2.1   Primary  healthcare/  technical  committee                             | 4.4.2.1   Checking        | 4.4.2.1   Not available  |
| 4.4.3 Apply   AMS   in primary  healthcare:  Monitoring  ABX  consumption  and   Link  prescription  to diagnoses | 4.4.3.1  Project ABX  consumption  documentati on and   surveillance  in primary  healthcare | 4.4.3.1.1 Put  a proposal  for this  project | 4.4.3.1.1  Project is put                                                      | 4.4.3.1.1  follow-up on  managemen t of  antimicrobial s in primary  healthcare | 4.4.3.1.1  Yes/No                                                                                                                          | 4.4.3.1.1  Once     | 4.4.3.1.1  Primary  healthcare   and AMR  committee                              | 4.4.3.1.1  Checking       | 4.4.3.1.1  Not available |
|                                                                                                                   | 4.4.3.2 Start  collecting  data and link  it to  diagnosis                                   |                                              | 4.4.3.2  Proportion  of primary  healthcare  centers that  are feeding         | 4.4.3.2  assessment  of the  practice in  these  centers and                    | 4.4.3.2   Number of  primary  healthcare  centers that  are feeding                                                                        | 4.4.3.2   Once/year | 4.4.3.2   National  Committee  for ABX use  /Primary                             | 4.4.3.2  Data  Collection | 4.4.3.2   Not available  |

|                                                              |                                                                | data into the  project                                                                                                        | thus ability  to give  feedback to  prescribers                                                                  | data into the  project/Total  number of  primary  healthcare  centers *100                                                                                                      |                     | healthcare  Directorate                                                            |                            |                           |
|--------------------------------------------------------------|----------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|------------------------------------------------------------------------------------|----------------------------|---------------------------|
| 4.4.3.3 Data  analysis   and  feedback to  prescribers       |                                                                | 4.4.3.3  Proportion  of    primary  healthcare  centers that  receive  annual  report with  feedback  about ABX  prescription | 4.4.3.3   improvemen t of practice  and thus  standard of  care and  proper  application  of AMS in  this sector | 4.4.3.3  Number of    primary  healthcare  centers that  receive  annual  report with  feedback  about ABX  prescription/  Total  number of  primary  Health care  centers *100 | 4.4.3.3   Once/year | 4.4.3.3   primary  healthcare  directorate                                         | 4.4.3.3   Data  collection | 4.4.3.3   Not available   |
| 4.4.3.4  Employ  more   pharmacists  in primary  healthcare  |                                                                | 4.4.3.4  Number of  pharmacists  that are  employed                                                                           | 4.4.3.4   Surveil,  monitor on  the proper  use of  antibiotics in  primary  healthcare                          | 4.4.3.4   Yes/NO                                                                                                                                                                | 4.4.3.4   Once      | 4.4.3.4   Primary  healthcare  directorate/  Pharmaceuti cal Services  Directorate | 4.4.3.4  Checking          | 4.4.3.4   Not available   |
| 4.4.3.5  Improve  manpower  with  professionals  for the AMS | 4.4.3.5.1  Train  available  pharmacists  on AMS and  clinical | 4.4.3.5.1  Number of  pharmacists  in primary  healthcare  who have a                                                         | 4.4.3.5.1   oversee AMS  practices by  qualified  pharmacists                                                    | 4.4.3.5.1   Yes/No                                                                                                                                                              | 4.4.3.5.1   Once    | 4.4.3.5.1   Primary  healthcare  directorate  /Pharmaceut                          | 4.4.3.5.1   Checking       | 4.4.3.5.1   Not available |

|                                                                                                                                                                                 | project in  primary  healthcare                                   | pharmacy  principles                                                                                                                              | certificate in  AMS training                                      |                                                                                                                             |                                                                   |                                                                   | ical Services  Directorate                                                          |                                                                   |                                                                   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------------------------------------------------|
|                                                                                                                                                                                 |                                                                   | 4.4.3.5.2  Employ new   clinical  pharmacist  specialized  in AMS and  1 full time  clinical  microbiologi st in primary  healthcare  directorate | 4.4.3.5.2  Clinical  pharmacists  are  employed,  Yes/No          | 4.4.3.5.2   oversee AMS  practices in  primary  healthcare  by qualified  professionals  (pharmacist  and  microbiologi st) | 4.4.3.5.2  Yes/No                                                 | 4.4.3.5.2   Once                                                  | 4.4.3.5.2  Primary  healthcare  directorate  /Pharmaceut ical Services  Directorate | 4.4.3.5.2   Checking                                              | 4.4.3.5.2  Not available                                          |
| 4.4.4 Update  the   digital  system   that is   available  in primary  healthcare  to integrate   the ABX  guidelines   into the   electronic  system in   the form of  pop-ups |                                                                   |                                                                                                                                                   | 4.4.4   updated  electronic  system  available or  not            | 4.4.4   facilitate  AMS  application  through user  friendly  software                                                      | 4.4.4   Yes/No                                                    | 4.4.4   Once                                                      | 4.4.4  Primary  Heath care  directorate/  /Information  System Dep.                 | 4.4.4   Checking                                                  | 4.4.4   Not available                                             |
| Strategic Objective 4.5 Apply AMS In Public and Private hospitals                                                                                                               | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals                                                                                 | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals                                                           | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals                   | Strategic Objective 4.5 Apply AMS In Public and Private hospitals | Strategic Objective 4.5 Apply AMS In Public and Private hospitals |
| 4.5.1                                                                                                                                                                           | 4.5.1.1                                                           |                                                                                                                                                   | 4.5.1.1                                                           | 4.5.1.1                                                                                                                     | 4.5.1.1  Yes/No                                                   | 4.5.1.1  Once                                                     | 4.5.1.1  MOH                                                                        | 4.5.1.1  Checking                                                 | 4.5.1.1  Not available                                            |

| Improve and  measure  appropriate  use of  antimicrobial  agents in  healthcare                                                                | Nominate  who will be  the AMS   focal person  (Could be  the ABX  pillar focal  person)                                          | AMS focal  person is  nominated                      | oversee AMS  work in  hospitals          |                 |               |              |                   |                        |
|------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------|------------------------------------------|-----------------|---------------|--------------|-------------------|------------------------|
| 4.5.2  Identify the  National  AMS Task  force (Could  be a  subcommitte e of the ABX  pillar Task  force) the  National  AMS  Technical  team | 4.5.2.1  AMS  technical  group is  assigned   (subgroup  from the  ABX  technical  committee.  +other  specialists  like IT, etc) | 4.5.2.1  Task force  members  are  nominated  Yes/No | 4.5.2.1  oversee AMS  work in  hospitals | 4.5.2.1  Yes/No | 4.5.2.1  Once | 4.5.2.1  MOH | 4.5.2.1  Checking | 4.5.2.1  Not available |
|                                                                                                                                                | 4.5.2.2  TOR of the  technical  groups   are well  defined   They  include:  -guidelines  for inpatient  and  outpatient  care.   | 4.5.2.2  TOR put                                     | 4.5.2.2  oversee AMS  work in  hospitals | 4.5.2.2  Yes/No | 4.5.2.2  Once | 4.5.2.2  MOH | 4.5.2.2  Checking | 4.5.2.2  Not available |

|                                                                                                                             | -put or  endorse   diagnostic  pathways,  treatment  and  national  AMS targets                                                                                                          |                                                                                                                                                   |                                              |                                                                   |                   |                 |                                  |                     |                          |
|-----------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------|-------------------------------------------------------------------|-------------------|-----------------|----------------------------------|---------------------|--------------------------|
| 4.5.3  Put national  guidelines  either  de  novo  or  Endorse  existing  international  guidelines  with regular   updates | 4.5.3.1  MOH puts  national  guidelines  for common  community  acquired  infections  (CAI)                                                                                              |                                                                                                                                                   | 4.5.3.1  CAI  guidelines   developed  Yes/No | 4.5.3.1  ensure  proper  prescribing  and use of  antimicrobial s | 4.5.3.1  Yes/No   | 4.5.3.1  Once   | 4.5.3.1  AMS   Task force  Group | 4.5.3.1  Checking   | 4.5.3.1  Not available   |
|                                                                                                                             | Hospitals put  institutional  guidelines  for  treatment of   Healthcare  associated  infections  (HAI)  according to  their local  epidemiolog y, with the  help of  taskforce  members | 4.5.3.2.1  Mandate for  hospitals to  issue HAI  treatment  guidelines  based on  local  epidemiolog y and   with the help  of taskforce  members | 4.5.3.2.1  Mandate  issued   Yes/No          | 4.5.3.2.1  putting HAI  guideline is  obligatory                  | 4.5.3.2.1  Yes/No | 4.5.3.2.1  Once | 4.5.3.2.1  MOH/task  force       | 4.5.3.2.1  Checking | 4.5.3.2.1  Not available |
|                                                                                                                             |                                                                                                                                                                                          | 4.5.3.2.2                                                                                                                                         | 4.5.3.2.2                                    | 4.5.3.2.2                                                         | 4.5.3.2.2         | 4.5.3.2.2       | 4.5.3.2.2                        | 4.5.3.2.2           | 4.5.3.2.2                |

|                                                                                                      | Organize the  work of  taskforce  members  with the  different  hospitals to  assist in  putting their  own   HAI  guidelines       | Proportion  of hospitals  that have  HAI   guidelines  based on  their own  epidemiolog y.   | to see if  hospitals  abide by  developing  institutional  HAI  guidelines           | number of  hospitals  with HAI  guidelines/T otal number  of  hospitals*10 0                    | Once/year            | MOH/  Hospitals            | data  collection            | Partially  available in  some  hospitals            |
|------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|----------------------|----------------------------|-----------------------------|-----------------------------------------------------|
|                                                                                                      | 4.5.3.2.3  HAI  treatment  guidelines  should be  reviewed  every year                                                              | 4.5.3.2.3  Proportion  of hospitals  that have   guidelines   updated                        | 4.5.3.2.3   continuous  follow-up  and  reduction of  inappropriat e antibiotic  use | 4.5.3.2.3  number of  hospitals  with HAI  guidelines  updated/Tot al number of  hospitals*10 0 | 4.5.3.2.3  Once/year | 4.5.3.2.3  MOH/  Hospitals | 4.5.3.2.3  data  collection | 4.5.3.2.3  Partially  available in  some  hospitals |
| 4.5.3.3  Disseminatio n and  implementat ion of these  treatment  guidelines in  hospital  practice. | 4.5.3.3.1  Workshops  for  discussion  and   endorsemen t of these  guidelines  with  practicing  physicians all  over the  country | 4.5.3.3.1  Number of  regions  where  guidelines  workshops  have been  performed            | 4.5.3.3.1  proper  application  of guidelines  recommend ations                      | 4.5.3.3.1  Yes/No                                                                               | 4.5.3.3.1  Once/year | 4.5.3.3.1  MOH             | 4.5.3.3.1  Checking         | 4.5.3.3.1  Not available                            |

| 4.5.3.3.2  Distribution  of  educational  material in  the form of  booklets,  brochures,  posters,  &pocket  cards, or  equivalent  softcopies  available on  mobile  phones   | 4.5.3.3.2  Proportion  of hospitals  that have  the  softcopies  available on  the mobile  phones of  staff   | 4.5.3.3.2  facilitate  disseminatio n and  implementat ion of these  treatment  guidelines in  hospital  practice   | 4.5.3.3.2  Number of  hospitals  that have  the  softcopies  available on  the mobile  phones of  staff/Total  number of  hospitals*10 0   | 4.5.3.3.2  Once/year   | 4.5.3.3.2  MOH/Hospit als   | 4.5.3.3.2  data  collection   | 4.5.3.3.2  not available   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|------------------------|-----------------------------|-------------------------------|----------------------------|
| 4.5.3.3.3  Post the  guidelines  on the MOH  website and  integrate  them into  the intranet  of each  hospital                                                                 | 4.5.3.3.3  Proportion  of hospitals  that have  the  guidelines  posted on  their  intranet                   | 4.5.3.3.3  facilitate  access to  these  treatment  guidelines                                                      | 4.5.3.3.3  Number of  hospitals  that have  the  guidelines  posted on  their  intranet/Tot al number of  hospitals*10 0                   | 4.5.3.3.3  Once/year   | 4.5.3.3.3  MOH/Hospit als   | 4.5.3.3.3  data  collection   | 4.5.3.3.3  not available   |
| 4.5.3.3.4  Integrate   the  guidelines   into the   electronic  medical  record, in                                                                                             | 4.5.3.3.4  Proportion  of hospitals  that have  guidelines  recommend ations  integrated in                   | 4.5.3.3.4  remind  prescribers  on a regular  basis of  recommend ations and  facilitate                            | 4.5.3.3.4  Number of  hospitals  that have  guidelines  recommend ations  integrated in                                                    | 4.5.3.3.4  Once/year   | 4.5.3.3.4  Hospitals        | 4.5.3.3.4  data  collection   | 4.5.3.3.4  Not available   |

|                                                                                              |                                                                                      | the form of  pop-ups                                                                                                                   | the  electronic  medical  records  system                                                                      | implementat ion of AMS  at the  bedside                                                                | the  electronic  medical  records  system  /Total  number of  hospitals*10 0                                                                                 |                                                                                      |                                                                                      |                                                                                      |                                                                                      |
|----------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|
| 4.5.4  Make AMS  programs  mandatory  in each  hospital  (presence of  AMS team/  committee) | 4.5.4.1  Mandate by  MOH for this  issue                                             |                                                                                                                                        | 4.5.4.1  Mandate  issued  Yes/No                                                                               | 4.5.4.1  standardize  the  application  of AMS in  hospitals and  make it  obligatory                  | 4.5.4.1  Yes/No                                                                                                                                              | 4.5.4.1  Once                                                                        | 4.5.4.1  MOH                                                                         | 4.5.4.1  Checking                                                                    | 4.5.4.1  Not available                                                               |
|                                                                                              | 4.5.4.2  Build AMS  manpower                                                         | 4.5.4.2.1  Train  microbiologi sts, clinical  pharmacists  and  Infectious  Disease  specialists  on AMS  through  national  workshops | 4.5.4.2.1  Percent  microbiologi sts and  clinical  pharmacists  that have  attended at  least 1 AMS  workshop | 4.5.4.2.1  build a  strong AMS  workforce  for better  implementat ion of AMS  standards in  hospitals | 4.5.4.2.1  Number of  microbiologi sts and  clinical  pharmacists  that have  attended at  least 1 AMS  workshop/T otal number  of these  professionals *100 | 4.5.4.2.1  Once/year                                                                 | 4.5.4.2.1  Task force                                                                | 4.5.4.2.1  Data  collection                                                          | 4.5.4.2.1  Not available                                                             |
| Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants         | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                                                   | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                           | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                   | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants                                                                         | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants | Strategic Objective 4.6 Quality control of antimicrobials used in animals and plants |
|                                                                                              |                                                                                      |                                                                                                                                        | 4.6 Already  available                                                                                         |                                                                                                        |                                                                                                                                                              |                                                                                      |                                                                                      |                                                                                      |                                                                                      |

## Strategic Objective 4.7 Restrict the use of critically important ABX to human health in the veterinary field

| 4.7.1  Establish the  list of  critically  important  antibiotics  for humans  in the animal  sector.   | 4.7.1  List put  Yes/No   | 4.7.1  limit the use  of critically  important  ABX in the  animal  sector.   | 4.7.1  Yes/No   | 4.7.1  Once   | 4.7.1  ABX task  force   | 4.7.1  Checking   | 4.7.1  Not available   |
|---------------------------------------------------------------------------------------------------------|---------------------------|-------------------------------------------------------------------------------|-----------------|---------------|--------------------------|-------------------|------------------------|
| 4.7.2  Determine  from this list  which  antibiotics  should be  restricted for                         | 4.7.2  List put  Yes/No   | 4.7.2  limit the use  of critically  important  ABX in the  animal  sector.   | 4.7.2  Yes/No   | 4.7.2  Once   | 4.7.2  ABX task  force   | 4.7.2  Checking   | 4.7.2  Not available   |

| use to  humans                                                                                                                                                         |                                                                                                                      |                                                                                                                      |                                                                                                                                               |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                                      |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------|
| 4.7.3  Issue a  decree that  the critically  important  ABX to  human  health are  not to be  used in  animals  whether in  individual  treatment or  in herd  therapy |                                                                                                                      | 4.7.3  Decree  issued   Yes /No                                                                                      | 4.7.3 put a  legal frame  work for  restricting  the use of  critically  important  antibiotics                                               | 4.7.3  Yes/No                                                                                                        | 4.7.3  Once                                                                                                          | 4.7.3  ABX task  force                                                                                               | 4.7.3  Checking                                                                                                      | 4.7.3  Not available                                                                                                 |
| 4.7.4  Prohibit the  importation  of these  critically   important  ABX for   vet use                                                                                  | 4.7.4.1  Decree  that  prohibits the   importation  and sale of  these ABX in  the vet field                         | 4.7.4.1  Decree is  issued   Yes/No                                                                                  | 4.7.4.1 put a  legal  framework  and  reinforce the  prohibition  of  importation  and sale of  critically   important  ABX in the  vet field | 4.7.4.1  Yes/No                                                                                                      | 4.7.4.1  Once                                                                                                        | 4.7.4.1  PAAF                                                                                                        | 4.7.4.1  Checking                                                                                                    | 4.7.4.1  Not available                                                                                               |
| Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture.                                                   | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture.                          | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. | Strategic Objective 4.8 Organize the use of antimicrobial agents in terrestrial and aquatic animals and agriculture. |
| 4.8.1  Put (or  endorse)  guidelines                                                                                                                                   |                                                                                                                      | 4.8.1  Guidelines  are  established                                                                                  | 4.8.1  ensure  proper  antimicrobial                                                                                                          | 4.8.1  Yes/No                                                                                                        | 4.8.1  Once                                                                                                          | 4.8.1  PAAF                                                                                                          | 4.8.1  Checking                                                                                                      | 4.8.1  Not available                                                                                                 |

| regarding  the use of  ABX in  animals and  agriculture                            |                                                                                                              | Yes/No                                                                                      | use in these  fields                                                                     |                                                                                                                            |                    |               |                           |                        |
|------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------|--------------------|---------------|---------------------------|------------------------|
| 4.8.2  Disseminate  these  guidelines  among  veterinarians                        | 4.8.2.1  Booklets/  Brochures/a pp that  summarize  the key  points in  these  guidelines.                   | 4.8.1.1  Proportion  of Vet clinics   that have  easy access  to these  updated  guidelines | 4.8.1.1  facilitate  access and  implementat ion of  guidelines  recommend ations        | 4.8.1.1  Number of  Vet clinics   that have  easy access  to these  updated  guidelines/to tal number  of vet  clinics*100 | 4.8.1.1  Once/year | 4.8.1.1  PAAF | 4.8.1.1  data  collection | 4.8.1.1  not available |
|                                                                                    | 4.8.2.1  Regular  workshops  for  veterinary  specialists  regarding  the  application  of these  guidelines | 4.8.2.1  proportion  of veterinary  specialists  attending  these  workshops                | 4.8.2.1  proper  implementat ion of these  guidelines                                    | 4.8.2.1  NUMBER of  veterinary  specialists  attending  these  workshops/t otal number  of  specialists*1 00               | 4.8.2.1  Once/year | 4.8.2.1  PAAF | 4.8.2.1  data  collection | 4.8.2.1  Not available |
| 4.8.3  Restrict  selling ABX  for animal  and  agriculture  health to  exclusively | 4.8.3.1  Decree that  vet  pharmacies  should  dispense  ABX only  according to  vet                         | 4.8.3.1  Decree is  issued   Yes/No                                                         | 4.8.3.1 put a  legal  framework  for  restricting  sale of  antibiotics in  these fields | 4.8.3.1  Yes/No                                                                                                            | 4.8.3.1  Once      | 4.8.3.1  PAAF | 4.8.3.1  Checking         | 4.8.3.1  Not available |

| prescriptions  by vets                                                                                        | prescriptions , and should  submit these  prescriptions  with the  evidence of  selling to  PAAF.               |                                                                                   |                                                                                                              |                                                                                              |                                                                                   |                                                                                   |                                                                                   |                                                                                   |
|---------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|
| 4.8.4  Control the  use of ABX in  animals                                                                    | 4.8.4.1.  Detection of  the ABX  residues in  milk, meat,  poultry and  eggs                                    | 4.8.4.1.  Already  available                                                      | 4.8.4.1. Abx  use in food is  controlled                                                                     |                                                                                              |                                                                                   |                                                                                   |                                                                                   |                                                                                   |
| Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR                             | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR                               | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR                            | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR            | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR | Strategic Objective 4.9 Capacity building among vets in antimicrobial use and AMR |
| 4.9.1 Provide  training  courses for  vets for ABX  use   according to  guidelines  and provide  certificate. |                                                                                                                 | 4.9.1  Proportion  of vets that  have a yearly  certificate                       | 4.9.1   make sure  that vets  properly  prescribe  and dispense  antimicrobial s                             | 4.9.1   number of  vets who  attend the  certification  training/tota l number of  vets *100 | 4.9.1   once/year                                                                 | 4.9.1   PAAF                                                                      | 4.9.1  data  collection                                                           | 4.9.1   Not available                                                             |
| 4.9.2 Study   baseline  consumption  imported  antibiotics in  this field                                     | Pharmaceuti cal Dep in  PAAF  Committee   that will  study and  document  this  consumption  and compare  it to | 4.9.2.1   Report  issued   Yes/No                                                 | 4.9.2.1 see  how much  vets are  abiding to  guidelines  and to be  able to  compare to  international  data | 4.9.2.1   Yes/No                                                                             | 4.9.2.1   Once                                                                    | 4.9.2.1  PAAF                                                                     | 4.9.2.1   Checking                                                                | 4.9.2.1   Not available                                                           |

## Kuwait national action plan on antimicrobial resistance 2022

international benchmark

Kuwait national action plan on antimicrobial resistance 2022